-
Notifications
You must be signed in to change notification settings - Fork 0
/
Copy pathL1021-DiscoveryProbe-FDA-approved-Drug-Library_Updated.csv
We can't make this file beautiful and searchable because it's too large.
2330 lines (2326 loc) · 712 KB
/
L1021-DiscoveryProbe-FDA-approved-Drug-Library_Updated.csv
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
61
62
63
64
65
66
67
68
69
70
71
72
73
74
75
76
77
78
79
80
81
82
83
84
85
86
87
88
89
90
91
92
93
94
95
96
97
98
99
100
101
102
103
104
105
106
107
108
109
110
111
112
113
114
115
116
117
118
119
120
121
122
123
124
125
126
127
128
129
130
131
132
133
134
135
136
137
138
139
140
141
142
143
144
145
146
147
148
149
150
151
152
153
154
155
156
157
158
159
160
161
162
163
164
165
166
167
168
169
170
171
172
173
174
175
176
177
178
179
180
181
182
183
184
185
186
187
188
189
190
191
192
193
194
195
196
197
198
199
200
201
202
203
204
205
206
207
208
209
210
211
212
213
214
215
216
217
218
219
220
221
222
223
224
225
226
227
228
229
230
231
232
233
234
235
236
237
238
239
240
241
242
243
244
245
246
247
248
249
250
251
252
253
254
255
256
257
258
259
260
261
262
263
264
265
266
267
268
269
270
271
272
273
274
275
276
277
278
279
280
281
282
283
284
285
286
287
288
289
290
291
292
293
294
295
296
297
298
299
300
301
302
303
304
305
306
307
308
309
310
311
312
313
314
315
316
317
318
319
320
321
322
323
324
325
326
327
328
329
330
331
332
333
334
335
336
337
338
339
340
341
342
343
344
345
346
347
348
349
350
351
352
353
354
355
356
357
358
359
360
361
362
363
364
365
366
367
368
369
370
371
372
373
374
375
376
377
378
379
380
381
382
383
384
385
386
387
388
389
390
391
392
393
394
395
396
397
398
399
400
401
402
403
404
405
406
407
408
409
410
411
412
413
414
415
416
417
418
419
420
421
422
423
424
425
426
427
428
429
430
431
432
433
434
435
436
437
438
439
440
441
442
443
444
445
446
447
448
449
450
451
452
453
454
455
456
457
458
459
460
461
462
463
464
465
466
467
468
469
470
471
472
473
474
475
476
477
478
479
480
481
482
483
484
485
486
487
488
489
490
491
492
493
494
495
496
497
498
499
500
501
502
503
504
505
506
507
508
509
510
511
512
513
514
515
516
517
518
519
520
521
522
523
524
525
526
527
528
529
530
531
532
533
534
535
536
537
538
539
540
541
542
543
544
545
546
547
548
549
550
551
552
553
554
555
556
557
558
559
560
561
562
563
564
565
566
567
568
569
570
571
572
573
574
575
576
577
578
579
580
581
582
583
584
585
586
587
588
589
590
591
592
593
594
595
596
597
598
599
600
601
602
603
604
605
606
607
608
609
610
611
612
613
614
615
616
617
618
619
620
621
622
623
624
625
626
627
628
629
630
631
632
633
634
635
636
637
638
639
640
641
642
643
644
645
646
647
648
649
650
651
652
653
654
655
656
657
658
659
660
661
662
663
664
665
666
667
668
669
670
671
672
673
674
675
676
677
678
679
680
681
682
683
684
685
686
687
688
689
690
691
692
693
694
695
696
697
698
699
700
701
702
703
704
705
706
707
708
709
710
711
712
713
714
715
716
717
718
719
720
721
722
723
724
725
726
727
728
729
730
731
732
733
734
735
736
737
738
739
740
741
742
743
744
745
746
747
748
749
750
751
752
753
754
755
756
757
758
759
760
761
762
763
764
765
766
767
768
769
770
771
772
773
774
775
776
777
778
779
780
781
782
783
784
785
786
787
788
789
790
791
792
793
794
795
796
797
798
799
800
801
802
803
804
805
806
807
808
809
810
811
812
813
814
815
816
817
818
819
820
821
822
823
824
825
826
827
828
829
830
831
832
833
834
835
836
837
838
839
840
841
842
843
844
845
846
847
848
849
850
851
852
853
854
855
856
857
858
859
860
861
862
863
864
865
866
867
868
869
870
871
872
873
874
875
876
877
878
879
880
881
882
883
884
885
886
887
888
889
890
891
892
893
894
895
896
897
898
899
900
901
902
903
904
905
906
907
908
909
910
911
912
913
914
915
916
917
918
919
920
921
922
923
924
925
926
927
928
929
930
931
932
933
934
935
936
937
938
939
940
941
942
943
944
945
946
947
948
949
950
951
952
953
954
955
956
957
958
959
960
961
962
963
964
965
966
967
968
969
970
971
972
973
974
975
976
977
978
979
980
981
982
983
984
985
986
987
988
989
990
991
992
993
994
995
996
997
998
999
1000
,CatalogNumber,Item Name,CAS Number,Plate Location,Rack Number,M.w.,Solvent ,Formula,SMILES,Solubility,Form,Pathway,Target,Information,URL,SMILES_check
0,A1042,Angiotensin II,4474-91-3,A01,L1021-01,1046.2,H2O,C50H71N13O12,CCC(C)C(C(=O)NC(CC1=CN=CN1)C(=O)N2CCCC2C(=O)NC(CC3=CC=CC=C3)C(=O)O)NC(=O)C(CC4=CC=C(C=C4)O)NC(=O)C(C(C)C)NC(=O)C(CCCN=C(N)N)NC(=O)C(CC(=O)O)N.CC(=O)O,insoluble in DMSO; insoluble in EtOH; ≥100.2 mg/mL in H2O ,,Cardiovascular,Angiotensin Receptor,,https://www.apexbt.com/search.php?catalog=A1042,1
1,A1198,Levetiracetam,102767-28-2,A02,L1021-01,170.21,DMSO,C8H14N2O2,CCC(C(=O)N)N1CCCC1=O,≥25.4 mg/mL in H2O; ≥27.4 mg/mL in EtOH; ≥8.51 mg/mL in DMSO ,Free Base,Membrane Transporter/Ion Channel,Calcium Channel,Antiepileptic drug,https://www.apexbt.com/search.php?catalog=A1198,1
2,A1206,Daptomycin,103060-53-3,A03,L1021-01,1620.67,DMSO,C72H101N17O26,CCCCCCCCCC(=O)NC(CC1=CNC2=CC=CC=C21)C(=O)NC(CC(=O)N)C(=O)NC(CC(=O)O)C(=O)NC3C(OC(=O)C(NC(=O)C(NC(=O)C(NC(=O)CNC(=O)C(NC(=O)C(NC(=O)C(NC(=O)C(NC(=O)CNC3=O)CCCN)CC(=O)O)C)CC(=O)O)CO)C(C)CC(=O)O)CC(=O)C4=CC=CC=C4N)C,≥81.03 mg/mL in H2O; ≥81.05 mg/mL in DMSO; insoluble in EtOH,Free Base,DNA Damage/DNA Repair,DNA Synthesis,Calcium-dependent antibiotic,https://www.apexbt.com/search.php?catalog=A1206,1
3,A1229,Lansoprazole,103577-45-3,A04,L1021-01,369.36,DMSO,C16H14F3N3O2S,CC1=C(C=CN=C1CS(=O)C2=NC3=CC=CC=C3N2)OCC(F)(F)F,insoluble in H2O; ≥10.32 mg/mL in EtOH with ultrasonic; ≥18.47 mg/mL in DMSO ,Free Base,Membrane Transporter/Ion Channel,Proton Pump,"H+,K+-ATPase inhibitor",https://www.apexbt.com/search.php?catalog=A1229,1
4,A1267,Adapalene,106685-40-9,A05,L1021-01,412.52,DMSO,C28H28O3,COC1=C(C=C(C=C1)C2=CC3=C(C=C2)C=C(C=C3)C(=O)O)C45CC6CC(C4)CC(C6)C5,insoluble in H2O; insoluble in EtOH; ≥10.31 mg/mL in DMSO ,Free Base,Others,Others,RARβ and RARγ agonist,https://www.apexbt.com/search.php?catalog=A1267,1
5,A1295,Granisetron HCl,107007-99-8,A06,L1021-01,348.87,H2O,C18H24N4O·HCl,CN1C2CCCC1CC(C2)NC(=O)C3=NN(C4=CC=CC=C43)C.Cl,insoluble in DMSO; ≥17.44 mg/mL in H2O; ≥17.44 mg/mL in DMSO with gentle warming,Hydrochloride,Neuroscience,5-HT Receptor,5-HT3 receptor antagonist,https://www.apexbt.com/search.php?catalog=A1295,1
6,A1296,Exemestane,107868-30-4,A07,L1021-01,296.4,DMSO,C20H24O2,CC12CCC3C(C1CCC2=O)CC(=C)C4=CC(=O)C=CC34C,insoluble in H2O; ≥14.82 mg/mL in DMSO; ≥15.23 mg/mL in EtOH ,Free Base,Endocrinology and Hormones,Aromatase,"Steroidal aromatase inhibitor,selective and irreversible",https://www.apexbt.com/search.php?catalog=A1296,1
7,A1307,Letrozole,112809-51-5,A08,L1021-01,285.3,DMSO,C17H11N5,N#CC1=CC=C(C(N2N=CN=C2)C3=CC=C(C#N)C=C3)C=C1,insoluble in EtOH;insoluble in H2O;≥14.265 mg/mL in DMSO ,Free Base,Endocrinology and Hormones,Aromatase,Non-steroidal aromatase inhibitor,https://www.apexbt.com/search.php?catalog=A1307,1
8,A1313,Gatifloxacin,112811-59-3,A09,L1021-01,375.39,DMSO,C19H22FN3O4,CC1CN(CCN1)C2=C(C=C3C(=C2OC)N(C=C(C3=O)C(=O)O)C4CC4)F,insoluble in EtOH; insoluble in H2O; ≥3.75 mg/mL in DMSO with gentle warming,Free Base,DNA Damage/DNA Repair,Topoisomerase,"Fluoroquinolone antibiotic,inhibits bacterial TOPO II",https://www.apexbt.com/search.php?catalog=A1313,1
9,A1334,Mosapride Citrate,112885-42-4,A10,L1021-01,614.02,DMSO,C21H25ClFN3O3·C6H8O7,CCOC1=CC(=C(C=C1C(=O)NCC2CN(CCO2)CC3=CC=C(C=C3)F)Cl)N.C(C(=O)O)C(CC(=O)O)(C(=O)O)O,≥30.7 mg/mL in DMSO; insoluble in H2O; insoluble in EtOH,Citrate,Neuroscience,5-HT Receptor,5-HT receptor agonist,https://www.apexbt.com/search.php?catalog=A1334,1
10,A1366,Rocuronium Bromide,119302-91-9,A11,L1021-01,609.68,DMSO,C32H53N2O4·Br,CC(=O)OC1C(CC2C1(CCC3C2CCC4C3(CC(C(C4)O)N5CCOCC5)C)C)[N+]6(CCCC6)CC=C.[Br-],≥30.48 mg/mL in DMSO; ≥40.6 mg/mL in H2O; ≥58.4 mg/mL in EtOH ,Bromide,Neuroscience,AChR,TGF-βR I kinase inhibitor,https://www.apexbt.com/search.php?catalog=A1366,1
11,A1373,Biapenem,120410-24-4,B01,L1021-01,350.39,H2O,C15H18N4O4S,CC1C2C(C(=O)N2C(=C1SC3CN4C=NC=[N+]4C3)C(=O)[O-])C(C)O,≥18.65 mg/mL in H2O with gentle warming; insoluble in DMSO; insoluble in EtOH,,Microbiology & Virology,Antibiotic,Highly broad spectrum antibiotic agent,https://www.apexbt.com/search.php?catalog=A1373,1
12,A1379,Nelarabine,121032-29-9,B02,L1021-01,297.27,DMSO,C11H15N5O5,COC1=NC(=NC2=C1N=CN2C3C(C(C(O3)CO)O)O)N,insoluble in EtOH; ≥14.85 mg/mL in DMSO; ≥2.77 mg/mL in H2O with gentle warming and ultrasonic,Free Base,DNA Damage/DNA Repair,DNA Synthesis,Prodrug of ara-G for T-LBL/T-ALL,https://www.apexbt.com/search.php?catalog=A1379,1
13,A1402,Gemcitabine HCl,122111-03-9,B03,L1021-01,299.66,DMSO,C9H11F2N3O4·HCI,C1=CN(C(=O)N=C1N)C2C(C(C(O2)CO)O)(F)F.Cl,≥10.1 mg/mL in H2O with ultrasonic; ≥2.64 mg/mL in EtOH with gentle warming and ultrasonic; ≥7.49 mg/mL in H2O ,Hydrochloride,DNA Damage/DNA Repair,DNA Synthesis,"Inhibits DNA synthesis,deoxycytidine analog",https://www.apexbt.com/search.php?catalog=A1402,0
14,A1404,Rigosertib sodium salt,1225497-78-8,B04,L1021-01,473.47,DMSO,C21H24NNaO8S,COC1=C(C=C(C=C1)CS(=O)(=O)C=CC2=C(C=C(C=C2OC)OC)OC)NCC(=O)[O-].[Na+],≥23.65 mg/mL in DMSO; insoluble in EtOH; ≥52.3 mg/mL in H2O ,Sodium Salt,Cell Cycle/Checkpoint,PLK,Plk1 inhibitor,https://www.apexbt.com/search.php?catalog=A1404,1
15,A1412,Clofarabine,123318-82-1,B05,L1021-01,303.68,DMSO,C10H11ClFN5O3,C1=NC2=C(N1C3C(C(C(O3)CO)O)F)N=C(N=C2N)Cl,insoluble in H2O; insoluble in EtOH; ≥15.18 mg/mL in DMSO ,Free Base,DNA Damage/DNA Repair,DNA Synthesis,"Antimetabolite,inhibit DNA polymerase and ribonucleotide reductase",https://www.apexbt.com/search.php?catalog=A1412,1
16,A1425,Losartan Potassium (DuP 753),124750-99-8,B06,L1021-01,461,DMSO,C22H22ClKN6O,ClC1=C(CO)N(C(CCCC)=N1)CC(C=C2)=CC=C2C3=CC=CC=C3C4=N[N-]N=N4.[K+],≥21.35 mg/mL in DMSO; ≥42.9 mg/mL in H2O; ≥47.7 mg/mL in EtOH ,Potassium,Endocrinology and Hormones,RAAS,Angiotensin AT1 receptor antagonist,https://www.apexbt.com/search.php?catalog=A1425,1
17,A1428,"Fulvestrant (ICI 182,780)",129453-61-8,B07,L1021-01,606.77,DMSO,C32H47F5O3S,CC12CCC3C(C1CCC2O)C(CC4=C3C=CC(=C4)O)CCCCCCCCCS(=O)CCCC(C(F)(F)F)(F)F,≥30.35 mg/mL in DMSO; insoluble in H2O; ≥58.9 mg/mL in EtOH ,Free Base,Endocrinology and Hormones,Estrogen/progestogen Receptor,"Estrogen receptor antagonist,high affinity",https://www.apexbt.com/search.php?catalog=A1428,1
18,A1435,CP-945598 HCl,686347-12-6,B08,L1021-01,546.88,DMSO,C25H25Cl2N7O·HCl,CCNC1(CCN(CC1)C2=NC=NC3=C2N=C(N3C4=CC=C(C=C4)Cl)C5=CC=CC=C5Cl)C(=O)N.Cl,≥27.35 mg/mL in DMSO with gentle warming; insoluble in H2O; insoluble in EtOH,,GPCR/G protein,Cannabinoid Receptor,"CB1 antagonist,selective and high affinity",https://www.apexbt.com/search.php?catalog=A1435,1
19,A1447,Cilnidipine,132203-70-4,B09,L1021-01,492.52,DMSO,C27H28N2O7,CC1=C(C(C(=C(N1)C)C(=O)OCC=CC2=CC=CC=C2)C3=CC(=CC=C3)[N+](=O)[O-])C(=O)OCCOC,≥24.63 mg/mL in DMSO; insoluble in H2O; ≥6.1 mg/mL in EtOH with ultrasonic,Free Base,Membrane Transporter/Ion Channel,Calcium Channel,Blocker of Dual L- and N-type calcium channel,https://www.apexbt.com/search.php?catalog=A1447,1
20,A1450,Lidocaine,137-58-6,B10,L1021-01,234.34,DMSO,C14H22N2O,CCN(CC)CC(=O)NC1=C(C=CC=C1C)C,insoluble in H2O; ≥11.72 mg/mL in DMSO; ≥227.27 mg/mL in EtOH ,Free Base,Neuroscience,Histamine Receptor,Anasthetic and class Ib antiarrhythmic agent,https://www.apexbt.com/search.php?catalog=A1450,1
21,A1602,"Dexrazoxane HCl (ICRF-187, ADR-529)",149003-01-0,B11,L1021-01,304.73,DMSO,C11H16N4O4·HCl,CC(CN1CC(=O)NC(=O)C1)N2CC(=O)NC(=O)C2.Cl,insoluble in EtOH; ≥15.24 mg/mL in DMSO; ≥16 mg/mL in H2O ,Hydrochloride,DNA Damage/DNA Repair,Topoisomerase,"Topoisomerase II inhibitor,intracellular ion chelator,cardioprotective agent",https://www.apexbt.com/search.php?catalog=A1602,1
22,A1607,Prasugrel,150322-43-3,C01,L1021-01,373.44,DMSO,C20H20FNO3S,CC(=O)OC1=CC2=C(S1)CCN(C2)C(C3=CC=CC=C3F)C(=O)C4CC4,insoluble in H2O; insoluble in EtOH; ≥6.22 mg/mL in DMSO ,Free Base,Neuroscience,P2 Receptor,ADP receptor inhibitor,https://www.apexbt.com/search.php?catalog=A1607,1
23,A1630,"Epothilone B (EPO906, Patupilone)",152044-54-7,C02,L1021-01,507.68,DMSO,C27H41NO6S,CC1CCCC2(C(O2)CC(OC(=O)CC(C(C(=O)C(C1O)C)(C)C)O)C(=CC3=CSC(=N3)C)C)C,≥25.4 mg/mL in DMSO; insoluble in H2O; ≥12.44 mg/mL in EtOH ,Free Base,Cell Cycle/Checkpoint,Microtubule/Tubulin,Microtubule stabilizing macrolide,https://www.apexbt.com/search.php?catalog=A1630,1
24,A1652,Dimesna,16208-51-8,C03,L1021-01,326.34,DMSO,C4H8Na2O6S4,C(CS(=O)(=O)[O-])SSCCS(=O)(=O)[O-].[Na+].[Na+],insoluble in EtOH; ≥16.35 mg/mL in DMSO; ≥58.6 mg/mL in H2O ,,Others,Others,Uroprotective agent,https://www.apexbt.com/search.php?catalog=A1652,1
25,A1659,Dutasteride,164656-23-9,C04,L1021-01,528.53,DMSO,C27H30F6N2O2,CC12CCC3C(C1CCC2C(=O)NC4=C(C=CC(=C4)C(F)(F)F)C(F)(F)F)CCC5C3(C=CC(=O)N5)C,≥26.43 mg/mL in DMSO; insoluble in EtOH; ≥13.75 mg/mL in H2O with ultrasonic,Free Base,Endocrinology and Hormones,5-alpha Reductase,5-alpha-reductase inhibitor,https://www.apexbt.com/search.php?catalog=A1659,1
26,A1664,Celecoxib,169590-42-5,C05,L1021-01,381.37,DMSO,C17H14F3N3O2S,CC1=CC=C(C=C1)C2=CC(=NN2C3=CC=C(C=C3)S(=O)(=O)N)C(F)(F)F,insoluble in H2O; ≥16.8 mg/mL in EtOH; ≥19.07 mg/mL in DMSO ,Free Base,Neuroscience,COX,Selective cyclooxygenase-2 (COX-2) inhibitor,https://www.apexbt.com/search.php?catalog=A1664,1
27,A1670,Enzastaurin (LY317615),170364-57-5,C06,L1021-01,515.61,DMSO,C32H29N5O2,CN1C=C(C2=CC=CC=C21)C3=C(C(=O)NC3=O)C4=CN(C5=CC=CC=C54)C6CCN(CC6)CC7=CC=CC=N7,insoluble in EtOH; insoluble in H2O; ≥8.59 mg/mL in DMSO ,Free Base,TGF-β / Smad Signaling,PKC,"PKC beta inhibitor,potent and selective",https://www.apexbt.com/search.php?catalog=A1670,1
28,A1684,Aprepitant,170729-80-3,C07,L1021-01,534.43,DMSO,C23H21F7N4O3,CC(C1=CC(=CC(=C1)C(F)(F)F)C(F)(F)F)OC2C(N(CCO2)CC3=NC(=O)NN3)C4=CC=C(C=C4)F,≥26.72 mg/mL in DMSO; insoluble in H2O; insoluble in EtOH,Free Base,Neuroscience,Substance P/NK1 Receptor,Substance P (SP) inhibitor,https://www.apexbt.com/search.php?catalog=A1684,1
29,A1718,Posaconazole,171228-49-2,C08,L1021-01,700.78,DMSO,C37H42F2N8O4,CCC(C(C)O)N1C(=O)N(C=N1)C2=CC=C(C=C2)N3CCN(CC3)C4=CC=C(C=C4)OCC5CC(OC5)(CN6C=NC=N6)C7=C(C=C(C=C7)F)F,≥35.04 mg/mL in DMSO; insoluble in H2O; ≥2.55 mg/mL in EtOH with ultrasonic,Free Base,Metabolism,C14ɑ demethylase,Sterol C14ɑ demethylase inhibitor,https://www.apexbt.com/search.php?catalog=A1718,1
30,A1720,"Duvelisib (IPI-145, INK1197)",1201438-56-3,C09,L1021-01,416.86,DMSO,C22H17ClN6O,CC(C1=CC2=C(C(=CC=C2)Cl)C(=O)N1C3=CC=CC=C3)NC4=NC=NC5=C4NC=N5,≥20.84 mg/mL in DMSO; insoluble in H2O; ≥24.9 mg/mL in EtOH ,Free Base,PI3K/Akt/mTOR Signaling,PI3K,PI3K-δ/PI3K-γ inhibitor,https://www.apexbt.com/search.php?catalog=A1720,0
31,A1723,"Roscovitine (Seliciclib,CYC202)",186692-46-6,C10,L1021-01,354.45,DMSO,C19H26N6O,CCC(CO)NC1=NC2=C(C(=N1)NCC3=CC=CC=C3)N=CN2C(C)C,insoluble in H2O; ≥17.72 mg/mL in DMSO; ≥53.5 mg/mL in EtOH ,Free Base,Cell Cycle/Checkpoint,Cyclin-Dependent Kinases,"CDK inhibitor,potent and selective",https://www.apexbt.com/search.php?catalog=A1723,1
32,A1736,PA-824,187235-37-6,C11,L1021-01,359.26,DMSO,C14H12F3N3O5,C1C(COC2=NC(=CN21)[N+](=O)[O-])OCC3=CC=C(C=C3)OC(F)(F)F,insoluble in EtOH; insoluble in H2O; ≥17.85 mg/mL in DMSO ,,Others,Others,,https://www.apexbt.com/search.php?catalog=A1736,1
33,A1745,Galanthamine HBr,1953-04-4,D01,L1021-01,368.27,DMSO,C17H21NO3·HBr,COC1=CC=C2C3=C1O[C@]4([H])[C@]3(C=C[C@H](O)C4)CCN(C)C2.Br,insoluble in ETOH; ≥36.9 mg/mL in H2O with gentle warming and ultrasonic; ≥4.60 mg/mL in DMSO ,Hydrobromide,Neuroscience,AChR,Acetylcholinesterase inhibitor,https://www.apexbt.com/search.php?catalog=A1745,0
34,A1748,Ramelteon,196597-26-9,D02,L1021-01,259.34,DMSO,C16H21NO2,CCC(=O)NCCC1CCC2=C1C3=C(C=C2)OCC3,insoluble in H2O; ≥12.95 mg/mL in DMSO; ≥54.9 mg/mL in EtOH ,Free Base,GPCR/G protein,MT Receptor,"Agonist of melatonin receptor(M1-M2),highly selective",https://www.apexbt.com/search.php?catalog=A1748,1
35,A1755,Tenofovir Disoproxil Fumarate,202138-50-9,D03,L1021-01,635.51,DMSO,C19H30N5O10P·C4H4O4,CC(C)OC(=O)OCOP(=O)(COC(C)CN1C=NC2=C1N=CN=C2N)OCOC(=O)OC(C)C.C(=CC(=O)O)C(=O)O,≥31.78 mg/mL in DMSO; ≥2.615 mg/mL in H2O with gentle warming and ultrasonic; ≥8.48 mg/mL in EtOH with ultrasonic,Fumarate,Microbiology & Virology,Reverse Transcriptase,Antiretroviral agent( HIV-1 RT inhibitor),https://www.apexbt.com/search.php?catalog=A1755,1
36,A1765,Vincristine sulfate,2068-78-2,D04,L1021-01,923.04,DMSO,C46H58N4O14S,CCC1(CC2CC(C3=C(CCN(C2)C1)C4=CC=CC=C4N3)(C5=C(C=C6C(=C5)C78CCN9C7C(C=CC9)(C(C(C8N6C=O)(C(=O)OC)O)OC(=O)C)CC)OC)C(=O)OC)O.OS(=O)(=O)O,≥46.15 mg/mL in DMSO; ≥57 mg/mL in EtOH; ≥58.5 mg/mL in H2O ,Sulfate,Cell Cycle/Checkpoint,Microtubule/Tubulin,"Microtubule disrupter,antitumor agent",https://www.apexbt.com/search.php?catalog=A1765,0
37,A1767,Entecavir Hydrate,209216-23-9,D05,L1021-01,295.29,DMSO,C12H15N5O3·H2O,C=C1C(CC(C1CO)O)N2C=NC3=C2NC(=NC3=O)N.O,insoluble in EtOH; insoluble in H2O; ≥9.7 mg/mL in DMSO ,Hydrate,Microbiology & Virology,Reverse Transcriptase,Antiviral drug used in hepatitis B infection,https://www.apexbt.com/search.php?catalog=A1767,1
38,A1778,Vatalanib (PTK787) 2HCl,212141-51-0,D06,L1021-01,419.73,DMSO,C20H15ClN4·2HCl,C1=CC=C2C(=C1)C(=NN=C2NC3=CC=C(C=C3)Cl)CC4=CC=NC=C4.Cl.Cl,≥21 mg/mL in DMSO; ≥24.5 mg/mL in H2O; ≥3.41 mg/mL in EtOH with ultrasonic,Dihydrochloride,Tyrosine Kinase,VEGFR,Tyrosine kinase receptor inhibitor,https://www.apexbt.com/search.php?catalog=A1778,1
39,A1794,LY2835219,1231930-82-7,D07,L1021-01,602.7,DMSO,C27H32F2N8·CH4O3S,CCN1CCN(CC1)CC2=CN=C(C=C2)NC3=NC=C(C(=N3)C4=CC5=C(C(=C4)F)N=C(N5C(C)C)C)F.CS(=O)(=O)O,≥30.15 mg/mL in DMSO; ≥55.2 mg/mL in H2O; ≥6.61 mg/mL in EtOH with ultrasonic,Mesylate,Cell Cycle/Checkpoint,Cyclin-Dependent Kinases,"CDK4/6 inhibitor,potent and selective",https://www.apexbt.com/search.php?catalog=A1794,1
40,A1796,Mianserin HCl,21535-47-7,D08,L1021-01,300.83,DMSO,C18H20N2·HCl,CN1CC2C3=C(C=CC=C3)CC4=C(C=CC=C4)N2CC1.Cl,≥15.04 mg/mL in DMSO; ≥2.71 mg/mL in H2O with gentle warming and ultrasonic; ≥8.23 mg/mL in EtOH with ultrasonic,Hydrochloride,Neuroscience,Histamine Receptor,5-HT2 receptor antagonist,https://www.apexbt.com/search.php?catalog=A1796,1
41,A1805,Imatinib Mesylate (STI571),220127-57-1,D09,L1021-01,589.71,DMSO,C29H31N7O·CH4SO3,CC1=C(C=C(C=C1)NC(=O)C2=CC=C(C=C2)CN3CCN(CC3)C)NC4=NC=CC(=N4)C5=CN=CC=C5.CS(=O)(=O)O,≥29.5 mg/mL in DMSO; ≥2.84 mg/mL in EtOH with gentle warming and ultrasonic; ≥49.9 mg/mL in H2O ,Mesylate,TGF-β / Smad Signaling,Bcr-Abl,Abl/c-kit/PDGFR inhibitor,https://www.apexbt.com/search.php?catalog=A1805,1
42,A1832,Doxorubicin (Adriamycin) HCl,25316-40-9,D10,L1021-01,579.98,DMSO,C27H29NO11·HCl,CC1C(C(CC(O1)OC2CC(CC3=C(C4=C(C(=C23)O)C(=O)C5=C(C4=O)C=CC=C5OC)O)(C(=O)CO)O)N)O.Cl,≥29 mg/mL in DMSO; ≥57.2 mg/mL in H2O; insoluble in EtOH,Hydrochloride,DNA Damage/DNA Repair,Topoisomerase,"Antitumour antibiotic,inhibits TOPO II.",https://www.apexbt.com/search.php?catalog=A1832,1
43,A1835,Pelitinib (EKB-569),257933-82-7,D11,L1021-01,467.92,DMSO,C24H23ClFN5O2,CCOC1=C(C=C2C(=C1)N=CC(=C2NC3=CC(=C(C=C3)F)Cl)C#N)NC(=O)C=CCN(C)C,insoluble in EtOH; insoluble in H2O; ≥11.7 mg/mL in DMSO ,Free Base,JAK/STAT Signaling,EGFR,"EGFR inhibitor,potent and irreversible",https://www.apexbt.com/search.php?catalog=A1835,1
44,A1855,Bumetanide,28395-03-1,E01,L1021-01,364.42,DMSO,C17H20N2O5S,CCCCNC1=C(C(=CC(=C1)C(=O)O)S(=O)(=O)N)OC2=CC=CC=C2,insoluble in H2O; ≥18.22 mg/mL in DMSO; ≥4.04 mg/mL in EtOH ,Free Base,Membrane Transporter/Ion Channel,NKCC,NKCC cotransporter inhibitor,https://www.apexbt.com/search.php?catalog=A1855,1
45,A1882,Cediranib (AZD217),288383-20-0,E02,L1021-01,450.51,DMSO,C25H27FN4O3,CC1=CC2=C(N1)C=CC(=C2F)OC3=NC=NC4=CC(=C(C=C43)OC)OCCCN5CCCC5,≥22.52 mg/mL in DMSO; insoluble in H2O; insoluble in EtOH,Free Base,Tyrosine Kinase,VEGFR,"VEGFR inhibitor receptor,highly potent",https://www.apexbt.com/search.php?catalog=A1882,1
46,A1903,E 64d,88321-09-9,E03,L1021-01,342.43,DMSO,C17H30N2O5,CCOC(=O)C1C(O1)C(=O)NC(CC(C)C)C(=O)NCCC(C)C,insoluble in H2O; ≥17.12 mg/mL in DMSO; ≥18.5 mg/mL in EtOH ,Free Base,Proteases,Cathepsin,Cysteine protease inhibitor,https://www.apexbt.com/search.php?catalog=A1903,1
47,A1906,"Decitabine (NSC127716, 5AZA-CdR)",2353-33-5,E04,L1021-01,228.08,DMSO,C8H12N4O4,C1C(C(OC1N2C=NC(=NC2=O)N)CO)O,insoluble in EtOH; ≥11.4 mg/mL in DMSO; ≥23.3 mg/mL in H2O with gentle warming,Free Base,Chromatin/Epigenetics,DNA Methyltransferase,Deoxycytidine analog and cellular diifferentiation inducer,https://www.apexbt.com/search.php?catalog=A1906,1
48,A1907,5-Azacytidine,320-67-2,E05,L1021-01,244.2,DMSO,C8H12N4O5,C1=NC(=NC(=O)N1C2C(C(C(O2)CO)O)O)N,insoluble in EtOH; ≥12.21 mg/mL in DMSO; ≥13.55 mg/mL in H2O with ultrasonic,Free Base,Chromatin/Epigenetics,DNA Methyltransferase,DNA methyltransferase inhibitor.,https://www.apexbt.com/search.php?catalog=A1907,1
49,A1929,Macitentan,441798-33-0,E06,L1021-01,588.27,DMSO,C19H20Br2N6O4S,CCCNS(=O)(=O)NC1=C(C(=NC=N1)OCCOC2=NC=C(C=N2)Br)C3=CC=C(C=C3)Br,≥24.4 mg/mL in DMSO; insoluble in H2O; insoluble in EtOH,Free Base,GPCR/G protein,Endothelin Receptor,Endothelin (ET)(A) and ET(B) receptor antagonist,https://www.apexbt.com/search.php?catalog=A1929,1
50,A1932,(-)-Huperzine A,102518-79-6,E07,L1021-01,242.3,DMSO,C15H18N2O,CC=C1C2CC3=C(C1(CC(=C2)C)N)C=CC(=O)N3,insoluble in H2O; ≥12.12 mg/mL in DMSO; ≥23.13 mg/mL in EtOH ,,Neuroscience,Alzheimer,NMDA receptor antagonist/AChE inhibitor,https://www.apexbt.com/search.php?catalog=A1932,0
51,A1933,Carfilzomib (PR-171),868540-17-4,E08,L1021-01,719.91,DMSO,C40H57N5O7,CC(C)CC(C(=O)C1(CO1)C)NC(=O)C(CC2=CC=CC=C2)NC(=O)C(CC(C)C)NC(=O)C(CCC3=CC=CC=C3)NC(=O)CN4CCOCC4,≥35.99 mg/mL in DMSO; insoluble in H2O; ≥2.64 mg/mL in EtOH with gentle warming and ultrasonic,Free Base,Ubiquitination/Proteasome,Proteasome,"Proteasome inhibitor,epoxomicin analog",https://www.apexbt.com/search.php?catalog=A1933,1
52,A1958,Etomidate,33125-97-2,E09,L1021-01,244.29,DMSO,C14H16N2O2,CCOC(=O)C1=CN=CN1C(C)C2=CC=CC=C2,insoluble in H2O; ≥12.212 mg/mL in DMSO; ≥16.87 mg/mL in EtOH ,Free Base,Neuroscience,GABA Receptor,General anesthetic with GABA modulatory and GABA-mimetic actions,https://www.apexbt.com/search.php?catalog=A1958,1
53,A1971,Etoposide,33419-42-0,E10,L1021-01,588.56,DMSO,C29H32O13,CC1OCC2C(O1)C(C(C(O2)OC3C4COC(=O)C4C(C5=CC6=C(C=C35)OCO6)C7=CC(=C(C(=C7)OC)O)OC)O)O,≥29.45 mg/mL in DMSO; insoluble in H2O; insoluble in EtOH,Free Base,DNA Damage/DNA Repair,Topoisomerase,Topo II inhibitor,https://www.apexbt.com/search.php?catalog=A1971,1
54,A1984,Bendamustine HCl,3543-75-7,E11,L1021-01,394.72,DMSO,C16H21Cl2N3O2·HCl,CN1C2=C(C=C(C=C2)N(CCCl)CCCl)N=C1CCCC(=O)O.Cl,insoluble in H2O; ≥10.4 mg/mL in EtOH; ≥19.74 mg/mL in DMSO ,Hydrochloride,Apoptosis,Apoptosis Inducers,Cytostatic agent for non-Hodgkin lymphomas,https://www.apexbt.com/search.php?catalog=A1984,1
55,A2025,Plerixafor (AMD3100),110078-46-1,F01,L1021-01,502.78,EtOH,C28H54N8,C1CNCCNCCCN(CCNC1)CC2=CC=C(C=C2)CN3CCCNCCNCCCNCC3,≥25.14 mg/mL in EtOH; insoluble in DMSO; ≥2.9 mg/mL in H2O with gentle warming,Free Base,GPCR/G protein,CXCR,CXCR4 chemokine receptor antagonist,https://www.apexbt.com/search.php?catalog=A2025,1
56,A2036,Doripenem Hydrate,364622-82-2,F02,L1021-01,438.52,DMSO,C15H24N4O6S2·H2O,CC1C2C(C(=O)N2C(=C1SC3CC(NC3)CNS(=O)(=O)N)C(=O)O)C(C)O.O,insoluble in EtOH; ≥10.96 mg/mL in DMSO; ≥9.4 mg/mL in H2O ,Free Base,Microbiology & Virology,Antibiotic,"Injectable antibiotic,ultra-broad spectrum",https://www.apexbt.com/search.php?catalog=A2036,1
57,A2097,Ifosfamide,3778-73-2,F03,L1021-01,261.09,DMSO,C7H15Cl2N2O2P,C1CN(P(=O)(OC1)NCCCl)CCCl,≥13.05 mg/mL in DMSO; ≥22 mg/mL in H2O; ≥61.5 mg/mL in EtOH,Free Base,DNA Damage/DNA Repair,DNA Synthesis,Cytostatic agent,https://www.apexbt.com/search.php?catalog=A2097,1
58,A2133,Saracatinib (AZD0530),379231-04-6,F04,L1021-01,542.03,DMSO,C27H32ClN5O5,CN1CCN(CC1)CCOC2=CC(=C3C(=C2)N=CN=C3NC4=C(C=CC5=C4OCO5)Cl)OC6CCOCC6,≥27.1 mg/mL in DMSO; insoluble in EtOH; ≥2.36 mg/mL in H2O with ultrasonic,Free Base,TGF-β / Smad Signaling,Bcr-Abl,"Src/Abl inhibitor,potent and selective",https://www.apexbt.com/search.php?catalog=A2133,1
59,A2149,Bosutinib (SKI-606),380843-75-4,F05,L1021-01,530.45,DMSO,C26H29Cl2N5O3,CN1CCN(CC1)CCCOC2=C(C=C3C(=C2)N=CC(=C3NC4=CC(=C(C=C4Cl)Cl)OC)C#N)OC,≥26.5 mg/mL in DMSO; insoluble in H2O; ≥2.16 mg/mL in EtOH with ultrasonic,Free Base,TGF-β / Smad Signaling,Bcr-Abl,Potent Abl/Src kinases,https://www.apexbt.com/search.php?catalog=A2149,1
60,A2168,"Dovitinib (TKI-258, CHIR-258)",405169-16-6,F06,L1021-01,392.43,DMSO,C21H21FN6O,CN1CCN(CC1)C2=CC3=C(C=C2)NC(=C4C(=C5C(=NC4=O)C=CC=C5F)N)N3,insoluble in H2O; insoluble in EtOH; ≥36.35 mg/mL in DMSO ,,Tyrosine Kinase,FGFR,Multitargeted RTK inhibitor,https://www.apexbt.com/search.php?catalog=A2168,1
61,A2171,Carboplatin,41575-94-4,F07,L1021-01,371.26,DMSO,C6H12N2O4Pt,C1CC(C1)(C(=O)O)C(=O)O.[NH2-].[NH2-].[Pt+2],insoluble in ETOH; ≥42.2 mg/mL in DMSO with gentle warming and ultrasonic; ≥9.28 mg/mL in H2O with gentle warming,Free Base,DNA Damage/DNA Repair,DNA Synthesis,Antitumor agent that forms platinum-DNA adducts.,https://www.apexbt.com/search.php?catalog=A2171,0
62,A2174,Lenvatinib (E7080),417716-92-8,F08,L1021-01,426.85,DMSO,C21H19ClN4O4,COC1=CC2=NC=CC(=C2C=C1C(=O)N)OC3=CC(=C(C=C3)NC(=O)NC4CC4)Cl,≥21.35 mg/mL in DMSO; insoluble in EtOH; insoluble in H2O,Free Base,Tyrosine Kinase,VEGFR,VEGFR inhibitor,https://www.apexbt.com/search.php?catalog=A2174,1
63,A2187,Cladribine,4291-63-8,F09,L1021-01,285.69,DMSO,C10H12ClN5O3,C1C(C(OC1N2C=NC3=C2N=C(N=C3N)Cl)CO)O,≥41.67 mg/mL in DMSO with gentle warming; insoluble in H2O; insoluble in EtOH,Free Base,DNA Damage/DNA Repair,DNA Synthesis,Apoptosis inducer in CLL cells,https://www.apexbt.com/search.php?catalog=A2187,1
64,A2197,Dacarbazine,4342-03-4,F10,L1021-01,182.18,DMSO,C6H10N6O,CN(C)NN=C1C(=NC=N1)C(=O)N,insoluble in EtOH; ≥0.54 mg/mL in H2O; ≥2.28 mg/mL in DMSO ,Free Base,DNA Damage/DNA Repair,DNA Synthesis,Antineoplastic( malignant melanoma and sarcomas),https://www.apexbt.com/search.php?catalog=A2197,1
65,A2198,Genistein,446-72-0,F11,L1021-01,270.24,DMSO,C15H10O5,C1=CC(=CC=C1C2=COC3=CC(=CC(=C3C2=O)O)O)O,≥13.5 mg/mL in DMSO; insoluble in H2O; ≥2.59 mg/mL in EtOH with gentle warming,Free Base,DNA Damage/DNA Repair,Topoisomerase,ER agonist,https://www.apexbt.com/search.php?catalog=A2198,1
66,A2251,Tivozanib (AV-951),475108-18-0,G01,L1021-01,454.86,DMSO,C22H19ClN4O5,CC1=CC(=NO1)NC(=O)NC2=C(C=C(C=C2)OC3=C4C=C(C(=CC4=NC=C3)OC)OC)Cl,≥22.75 mg/mL in DMSO; insoluble in H2O; ≥2.68 mg/mL in EtOH with gentle warming,Free Base,Tyrosine Kinase,VEGFR,"VEGFR inhibitor,potent and selective",https://www.apexbt.com/search.php?catalog=A2251,1
67,A2306,Ellagic acid,476-66-4,G02,L1021-01,302.19,DMSO,C14H6O8,OC1=C(O)C2=C3C(C(OC4=C3C(C(O2)=O)=CC(O)=C4O)=O)=C1,insoluble in H2O; insoluble in EtOH; ≥3.78 mg/mL in DMSO with gentle warming,,DNA Damage/DNA Repair,Topoisomerase,Casein kinase 2 (CK2) inhibitor,https://www.apexbt.com/search.php?catalog=A2306,1
68,A2308,TAK-438,1260141-27-2,G03,L1021-01,461.46,DMSO,C17H16FN3O2S·C4H4O4,CNCC1=CN(C(=C1)C2=CC=CC=C2F)S(=O)(=O)C3=CN=CC=C3.C(=CC(=O)O)C(=O)O,insoluble in H2O; insoluble in EtOH; ≥18.9 mg/mL in DMSO ,,Membrane Transporter/Ion Channel,ATPase,Blocker of potassium-competitive acid,https://www.apexbt.com/search.php?catalog=A2308,1
69,A2324,Dexamethasone (DHAP),50-02-2,G04,L1021-01,392.46,DMSO,C22H29FO5,CC1CC2C3CCC4=CC(=O)C=CC4(C3(C(CC2(C1(C(=O)CO)O)C)O)F)C,insoluble in H2O; ≥19.623 mg/mL in DMSO; ≥5.18 mg/mL in EtOH ,Free Base,Ubiquitination/Proteasome,Autophagy,Glucocorticoidan;anti-inflammatory,https://www.apexbt.com/search.php?catalog=A2324,0
70,A2343,Cyclophosphamide,50-18-0,G05,L1021-01,261.09,DMSO,C7H15Cl2N2O2P,C1CNP(=O)(OC1)N(CCCl)CCCl,≥11.85 mg/mL in H2O with gentle warming and ultrasonic; ≥13.05 mg/mL in DMSO; ≥50.8 mg/mL in EtOH ,Free Base,DNA Damage/DNA Repair,DNA Synthesis,Nitrogen mustard alkylating agent and prodrug.,https://www.apexbt.com/search.php?catalog=A2343,1
71,A2355,Mercaptopurine (6-MP),50-44-2,G06,L1021-01,152.18,DMSO,C5H4N4S,C1=NC2=C(N1)C(=S)N=CN2,insoluble in EtOH; insoluble in H2O; ≥7.61 mg/mL in DMSO ,Free Base,DNA Damage/DNA Repair,DNA Synthesis,Purine synthesis inhibitor,https://www.apexbt.com/search.php?catalog=A2355,1
72,A2402,Floxuridine,50-91-9,G07,L1021-01,246.19,DMSO,C9H11FN2O5,C1C(C(OC1N2C=C(C(=O)NC2=O)F)CO)O,≥12.31 mg/mL in DMSO; ≥19.53 mg/mL in EtOH; ≥85.5 mg/mL in H2O ,Free Base,DNA Damage/DNA Repair,DNA Synthesis,Antineoplastic antimetabolite,https://www.apexbt.com/search.php?catalog=A2402,1
73,A2415,Acitretin,55079-83-9,G08,L1021-01,326.43,DMSO,C21H26O3,CC1=CC(=C(C(=C1C=CC(=CC=CC(=CC(=O)O)C)C)C)C)OC,insoluble in EtOH; insoluble in H2O; ≥16.32 mg/mL in DMSO ,Free Base,Others,RAR/RXR,Metabolite of etretinate,https://www.apexbt.com/search.php?catalog=A2415,1
74,A2431,Acarbose,56180-94-0,G09,L1021-01,645.6,DMSO,C25H43NO18,CC1C(C(C(C(O1)OC2C(OC(C(C2O)O)OC3C(OC(C(C3O)O)O)CO)CO)O)O)NC4C=C(C(C(C4O)O)O)CO,≥22.35 mg/mL in DMSO; insoluble in EtOH; ≥51 mg/mL in H2O ,Free Base,Others,Others,Alpha-glucosidase inhibitor,https://www.apexbt.com/search.php?catalog=A2431,1
75,A2436,Fluoxetine HCl,56296-78-7,G10,L1021-01,345.79,DMSO,C17H18F3NO·HCl,CNCCC(C1=CC=CC=C1)OC2=CC=C(C=C2)C(F)(F)F.Cl,insoluble in H2O; ≥17.3 mg/mL in DMSO; ≥32.2 mg/mL in EtOH ,Hydrochloride,Neuroscience,5-HT Receptor,"Serotonin reuptake inhibitor,selective",https://www.apexbt.com/search.php?catalog=A2436,1
76,A2451,Epirubicin HCl,56390-09-1,G11,L1021-01,579.98,DMSO,C27H29NO11·HCl,CC1C(C(CC(O1)OC2CC(CC3=C(C4=C(C(=C23)O)C(=O)C5=C(C4=O)C=CC=C5OC)O)(C(=O)CO)O)N)O.Cl,≥29.00 mg/mL in DMSO; ≥10.12 mg/mL in EtOH with gentle warming and ultrasonic; ≥40.33 mg/mL in H2O with gentle warming,Hydrochloride,DNA Damage/DNA Repair,Topoisomerase,Antibiotic antitumor agent,https://www.apexbt.com/search.php?catalog=A2451,1
77,A2456,Pamidronate Disodium,57248-88-1,H01,L1021-01,279.03,H2O,C3H9NNa2O7P2,O=P([O-])(O)C(CCN)(P([O-])(O)=O)O.[Na+].[Na+],insoluble in EtOH; insoluble in DMSO; ≥13.95 mg/mL in H2O ,Disodium,Others,Others,Bisphosphonate antiresorptive agent & bone resorption inhibitor,https://www.apexbt.com/search.php?catalog=A2456,1
78,A2476,Idarubicin HCl,57852-57-0,H02,L1021-01,533.95,DMSO,C26H28ClNO9,CC1C(C(CC(O1)OC2CC(CC3=C2C(=C4C(=C3O)C(=O)C5=CC=CC=C5C4=O)O)(C(=O)C)O)N)O.Cl,≥26.7 mg/mL in DMSO; insoluble in EtOH; ≥2.39 mg/mL in H2O with ultrasonic,Hydrochloride,DNA Damage/DNA Repair,Topoisomerase,"Anthracycline and daunorubicin analog,topoisomerase inhibitor",https://www.apexbt.com/search.php?catalog=A2476,0
79,A2486,Malotilate,59937-28-9,H03,L1021-01,288.38,DMSO,C12H16O4S2,CC(C)OC(=O)C(=C1SC=CS1)C(=O)OC(C)C,insoluble in H2O; ≥14.419 mg/mL in DMSO; ≥25.83 mg/mL in EtOH ,Free Base,Metabolism,5-Lipoxygenase,Stimulates hepatocyte regeneration,https://www.apexbt.com/search.php?catalog=A2486,1
80,A2489,Leucovorin Calcium,6035-45-6,H04,L1021-01,601.58,H2O,C20H31CaN7O12,O=C1C(N2C([H])=O)=C(NCC2CNC3=CC=C(C(N[C@@H](CCC([O-])=O)C([O-])=O)=O)C=C3)NC(N)=N1.O.O.O.O.[Ca+2].O,insoluble in DMSO; insoluble in EtOH; ≥15.04 mg/mL in H2O with gentle warming,Calcium,Metabolism,Folate Analogue,Derivative of folic acid,https://www.apexbt.com/search.php?catalog=A2489,0
81,A2510,Ampicillin,69-52-3,H05,L1021-01,371.4,DMSO,C16H18N3NaO4S,CC1(C(N2C(S1)C(C2=O)NC(=O)C(C3=CC=CC=C3)N)C(=O)[O-])C.[Na+],≥18.57 mg/mL in H2O; ≥73.6 mg/mL in DMSO; ≥75.2 mg/mL in EtOH ,Sodium,Microbiology & Virology,Antibiotic,β-lactam antibiotic,https://www.apexbt.com/search.php?catalog=A2510,1
82,A2511,"Carbenicillin, Disodium Salt",4800-94-6,H06,L1021-01,422.4,H2O,C17H16N2O6SNa2,CC1(C(N2C(S1)C(C2=O)NC(=O)C(C3=CC=CC=C3)C(=O)[O-])C(=O)[O-])C.[Na+].[Na+],insoluble in EtOH; ≥8.64 mg/mL in DMSO with gentle warming and ultrasonic; ≥80.8 mg/mL in H2O ,,Microbiology & Virology,Antibiotic,"Inhibits the cell-wall synthesis,antibiotic",https://www.apexbt.com/search.php?catalog=A2511,1
83,A2512,Chloramphenicol,56-75-7,H07,L1021-01,323.13,DMSO,C11H12Cl2N2O5,C1=CC(=CC=C1C(C(CO)NC(=O)C(Cl)Cl)O)[N+](=O)[O-],≥16.16 mg/mL in DMSO; ≥16.25 mg/mL in H2O with gentle warming and ultrasonic; ≥33 mg/mL in EtOH ,Free Base,Microbiology & Virology,Antibiotic,Inhibits translation(blocking peptidyl transferase),https://www.apexbt.com/search.php?catalog=A2512,1
84,A2513,"Geneticin, G-418 Sulfate",108321-42-2,H08,L1021-01,692.71,H2O,C20H40N4O10·2H2SO4,CC(C1C(C(C(C(O1)OC2C(CC(C(C2O)OC3C(C(C(CO3)(C)O)NC)O)N)N)N)O)O)O.OS(=O)(=O)O.OS(=O)(=O)O,insoluble in EtOH; insoluble in DMSO; ≥64.6 mg/mL in H2O ,,Microbiology & Virology,Antibiotic,Aminoglycosidic antibiotic,https://www.apexbt.com/search.php?catalog=A2513,1
85,A2514,Gentamycin Sulfate,1405-41-0,H09,L1021-01,1506.80,H2O,C60H127N15O26S,CC(C1CCC(C(O1)OC2C(CC(C(C2O)OC3C(C(C(CO3)(C)O)NC)O)N)N)N)NC,≥51.1 mg/mL in H2O; insoluble in DMSO; insoluble in EtOH,Free Base,Microbiology & Virology,Antibiotic,Aminoglycoside antibiotic,https://www.apexbt.com/search.php?catalog=A2514,0
86,A2515,Hygromycin B,31282-04-9,H10,L1021-01,527.5,DMSO,C20H37N3O13,CNC1CC(C(C(C1O)OC2C3C(C(C(O2)CO)O)OC4(O3)C(C(C(C(O4)C(CO)N)O)O)O)O)N,≥26.38 mg/mL in H2O; ≥5.35 mg/mL in EtOH; ≥9.14 mg/mL in DMSO ,Free Base,Microbiology & Virology,Antibiotic,Suitable for mammalian cell selection,https://www.apexbt.com/search.php?catalog=A2515,1
87,A2516,Kanamycin Sulfate,25389-94-0,H11,L1021-01,582.58,H2O,C18H36N4O11·H2SO4,C1C(C(C(C(C1N)OC2C(C(C(C(O2)CN)O)O)O)O)OC3C(C(C(C(O3)CO)O)N)O)N.OS(=O)(=O)O,≥29.13 mg/mL in H2O; insoluble in EtOH; insoluble in DMSO,Sulfate,Microbiology & Virology,Antibiotic,Water-soluble antibiotic,https://www.apexbt.com/search.php?catalog=A2516,1
88,A2517,Tetracycline Hydrochloride,64-75-5,A01,L1021-02,480.90,DMSO,C22H25ClN2O8,CC1(C2CC3C(C(=O)C(=C(C3(C(=O)C2=C(C4=C1C=CC=C4O)O)O)O)C(=O)N)N(C)C)O.Cl,insoluble in EtOH; ≥12.02 mg/mL in DMSO with gentle warming; ≥57.7 mg/mL in H2O ,Hydrochloride,Microbiology & Virology,Antibiotic,Bacteriostatic antibiotics,https://www.apexbt.com/search.php?catalog=A2517,1
89,A2547,Vortioxetine (Lu AA21004) HBr,960203-27-4,A02,L1021-02,379.36,DMSO,C18H22N2S·HBr,CC1=CC(=C(C=C1)SC2=CC=CC=C2N3CCNCC3)C.Br,insoluble in H2O; ≥50 mg/mL in DMSO; ≥5.44 mg/mL in EtOH with ultrasonic,HBr,Neuroscience,5-HT Receptor,"5-HT receptor modulator, antidepressant and anxiolytic",https://www.apexbt.com/search.php?catalog=A2547,1
90,A2548,Carmofur,61422-45-5,A03,L1021-02,257.26,DMSO,C11H16FN3O3,CCCCCCNC(=O)N1C=C(C(=O)NC1=O)F,insoluble in H2O; ≥10.5 mg/mL in EtOH with ultrasonic; ≥12.2 mg/mL in DMSO ,Free Base,DNA Damage/DNA Repair,DNA Synthesis,"Cytostatic derivative of fluorouracilm,antineoplatic agent",https://www.apexbt.com/search.php?catalog=A2548,1
91,A2552,Quercetin dihydrate,6151-25-3,A04,L1021-02,338.27,DMSO,C15H10O7·2H2O,C1=CC(=C(C=C1C2=C(C(=O)C3=C(C=C(C=C3O2)O)O)O)O)O.O.O,≥33.8 mg/mL in DMSO; insoluble in EtOH; insoluble in H2O,,PI3K/Akt/mTOR Signaling,PI3K,,https://www.apexbt.com/search.php?catalog=A2552,1
92,A2553,Fluvoxamine maleate,61718-82-9,A05,L1021-02,434.41,DMSO,C14H18F3N2O2·C4H4O4,COCCCCC(=NOCCN)C1=CC=C(C=C1)C(F)(F)F.C(=CC(=O)O)C(=O)O,≥21.72 mg/mL in DMSO; ≥2.78 mg/mL in H2O with gentle warming and ultrasonic; ≥56.7 mg/mL in EtOH ,Maleate,Neuroscience,5-HT Receptor,"Serotonin reuptake inhibitor,selective,antidepressant",https://www.apexbt.com/search.php?catalog=A2553,1
93,A2559,Altretamine,645-05-6,A06,L1021-02,210.28,EtOH,C9H18N6,CN(C)C1=NC(=NC(=N1)N(C)C)N(C)C,insoluble in H2O; ≥36.3 mg/mL in DMSO with ultrasonic; ≥8.85 mg/mL in EtOH ,,DNA Damage/DNA Repair,DNA Alkylating,Antineoplastic agent,https://www.apexbt.com/search.php?catalog=A2559,1
94,A2574,Aprotinin,9087-70-1,A07,L1021-02,6511.44,H2O,C284H432N84O79S7,CCC(C)C1C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NCC(=O)NC(C(=O)NC2CSSCC3C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(CSSCC(C(=O)NC(C(=O)NC(C(=O)N4CCCC4C(=O)N5CCCC5C(=O)NC(C(=O)NC(C(=O)NCC(=O)N6CCCC6C(=O)NC(CSSCC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)N3)CC(=O)O)CCC(=O)O)C)CO)CCCCN)CC7=CC=CC=C7)CC(=O)N)CC(=O)N)CCCNC(=N)N)CCCCN)C)CCCNC(=N)N)NC(=O)CNC(=O)CNC(=O)C(NC(=O)C(NC(=O)C(NC(=O)C(NC(=O)C(NC2=O)CCC(=O)N)C(C)O)CC8=CC=CC=C8)C(C)C)CC9=CC=C(C=C9)O)C(=O)NC(C(=O)NC(C(=O)NC(C(=O)N1)CCCNC(=N)N)C)CCCCN)C(C)O)CC1=CC=C(C=C1)O)CCC(=O)O)CC(C)C)NC(=O)C(CC1=CC=CC=C1)NC(=O)C(CC(=O)O)NC(=O)C1CCCN1C(=O)C(CCCNC(=N)N)N)C(=O)NCC(=O)NCC(=O)NC(C)C(=O)O)C(C)O)CCCNC(=N)N)CCSC)CC(C)C)C)CCCCN)C)CC(=O)N)CC1=CC=C(C=C1)O)CC1=CC=CC=C1)CC1=CC=C(C=C1)O)CCCNC(=N)N)C(C)CC,≥195 mg/mL in H2O; insoluble in DMSO; insoluble in EtOH,Free Base,Proteases,Serine Protease,Inhibitor of bovine pancreatic trypsin,https://www.apexbt.com/search.php?catalog=A2574,0
95,A2575,Bestatin,58970-76-6,A08,L1021-02,308.37,DMSO,C16H24N2O4,CC(C)CC(C(=O)O)NC(=O)C(C(CC1=CC=CC=C1)N)O,insoluble in H2O; insoluble in EtOH; ≥12.34 mg/mL in DMSO ,,Proteases,Aminopeptidase,Aminopeptidase inhibitor,https://www.apexbt.com/search.php?catalog=A2575,1
96,A2577,Batimastat (BB-94),130370-60-4,A09,L1021-02,477.64,DMSO,C23H31N3O4S2,CC(C)CC(C(CSC1=CC=CS1)C(=O)NO)C(=O)NC(CC2=CC=CC=C2)C(=O)NC,≥23.88 mg/mL in DMSO; insoluble in H2O; insoluble in EtOH,Free Base,Proteases,MMP,MMP inhibitor,https://www.apexbt.com/search.php?catalog=A2577,0
97,A2586,Nafamostat Mesylate(FUT-175),82956-11-4,A10,L1021-02,539.59,DMSO,C19H17N5O2·2CH4O3S,CS(=O)(=O)O.CS(=O)(=O)O.C1=CC(=CC=C1C(=O)OC2=CC3=C(C=C2)C=C(C=C3)C(=N)N)N=C(N)N,≥27 mg/mL in DMSO; ≥54 mg/mL in H2O; insoluble in EtOH,Mesylate,Proteases,Serine Protease,Serine protease inhibitor,https://www.apexbt.com/search.php?catalog=A2586,1
98,A2587,PMSF,329-98-6,A11,L1021-02,174.2,DMSO,C7H7FO2S,C1=CC=C(C=C1)CS(=O)(=O)F,insoluble in H2O; ≥17.4 mg/mL in DMSO; ≥28.3 mg/mL in EtOH ,Free Base,Proteases,Serine Protease,"Serine proteinases inhibitor, irreversible",https://www.apexbt.com/search.php?catalog=A2587,1
99,A2600,(-)-Epigallocatechin gallate (EGCG),989-51-5,B01,L1021-02,458.37,DMSO,C22H18O11,C1C(C(OC2=CC(=CC(=C21)O)O)C3=CC(=C(C(=C3)O)O)O)OC(=O)C4=CC(=C(C(=C4)O)O)O,≥22.9 mg/mL in DMSO; ≥10.9 mg/mL in H2O with ultrasonic; ≥6.76 mg/mL in EtOH with ultrasonic,,TGF-β / Smad Signaling,PKC,"Antioxidant, antiangiogenic and antitumor agent",https://www.apexbt.com/search.php?catalog=A2600,1
100,A2610,Fenbendazole,43210-67-9,B02,L1021-02,299.35,DMSO,C15H13N3O2S,COC(=O)NC1=NC2=C(N1)C=C(C=C2)SC3=CC=CC=C3,insoluble in EtOH; insoluble in H2O; ≥7.48 mg/mL in DMSO ,Free Base,Others,Others,For pinworm treatment in animals,https://www.apexbt.com/search.php?catalog=A2610,1
101,A2614,Bortezomib (PS-341),179324-69-7,B03,L1021-02,384.24,DMSO,C19H25BN4O4,B(C(CC(C)C)NC(=O)C(CC1=CC=CC=C1)NC(=O)C2=NC=CN=C2)(O)O,insoluble in EtOH; insoluble in H2O; ≥19.21 mg/mL in DMSO ,,Ubiquitination/Proteasome,Proteasome,,https://www.apexbt.com/search.php?catalog=A2614,1
102,A2664,VX-661,1152311-62-0,B04,L1021-02,520.5,DMSO,C26H27F3N2O6,CC(C)(CO)C1=CC2=CC(=C(C=C2N1CC(CO)O)F)NC(=O)C3(CC3)C4=CC5=C(C=C4)OC(O5)(F)F,≥21.8 mg/mL in DMSO; insoluble in EtOH; ≥24.3 mg/mL in H2O ,,Membrane Transporter/Ion Channel,CFTR,,https://www.apexbt.com/search.php?catalog=A2664,1
103,A2782,Amonafide,69408-81-7,B05,L1021-02,283.33,DMSO,C16H17N3O2,CN(C)CCN1C(=O)C2=CC=CC3=CC(=CC(=C32)C1=O)N,insoluble in EtOH; insoluble in H2O; ≥14.17 mg/mL in DMSO ,Free Base,DNA Damage/DNA Repair,Topoisomerase,"DNA intercalator,Topo II inhibitor",https://www.apexbt.com/search.php?catalog=A2782,1
104,A2813,Ivermectin,70288-86-7,B06,L1021-02,875.09,DMSO,C48H74O14,CCC(C)C1C(CCC2(O1)CC3CC(O2)CC=C(C(C(C=CC=C4COC5C4(C(C=C(C5O)C)C(=O)O3)O)C)OC6CC(C(C(O6)C)OC7CC(C(C(O7)C)O)OC)OC)C)C,≥43.75 mg/mL in DMSO; insoluble in H2O; ≥19.8 mg/mL in EtOH,Free Base,Membrane Transporter/Ion Channel,P2X purinergic receptor,NAChR/purinergic P2X4 receptor modulator,https://www.apexbt.com/search.php?catalog=A2813,0
105,A2842,Melatonin,73-31-4,B07,L1021-02,232.28,DMSO,C13H16N2O2,CC(=O)NCCC1=CNC2=C1C=C(C=C2)OC,≥23.2 mg/mL in DMSO; insoluble in H2O; ≥79.9 mg/mL in EtOH,Free Base,Others,Others,Melatonin receptors agonist,https://www.apexbt.com/search.php?catalog=A2842,1
106,A2845,Omeprazole,73590-58-6,B08,L1021-02,345.42,DMSO,C17H19N3O3S,CC1=CN=C(C(=C1OC)C)CS(=O)C2=NC3=C(N2)C=C(C=C3)OC,insoluble in H2O; insoluble in EtOH; ≥17.27 mg/mL in DMSO,Free Base,Ubiquitination/Proteasome,Autophagy,"H+,K+-ATPase inhibitor",https://www.apexbt.com/search.php?catalog=A2845,1
107,A2852,Leflunomide,75706-12-6,B09,L1021-02,270.21,DMSO,C12H9F3N2O2,CC1=C(C=NO1)C(=O)NC2=CC=C(C=C2)C(F)(F)F,≥83.33 mg/mL in DMSO; insoluble in H2O; ≥18.57 mg/mL in EtOH,Free Base,DNA Damage/DNA Repair,Nucleoside Antimetabolite/Analogue,"AHR agonist,immunosuppressive agent",https://www.apexbt.com/search.php?catalog=A2852,1
108,A2877,Camptothecin,7689-03-4,B10,L1021-02,348.35,DMSO,C20H16N2O4,CCC1(C2=C(COC1=O)C(=O)N3CC4=CC5=CC=CC=C5N=C4C3=C2)O,insoluble in H2O; insoluble in EtOH; ≥8.7 mg/mL in DMSO,,DNA Damage/DNA Repair,Topoisomerase,,https://www.apexbt.com/search.php?catalog=A2877,0
109,A2884,Doxazosin Mesylate,77883-43-3,B11,L1021-02,547.58,DMSO,C23H25N5O5·CH4O3S,COC1=C(C=C2C(=C1)C(=NC(=N2)N3CCN(CC3)C(=O)C4COC5=CC=CC=C5O4)N)OC.CS(=O)(=O)O,insoluble in EtOH; insoluble in H2O; ≥13.69 mg/mL in DMSO with gentle warming,Mesylate,GPCR/G protein,Adrenergic Receptor,α1-adrenergic receptor antagonist,https://www.apexbt.com/search.php?catalog=A2884,1
110,A2890,Nepafenac,78281-72-8,C01,L1021-02,254.28,DMSO,C15H14N2O2,C1=CC=C(C=C1)C(=O)C2=C(C(=CC=C2)CC(=O)N)N,insoluble in EtOH; insoluble in H2O; ≥9.95 mg/mL in DMSO,Free Base,Neuroscience,COX,COX-1 and COX-2 inhibitor,https://www.apexbt.com/search.php?catalog=A2890,1
111,A2917,Flumazenil,78755-81-4,C02,L1021-02,303.29,DMSO,C15H14FN3O3,CCOC(=O)C1=C2CN(C(=O)C3=C(N2C=N1)C=CC(=C3)F)C,insoluble in H2O; insoluble in EtOH; ≥15.16 mg/mL in DMSO,Free Base,Neuroscience,GABA Receptor,Benzodiazepine antagonist,https://www.apexbt.com/search.php?catalog=A2917,1
112,A2942,Masitinib (AB1010),790299-79-5,C03,L1021-02,498.64,DMSO,C28H30N6OS,CC1=C(C=C(C=C1)NC(=O)C2=CC=C(C=C2)CN3CCN(CC3)C)NC4=NC(=CS4)C5=CN=CC=C5,≥24.95 mg/mL in DMSO; insoluble in H2O; insoluble in EtOH,Free Base,Tyrosine Kinase,c-Kit,"Tyrosine kinase inhibitor, potent and selective",https://www.apexbt.com/search.php?catalog=A2942,1
113,A2949,Linifanib (ABT-869),796967-16-3,C04,L1021-02,375.41,DMSO,C21H18FN5O,CC1=CC(=C(C=C1)F)NC(=O)NC2=CC=C(C=C2)C3=C4C(=CC=C3)NN=C4N,insoluble in H2O; insoluble in EtOH; ≥18.75 mg/mL in DMSO,,Tyrosine Kinase,VEGFR,VEGFR/PDGFR inhibitor,https://www.apexbt.com/search.php?catalog=A2949,1
114,A2960,Loratadine,79794-75-5,C05,L1021-02,382.88,DMSO,C22H23ClN2O2,CCOC(=O)N1CCC(=C2C3=C(CCC4=C2N=CC=C4)C=C(C=C3)Cl)CC1,insoluble in H2O; ≥19.14 mg/mL in DMSO; ≥21.85 mg/mL in EtOH,Free Base,Neuroscience,Histamine Receptor,Peripheral HH1R antagonist,https://www.apexbt.com/search.php?catalog=A2960,1
115,A2974,Foretinib (GSK1363089),849217-64-7,C06,L1021-02,632.65,DMSO,C34H34F2N4O6,COC1=CC2=C(C=CN=C2C=C1OCCCN3CCOCC3)OC4=C(C=C(C=C4)NC(=O)C5(CC5)C(=O)NC6=CC=C(C=C6)F)F,≥31.65 mg/mL in DMSO; insoluble in H2O; insoluble in EtOH,Free Base,Tyrosine Kinase,VEGFR,VEGF and HGF receptor inhibitor,https://www.apexbt.com/search.php?catalog=A2974,1
116,A2977,"Cabozantinib (XL184, BMS-907351)",849217-68-1,C07,L1021-02,501.51,DMSO,C28H24FN3O5,COC1=CC2=C(C=CN=C2C=C1OC)OC3=CC=C(C=C3)NC(=O)C4(CC4)C(=O)NC5=CC=C(C=C5)F,≥25.08 mg/mL in DMSO; insoluble in H2O; ≥20.65 mg/mL in EtOH,Free Base,Tyrosine Kinase,c-MET,VEGFR2/Met/Ret/Kit/FLT//AXL inhibitor,https://www.apexbt.com/search.php?catalog=A2977,1
117,A3001,PCI-32765 (Ibrutinib),936563-96-1,C08,L1021-02,440.5,DMSO,C25H24N6O2,C=CC(=O)N1CCCC(C1)N2C3=C(C(=N2)C4=CC=C(C=C4)OC5=CC=CC=C5)C(=NC=N3)N,≥22.02 mg/mL in DMSO; insoluble in H2O; ≥10.4 mg/mL in EtOH with ultrasonic,Free Base,Angiogenesis,BTK,Bruton's tyrosine kinase (BTK) inhibitor,https://www.apexbt.com/search.php?catalog=A3001,1
118,A3002,ABT-888 (Veliparib),912444-00-9,C09,L1021-02,244.3,DMSO,C13H16N4O,CC1(CCCN1)C2=NC3=C(C=CC=C3N2)C(=O)N,insoluble in H2O; ≥10.6 mg/mL in EtOH with ultrasonic; ≥6.11 mg/mL in DMSO,Free Base,Chromatin/Epigenetics,PARP,Potent PARP inhibitor,https://www.apexbt.com/search.php?catalog=A3002,1
119,A3003,MDV3100 (Enzalutamide),915087-33-1,C10,L1021-02,464.4,DMSO,C21H16F4N4O2S,CC1(C(=O)N(C(=S)N1C2=CC(=C(C=C2)C(=O)NC)F)C3=CC(=C(C=C3)C#N)C(F)(F)F)C,≥23.22 mg/mL in DMSO; insoluble in H2O; ≥9.44 mg/mL in EtOH,Free Base,Endocrinology and Hormones,Androgen Receptor,Androgen receptor antagonist,https://www.apexbt.com/search.php?catalog=A3003,1
120,A3004,"Vemurafenib (PLX4032, RG7204)",918504-65-1,C11,L1021-02,489.93,DMSO,C23H18ClF2N3O3S,CCCS(=O)(=O)NC1=C(C(=C(C=C1)F)C(=O)C2=CNC3=NC=C(C=C23)C4=CC=C(C=C4)Cl)F,≥24.5 mg/mL in DMSO; insoluble in H2O; insoluble in EtOH,Free Base,MAPK Signaling,MEK1/2,BRAF kinase inhibitor,https://www.apexbt.com/search.php?catalog=A3004,1
121,A3005,"CAL-101 (Idelalisib, GS-1101)",870281-82-6,D01,L1021-02,415.43,DMSO,C22H18FN7O,CCC(C1=NC2=C(C(=CC=C2)F)C(=O)N1C3=CC=CC=C3)NC4=NC=NC5=C4NC=N5,insoluble in H2O; ≥2.1 mg/mL in EtOH with gentle warming and ultrasonic; ≥80.2 mg/mL in DMSO,Free Base,PI3K/Akt/mTOR Signaling,PI3K,PI3K inhibitor,https://www.apexbt.com/search.php?catalog=A3005,1
122,A3007,ABT-263 (Navitoclax),923564-51-6,D02,L1021-02,974.61,DMSO,C47H55ClF3N5O6S3,CC1(CCC(=C(C1)CN2CCN(CC2)C3=CC=C(C=C3)C(=O)NS(=O)(=O)C4=CC(=C(C=C4)NC(CCN5CCOCC5)CSC6=CC=CC=C6)S(=O)(=O)C(F)(F)F)C7=CC=C(C=C7)Cl)C,≥48.73 mg/mL in DMSO; insoluble in EtOH; insoluble in H2O,Free Base,Apoptosis,Bcl-2 Family,"Potent Bcl-2 family inhibitor, inhibits Bcl-2, Bcl-xL, and Bcl-w",https://www.apexbt.com/search.php?catalog=A3007,0
123,A3009,Sorafenib,284461-73-0,D03,L1021-02,464.82,DMSO,C21H16ClF3N4O3,CNC(=O)C1=NC=CC(=C1)OC2=CC=C(C=C2)NC(=O)NC3=CC(=C(C=C3)Cl)C(F)(F)F,≥23.25 mg/mL in DMSO; insoluble in H2O; insoluble in EtOH,Free Base,MAPK Signaling,Raf,Raf kinases and tyrosine kinases inhibitor,https://www.apexbt.com/search.php?catalog=A3009,1
124,A3012,Ruxolitinib (INCB018424),941678-49-5,D04,L1021-02,306.37,DMSO,C17H18N6,C1CCC(C1)C(CC#N)N2C=C(C=N2)C3=C4C=CNC4=NC=N3,insoluble in H2O; ≥15.32 mg/mL in DMSO; ≥17.53 mg/mL in EtOH,Free Base,Chromatin/Epigenetics,JAK,JAK inhibitor,https://www.apexbt.com/search.php?catalog=A3012,1
125,A3017,Dasatinib (BMS-354825),302962-49-8,D05,L1021-02,488.01,DMSO,C22H26ClN7O2S,CC1=C(C(=CC=C1)Cl)NC(=O)C2=CN=C(S2)NC3=NC(=NC(=C3)N4CCN(CC4)CCO)C,≥24.4 mg/mL in DMSO; insoluble in EtOH; insoluble in H2O,Free Base,TGF-β / Smad Signaling,Bcr-Abl,Src and BCR-Abl inhibitor,https://www.apexbt.com/search.php?catalog=A3017,1
126,A3018,Trametinib (GSK1120212),871700-17-3,D06,L1021-02,615.39,DMSO,C26H23FIN5O4,CC1=C2C(=C(N(C1=O)C)NC3=C(C=C(C=C3)I)F)C(=O)N(C(=O)N2C4=CC(=CC=C4)NC(=O)C)C5CC5,insoluble in H2O; insoluble in EtOH; ≥15.38 mg/mL in DMSO,Free Base,MAPK Signaling,MEK1/2,"MEK1 and MEK2 inhibitor, potent and selective",https://www.apexbt.com/search.php?catalog=A3018,1
127,A3020,(R)-Crizotinib,877399-52-5,D07,L1021-02,450.34,DMSO,C21H22Cl2FN5O,CC(C1=C(C=CC(=C1Cl)F)Cl)OC2=C(N=CC(=C2)C3=CN(N=C3)C4CCNCC4)N,insoluble in H2O; insoluble in EtOH; ≥7.51 mg/mL in DMSO,Free Base,Tyrosine Kinase,c-MET,"C-MET/ALK inhibitor,potent and ATP-competitve",https://www.apexbt.com/search.php?catalog=A3020,1
128,A3021,GDC-0449 (Vismodegib),879085-55-9,D08,L1021-02,421.3,DMSO,C19H14Cl2N2O3S,CS(=O)(=O)C1=CC(=C(C=C1)C(=O)NC2=CC(=C(C=C2)Cl)C3=CC=CC=N3)Cl,≥21.08 mg/mL in DMSO; insoluble in H2O; ≥4.96 mg/mL in EtOH with gentle warming and ultrasonic,Free Base,Stem Cell,Hedgehog,"Hedgehog antagonist,potent and selective",https://www.apexbt.com/search.php?catalog=A3021,1
129,A3022,Pazopanib (GW-786034),444731-52-6,D09,L1021-02,437.52,DMSO,C21H23N7O2S,CC1=C(C=C(C=C1)NC2=NC=CC(=N2)N(C)C3=CC4=NN(C(=C4C=C3)C)C)S(=O)(=O)N.Cl,insoluble in EtOH; insoluble in H2O; ≥10.95 mg/mL in DMSO,Hydrochloride,Tyrosine Kinase,PDGFR,VEGFR/PDGFR/FGFR inhibitor,https://www.apexbt.com/search.php?catalog=A3022,1
130,A3139,Abacavir,136470-78-5,D10,L1021-02,286.33,DMSO,C14H18N6O,C1CC1NC2=NC(=NC3=C2N=CN3C4CC(C=C4)CO)N,≥39.3 mg/mL in EtOH with gentle warming; ≥57 mg/mL in DMSO; ≥7.16 mg/mL in H2O,Free Base,DNA Damage/DNA Repair,Nucleoside Antimetabolite/Analogue,Inhibitor of HIV reverse transcriptase,https://www.apexbt.com/search.php?catalog=A3139,1
131,A3142,Acamprosate calcium,77337-73-6,D11,L1021-02,400.48,H2O,C10H20CaN2O8S2,CC(=O)NCCCS(=O)(=O)[O-].CC(=O)NCCCS(=O)(=O)[O-].[Ca+2],≥40 mg/mL in H2O; insoluble in DMSO; insoluble in EtOH,,Membrane Transporter/Ion Channel,GABA Receptor,GABA receptor agonist and modulator of glutamatergic systems,https://www.apexbt.com/search.php?catalog=A3142,1
132,A3145,Afatinib dimaleate,850140-73-7,E01,L1021-02,718.08,DMSO,C32H33ClFN5O11,CN(C)CC=CC(=O)NC1=C(C=C2C(=C1)C(=NC=N2)NC3=CC(=C(C=C3)F)Cl)OC4CCOC4.C(=CC(=O)O)C(=O)O.C(=CC(=O)O)C(=O)O,≥35.9 mg/mL in DMSO; ≥147.2 mg/mL in H2O; ≥6.39 mg/mL in EtOH with gentle warming and ultrasonic,Salt,Tyrosine Kinase,HER2,EGFR inhibitor,https://www.apexbt.com/search.php?catalog=A3145,1
133,A3151,Alarelin Acetate,79561-22-1,E02,L1021-02,1287.42,DMSO,C60H86N16O16,CCNC(=O)C1CCCN1C(=O)C(CCCN=C(N)N)NC(=O)C(CC(C)C)NC(=O)C(C)NC(=O)C(CC2=CC=C(C=C2)O)NC(=O)C(CO)NC(=O)C(CC3=CNC4=CC=CC=C43)NC(=O)C(CC5=CN=CN5)NC(=O)C6CCC(=O)N6.CC(=O)O.CC(=O)O,≥128.7 mg/mL in DMSO; ≥128.6 mg/mL in EtOH; ≥128.8 mg/mL in H2O,,Endocrinology and Hormones,GnRH,,https://www.apexbt.com/search.php?catalog=A3151,0
134,A3153,Aliskiren,173334-57-1,E03,L1021-02,551.77,DMSO,C30H53N3O6,CC(C)C(CC1=CC(=C(C=C1)OC)OCCCOC)CC(C(CC(C(C)C)C(=O)NCC(C)(C)C(=O)N)O)N,insoluble in H2O; ≥13.93 mg/mL in EtOH; ≥23.35 mg/mL in DMSO,,Others,Renin,Direct renin inhibitor,https://www.apexbt.com/search.php?catalog=A3153,1
135,A3156,Alogliptin Benzoate,850649-62-6,E04,L1021-02,461.51,DMSO,C25H27N5O4,CN1C(=O)C=C(N(C1=O)CC2=CC=CC=C2C#N)N3CCCC(C3)N.C1=CC=C(C=C1)C(=O)O,≥46.2 mg/mL in DMSO; ≥3.02 mg/mL in EtOH with gentle warming and ultrasonic; ≥46.2 mg/mL in H2O with gentle warming,,Proteases,DPP-4,"DPP-4 inhibitor,selective and potent,antidiabetic drug",https://www.apexbt.com/search.php?catalog=A3156,1
136,A3159,Alosetron Hydrochloride,122852-69-1,E05,L1021-02,330.81,DMSO,C17H19ClN4O,CC1=C(N=CN1)CN2CCC3=C(C2=O)C4=CC=CC=C4N3C.Cl,insoluble in EtOH; ≥16.54 mg/mL in DMSO; ≥46.4 mg/mL in H2O with gentle warming,,Neuroscience,5-HT Receptor,"5-HT3 receptor antagonist,potent and highly selective",https://www.apexbt.com/search.php?catalog=A3159,1
137,A3162,Alvimopan,156053-89-3,E06,L1021-02,424.53,DMSO,C25H32N2O4,CC1CN(CCC1(C)C2=CC(=CC=C2)O)CC(CC3=CC=CC=C3)C(=O)NCC(=O)O,insoluble in H2O; insoluble in EtOH; ≥25.7 mg/mL in DMSO,,Endocrinology and Hormones,Opioid Receptor,Mu-opioid receptors antagonist,https://www.apexbt.com/search.php?catalog=A3162,0
138,A3176,Ampalex,154235-83-3,E07,L1021-02,241.29,DMSO,C14H15N3O,C1CCN(CC1)C(=O)C2=CC3=NC=CN=C3C=C2,≥13.45 mg/mL in DMSO; ≥24.1 mg/mL in H2O with gentle warming; ≥92 mg/mL in EtOH,,Membrane Transporter/Ion Channel,AMPAR,Ampakine and nootropic,https://www.apexbt.com/search.php?catalog=A3176,1
139,A3177,AN-2690,174671-46-6,E08,L1021-02,151.93,DMSO,C7H6BFO2,B1(C2=C(CO1)C=C(C=C2)F)O,≥3.72 mg/mL in H2O with gentle warming; ≥7.05 mg/mL in DMSO; ≥88.6 mg/mL in EtOH,,Microbiology & Virology,Antibiotic,Antifungal agent,https://www.apexbt.com/search.php?catalog=A3177,1
140,A3178,AN-2728,906673-24-3,E09,L1021-02,251.05,DMSO,C14H10BNO3,N#CC1=CC=C(OC2=CC=C3C(COB3O)=C2)C=C1,insoluble in H2O; ≥12.55 mg/mL in DMSO; ≥94.4 mg/mL in EtOH,,Metabolism,PDE,"PDE4 inhibitor,anti-inflammatory compound",https://www.apexbt.com/search.php?catalog=A3178,1
141,A3179,Anamorelin,249921-19-5,E10,L1021-02,546.7,DMSO,C31H42N6O3,CC(C)(C(=O)NC(CC1=CNC2=CC=CC=C21)C(=O)N3CCCC(C3)(CC4=CC=CC=C4)C(=O)N(C)N(C)C)N,insoluble in H2O; ≥20.52 mg/mL in EtOH; ≥91.4 mg/mL in DMSO,,GPCR/G protein,GHSR,"Ghrelin receptor agonist, synthetic, orally active",https://www.apexbt.com/search.php?catalog=A3179,1
142,A3191,Ascomycin(FK 520),104987-12-4,E11,L1021-02,792.01,DMSO,C43H69NO12,CCC1C=C(CC(CC(C2C(CC(C(O2)(C(=O)C(=O)N3CCCCC3C(=O)OC(C(C(CC1=O)O)C)C(=CC4CCC(C(C4)OC)O)C)O)C)OC)OC)C)C,≥38.9 mg/mL in DMSO; insoluble in H2O; ≥98.6 mg/mL in EtOH,,Microbiology & Virology,Antibiotic,,https://www.apexbt.com/search.php?catalog=A3191,1
143,A3195,Asunaprevir (BMS-650032),630420-16-5,F01,L1021-02,748.29,DMSO,C35H46ClN5O9S,CC(C)(C)C(C(=O)N1CC(CC1C(=O)NC2(CC2C=C)C(=O)NS(=O)(=O)C3CC3)OC4=NC=C(C5=C4C=C(C=C5)Cl)OC)NC(=O)OC(C)(C)C,≥37.41 mg/mL in DMSO; insoluble in H2O; ≥48.6 mg/mL in EtOH,,Proteases,HCV Protease,NS3 protease inhibitor,https://www.apexbt.com/search.php?catalog=A3195,1
144,A3209,AXL1717,477-47-4,F02,L1021-02,414.41,DMSO,C22H22O8,COC1=CC(=CC(=C1OC)OC)C2C3C(COC3=O)C(C4=CC5=C(C=C24)OCO5)O,≥20.7 mg/mL in DMSO; insoluble in EtOH; insoluble in H2O,,Tyrosine Kinase,IGF1R,,https://www.apexbt.com/search.php?catalog=A3209,1
145,A3221,Bardoxolone methyl,218600-53-4,F03,L1021-02,505.69,DMSO,C32H43NO4,CC1(CCC2(CCC3(C(C2C1)C(=O)C=C4C3(CCC5C4(C=C(C(=O)C5(C)C)C#N)C)C)C)C(=O)OC)C,≥25.3 mg/mL in DMSO; insoluble in EtOH; insoluble in H2O,Free Base,Chromatin/Epigenetics,JAK,"IKK inhibitor, potent antioxidant inflammation modulator",https://www.apexbt.com/search.php?catalog=A3221,1
146,A3222,Baricitinib phosphate,1187595-84-1,F04,L1021-02,469.41,DMSO,C16H20N7O6PS,CCS(=O)(=O)N1CC(C1)(CC#N)N2C=C(C=N2)C3=C4C=CNC4=NC=N3.OP(=O)(O)O,insoluble in EtOH; insoluble in H2O; ≥172.6 mg/mL in DMSO,,Chromatin/Epigenetics,JAK,JAK1/JAK2 inhibitor,https://www.apexbt.com/search.php?catalog=A3222,1
147,A3233,Bazedoxifene acetate,198481-33-3,F05,L1021-02,530.65,DMSO,C32H38N2O5,CC1=C(N(C2=C1C=C(C=C2)O)CC3=CC=C(C=C3)OCCN4CCCCCC4)C5=CC=C(C=C5)O.CC(=O)O,insoluble in H2O; ≥182 mg/mL in DMSO; ≥8.483 mg/mL in EtOH with gentle warming and ultrasonic,,Endocrinology and Hormones,Estrogen/progestogen Receptor,Estrogen receptor modulator,https://www.apexbt.com/search.php?catalog=A3233,1
148,A3242,Bitopertin,845614-11-1,F06,L1021-02,543.46,DMSO,C21H20F7N3O4S,CC(C(F)(F)F)OC1=C(C=C(C=C1)S(=O)(=O)C)C(=O)N2CCN(CC2)C3=C(C=C(C=N3)C(F)(F)F)F,insoluble in H2O; ≥17.94 mg/mL in EtOH; ≥88.9 mg/mL in DMSO with ultrasonic,,Membrane Transporter/Ion Channel,GlyT1,Glycine reuptake inhibitor(GlyT1),https://www.apexbt.com/search.php?catalog=A3242,1
149,A3244,Bivalirudin Trifluoroacetate,128270-60-0,F07,L1021-02,2180.29,DMSO,C98H138N24O33,CCC(C)C(C(=O)N1CCCC1C(=O)NC(CCC(=O)O)C(=O)NC(CCC(=O)O)C(=O)NC(CC2=CC=C(C=C2)O)C(=O)NC(CC(C)C)C(=O)O)NC(=O)C(CCC(=O)O)NC(=O)C(CCC(=O)O)NC(=O)C(CC3=CC=CC=C3)NC(=O)C(CC(=O)O)NC(=O)CNC(=O)C(CC(=O)N)NC(=O)CNC(=O)CNC(=O)CNC(=O)CNC(=O)C4CCCN4C(=O)C(CCCNC(=N)N)NC(=O)C5CCCN5C(=O)C(CC6=CC=CC=C6)N,≥54.5 mg/mL in DMSO with gentle warming; ≥10.18 mg/mL in EtOH with gentle warming and ultrasonic; ≥43.5 mg/mL in H2O with gentle warming,,Proteases,Thrombin,Reversible thrombin inhibitor,https://www.apexbt.com/search.php?catalog=A3244,0
150,A3261,Boceprevir,394730-60-0,F08,L1021-02,519.68,DMSO,C27H45N5O5,CC1(C2C1C(N(C2)C(=O)C(C(C)(C)C)NC(=O)NC(C)(C)C)C(=O)NC(CC3CCC3)C(=O)C(=O)N)C,≥25.98 mg/mL in DMSO; insoluble in H2O; ≥89.8 mg/mL in EtOH,Free Base,Proteases,HCV Protease,"HCV protease inhibitor,potent and selective",https://www.apexbt.com/search.php?catalog=A3261,1
151,A3271,Calcipotriol,112965-21-6,F09,L1021-02,412.60,DMSO,C27H40O3,CC(C=CC(C1CC1)O)C2CCC3C2(CCCC3=CC=C4CC(CC(C4=C)O)O)C,≥16.7 mg/mL in DMSO ,,Vitamin D Related,VD/VDR,"Vitamin D3 analog,regulates cell differentiation and proliferation",https://www.apexbt.com/search.php?catalog=A3271,0
152,A3278,Capsaicin,404-86-4,F10,L1021-02,293.40,DMSO,C17H27NO3,OC1=CC=C(CNC(CCCCCCCC)=O)C=C1OC,insoluble in H2O; ≥15.27 mg/mL in DMSO; ≥52.3 mg/mL in EtOH with gentle warming,Free Base,Apoptosis,Apoptosis Inducers,TRPV1 receptor agonist,https://www.apexbt.com/search.php?catalog=A3278,1
153,A3282,Cariprazine,839712-12-8,F11,L1021-02,427.41,DMSO,C21H32Cl2N4O,CN(C)C(=O)NC1CCC(CC1)CCN2CCN(CC2)C3=C(C(=CC=C3)Cl)Cl,≥21.05 mg/mL in EtOH with gentle warming; ≥3.22 mg/mL in H2O with gentle warming and ultrasonic; ≥7.12 mg/mL in DMSO,Free Base,Neuroscience,Dopamine Receptor,"D2/D3 partial agonist,antipsychotic drug",https://www.apexbt.com/search.php?catalog=A3282,1
154,A3298,Cetirizine,83881-51-0,G01,L1021-02,388.89,DMSO,C21H25ClN2O3,C1CN(CCN1CCOCC(=O)O)C(C2=CC=CC=C2)C3=CC=C(C=C3)Cl,insoluble in EtOH; ≥122 mg/mL in H2O; ≥19.44 mg/mL in DMSO,Free Base,Neuroscience,Histamine Receptor,Antihistamine,https://www.apexbt.com/search.php?catalog=A3298,1
155,A3308,Choline Fenofibrate,856676-23-8,G02,L1021-02,421.91,DMSO,C22H28ClNO5,CC(C([O-])=O)(OC1=CC=C(C(C2=CC=C(Cl)C=C2)=O)C=C1)C.C[N+](C)(CCO)C,≥106.6 mg/mL in H2O; ≥55.8 mg/mL in EtOH with gentle warming; ≥8.44 mg/mL in DMSO with gentle warming,,Immunology/Inflammation,IκB/IKK,Choline salt of fenofibric acid,https://www.apexbt.com/search.php?catalog=A3308,1
156,A3313,Cinacalcet,226256-56-0,G03,L1021-02,357.41,DMSO,C22H22F3N,CC(C1=CC=CC2=CC=CC=C21)NCCCC3=CC(=CC=C3)C(F)(F)F,≥20.9 mg/mL in DMSO; insoluble in H2O; ≥68.5 mg/mL in EtOH,Free Base,GPCR/G protein,Calcimimetic Agent,"Calcimimetic agent,orally active",https://www.apexbt.com/search.php?catalog=A3313,1
157,A3315,Clemizole,442-52-4,G04,L1021-02,325.84,DMSO,C19H20ClN3,C1CCN(C1)CC2=NC3=CC=CC=C3N2CC4=CC=C(C=C4)Cl,insoluble in H2O; ≥16.2 mg/mL in DMSO; ≥95.8 mg/mL in EtOH,,Neuroscience,Histamine Receptor,H1 histamine receptor antagonist,https://www.apexbt.com/search.php?catalog=A3315,1
158,A3316,Clemizole hydrochloride,1163-36-6,G05,L1021-02,362.3,DMSO,C19H21Cl2N3,C1CCN(C1)CC2=NC3=CC=CC=C3N2CC4=CC=C(C=C4)Cl.Cl,≥15.13 mg/mL in EtOH with gentle warming and ultrasonic; ≥18.12 mg/mL in DMSO; ≥5.12 mg/mL in H2O with gentle warming and ultrasonic,,Neuroscience,HCV; HCV Protease; Histamine Receptor,H1 histamine receptor antagonist,https://www.apexbt.com/search.php?catalog=A3316,1
159,A3317,Clozapine N-oxide (CNO),34233-69-7,G06,L1021-02,342.82,DMSO,C18H19ClN4O,C[N+]1(CCN(CC1)C2=C3C=CC=CC3=NC4=C(N2)C=C(C=C4)Cl)[O-],insoluble in EtOH; ≥17.15 mg/mL in DMSO; ≥49 mg/mL in H2O with gentle warming,,Neuroscience,5-HT Receptor,"Metabolite of clozapine, used in chemogenetics.",https://www.apexbt.com/search.php?catalog=A3317,1
160,A3320,CO-1686 (AVL-301),1374640-70-6,G07,L1021-02,555.55,DMSO,C27H28F3N7O3,CC(=O)N1CCN(CC1)C2=CC(=C(C=C2)NC3=NC=C(C(=N3)NC4=CC(=CC=C4)NC(=O)C=C)C(F)(F)F)OC,≥27.8 mg/mL in DMSO; insoluble in H2O; ≥4.68 mg/mL in EtOH with gentle warming and ultrasonic,Free Base,JAK/STAT Signaling,EGFR,EGFR inhibitor,https://www.apexbt.com/search.php?catalog=A3320,1
161,A3321,Cobimetinib,934660-93-2,G08,L1021-02,531.31,DMSO,C21H21F3IN3O2,C1CCNC(C1)C2(CN(C2)C(=O)C3=C(C(=C(C=C3)F)F)NC4=C(C=C(C=C4)I)F)O,≥26.55 mg/mL in DMSO; insoluble in H2O; ≥33.53 mg/mL in EtOH with gentle warming,Free Base,MAPK Signaling,MEK1/2,Selective MEK inhibitor,https://www.apexbt.com/search.php?catalog=A3321,1
162,A3324,Colchicine,64-86-8,G09,L1021-02,399.44,DMSO,C22H25NO6,CC(=O)NC1CCC2=CC(=C(C(=C2C3=CC=C(C(=O)C=C13)OC)OC)OC)OC,≥19.97 mg/mL in DMSO; ≥45.5 mg/mL in H2O with gentle warming; ≥50.8 mg/mL in EtOH with gentle warming,Free Base,Cell Cycle/Checkpoint,Microtubule/Tubulin,Tubulin Inhibitor,https://www.apexbt.com/search.php?catalog=A3324,1
163,A3327,Costunolide,553-21-9,G10,L1021-02,232.32,DMSO,C15H20O2,CC1=CCCC(=CC2C(CC1)C(=C)C(=O)O2)C,≥35.71 mg/mL in DMSO; insoluble in H2O; ≥45.2 mg/mL in EtOH with gentle warming and ultrasonic,,DNA Damage/DNA Repair,Telomerase,,https://www.apexbt.com/search.php?catalog=A3327,1
164,A3335,Curcumin,458-37-7,G11,L1021-02,368.38,DMSO,C21H20O6,COC1=C(C=CC(=C1)C=CC(=O)CC(=O)C=CC2=CC(=C(C=C2)O)OC)O,≥36.8 mg/mL in DMSO; insoluble in H2O; ≥3.5 mg/mL in EtOH with gentle warming and ultrasonic,Free Base,Immunology/Inflammation,KEAP1-Nrf2,Tyrosinase inhibitor,https://www.apexbt.com/search.php?catalog=A3335,1
165,A3345,Dabigatran etexilate mesylate,872728-81-9,H01,L1021-02,723.84,DMSO,C35H45N7O8S,CCCCCCOC(NC(C1=CC=C(NCC2=NC3=C(C=CC(C(N(C4=CC=CC=N4)CCC(OCC)=O)=O)=C3)N2C)C=C1)=N)=O.CS(=O)(O)=O,≥36.19 mg/mL in DMSO; insoluble in H2O; ≥45.8 mg/mL in EtOH with gentle warming,mesylate,Proteases,Thrombin,"Direct thrombin inhibitor,anticoagulant,prodrug of dabigatran",https://www.apexbt.com/search.php?catalog=A3345,1
166,A3347,Dabrafenib Mesylate (GSK-2118436),1195768-06-9,H02,L1021-02,615.67,DMSO,C24H24F3N5O5S3,CC(C)(C)C1=NC(=C(S1)C2=NC(=NC=C2)N)C3=C(C(=CC=C3)NS(=O)(=O)C4=C(C=CC=C4F)F)F.CS(=O)(=O)O,≥30.75 mg/mL in DMSO; insoluble in H2O; ≥2.74 mg/mL in EtOH with gentle warming and ultrasonic,,MAPK Signaling,Raf,Inhibitor of BRAF(V600) mutants,https://www.apexbt.com/search.php?catalog=A3347,1
167,A3348,Daminozide,1596-84-5,H03,L1021-02,160.17,DMSO,C6H12N2O3,CN(C)NC(=O)CCC(=O)O,≥16.3 mg/mL in EtOH with gentle warming and ultrasonic; ≥21.4 mg/mL in H2O with gentle warming; ≥7.3 mg/mL in DMSO,,DNA Damage/DNA Repair,HDAC,,https://www.apexbt.com/search.php?catalog=A3348,1
168,A3351,Dasatinib hydrochloride,854001-07-3,H04,L1021-02,524.47,DMSO,C22H27Cl2N7O2S,CC1=C(/N=C(O)/C(S2)=CN=C2NC3=CC(N4CCN(CCO)CC4)=NC(C)=N3)C(Cl)=CC=C1.Cl,insoluble in EtOH; insoluble in H2O; ≥8.41 mg/mL in DMSO with ultrasonic,,Tyrosine Kinase,Src,"Multi-BCR/Abl and Src kinase inhibitor, oral active",https://www.apexbt.com/search.php?catalog=A3351,1
169,A3359,Desmopressin,16679-58-6,H05,L1021-02,1069.22,H2O,C46H64N14O12S2,O=C(C1CSSCCC(NC(CC2=CC=C(O)C=C2)C(NC(CC3=CC=CC=C3)C(NC(CCC(N)=O)C(NC(CC(N)=O)C(N1)=O)=O)=O)=O)=O)N4C(C(NC(C(NCC(N)=O)=O)CCC/N=C(N)\N)=O)CCC4,insoluble in EtOH; ≥106.4 mg/mL in DMSO; ≥119.8 mg/mL in H2O,,GPCR/G protein,Vasopressin Receptor,Hemostatic and anti-diuretic,https://www.apexbt.com/search.php?catalog=A3359,1
170,A3370,Docetaxel Trihydrate,148408-66-6,H06,L1021-02,861.93,DMSO,C43H59NO17,CC1=C2C(C(=O)C3(C(CC4C(C3C(C(C2(C)C)(CC1OC(=O)C(C(C5=CC=CC=C5)NC(=O)OC(C)(C)C)O)O)OC(=O)C6=CC=CC=C6)(CO4)OC(=O)C)O)C)O.O.O.O,≥43.1 mg/mL in DMSO; insoluble in H2O; ≥87.6 mg/mL in EtOH with gentle warming,Trihydrate,Cell Cycle/Checkpoint,Microtubule/Tubulin,Depolymerisation of microtubules inhibitor,https://www.apexbt.com/search.php?catalog=A3370,0
171,A3371,Doramectin,117704-25-3,H07,L1021-02,899.11,DMSO,C50H74O14,CC1/C=C/C=C2COC3C\2(O)C(C(OC4CC(OC5(C=CC(C)C(C6CCCCC6)O5)C4)C/C=C(C)/C1OC7CC(OC)C(OC8CC(OC)C(O)C(C)O8)C(C)O7)=O)C=C(C)C3O,≥89.9 mg/mL in DMSO; insoluble in H2O; ≥14.43 mg/mL in EtOH with gentle warming,,Microbiology & Virology,Antibiotic,,https://www.apexbt.com/search.php?catalog=A3371,1
172,A3374,Dronedarone,141626-36-0,H08,L1021-02,556.77,DMSO,C31H44N2O5S,CCCCC1=C(C2=C(O1)C=CC(=C2)NS(=O)(=O)C)C(=O)C3=CC=C(C=C3)OCCCN(CCCC)CCCC,≥27.84 mg/mL in DMSO; insoluble in H2O; ≥49.8 mg/mL in EtOH,Free Base,Metabolism,CYP3A/CYP450,"CYP3A4 and 2D6 inhibitor,moderate",https://www.apexbt.com/search.php?catalog=A3374,1
173,A3381,Edoxaban,480449-70-5,H09,L1021-02,548.06,DMSO,C24H30ClN7O4S,CN1CCC2=C(C1)SC(=N2)C(=O)NC3CC(CCC3NC(=O)C(=O)NC4=NC=C(C=C4)Cl)C(=O)N(C)C,≥27.3 mg/mL in DMSO; insoluble in EtOH; insoluble in H2O,,Proteases,Thrombin,,https://www.apexbt.com/search.php?catalog=A3381,1
174,A3383,Edoxaban tosylate monohydrate,1229194-11-9,H10,L1021-02,738.27,DMSO,C31H40ClN7O8S2,CC1=CC=C(C=C1)S(=O)(=O)O.CN1CCC2=C(C1)SC(=N2)C(=O)NC3CC(CCC3NC(=O)C(=O)NC4=NC=C(C=C4)Cl)C(=O)N(C)C.O,≥36.91 mg/mL in DMSO; insoluble in H2O; ≥5.78 mg/mL in EtOH with gentle warming and ultrasonic,tosylate,Proteases,Thrombin,Oral factor Xa inhibitor,https://www.apexbt.com/search.php?catalog=A3383,1
175,A3384,Elacridar,143664-11-3,H11,L1021-02,563.64,DMSO,C34H33N3O5,COC1=CC=CC2=C1NC3=C(C2=O)C=CC=C3C(=O)NC4=CC=C(C=C4)CCN5CCC6=CC(=C(C=C6C5)OC)OC,≥56.4 mg/mL in DMSO; insoluble in EtOH; insoluble in H2O,Free Base,Others,Others,BCRP inhibitor,https://www.apexbt.com/search.php?catalog=A3384,1
176,A3387,Eltrombopag Olamine,496775-62-3,A01,L1021-03,564.63,DMSO,C29H36N6O6,CC1=C(C=C(C=C1)N2C(=O)C(=C(N2)C)NN=C3C=CC=C(C3=O)C4=CC(=CC=C4)C(=O)O)C.C(CO)N.C(CO)N,insoluble in EtOH; insoluble in H2O; ≥14.12 mg/mL in DMSO with gentle warming,Free Base,Others,Thrombopoietin Receptor,C-mpl agonist,https://www.apexbt.com/search.php?catalog=A3387,1
177,A3388,EMD-1214063,1100598-32-0,A02,L1021-03,492.57,DMSO,C29H28N6O2,CN1CCC(CC1)COC2=CN=C(N=C2)C3=CC(=CC=C3)CN4C(=O)C=CC(=N4)C5=CC=CC(=C5)C#N,>4.9mg/mL in DMSO,Free Base,Tyrosine Kinase,c-MET,"C-Met inhibitor,potent and selective",https://www.apexbt.com/search.php?catalog=A3388,1
178,A3392,Emodin,518-82-1,A03,L1021-03,270.24,DMSO,C15H10O5,CC1=CC(O)=C2C(C(C3=CC(O)=CC(O)=C3C2=O)=O)=C1,≥27 mg/mL in DMSO; insoluble in H2O; insoluble in EtOH,,Immunology/Inflammation,NF-κB,,https://www.apexbt.com/search.php?catalog=A3392,1
179,A3397,Erlotinib,183321-74-6,A04,L1021-03,393.44,DMSO,C22H23N3O4,COCCOC1=C(C=C2C(=C1)C(=NC=N2)NC3=CC=CC(=C3)C#C)OCCOC,insoluble in H2O; ≥19.65 mg/mL in DMSO; ≥30.27 mg/mL in EtOH with gentle warming,Free Base,JAK/STAT Signaling,EGFR,EGFR tyrosine kinase inhibitor,https://www.apexbt.com/search.php?catalog=A3397,1
180,A3399,Esomeprazole Magnesium trihydrate,217087-09-7,A05,L1021-03,767.17,DMSO,C34H42MgN6O9S2,CC1=CN=C(C(=C1OC)C)CS(=O)C2=NC3=C([N-]2)C=CC(=C3)OC.CC1=CN=C(C(=C1OC)C)CS(=O)C2=NC3=C([N-]2)C=CC(=C3)OC.O.O.O.[Mg+2],≥110.6 mg/mL in DMSO; ≥39 mg/mL in EtOH; insoluble in H2O,,Autophagy; Membrane Transporter/Ion Channel,Autophagy; Proton Pump, proton pump inhibitor,https://www.apexbt.com/search.php?catalog=A3399,1
181,A3403,Etofenamate,30544-47-9,A06,L1021-03,369.34,DMSO,C18H18F3NO4,C1=CC=C(C(=C1)C(=O)OCCOCCO)NC2=CC=CC(=C2)C(F)(F)F,insoluble in H2O; ≥108.4 mg/mL in EtOH; ≥16.45 mg/mL in DMSO,,Others,Others,Non-steroidal anti-inflammatory drug,https://www.apexbt.com/search.php?catalog=A3403,1
182,A3405,Etoricoxib,202409-33-4,A07,L1021-03,358.84,DMSO,C18H15ClN2O2S,CC1=NC=C(C=C1)C2=NC=C(C=C2C3=CC=C(C=C3)S(=O)(=O)C)Cl,insoluble in H2O; ≥10.85 mg/mL in DMSO; ≥49.4 mg/mL in EtOH with gentle warming,,Neuroscience,COX,Specific COX-2 inhibitor,https://www.apexbt.com/search.php?catalog=A3405,1
183,A3412,Fenretinide,65646-68-6,A08,L1021-03,391.55,DMSO,C26H33NO2,CC1=C(C(CCC1)(C)C)C=CC(=CC=CC(=CC(=O)NC2=CC=C(C=C2)O)C)C,insoluble in H2O; ≥19.6 mg/mL in DMSO; ≥47.8 mg/mL in EtOH with gentle warming,,Others,RAR/RXR,,https://www.apexbt.com/search.php?catalog=A3412,1
184,A3418,Flecainide acetate,54143-56-5,A09,L1021-03,474.39,DMSO,C19H24F6N2O5,CC(=O)O.C1CCNC(C1)CNC(=O)C2=C(C=CC(=C2)OCC(F)(F)F)OCC(F)(F)F,≥23.7 mg/mL in H2O with gentle warming and ultrasonic; ≥47.4 mg/mL in DMSO; ≥47.4 mg/mL in EtOH,,Membrane Transporter/Ion Channel,Sodium Channel,Antiarrhythmic drug,https://www.apexbt.com/search.php?catalog=A3418,1
185,A3419,Fluvastatin,93957-54-1,A10,L1021-03,411.47,DMSO,C24H26FNO4,CC(C)N1C2=CC=CC=C2C(=C1C=CC(CC(CC(=O)O)O)O)C3=CC=C(C=C3)F,≥20.57 mg/mL in DMSO; ≥32.53 mg/mL in H2O with gentle warming; ≥42.2 mg/mL in EtOH with gentle warming,Free Base,Metabolism,HMG-CoA Reductase,HMGCR inhibitor,https://www.apexbt.com/search.php?catalog=A3419,1
186,A3421,Fosamprenavir Calcium Salt,226700-81-8,A11,L1021-03,623.67,DMSO,C25H34CaN3O9PS,CC(C)CN(CC(C(CC1=CC=CC=C1)NC(=O)OC2CCOC2)OP(=O)([O-])[O-])S(=O)(=O)C3=CC=C(C=C3)N.[Ca+2],≥6.66 mg/mL in DMSO with gentle warming; insoluble in H2O; insoluble in EtOH,,Proteases/Proteasome,HIV Protease,Prodrug of antiretroviral protease inhibitor amprenavir,https://www.apexbt.com/search.php?catalog=A3421,1
187,A3423,Galanthamine,357-70-0,B01,L1021-03,287.35,DMSO,C17H21NO3,CN1CCC23C=CC(CC2OC4=C(C=CC(=C34)C1)OC)O,≥14.37 mg/mL in DMSO; ≥14.43 mg/mL in H2O with gentle warming; ≥45 mg/mL in EtOH with gentle warming,,Neuroscience,AChR,Acetylcholinesterase inhibitor,https://www.apexbt.com/search.php?catalog=A3423,0
188,A3433,Gefitinib hydrochloride,184475-55-6,B02,L1021-03,483.36,DMSO,C22H25Cl2FN4O3,COC1=C(C=C2C(=C1)N=CN=C2NC3=CC(=C(C=C3)F)Cl)OCCCN4CCOCC4.Cl,insoluble in EtOH; ≥4.28 mg/mL in H2O with gentle warming and ultrasonic; ≥6.9 mg/mL in DMSO with gentle warming,,JAK/STAT Signaling,EGFR,Potent EGFR inhibitor,https://www.apexbt.com/search.php?catalog=A3433,1
189,A3451,Guanfacine hydrochloride,29110-48-3,B03,L1021-03,282.55,DMSO,C9H10Cl3N3O,C1=CC(=C(C(=C1)Cl)CC(=O)N=C(N)N)Cl.Cl,≥14.13 mg/mL in DMSO; ≥17.17 mg/mL in EtOH with gentle warming and ultrasonic; ≥50.6 mg/mL in H2O with gentle warming,Hydrochloride,GPCR/G protein,Adrenergic Receptor,α2A-adrenoceptor agonist,https://www.apexbt.com/search.php?catalog=A3451,1
190,A3479,Hydroxyfasudil hydrochloride,155558-32-0,B04,L1021-03,343.83,DMSO,C14H18ClN3O3S,C1CNCCN(C1)S(=O)(=O)C2=CC=CC3=C2C=CNC3=O.Cl,insoluble in EtOH; ≥7.88 mg/mL in DMSO with gentle warming; ≥5.04 mg/mL in H2O with gentle warming and ultrasonic,,TGF-β / Smad Signaling,ROCK,Rho-kinase inhibitor and vasodilator,https://www.apexbt.com/search.php?catalog=A3479,1
191,A3496,Indacaterol,312753-06-3,B05,L1021-03,392.49,DMSO,C24H28N2O3,CCC1=C(C=C2CC(CC2=C1)NCC(C3=C4C=CC(=O)NC4=C(C=C3)O)O)CC,insoluble in H2O; ≥12.85 mg/mL in DMSO; ≥6.93 mg/mL in EtOH with gentle warming and ultrasonic,,GPCR/G protein,Adrenergic Receptor,,https://www.apexbt.com/search.php?catalog=A3496,1
192,A3513,Ixabepilone,219989-84-1,B06,L1021-03,506.7,DMSO,C27H42N2O5S,CC1CCCC2(C(O2)CC(NC(=O)CC(C(C(=O)C(C1O)C)(C)C)O)C(=CC3=CSC(=N3)C)C)C,≥22.25 mg/mL in DMSO; insoluble in H2O; ≥41.3 mg/mL in EtOH with gentle warming,,Tyrosine Kinase,EGFR,,https://www.apexbt.com/search.php?catalog=A3513,0
193,A3528,Kinetin,525-79-1,B07,L1021-03,215.21,DMSO,C10H9N5O,C1=COC(=C1)CNC2=NC=NC3=C2NC=N3,insoluble in H2O; insoluble in EtOH; ≥5.38 mg/mL in DMSO with gentle warming,Free Base,Others,Others,Plant growth hormones,https://www.apexbt.com/search.php?catalog=A3528,1
194,A3543,LDE225 Diphosphate,1218778-77-8,B08,L1021-03,681.49,DMSO,C26H32F3N3O11P2,CC1CN(CC(O1)C)C2=NC=C(C=C2)NC(=O)C3=CC=CC(=C3C)C4=CC=C(C=C4)OC(F)(F)F.OP(=O)(O)O.OP(=O)(O)O,≥27.85 mg/mL in DMSO; insoluble in H2O; insoluble in EtOH,,Stem Cell,Smoothened,,https://www.apexbt.com/search.php?catalog=A3543,1
195,A3546,Ledipasvir,1256388-51-8,B09,L1021-03,889,DMSO,C49H54F2N8O6,CC(C)C(C(=O)N1CC2(CC2)CC1C3=NC=C(N3)C4=CC5=C(C=C4)C6=C(C5(F)F)C=C(C=C6)C7=CC8=C(C=C7)N=C(N8)C9C1CCC(C1)N9C(=O)C(C(C)C)NC(=O)OC)NC(=O)OC,≥44.45 mg/mL in DMSO; insoluble in H2O; ≥46.9 mg/mL in EtOH with gentle warming,Free Base,Microbiology & Virology,HCV,HCV NS5A protein inhibitor,https://www.apexbt.com/search.php?catalog=A3546,0
196,A3549,Lesinurad,878672-00-5,B10,L1021-03,404.28,DMSO,C17H14BrN3O2S,C1CC1C2=CC=C(C3=CC=CC=C23)N4C(=NN=C4Br)SCC(=O)O,insoluble in H2O; ≥40.9 mg/mL in EtOH with ultrasonic; ≥92.2 mg/mL in DMSO with ultrasonic,,Membrane Transporter/Ion Channel,URAT1,URAT1 inhibitor,https://www.apexbt.com/search.php?catalog=A3549,1
197,A3550,Letermovir,917389-32-3,B11,L1021-03,572.55,DMSO,C29H28F4N4O4,COC1=C(C=C(C=C1)C(F)(F)F)N2C(C3=C(C(=CC=C3)F)N=C2N4CCN(CC4)C5=CC(=CC=C5)OC)CC(=O)O,≥57.3 mg/mL in DMSO; insoluble in EtOH; insoluble in H2O,,Microbiology & Virology,CMV,Novel anti-CMV compound,https://www.apexbt.com/search.php?catalog=A3550,1
198,A3551,Leuprolide Acetate,74381-53-6,C01,L1021-03,1269.45,DMSO,C61H88N16O14,CCNC(=O)C1CCCN1C(=O)C(CCCN=C(N)N)NC(=O)C(CC(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC2=CC=C(C=C2)O)NC(=O)C(CO)NC(=O)C(CC3=CNC4=CC=CC=C43)NC(=O)C(CC5=CN=CN5)NC(=O)C6CCC(=O)N6.CC(=O)O,≥126.9 mg/mL in DMSO; ≥102 mg/mL in H2O with gentle warming; ≥31.4 mg/mL in EtOH with gentle warming,,Endocrinology and Hormones,GnRH,Pituitary GnRH receptors agonist,https://www.apexbt.com/search.php?catalog=A3551,1
199,A3564,Luliconazole,187164-19-8,C02,L1021-03,354.28,DMSO,C14H9Cl2N3S2,C1C(SC(=C(C#N)N2C=CN=C2)S1)C3=C(C=C(C=C3)Cl)Cl,insoluble in H2O; ≥17.71 mg/mL in DMSO; ≥32.53 mg/mL in EtOH with gentle warming,Free Base,Microbiology & Virology,Antibiotic,Azole antifungal agent(interdigital tinea pedis),https://www.apexbt.com/search.php?catalog=A3564,1
200,A3575,LY2835219 free base,1231929-97-7,C03,L1021-03,506.59,EtOH,C27H32F2N8,CCN1CCN(CC2=CN=C(NC3=NC=C(F)C(C4=CC5=C(N=C(C)N5C(C)C)C(F)=C4)=N3)C=C2)CC1,insoluble in H2O; ≥4.83 mg/mL in DMSO with gentle warming and ultrasonic; ≥6.34 mg/mL in EtOH with gentle warming,,Cell Cycle/Checkpoint,Cyclin-Dependent Kinases,CDK inhibitor,https://www.apexbt.com/search.php?catalog=A3575,1
201,A3583,Matrine,519-02-8,C04,L1021-03,248.36,DMSO,C15H24N2O,C1CC2C3CCCN4C3C(CCC4)CN2C(=O)C1,≥12.42 mg/mL in DMSO; ≥47.2 mg/mL in EtOH; ≥50.3 mg/mL in H2O with gentle warming and ultrasonic,,Apoptosis,Apoptosis Inducers,Alkaloid found in Sophora plant,https://www.apexbt.com/search.php?catalog=A3583,0
202,A3593,Mefloquine hydrochloride,51773-92-3,C05,L1021-03,414.77,DMSO,C17H17ClF6N2O,C1CCNC(C1)C(C2=CC(=NC3=C2C=CC=C3C(F)(F)F)C(F)(F)F)O.Cl,insoluble in H2O; ≥20.74 mg/mL in DMSO; ≥33.67 mg/mL in EtOH,Salt,Microbiology & Virology,Antimalaria,"Quinoline methanol antimalarial agent,",https://www.apexbt.com/search.php?catalog=A3593,1
203,A3599,Metoclopramide,364-62-5,C06,L1021-03,299.8,DMSO,C14H22ClN3O2,CCN(CC)CCNC(=O)C1=CC(=C(C=C1OC)N)Cl,insoluble in H2O; ≥14.99 mg/mL in DMSO; ≥24.6 mg/mL in EtOH with gentle warming,Free Base,Neuroscience,Dopamine Receptor,Dopamine receptor antagonist,https://www.apexbt.com/search.php?catalog=A3599,1
204,A3606,Micafungin sodium,208538-73-2,C07,L1021-03,1292.26,DMSO,C56H70N9NaO23S,CCCCCOC1=CC=C(C=C1)C2=CC(=NO2)C3=CC=C(C=C3)C(=O)NC4CC(C(NC(=O)C5C(C(CN5C(=O)C(NC(=O)C(NC(=O)C6CC(CN6C(=O)C(NC4=O)C(C)O)O)C(C(C7=CC(=C(C=C7)O)OS(=O)(=O)[O-])O)O)C(CC(=O)N)O)C)O)O)O.[Na+],≥64.66 mg/mL in DMSO; insoluble in EtOH; ≥17.5 mg/mL in H2O with gentle warming and ultrasonic,sodium,Others,"β(1,3)-D-Glucan Synthase","Inhibitor of β-(1,3)-D-glucan synthesis;fungicide",https://www.apexbt.com/search.php?catalog=A3606,1
205,A3617,MK-4827,1038915-60-4,C08,L1021-03,320.39,DMSO,C19H20N4O,C1CC(CNC1)C2=CC=C(C=C2)N3C=C4C=CC=C(C4=N3)C(=O)N,≥32 mg/mL in DMSO; insoluble in H2O; ≥50.9 mg/mL in EtOH with gentle warming,,Chromatin/Epigenetics,PARP,"PARP-1/-2 inhibitor,potent and selective",https://www.apexbt.com/search.php?catalog=A3617,1
206,A3618,MK-5172,1350514-68-9,C09,L1021-03,766.9,DMSO,C38H50N6O9S,COC1=CC2=C(N=C(CCCCC[C@@H]3C[C@H]3OC(N[C@@H](C(C)(C)C)C(N4[C@H](C(N[C@@]5(C(NS(=O)(C6CC6)=O)=O)[C@H](C5)C=C)=O)C[C@@H]7C4)=O)=O)C(O7)=N2)C=C1,≥38.35 mg/mL in DMSO; insoluble in H2O; ≥24 mg/mL in EtOH with gentle warming and ultrasonic,,Proteases,NS3/4a protease,HCV NS3/4a protease inhibitor,https://www.apexbt.com/search.php?catalog=A3618,0
207,A3631,Monomethyl auristatin E,474645-27-7,C10,L1021-03,717.98,DMSO,C39H67N5O7,CCC(C)C(C(CC(=O)N1CCCC1C(C(C)C(=O)NC(C)C(C2=CC=CC=C2)O)OC)OC)N(C)C(=O)C(C(C)C)NC(=O)C(C(C)C)NC,≥35.9 mg/mL in DMSO; insoluble in H2O; ≥48.5 mg/mL in EtOH with gentle warming and ultrasonic,,Cell Cycle/Checkpoint,Microtubule/Tubulin,,https://www.apexbt.com/search.php?catalog=A3631,1
208,A3653,Nelfinavir Mesylate,159989-65-8,C11,L1021-03,663.89,DMSO,C33H49N3O7S2,CC1=C(C=CC=C1O)C(=O)NC(CSC2=CC=CC=C2)C(CN3CC4CCCCC4CC3C(=O)NC(C)(C)C)O.CS(=O)(=O)O,≥66.4 mg/mL in DMSO; insoluble in H2O; ≥100.4 mg/mL in EtOH with gentle warming,Mesylate,Proteases,HIV Protease,"HIV protease inhibitor,antiretroviral drug for HIV treatment",https://www.apexbt.com/search.php?catalog=A3653,1
209,A3660,Nilotinib monohydrochloride monohydrate,923288-90-8,D01,L1021-03,583.99,DMSO,C28H25ClF3N7O2,CC1=C(C=C(C=C1)C(=O)NC2=CC(=CC(=C2)N3C=C(N=C3)C)C(F)(F)F)NC4=NC=CC(=N4)C5=CN=CC=C5.O.Cl,≥50 mg/mL in EtOH with gentle warming; insoluble in H2O; ≥210.8 mg/mL in DMSO,,TGF-β / Smad Signaling,Bcr-Abl,Bcr-Abl inhibitor,https://www.apexbt.com/search.php?catalog=A3660,1
210,A3664,Nordihydroguaiaretic acid,500-38-9,D02,L1021-03,302.36,DMSO,C18H22O4,CC(C(CC1=CC(O)=C(O)C=C1)C)CC2=CC(O)=C(O)C=C2,insoluble in H2O; ≥107 mg/mL in EtOH; ≥121 mg/mL in DMSO,,PI3K/Akt/mTOR Signaling,mTOR,,https://www.apexbt.com/search.php?catalog=A3664,1
211,A3681,Olmesartan,144689-24-7,D03,L1021-03,446.5,DMSO,C24H26N6O3,CCCC1=NC(=C(N1CC2=CC=C(C=C2)C3=CC=CC=C3C4=NNN=N4)C(=O)O)C(C)(C)O,≥22.32 mg/mL in DMSO; insoluble in EtOH; insoluble in H2O,Free Base,GPCR/G protein,Angiotensin Receptor,Angiotensin II receptor antagonist,https://www.apexbt.com/search.php?catalog=A3681,1
212,A3683,Olprinone Hydrochloride,119615-63-3,D04,L1021-03,286.72,DMSO,C14H11ClN4O,CC1=C(C=C(C(=O)N1)C#N)C2=CN3C=CN=C3C=C2.Cl,insoluble in EtOH; ≥13.2 mg/mL in H2O with gentle warming; ≥52.1 mg/mL in DMSO with gentle warming,,Metabolism,PDE,"Phosphodiesterase 3 (PDE3) inhibitor, selective",https://www.apexbt.com/search.php?catalog=A3683,1
213,A3688,Oseltamivir,196618-13-0,D05,L1021-03,312.4,DMSO,C16H28N2O4,CCC(CC)OC1C=C(CC(C1NC(=O)C)N)C(=O)OCC,≥31.2 mg/mL in DMSO; ≥119.4 mg/mL in EtOH with gentle warming; ≥82 mg/mL in H2O with gentle warming,Free Base,Microbiology & Virology,,inhibitor of influenza neuraminidase,https://www.apexbt.com/search.php?catalog=A3688,1
214,A3689,Oseltamivir acid,187227-45-8,D06,L1021-03,284.35,DMSO,C14H24N2O4,CCC(CC)OC1C=C(CC(C1NC(=O)C)N)C(=O)O,≥14.2 mg/mL in DMSO; ≥46.1 mg/mL in H2O with gentle warming; ≥97 mg/mL in EtOH with gentle warming,,Microbiology & Virology,,Influenza neuraminidase inhibitor,https://www.apexbt.com/search.php?catalog=A3689,1
215,A3707,Pemetrexed disodium hemipenta hydrate,357166-30-4,D07,L1021-03,516.41,H2O,C20H24N5Na2O8.5,C1=CC(=CC=C1CCC2=CNC3=C2C(=O)NC(=N3)N)C(=O)NC(CCC(=O)[O-])C(=O)[O-].C1=CC(=CC=C1CCC2=CNC3=C2C(=O)NC(=N3)N)C(=O)NC(CCC(=O)[O-])C(=O)[O-].O.O.O.O.O.[Na+].[Na+].[Na+].[Na+],≥23.42 mg/mL in H2O with gentle warming; insoluble in EtOH; insoluble in DMSO,Free Base,Apoptosis,Thymidylate Synthase,Antifolate and antimetabolite agent,https://www.apexbt.com/search.php?catalog=A3707,0
216,A3708,Pentostatin,53910-25-1,D08,L1021-03,268.27,DMSO,C11H16N4O4,C1C(C(OC1N2C=NC3=C2NC=NCC3O)CO)O,≥26.8 mg/mL in H2O; insoluble in EtOH; ≥13.4 mg/mL in DMSO,,GPCR/G protein,Adenosine Receptor,Irreversible adenosine deaminase inhibitor,https://www.apexbt.com/search.php?catalog=A3708,1
217,A3709,Peramivir,330600-85-6,D09,L1021-03,328.41,DMSO,C15H28N4O4,CCC(CC)C(C1C(CC(C1O)C(=O)O)N=C(N)N)NC(=O)C,insoluble in DMSO; ≥5.66 mg/mL in H2O with gentle warming and ultrasonic; ≥7.6 mg/mL in EtOH,Free Base,Microbiology & Virology,,Aeuraminidase inhibitor;antiviral drug,https://www.apexbt.com/search.php?catalog=A3709,1
218,A3722,Phenylpiracetam,77472-70-9,D10,L1021-03,218.25,DMSO,C12H14N2O2,O=C1N(CC(N)=O)CC(C2=CC=CC=C2)C1,≥10.92 mg/mL in DMSO; ≥18.5 mg/mL in H2O with gentle warming and ultrasonic; ≥58.2 mg/mL in EtOH with gentle warming,,Others,Others,Nootropic derivative of piracetam,https://www.apexbt.com/search.php?catalog=A3722,1
219,A3727,Pitolisant hydrochloride,903576-44-3,D11,L1021-03,332.31,DMSO,C17H27Cl2NO,C1CCN(CC1)CCCOCCCC2=CC=C(C=C2)Cl.Cl,≥16.6 mg/mL in DMSO; ≥57.4 mg/mL in H2O; ≥94.2 mg/mL in EtOH,,Neuroscience,Histamine Receptor,Nonimidazole inverse agonist,https://www.apexbt.com/search.php?catalog=A3727,1
220,A3733,Pramipexole dihydrochloride,104632-25-9,E01,L1021-03,284.25,DMSO,C10H19Cl2N3S,CCCNC1CCC2=C(C1)SC(=N2)N.Cl.Cl,≥105.2 mg/mL in H2O; ≥14.21 mg/mL in DMSO; ≥3.43 mg/mL in EtOH with gentle warming and ultrasonic,,Neuroscience,Dopamine Receptor,Dopamine receptor agonist,https://www.apexbt.com/search.php?catalog=A3733,1
221,A3738,PSI-7977,1190307-88-0,E02,L1021-03,529.45,DMSO,C22H29FN3O9P,CC(C)OC(=O)C(C)NP(=O)(OCC1C(C(C(O1)N2C=CC(=O)NC2=O)(C)F)O)OC3=CC=CC=C3,insoluble in H2O; ≥183 mg/mL in DMSO; ≥84.4 mg/mL in EtOH with gentle warming,,DNA Damage/DNA Repair,DNA Synthesis,Antiviral agents for chronic HCV infection,https://www.apexbt.com/search.php?catalog=A3738,1
222,A3740,Puromycin aminonucleoside,58-60-6,E03,L1021-03,294.31,DMSO,C12H18N6O3,CN(C)C1=NC=NC2=C1N=CN2C3C(C(C(O3)CO)N)O,≥14.45 mg/mL in DMSO; ≥29.4 mg/mL in EtOH with gentle warming; ≥29.5 mg/mL in H2O with gentle warming,,Others,Others,Aminonucleoside portion of the antibiotic puromycin,https://www.apexbt.com/search.php?catalog=A3740,1
223,A3744,Quetiapine,111974-69-7,E04,L1021-03,383.51,DMSO,C21H25N3O2S,C1CN(CCN1CCOCCO)C2=NC3=CC=CC=C3SC4=CC=CC=C42,insoluble in H2O; ≥19.18 mg/mL in DMSO; ≥29.55 mg/mL in EtOH with gentle warming,Free Base,Neuroscience,Dopamine Receptor,Dopamine receptor antagonist,https://www.apexbt.com/search.php?catalog=A3744,1
224,A3750,Regorafenib hydrochloride,835621-07-3,E05,L1021-03,519.28,DMSO,C21H16Cl2F4N4O3,CNC(=O)C1=NC=CC(=C1)OC2=CC(=C(C=C2)NC(=O)NC3=CC(=C(C=C3)Cl)C(F)(F)F)F.Cl,≥25.95 mg/mL in DMSO; insoluble in H2O; ≥8.75 mg/mL in EtOH with gentle warming and ultrasonic,hydrochloride,Tyrosine Kinase,c-RET,Tyrosine kinase inhibitor,https://www.apexbt.com/search.php?catalog=A3750,1
225,A3751,Regorafenib monohydrate,1019206-88-2,E06,L1021-03,500.83,DMSO,C21H17ClF4N4O4,CNC(=O)C1=NC=CC(=C1)OC2=CC(=C(C=C2)NC(=O)NC3=CC(=C(C=C3)Cl)C(F)(F)F)F.O,≥25.05 mg/mL in DMSO; insoluble in H2O,,Tyrosine Kinase,c-RET,Tyrosine kinase inhibitor,https://www.apexbt.com/search.php?catalog=A3751,1
226,A3758,Retigabine dihydrochloride,150812-13-8,E07,L1021-03,376.25,DMSO,C16H20Cl2FN3O2,CCOC(=O)NC1=C(C=C(C=C1)NCC2=CC=C(C=C2)F)N.Cl.Cl,≥18.8 mg/mL in DMSO; ≥52.4 mg/mL in H2O with gentle warming; ≥8.71 mg/mL in EtOH with gentle warming and ultrasonic,,Membrane Transporter/Ion Channel,GABA Receptor,,https://www.apexbt.com/search.php?catalog=A3758,1
227,A3763,RG7388,1229705-06-9,E08,L1021-03,616.48,DMSO,C31H29Cl2F2N3O4,CC(C)(C)CC1C(C(C(N1)C(=O)NC2=C(C=C(C=C2)C(=O)O)OC)C3=C(C(=CC=C3)Cl)F)(C#N)C4=C(C=C(C=C4)Cl)F,≥30.82 mg/mL in DMSO; insoluble in H2O; ≥6.96 mg/mL in EtOH with gentle warming,Free Base,Apoptosis,p53,"MDM2 antagonist, oral, selective",https://www.apexbt.com/search.php?catalog=A3763,1
228,A3765,Rilpivirine,500287-72-9,E09,L1021-03,366.42,DMSO,C22H18N6,CC1=CC(=CC(=C1NC2=NC(=NC=C2)NC3=CC=C(C=C3)C#N)C)C=CC#N,insoluble in H2O; ≥12.25 mg/mL in DMSO; ≥6.58 mg/mL in EtOH with gentle warming and ultrasonic,Free Base,Microbiology & Virology,HIV,Inhibitor of next-generation nonnucleoside reverse transcriptase,https://www.apexbt.com/search.php?catalog=A3765,1
229,A3767,Riociguat,625115-55-1,E10,L1021-03,422.42,DMSO,C20H19FN8O2,CN(C1=C(N=C(N=C1N)C2=NN(C3=C2C=CC=N3)CC4=CC=CC=C4F)N)C(=O)OC,insoluble in EtOH; insoluble in H2O; ≥16.95 mg/mL in DMSO,Free Base,Others,Guanylate Cyclase,Soluble guanylate cyclase (sGC) stimulator,https://www.apexbt.com/search.php?catalog=A3767,1
230,A3768,Rivastigmine,123441-03-2,E11,L1021-03,250.34,DMSO,C14H22N2O2,CCN(C)C(=O)OC1=CC=CC(=C1)C(C)N(C)C,≥12.52 mg/mL in DMSO; ≥23.6 mg/mL in H2O with ultrasonic; ≥92.8 mg/mL in EtOH with ultrasonic,Free Base,Neuroscience,AChR,Cholinesterase inhibitor,https://www.apexbt.com/search.php?catalog=A3768,1
231,A3781,Ruxolitinib phosphate,1092939-17-7,F01,L1021-03,404.36,DMSO,C17H21N6O4P,[HH].C1CCC(C1)C(CC#N)N2C=C(C=N2)C3=C4C=CNC4=NC=N3.OOP(=O)=O,≥20.2 mg/mL in DMSO; ≥6.92 mg/mL in EtOH with gentle warming and ultrasonic; ≥8.03 mg/mL in H2O with gentle warming and ultrasonic,,Chromatin/Epigenetics,JAK,JAK1/JAK2 inhibitor,https://www.apexbt.com/search.php?catalog=A3781,1
232,A3787,Salirasib,162520-00-5,F02,L1021-03,358.54,DMSO,C22H30O2S,CC(=CCCC(=CCCC(=CCSC1=CC=CC=C1C(=O)O)C)C)C,insoluble in H2O; ≥16.2 mg/mL in EtOH; ≥16.75 mg/mL in DMSO ,Free Base,MAPK Signaling,RasGAP (Ras- P21),Inhibitor of active Ras protein,https://www.apexbt.com/search.php?catalog=A3787,1
233,A3789,Salmeterol xinafoate,94749-08-3,F03,L1021-03,603.75,DMSO,C36H45NO7,C1=CC=C(C=C1)CCCCOCCCCCCNCC(C2=CC(=C(C=C2)O)CO)O.C1=CC=C2C(=C1)C=CC(=C2O)C(=O)O,≥30.19 mg/mL in DMSO; insoluble in H2O; ≥15.83 mg/mL in EtOH with gentle warming and ultrasonic,Free Base,GPCR/G protein,Adrenergic Receptor,β2-adrenergic receptor agonist,https://www.apexbt.com/search.php?catalog=A3789,1
234,A3791,Saquinavir mesylate,149845-06-7,F04,L1021-03,766.95,DMSO,C39H54N6O8S,CC(C)(C)NC(=O)C1CC2CCCCC2CN1CC(C(CC3=CC=CC=C3)NC(=O)C(CC(=O)N)NC(=O)C4=NC5=CC=CC=C5C=C4)O.CS(=O)(=O)O,insoluble in H2O; ≥6.71 mg/mL in EtOH with gentle warming and ultrasonic; ≥7.67 mg/mL in DMSO ,mesylate,Proteases,HIV Protease,HIV Protease Inhibitor,https://www.apexbt.com/search.php?catalog=A3791,1
235,A3817,Sildenafil,139755-83-2,F05,L1021-03,474.58,DMSO,C22H30N6O4S,CCCC1=NN(C2=C1NC(=NC2=O)C3=C(C=CC(=C3)S(=O)(=O)N4CCN(CC4)C)OCC)C,≥22.65 mg/mL in H2O; insoluble in EtOH; ≥46.3 mg/mL in DMSO with ultrasonic,,Metabolism,PDE,"PDE5 inhibitor, selective",https://www.apexbt.com/search.php?catalog=A3817,1
236,A3820,Simeprevir,923604-59-5,F06,L1021-03,749.96,DMSO,C38H47N5O7S2,CC1=C(C=CC2=C1N=C(C=C2OC3CC4C(C3)C(=O)N(CCCCC=CC5CC5(NC4=O)C(=O)NS(=O)(=O)C6CC6)C)C7=NC(=CS7)C(C)C)OC,insoluble in H2O; insoluble in EtOH; ≥18.75 mg/mL in DMSO ,Free Base,Proteases,HCV Protease,Inhibitor of HCV NS3/4A protease,https://www.apexbt.com/search.php?catalog=A3820,0
237,A3856,Tamibarotene,94497-51-5,F07,L1021-03,351.44,DMSO,C22H25NO3,CC1(CCC(C2=C1C=CC(=C2)NC(=O)C3=CC=C(C=C3)C(=O)O)(C)C)C,insoluble in H2O; ≥13.35 mg/mL in DMSO; ≥52.5 mg/mL in EtOH with ultrasonic,Free Base,Others,RARs,RARα agonist,https://www.apexbt.com/search.php?catalog=A3856,1
238,A3863,Tedizolid,856866-72-3,F08,L1021-03,370.34,DMSO,C17H15FN6O3,CN1N=C(N=N1)C2=NC=C(C=C2)C3=C(C=C(C=C3)N4CC(OC4=O)CO)F,insoluble in EtOH; insoluble in H2O; ≥9.25 mg/mL in DMSO with gentle warming,Free Base,Microbiology & Virology,Antibiotic,Oxazolidinone for gram-positive infections,https://www.apexbt.com/search.php?catalog=A3863,1
239,A3865,Teneligliptin hydrobromide,906093-29-6,F09,L1021-03,1257.72,DMSO,C44H65Br5N12O2S2,CC1=NN(C(=C1)N2CCN(CC2)C3CC(NC3)C(=O)N4CCSC4)C5=CC=CC=C5.CC1=NN(C(=C1)N2CCN(CC2)C3CC(NC3)C(=O)N4CCSC4)C5=CC=CC=C5.Br.Br.Br.Br.Br,≥62.9 mg/mL in DMSO; ≥104.8 mg/mL in H2O; ≥12.1 mg/mL in EtOH with gentle warming and ultrasonic,hydrobromide,Proteases,DPP-4,Dipeptidyl peptidase-4 inhibitor,https://www.apexbt.com/search.php?catalog=A3865,1
240,A3872,TH-302,918633-87-1,F10,L1021-03,449.04,DMSO,C9H16Br2N5O4P,CN1C(=CN=C1[N+](=O)[O-])COP(=O)(NCCBr)NCCBr,≥22.45 mg/mL in DMSO; ≥34.2 mg/mL in EtOH with ultrasonic; ≥4.73 mg/mL in H2O with gentle warming and ultrasonic,free base,DNA Damage/DNA Repair,Topoisomerase,"Hypoxia-activated prodrug,inhibits H460/HT29 cell growth",https://www.apexbt.com/search.php?catalog=A3872,1
241,A3873,Tianeptine,72797-41-2,F11,L1021-03,436.96,DMSO,C21H25ClN2O4S,CN1C2=CC=CC=C2C(C3=C(S1(=O)=O)C=C(C=C3)Cl)NCCCCCCC(=O)O,insoluble in H2O; ≥4.08 mg/mL in EtOH with gentle warming and ultrasonic; ≥82.4 mg/mL in DMSO,,Neuroscience,5-HT Receptor,5-HT facilitator,https://www.apexbt.com/search.php?catalog=A3873,1
242,A3874,Tiotropium Bromide,136310-93-5,G01,L1021-03,472.42,DMSO,C19H22BrNO4S2,C[N+]1(C2CC(CC1C3C2O3)OC(=O)C(C4=CC=CS4)(C5=CC=CS5)O)C.[Br-],≥23.62 mg/mL in DMSO; insoluble in EtOH; ≥33.07 mg/mL in H2O with ultrasonic,Bromide,Neuroscience,AChR,MAChR M antagonist,https://www.apexbt.com/search.php?catalog=A3874,0
243,A3875,Tipiracil hydrochloride,183204-72-0,G02,L1021-03,279.12,H2O,C9H12Cl2N4O2,C1CC(=N)N(C1)CC2=C(C(=O)NC(=O)N2)Cl.Cl,insoluble in DMSO; insoluble in EtOH; ≥13.25 mg/mL in H2O,,Others,Thymidine phosphorylase,Thymidine phosphorylase inhibitor,https://www.apexbt.com/search.php?catalog=A3875,1
244,A3877,Tirofiban hydrochloride monohydrate,150915-40-5,G03,L1021-03,495.07,DMSO,C22H39ClN2O6S,CCCCS(=O)(=O)NC(CC1=CC=C(C=C1)OCCCCC2CCNCC2)C(=O)O.O.Cl,≥24.75 mg/mL in DMSO; ≥105 mg/mL in EtOH with ultrasonic; ≥3.84 mg/mL in H2O with gentle warming and ultrasonic,Hydrochloride,Others,Glycoprotein,Glycoprotein IIb/IIIa inhibitor,https://www.apexbt.com/search.php?catalog=A3877,0
245,A3887,Trametinib DMSO solvate,1187431-43-1,G04,L1021-03,693.53,DMSO,C28H29FIN5O5S,CC1=C2C(=C(N(C1=O)C)NC3=C(C=C(C=C3)I)F)C(=O)N(C(=O)N2C4=CC(=CC=C4)NC(=O)C)C5CC5.CS(=O)C,insoluble in EtOH; insoluble in H2O; ≥11.2 mg/mL in DMSO with gentle warming and ultrasonic,,MAPK Signaling,MEK1/2,Allosteric MEK1/MEK2 kinase inhibitor,https://www.apexbt.com/search.php?catalog=A3887,1
246,A3888,Trelagliptin,865759-25-7,G05,L1021-03,357.38,DMSO,C18H20FN5O2,CN1C(=O)C=C(N(C1=O)CC2=C(C=CC(=C2)F)C#N)N3CCCC(C3)N,≥11.6 mg/mL in DMSO; ≥3.68 mg/mL in EtOH with gentle warming and ultrasonic; ≥93.8 mg/mL in H2O,Free Base,Proteases,DPP-4,"DPP-4 inhibitor,long-acting and selective",https://www.apexbt.com/search.php?catalog=A3888,1
247,A3891,Triptolide,38748-32-2,G06,L1021-03,360.41,DMSO,C20H24O6,CC(C)C12C(O1)C3C4(O3)C5(CCC6=C(C5CC7C4(C2O)O7)COC6=O)C,≥36 mg/mL in DMSO; insoluble in H2O; insoluble in EtOH,,Immunology/Inflammation,NF-κB,,https://www.apexbt.com/search.php?catalog=A3891,1
248,A3892,Triptonide,38647-11-9,G07,L1021-03,358.39,DMSO,C20H22O6,CC(C)C12C(O1)C3C4(O3)C5(CCC6=C(C5CC7C4(C2=O)O7)COC6=O)C,insoluble in H2O; insoluble in EtOH; ≥16.35 mg/mL in DMSO ,,Others,dCTP Pyrophosphatase,,https://www.apexbt.com/search.php?catalog=A3892,0
249,A3893,Troglitazone,97322-87-7,G08,L1021-03,441.54,DMSO,C24H27NO5S,CC1=C(C(=C2CCC(OC2=C1C)(C)COC3=CC=C(C=C3)CC4C(=O)NC(=O)S4)C)O,insoluble in H2O; ≥20.9 mg/mL in DMSO; ≥3.34 mg/mL in EtOH with gentle warming and ultrasonic,,Metabolism,PPAR,Selective PPARγ agonist,https://www.apexbt.com/search.php?catalog=A3893,1
250,A3900,Umeclidinium bromide,869113-09-7,G09,L1021-03,508.49,DMSO,C29H34BrNO2,C1C[N+]2(CCC1(CC2)C(C3=CC=CC=C3)(C4=CC=CC=C4)O)CCOCC5=CC=CC=C5.[Br-],insoluble in H2O; insoluble in EtOH; ≥61.5 mg/mL in DMSO,,Neuroscience,Muscarinic Receptor,MAChR antagonist,https://www.apexbt.com/search.php?catalog=A3900,1
251,A3919,Vilazodone Hydrochloride,163521-08-2,G10,L1021-03,477.99,DMSO,C26H28ClN5O2,C1CN(CCN1CCCCC2=CNC3=C2C=C(C=C3)C#N)C4=CC5=C(C=C4)OC(=C5)C(=O)N.Cl,≥23.9 mg/mL in DMSO; insoluble in EtOH; insoluble in H2O,Hydrochloride,Neuroscience,5-HT Receptor,Combined SSRI and 5-HT1A receptor partial agonist,https://www.apexbt.com/search.php?catalog=A3919,1
252,A3920,Vinblastine sulfate,143-67-9,G11,L1021-03,909.05,DMSO,C46H60N4O13S,CCC1(CC2CC(C3=C(CCN(C2)C1)C4=CC=CC=C4N3)(C5=C(C=C6C(=C5)C78CCN9C7C(C=CC9)(C(C(C8N6C)(C(=O)OC)O)OC(=O)C)CC)OC)C(=O)OC)O.OS(=O)(=O)O,≥28.85 mg/mL in DMSO; insoluble in EtOH; ≥48.2 mg/mL in H2O with ultrasonic,sulfate,Ubiquitination/Proteasome,Autophagy,Anti-mitotic agent,https://www.apexbt.com/search.php?catalog=A3920,1
253,A3921,Vinorelbine ditartrate,125317-39-7,H01,L1021-03,1079.11,DMSO,C53H66N4O20,CCC1=CC2CC(C3=C(CN(C2)C1)C4=CC=CC=C4N3)(C5=C(C=C6C(=C5)C78CCN9C7C(C=CC9)(C(C(C8N6C)(C(=O)OC)O)OC(=O)C)CC)OC)C(=O)OC.C(C(C(=O)O)O)(C(=O)O)O.C(C(C(=O)O)O)(C(=O)O)O,≥33.7 mg/mL in DMSO; ≥41.9 mg/mL in EtOH with ultrasonic; ≥43 mg/mL in H2O with ultrasonic,ditartrate,Others,Others,Anti-mitotic chemotherapy drug,https://www.apexbt.com/search.php?catalog=A3921,1
254,A3926,Vortioxetine,508233-74-7,H02,L1021-03,298.45,DMSO,C18H22N2S,CC1=CC(=C(C=C1)SC2=CC=CC=C2N3CCNCC3)C,insoluble in H2O; ≥14.92 mg/mL in DMSO; ≥4.31 mg/mL in EtOH with ultrasonic,,Neuroscience,5-HT Receptor,5-HT receptors antagonist,https://www.apexbt.com/search.php?catalog=A3926,1
255,A3952,Ziprasidone,146939-27-7,H03,L1021-03,412.94,DMSO,C21H21ClN4OS,C1CN(CCN1CCC2=C(C=C3C(=C2)CC(=O)N3)Cl)C4=NSC5=CC=CC=C54,≥20.65 mg/mL in DMSO with gentle warming; insoluble in H2O; insoluble in EtOH,Free Base,Neuroscience,5-HT Receptor,5-HT (serotonin)/dopamine receptor antagonist,https://www.apexbt.com/search.php?catalog=A3952,1
256,A3953,Ziprasidone hydrochloride monohydrate,138982-67-9,H04,L1021-03,467.41,DMSO,C21H24Cl2N4O2S,C1CN(CCN1CCC2=C(C=C3C(=C2)CC(=O)N3)Cl)C4=NSC5=CC=CC=C54.O.Cl,insoluble in H2O; insoluble in EtOH; ≥11.69 mg/mL in DMSO,Hydrochloride,Neuroscience,5-HT Receptor,5-HT (serotonin)/dopamine receptor antagonist,https://www.apexbt.com/search.php?catalog=A3953,1
257,A3966,Doxorubicin,23214-92-8,H05,L1021-03,543.52,DMSO,C27H29NO11,CC1C(C(CC(O1)OC2CC(CC3=C(C4=C(C(=C23)O)C(=O)C5=C(C4=O)C=CC=C5OC)O)(C(=O)CO)O)N)O,≥27.2 mg/mL in DMSO; insoluble in EtOH; ≥24.8 mg/mL in H2O with ultrasonic,Free Base,DNA Damage/DNA Repair,Topoisomerase,"Topo II inhibitor,immunosuppresive antineoplastic antibiotic",https://www.apexbt.com/search.php?catalog=A3966,1
258,A3967,Lapatinib Ditosylate,388082-77-7,H06,L1021-03,925.46,DMSO,C29H26ClFN4O4S 2C7H8O3S,O=S(CCNCC1=CC=C(C2=CC3=C(NC4=CC=C(OCC5=CC=CC(F)=C5)C(Cl)=C4)N=CN=C3C=C2)O1)(C)=O.O=S(C6=CC=C(C)C=C6)(O)=O.O=S(C7=CC=C(C)C=C7)(O)=O,≥24.3 mg/mL in DMSO; insoluble in EtOH; insoluble in H2O,Ditosylate,JAK/STAT Signaling,EGFR,"EGFR/HER2 inhibitor,potent and selective",https://www.apexbt.com/search.php?catalog=A3967,1
259,A4007,MLN9708,1201902-80-8,H07,L1021-03,517.1,DMSO,C20H23BCl2N2O9,B1(OC(=O)CC(O1)(CC(=O)O)C(=O)O)C(CC(C)C)NC(=O)CNC(=O)C2=C(C=CC(=C2)Cl)Cl,insoluble in H2O; ≥20.85 mg/mL in DMSO; ≥4.56 mg/mL in EtOH with gentle warming and ultrasonic,,Ubiquitination/Proteasome,Proteasome,Proteasome inhibitor,https://www.apexbt.com/search.php?catalog=A4007,1
260,A4008,MLN2238,1072833-77-2,H08,L1021-03,361,DMSO,C14H19BCl2N2O4,B(C(CC(C)C)NC(=O)CNC(=O)C1=C(C=CC(=C1)Cl)Cl)(O)O,insoluble in H2O; ≥103 mg/mL in EtOH with ultrasonic; ≥16.8 mg/mL in DMSO,Free Base,Ubiquitination/Proteasome,Proteasome,β5 site of the 20S proteasome inhibitor,https://www.apexbt.com/search.php?catalog=A4008,1
261,A4009,CEP-18770,847499-27-8,H09,L1021-03,413.3,DMSO,C21H28BN3O5,B(C(CC(C)C)NC(=O)C(C(C)O)NC(=O)C1=CC=CC(=N1)C2=CC=CC=C2)(O)O,insoluble in H2O; ≥16.75 mg/mL in DMSO; ≥32.27 mg/mL in EtOH with ultrasonic,Free Base,Ubiquitination/Proteasome,Proteasome,Proteasome inhibitor,https://www.apexbt.com/search.php?catalog=A4009,1
262,A4012,Gabexate mesylate,56974-61-9,H10,L1021-03,417.48,DMSO,C16H23N3O4·CH4O3S,CCOC(=O)C1=CC=C(C=C1)OC(=O)CCCCCN=C(N)N.CS(=O)(=O)O,≥102.4 mg/mL in H2O; ≥18.2 mg/mL in DMSO; ≥99.8 mg/mL in EtOH,Mesylate,Proteases,Serine Protease,Trypsin-like serine proteinases inhibitor,https://www.apexbt.com/search.php?catalog=A4012,1
263,A4013,Aspirin (Acetylsalicylic acid),50-78-2,H11,L1021-03,180.16,DMSO,C9H8O4,CC(=O)OC1=CC=CC=C1C(=O)O,insoluble in H2O; ≥104.2 mg/mL in EtOH with ultrasonic; ≥8.55 mg/mL in DMSO,Free Base,Neuroscience,COX,Cyclooxygenase (COX) inhibitor,https://www.apexbt.com/search.php?catalog=A4013,1
264,A4014,Artemether (SM-224),71963-77-4,A01,L1021-04,298.4,DMSO,C16H26O5,CC1CCC2C(C(OC3C24C1CCC(O3)(OO4)C)OC)C,insoluble in H2O; ≥15.3 mg/mL in DMSO; ≥90.2 mg/mL in EtOH,,Ubiquitination/Proteasome,Proteasome,,https://www.apexbt.com/search.php?catalog=A4014,0
265,A4015,Disulfiram,97-77-8,A02,L1021-04,296.54,DMSO,C10H20N2S4,CCN(CC)C(=S)SSC(=S)N(CC)CC,insoluble in H2O; ≥12 mg/mL in DMSO; ≥24.2 mg/mL in EtOH with ultrasonic,Free Base,Metabolism,Dopamine β-hydroxylase,Dopamine β-hydroxylase inhibitor,https://www.apexbt.com/search.php?catalog=A4015,1
266,A4022,BMS-708163 (Avagacestat),1146699-66-2,A03,L1021-04,520.88,DMSO,C20H17ClF4N4O4S,C1=CC(=CC=C1S(=O)(=O)N(CC2=C(C=C(C=C2)C3=NOC=N3)F)C(CCC(F)(F)F)C(=O)N)Cl,insoluble in H2O; ≥177.6 mg/mL in DMSO; ≥47.6 mg/mL in EtOH with ultrasonic,,Proteases,Gamma Secretase,γ-secretase inhibitor,https://www.apexbt.com/search.php?catalog=A4022,1
267,A4024,Danoprevir (RG7227),850876-88-9,A04,L1021-04,731.83,DMSO,C35H46FN5O9S,CC(C)(C)OC(=O)NC1CCCCCC=CC2CC2(NC(=O)C3CC(CN3C1=O)OC(=O)N4CC5=C(C4)C(=CC=C5)F)C(=O)NS(=O)(=O)C6CC6,≥32.6 mg/mL in DMSO; insoluble in H2O; ≥46.4 mg/mL in EtOH with ultrasonic,,Proteases,HCV Protease,,https://www.apexbt.com/search.php?catalog=A4024,0
268,A4031,Telaprevir (VX-950),402957-28-2,A05,L1021-04,679.9,DMSO,C36H53N7O6,CCCC(C(=O)C(=O)NC1CC1)NC(=O)C2C3CCCC3CN2C(=O)C(C(C)(C)C)NC(=O)C(C4CCCCC4)NC(=O)C5=NC=CN=C5,≥32.95 mg/mL in DMSO; insoluble in EtOH; insoluble in H2O,Free Base,Proteases,HCV Protease,HCV NS3-4A protease inhibitor,https://www.apexbt.com/search.php?catalog=A4031,1
269,A4032,"VX-222 (VCH-222, Lomibuvir)",1026785-59-0,A06,L1021-04,445.6,DMSO,C25H35NO4S,CC1CCC(CC1)C(=O)N(C2CCC(CC2)O)C3=C(SC(=C3)C#CC(C)(C)C)C(=O)O,≥44.6 mg/mL in DMSO; insoluble in H2O; ≥97.2 mg/mL in EtOH,,Proteases,HCV Protease,NNI of HCV RNA polymerase,https://www.apexbt.com/search.php?catalog=A4032,1
270,A4033,Glimepiride,93479-97-1,A07,L1021-04,490.62,DMSO,C24H34N4O5S,CCC1=C(CN(C1=O)C(=O)NCCC2=CC=C(C=C2)S(=O)(=O)NC(=O)NC3CCC(CC3)C)C,≥21.45 mg/mL in DMSO; insoluble in H2O; insoluble in EtOH,Free Base,Proteases,DPP-4,Sulfonylurea compound,https://www.apexbt.com/search.php?catalog=A4033,1
271,A4034,Linagliptin (BI-1356),668270-12-0,A08,L1021-04,472.5,DMSO,C25H28N8O2,CC#CCN1C2=C(N=C1N3CCCC(C3)N)N(C(=O)N(C2=O)CC4=NC5=CC=CC=C5C(=N4)C)C,insoluble in H2O; insoluble in EtOH; ≥17.85 mg/mL in DMSO,Free Base,Proteases,DPP-4,"DDP-4 inhibitor,highly potent and competitive",https://www.apexbt.com/search.php?catalog=A4034,1
272,A4036,Sitagliptin phosphate monohydrate,654671-77-9,A09,L1021-04,523.3,DMSO,C16H15F6N5O·H3PO4·H2O,[HH].C1CN2C(=NN=C2C(F)(F)F)CN1C(=O)CC(CC3=CC(=C(C=C3F)F)F)N.O.OOP(=O)=O,≥23.8 mg/mL in DMSO; insoluble in EtOH; ≥30.6 mg/mL in H2O with ultrasonic,phosphate,Proteases,DPP-4,Potent DPP-4 inhibitor,https://www.apexbt.com/search.php?catalog=A4036,1
273,A4037,Vildagliptin (LAF-237),274901-16-5,A10,L1021-04,303.4,DMSO,C17H25N3O2,C1CC(N(C1)C(=O)CNC23CC4CC(C2)CC(C4)(C3)O)C#N,≥12.05 mg/mL in DMSO; ≥96.4 mg/mL in EtOH with ultrasonic; ≥96.8 mg/mL in H2O with ultrasonic,Free Base,Proteases,DPP-4,DPP-4 inhibitor,https://www.apexbt.com/search.php?catalog=A4037,0
274,A4038,Alogliptin (SYR-322),850649-61-5,A11,L1021-04,339.39,DMSO,C18H21N5O2,CN1C(=O)C=C(N(C1=O)CC2=CC=CC=C2C#N)N3CCCC(C3)N,insoluble in H2O; ≥100 mg/mL in EtOH with ultrasonic; ≥14.75 mg/mL in DMSO,Free Base,Proteases,DPP-4,"DPP-4 inhibitor,potent and highly selective",https://www.apexbt.com/search.php?catalog=A4038,1
275,A4040,Atazanavir sulfate (BMS-232632-05),229975-97-7,B01,L1021-04,802.9,DMSO,C38H52N6O7·H2SO4,CC(C)(C)C(C(=O)NC(CC1=CC=CC=C1)C(CN(CC2=CC=C(C=C2)C3=CC=CC=N3)NC(=O)C(C(C)(C)C)NC(=O)OC)O)NC(=O)OC.OS(=O)(=O)O,≥28.7 mg/mL in DMSO with gentle warming; insoluble in H2O; ≥4.05 mg/mL in EtOH with gentle warming and ultrasonic,Sulfate,Proteases,HIV Protease,Protease inhibitor,https://www.apexbt.com/search.php?catalog=A4040,1
276,A4049,Marimastat,154039-60-8,B02,L1021-04,331.41,DMSO,C15H29N3O5,CC(C)CC(C(C(=O)NO)O)C(=O)NC(C(=O)NC)C(C)(C)C,≥2.8 mg/mL in H2O with gentle warming and ultrasonic; ≥20.43 mg/mL in EtOH; ≥80.1 mg/mL in DMSO,Free Base,Proteases,MMP,"MMPs inhibitor,board spectrum",https://www.apexbt.com/search.php?catalog=A4049,1
277,A4050,GM 6001,142880-36-2,B03,L1021-04,388.46,DMSO,C20H28N4O4,CC(C)CC(CC(=O)NO)C(=O)NC(CC1=CNC2=CC=CC=C21)C(=O)NC,insoluble in H2O; insoluble in EtOH; ≥19.42 mg/mL in DMSO,Free Base,Proteases,MMP,Broad spectrum MMP inhibitor,https://www.apexbt.com/search.php?catalog=A4050,1
278,A4052,Doxycycline hyclate,24390-14-5,B04,L1021-04,512.94,DMSO,C23H29ClN2O9,CCO.CC1C2C(C3C(C(=O)C(=C(C3(C(=O)C2=C(C4=C1C=CC=C4O)O)O)O)C(=O)N)N(C)C)O.CC1C2C(C3C(C(=O)C(=C(C3(C(=O)C2=C(C4=C1C=CC=C4O)O)O)O)C(=O)N)N(C)C)O.O.Cl.Cl,≥22.15 mg/mL in DMSO; insoluble in EtOH; ≥49.2 mg/mL in H2O with ultrasonic,Hydrochloride,Others,Others,MMP inhibitor,https://www.apexbt.com/search.php?catalog=A4052,0
279,A4054,17-AAG (KOS953),75747-14-7,B05,L1021-04,585.7,DMSO,C31H43N3O8,CC1CC(C(C(C=C(C(C(C=CC=C(C(=O)NC2=CC(=O)C(=C(C1)C2=O)NCC=C)C)OC)OC(=O)N)C)C)O)OC,≥24.95 mg/mL in DMSO; insoluble in H2O; ≥9.56 mg/mL in EtOH with ultrasonic,Free Base,Proteases,HSP,Hsp90 inhibitor,https://www.apexbt.com/search.php?catalog=A4054,1
280,A4056,AT13387,912999-49-6,B06,L1021-04,409.5,DMSO,C24H31N3O3,CC(C)C1=C(C=C(C(=C1)C(=O)N2CC3=C(C2)C=C(C=C3)CN4CCN(CC4)C)O)O,insoluble in H2O; ≥13.25 mg/mL in DMSO; ≥47.7 mg/mL in EtOH with ultrasonic,Free Base,Proteases,HSP,Hsp90 inhibitor,https://www.apexbt.com/search.php?catalog=A4056,1
281,A4070,Elvitegravir (GS-9137),697761-98-1,B07,L1021-04,447.9,DMSO,C23H23ClFNO5,CC(C)C(CO)N1C=C(C(=O)C2=CC(=C(C=C21)OC)CC3=C(C(=CC=C3)Cl)F)C(=O)O,insoluble in H2O; insoluble in EtOH; ≥20.35 mg/mL in DMSO,Free Base,Proteases,HIV Integrase,"HIV-1 integrase inhibitor,potent",https://www.apexbt.com/search.php?catalog=A4070,1
282,A4071,Fluorouracil (Adrucil),51-21-8,B08,L1021-04,130.1,DMSO,C4H3FN2O2,C1=C(C(=O)NC(=O)N1)F,insoluble in EtOH; ≥10.04 mg/mL in H2O with gentle warming and ultrasonic; ≥13.04 mg/mL in DMSO,Free Base,Proteases,HIV Integrase,Antitumor agent;inhibitor of thymidylate synthase,https://www.apexbt.com/search.php?catalog=A4071,1
283,A4073,Raltegravir (MK-0518),518048-05-0,B09,L1021-04,444.4,DMSO,C20H21FN6O5,CC1=NN=C(O1)C(=O)NC(C)(C)C2=NC(=C(C(=O)N2C)O)C(=O)NCC3=CC=C(C=C3)F,insoluble in EtOH; insoluble in H2O; ≥19.95 mg/mL in DMSO ,Free Base,Proteases,HIV Integrase,HIV-1 integrase inhibitor,https://www.apexbt.com/search.php?catalog=A4073,1
284,A4074,S/GSK1349572,1051375-16-6,B10,L1021-04,419.4,DMSO,C20H19F2N3O5,CC1CCOC2N1C(=O)C3=C(C(=O)C(=CN3C2)C(=O)NCC4=C(C=C(C=C4)F)F)O,≥41.9 mg/mL in DMSO; insoluble in H2O; insoluble in EtOH,Free Base,Proteases,HIV Integrase,"HIV integrase inhibitor, novel and potent",https://www.apexbt.com/search.php?catalog=A4074,1
285,A4078,Captopril,62571-86-2,B11,L1021-04,217.29,DMSO,C9H15NO3S,OC(C1CCCN1C(C(CS)C)=O)=O,≥21.7 mg/mL in DMSO; ≥105.2 mg/mL in EtOH with ultrasonic; ≥48.6 mg/mL in H2O with ultrasonic,,Endocrinology and Hormones,RAAS,,https://www.apexbt.com/search.php?catalog=A4078,1
286,A4080,Moxonidine,75438-57-2,C01,L1021-04,241.68,DMSO,C9H12ClN5O,CC1=NC(=C(C(=N1)Cl)NC2=NCCN2)OC,insoluble in H2O; ≥11.3 mg/mL in DMSO; ≥4.74 mg/mL in EtOH with ultrasonic,Free Base,Others,Imidazoline Receptors,I1R/α2AR agonist,https://www.apexbt.com/search.php?catalog=A4080,1
287,A4082,Olmesartan medoxomil,144689-63-4,C02,L1021-04,558.6,DMSO,C29H30N6O6,CCCC1=NC(=C(N1CC2=CC=C(C=C2)C3=CC=CC=C3C4=NNN=N4)C(=O)OCC5=C(OC(=O)O5)C)C(C)(C)O,≥21.1 mg/mL in DMSO; insoluble in H2O; ≥4.6 mg/mL in EtOH with gentle warming and ultrasonic,Free Base,Proteases,ACE,AT1 receptor antagonist,https://www.apexbt.com/search.php?catalog=A4082,1
288,A4083,Rocilinostat (ACY-1215),1316214-52-4,C03,L1021-04,433.5,DMSO,C24H27N5O3,C1=CC=C(C=C1)N(C2=CC=CC=C2)C3=NC=C(C=N3)C(=O)NCCCCCCC(=O)NO,≥21.675 mg/mL in DMSO; insoluble in H2O; insoluble in EtOH,Free Base,DNA Damage/DNA Repair,HDAC,Selective HDAC6 inhibitor,https://www.apexbt.com/search.php?catalog=A4083,1
289,A4084,"Vorinostat (SAHA, MK0683)",149647-78-9,C04,L1021-04,264.3,DMSO,C14H20N2O3,C1=CC=C(C=C1)NC(=O)CCCCCCC(=O)NO,insoluble in EtOH; insoluble in H2O; ≥4.41 mg/mL in DMSO ,Free Base,DNA Damage/DNA Repair,HDAC,HDAC inhibitor,https://www.apexbt.com/search.php?catalog=A4084,1
290,A4089,"Mocetinostat (MGCD0103, MG0103)",726169-73-9,C05,L1021-04,396.44,DMSO,C23H20N6O,C1=CC=C(C(=C1)N)NC(=O)C2=CC=C(C=C2)CNC3=NC=CC(=N3)C4=CN=CC=C4,insoluble in EtOH; insoluble in H2O; ≥19.8 mg/mL in DMSO ,Free Base,DNA Damage/DNA Repair,HDAC,"HDAC inhibitor,isotype-selective and potent",https://www.apexbt.com/search.php?catalog=A4089,1
291,A4092,CUDC-101,1012054-59-9,C06,L1021-04,434.49,DMSO,C24H26N4O4,COC1=C(C=C2C(=C1)N=CN=C2NC3=CC=CC(=C3)C#C)OCCCCCCC(=O)NO,≥21.7 mg/mL in DMSO; insoluble in EtOH; insoluble in H2O,Free Base,DNA Damage/DNA Repair,HDAC,Multitargeted HDAC inhibitor,https://www.apexbt.com/search.php?catalog=A4092,1
292,A4095,Pracinostat (SB939),929016-96-6,C07,L1021-04,358.48,DMSO,C20H30N4O2,ONC(/C=C/C1=CC=C2N(CCN(CC)CC)C(CCCC)=NC2=C1)=O,insoluble in H2O; ≥11.4 mg/mL in DMSO; ≥24.8 mg/mL in EtOH with ultrasonic,Free Base,DNA Damage/DNA Repair,HDAC,Pan-HDAC inhibitor,https://www.apexbt.com/search.php?catalog=A4095,1
293,A4096,Belinostat (PXD101),414864-00-9,C08,L1021-04,318.35,DMSO,C15H14N2O4S,C1=CC=C(C=C1)NS(=O)(=O)C2=CC=CC(=C2)C=CC(=O)NO,insoluble in H2O; ≥15.92 mg/mL in DMSO; ≥44.1 mg/mL in EtOH with ultrasonic,Free Base,DNA Damage/DNA Repair,HDAC,Hydroxamate-type HDAC inhibitor,https://www.apexbt.com/search.php?catalog=A4096,1
294,A4098,PCI-24781 (CRA-024781),783355-60-2,C09,L1021-04,397.42,DMSO,C21H23N3O5,CN(C)CC1=C(OC2=CC=CC=C21)C(=O)NCCOC3=CC=C(C=C3)C(=O)NO,insoluble in H2O; insoluble in EtOH; ≥11.75 mg/mL in DMSO with gentle warming,Free Base,DNA Damage/DNA Repair,HDAC,Pan-HDAC inhibitor,https://www.apexbt.com/search.php?catalog=A4098,1
295,A4099,Valproic acid sodium salt (Sodium valproate),1069-66-5,C10,L1021-04,166.19,DMSO,C8H15NaO2,CCCC(CCC)C(=O)[O-].[Na+],≥8.35 mg/mL in DMSO; ≥88.2 mg/mL in H2O; ≥90.2 mg/mL in EtOH,Free Base,DNA Damage/DNA Repair,HDAC,HDAC inhibitor,https://www.apexbt.com/search.php?catalog=A4099,1
296,A4107,Sodium Phenylbutyrate,1716-12-7,C11,L1021-04,186.18,DMSO,C10H11O2·Na,C1=CC=C(C=C1)CCCC(=O)[O-].[Na+],≥27.65 mg/mL in H2O; ≥50.9 mg/mL in EtOH with ultrasonic; ≥6.3 mg/mL in DMSO,Sodium,DNA Damage/DNA Repair,HDAC,Histone deacetylase inhibitor,https://www.apexbt.com/search.php?catalog=A4107,1
297,A4110,MLN8237 (Alisertib),1028486-01-2,D01,L1021-04,518.92,DMSO,C27H20ClFN4O4,COC1=C(C(=CC=C1)F)C2=NCC3=CN=C(N=C3C4=C2C=C(C=C4)Cl)NC5=CC(=C(C=C5)C(=O)O)OC,≥25.95 mg/mL in DMSO; insoluble in H2O; insoluble in ETOH,Free Base,Chromatin/Epigenetics,Aurora Kinase,"Aurora A Kinase inhibitor, Potent and selective",https://www.apexbt.com/search.php?catalog=A4110,1
298,A4111,"VX-680 (MK-0457,Tozasertib)",639089-54-6,D02,L1021-04,464.59,DMSO,C23H28N8OS,CC1=CC(=NN1)NC2=NC(=NC(=C2)N3CCN(CC3)C)SC4=CC=C(C=C4)NC(=O)C5CC5,≥23.25 mg/mL in DMSO; insoluble in EtOH; insoluble in H2O,Free Base,Chromatin/Epigenetics,Aurora Kinase,Aurora kinase inhibitor,https://www.apexbt.com/search.php?catalog=A4111,1
299,A4112,Barasertib (AZD1152-HQPA),722544-51-6,D03,L1021-04,507.56,DMSO,C26H30FN7O3,CCN(CCCOC1=CC2=C(C=C1)C(=NC=N2)NC3=NNC(=C3)CC(=O)NC4=CC(=CC=C4)F)CCO,≥25.4 mg/mL in DMSO; insoluble in EtOH; insoluble in H2O,Free Base,Chromatin/Epigenetics,Aurora Kinase,"Aurora Kinase B inhibitor, Potent and selective",https://www.apexbt.com/search.php?catalog=A4112,1
300,A4135,Tofacitinib (CP-690550) Citrate,540737-29-9,D04,L1021-04,504.49,DMSO,C16H20N6O·C6H8O7,CC1CCN(CC1N(C)C2=NC=NC3=C2C=CN3)C(=O)CC#N.C(C(=O)O)C(CC(=O)O)(C(=O)O)O,≥25.22 mg/mL in DMSO; insoluble in EtOH; ≥3.4 mg/mL in H2O with gentle warming and ultrasonic,Citrate,Chromatin/Epigenetics,JAK,Potent JAK inhibitor,https://www.apexbt.com/search.php?catalog=A4135,1
301,A4136,TG101348 (SAR302503),936091-26-8,D05,L1021-04,524.68,DMSO,C27H36N6O3S,CC1=CN=C(N=C1NC2=CC(=CC=C2)S(=O)(=O)NC(C)(C)C)NC3=CC=C(C=C3)OCCN4CCCC4,≥26.23 mg/mL in DMSO; insoluble in H2O; ≥6.69 mg/mL in EtOH with gentle warming and ultrasonic,Free Base,Chromatin/Epigenetics,JAK,"JAK-2 inhibitor,potent and selective",https://www.apexbt.com/search.php?catalog=A4136,1
302,A4138,"Tofacitinib (CP-690550,Tasocitinib)",477600-75-2,D06,L1021-04,312.37,DMSO,C16H20N6O,CC1CCN(CC1N(C)C2=NC=NC3=C2C=CN3)C(=O)CC#N,insoluble in EtOH; insoluble in H2O; ≥15.6 mg/mL in DMSO,Free Base,Chromatin/Epigenetics,JAK,Janus kinase inhibitor,https://www.apexbt.com/search.php?catalog=A4138,1
303,A4141,"Baricitinib (LY3009104, INCB028050)",1187594-09-7,D07,L1021-04,371.42,DMSO,C16H17N7O2S,CCS(=O)(=O)N1CC(C1)(CC#N)N2C=C(C=N2)C3=C4C=CNC4=NC=N3,insoluble in EtOH; insoluble in H2O; ≥18.57 mg/mL in DMSO,,Chromatin/Epigenetics,JAK,"JAK1/JAK2 inhibitor,selective orally bioavailable",https://www.apexbt.com/search.php?catalog=A4141,1
304,A4147,LY2784544,1229236-86-5,D08,L1021-04,469.94,DMSO,C23H25ClFN7O,CC1=CC(=NN1)NC2=NN3C(=C(N=C3C(=C2)CN4CCOCC4)C)CC5=C(C=C(C=C5)Cl)F,≥23.5 mg/mL in DMSO; insoluble in H2O; ≥5.65 mg/mL in EtOH with gentle warming and ultrasonic,Free Base,Chromatin/Epigenetics,JAK,"JAK2 inhibitor,highly potent and selective",https://www.apexbt.com/search.php?catalog=A4147,1
305,A4153,BMN 673,1207456-01-6,D09,L1021-04,380.35,DMSO,C19H14F2N6O,CN1C(=NC=N1)C2C(NC3=CC(=CC4=C3C2=NNC4=O)F)C5=CC=C(C=C5)F,insoluble in H2O; ≥14.2 mg/mL in EtOH with gentle warming and ultrasonic; ≥19.02 mg/mL in DMSO,,DNA Damage/DNA Repair,PARP,,https://www.apexbt.com/search.php?catalog=A4153,0
306,A4154,"Olaparib (AZD2281, Ku-0059436)",763113-22-0,D10,L1021-04,434.46,DMSO,C24H23FN4O3,C1CC1C(=O)N2CCN(CC2)C(=O)C3=C(C=CC(=C3)CC4=NNC(=O)C5=CC=CC=C54)F,≥21.72 mg/mL in DMSO; insoluble in EtOH; insoluble in H2O,Free Base,Chromatin/Epigenetics,PARP,Potent PARP1/PARP2 inhibitor,https://www.apexbt.com/search.php?catalog=A4154,1
307,A4156,"Rucaparib (AG-014699,PF-01367338)",459868-92-9,D11,L1021-04,421.36,DMSO,C19H18FN3O·H3PO4,OP(O)(O)=O.FC1=CC2=C3C(CCNC2=O)=C(C4=CC=C(CNC)C=C4)NC3=C1,≥21.08 mg/mL in DMSO; insoluble in EtOH; insoluble in H2O,Phosphate,Chromatin/Epigenetics,PARP,Potent PARP inhibitor,https://www.apexbt.com/search.php?catalog=A4156,1
308,A4157,Iniparib (BSI-201),160003-66-7,E01,L1021-04,292.03,DMSO,C7H5IN2O3,C1=CC(=C(C=C1C(=O)N)[N+](=O)[O-])I,insoluble in H2O; ≥103.4 mg/mL in DMSO; ≥24.3 mg/mL in EtOH with gentle warming and ultrasonic,,Chromatin/Epigenetics,PARP,"PARP1 inhibitor,intravenously adminsitered",https://www.apexbt.com/search.php?catalog=A4157,1
309,A4168,Entacapone,130929-57-6,E02,L1021-04,305.29,DMSO,C14H15N3O5,CCN(CC)C(=O)C(=CC1=CC(=C(C(=C1)O)O)[N+](=O)[O-])C#N,insoluble in H2O; ≥12.65 mg/mL in EtOH with ultrasonic; ≥13.1 mg/mL in DMSO,,Chromatin/Epigenetics,Histone Methyltransferase,COMT inhibitor,https://www.apexbt.com/search.php?catalog=A4168,1
310,A4176,Thioguanine,154-42-7,E03,L1021-04,167.19,DMSO,C5H5N5S,C1=NC2=C(N1)C(=S)N=C(N2)N,insoluble in EtOH; insoluble in H2O; ≥8.35 mg/mL in DMSO with gentle warming,,DNA Damage/DNA Repair,DNA Methyltransferase,Purine antimetabolite,https://www.apexbt.com/search.php?catalog=A4176,1
311,A4181,EX 527 (SEN0014196),49843-98-3,E04,L1021-04,248.71,DMSO,C13H13ClN2O,ClC1=CC2=C(C=C1)NC3=C2CCCC3C(N)=O,insoluble in H2O; ≥12.43 mg/mL in DMSO; ≥25.45 mg/mL in EtOH with ultrasonic,Free Base,Chromatin/Epigenetics,Sirtuin,SIRT1 inhibitor,https://www.apexbt.com/search.php?catalog=A4181,1
312,A4182,Resveratrol,501-36-0,E05,L1021-04,228.24,DMSO,C14H12O3,C1=CC(=CC=C1C=CC2=CC(=CC(=C2)O)O)O,insoluble in H2O; ≥48.2 mg/mL in EtOH with ultrasonic; ≥9.65 mg/mL in DMSO,Free Base,Chromatin/Epigenetics,Sirtuin,SIRT1 activator,https://www.apexbt.com/search.php?catalog=A4182,1
313,A4187,FG-4592 (ASP1517),808118-40-3,E06,L1021-04,352.34,DMSO,C19H16N2O5,CC1=NC(=C(C2=C1C=C(C=C2)OC3=CC=CC=C3)O)C(=O)NCC(=O)O,insoluble in H2O; ≥17.62 mg/mL in DMSO; ≥2.9 mg/mL in EtOH with gentle warming and ultrasonic,Free Base,Angiogenesis,HIF,HIF prolyl-hydroxylase inhibitor,https://www.apexbt.com/search.php?catalog=A4187,1
314,A4188,2-Methoxyestradiol (2-MeOE2),362-07-2,E07,L1021-04,302.41,DMSO,C19H26O3,CC12CCC3C(C1CCC2O)CCC4=CC(=C(C=C34)OC)O,insoluble in H2O; ≥15.25 mg/mL in DMSO; ≥24.25 mg/mL in EtOH with ultrasonic,Free Base,Apoptosis,Apoptosis Inducers,"Apoptotic, antiproliferative and antiangiogenic agent",https://www.apexbt.com/search.php?catalog=A4188,1
315,A4211,Lenalidomide (CC-5013),191732-72-6,E08,L1021-04,259.3,DMSO,C13H13N3O3,C1CC(=O)NC(=O)C1N2CC3=C(C2=O)C=CC=C3N,insoluble in EtOH; insoluble in H2O; ≥100.8 mg/mL in DMSO,Free Base,Apoptosis,TNF-α,"Antineoplastic agent,inhibits angiogenesis",https://www.apexbt.com/search.php?catalog=A4211,1
316,A4212,Pomalidomide (CC-4047),19171-19-8,E09,L1021-04,273.2,DMSO,C13H11N3O4,C1CC(=O)NC(=O)C1N2C(=O)C3=C(C2=O)C(=CC=C3)N,insoluble in EtOH; insoluble in H2O; ≥7.5 mg/mL in DMSO,Free Base,Apoptosis,TNF-α,"Immunomodulator,antumor/anti-angiogenic",https://www.apexbt.com/search.php?catalog=A4212,1
317,A4216,Thalidomide,50-35-1,E10,L1021-04,258.23,DMSO,C13H10N2O4,C1CC(=O)NC(=O)C1N2C(=O)C3=CC=CC=C3C2=O,insoluble in H2O; insoluble in EtOH; ≥11.8 mg/mL in DMSO,Free Base,Apoptosis,TNF-α,"Immunomodulatory agent,sedative drug,angiogenesis inhibitor",https://www.apexbt.com/search.php?catalog=A4216,1
318,A4219,Birinapant (TL32711),1260251-31-7,E11,L1021-04,806.94,DMSO,C42H56F2N8O6,CCC(C(=O)N1CC(CC1CC2=C(NC3=C2C=CC(=C3)F)C4=C(C5=C(N4)C=C(C=C5)F)CC6CC(CN6C(=O)C(CC)NC(=O)C(C)NC)O)O)NC(=O)C(C)NC,≥40.35 mg/mL in DMSO; insoluble in H2O; ≥46.9 mg/mL in EtOH,Free Base,Apoptosis,IAP,Potent XIAP/cIAP1 antagonist,https://www.apexbt.com/search.php?catalog=A4219,1
319,A4221,YM155,781661-94-7,F01,L1021-04,443.3,DMSO,C20H19BrN4O3,CC1=[N+](C2=C(N1CCOC)C(=O)C3=CC=CC=C3C2=O)CC4=NC=CN=C4.[Br-],≥22.15 mg/mL in DMSO; ≥13.49 mg/mL in EtOH with ultrasonic; ≥96.2 mg/mL in H2O with ultrasonic,Free Base,Apoptosis,IAP,"Survivin suppressant,apoptosis inhibitor",https://www.apexbt.com/search.php?catalog=A4221,1
320,A4227,Tipifarnib (Zarnestra),192185-72-1,F02,L1021-04,489.4,DMSO,C27H22Cl2N4O,CN1C=NC=C1C(C2=CC=C(C=C2)Cl)(C3=CC4=C(C=C3)N(C(=O)C=C4C5=CC(=CC=C5)Cl)C)N,insoluble in H2O; ≥8.16 mg/mL in DMSO; ≥9.16 mg/mL in EtOH with ultrasonic,,Metabolism,Transferase,,https://www.apexbt.com/search.php?catalog=A4227,1
321,A4232,Cyclophosphamide monohydrate,6055-19-2,F03,L1021-04,279.1,DMSO,C7H15Cl2N2O2P·H2O,C1CNP(=O)(OC1)N(CCCl)CCCl.O,≥13.95 mg/mL in DMSO; ≥51.5 mg/mL in H2O with gentle warming and ultrasonic; ≥96 mg/mL in EtOH,Monohydrate,Others,Others,"alkylating, cytotoxic agent,antitumor activity",https://www.apexbt.com/search.php?catalog=A4232,1
322,A4233,Methylprednisolone,83-43-2,F04,L1021-04,374.48,DMSO,C22H30O5,CC1CC2C3CCC(C3(CC(C2C4(C1=CC(=O)C=C4)C)O)C)(C(=O)CO)O,insoluble in H2O; ≥15.35 mg/mL in DMSO; ≥9.5 mg/mL in EtOH with ultrasonic,Free Base,GPCR/G protein,Glucocorticoid Receptor,"Apoptosis inducer,GR agonist",https://www.apexbt.com/search.php?catalog=A4233,1
323,A4237,"Amuvatinib (MP-470, HPK 56)",850879-09-3,F05,L1021-04,447.51,DMSO,C23H21N5O3S,C1CN(CCN1C2=NC=NC3=C2OC4=CC=CC=C43)C(=S)NCC5=CC6=C(C=C5)OCO6,≥22.4 mg/mL in DMSO; insoluble in H2O; insoluble in EtOH,Free Base,Tyrosine Kinase,c-RET,Tyrosine kinase inhibitor,https://www.apexbt.com/search.php?catalog=A4237,1
324,A4240,Abiraterone,154229-19-3,F06,L1021-04,349.52,DMSO,C24H31NO,CC12CCC(CC1=CCC3C2CCC4(C3CC=C4C5=CN=CC=C5)C)O,insoluble in EtOH; insoluble in H2O; ≥5.57 mg/mL in DMSO with gentle warming,Free Base,Metabolism,P450,Potent CYP17 inhibitor,https://www.apexbt.com/search.php?catalog=A4240,1
325,A4302,Rosiglitazone maleate,155141-29-0,F07,L1021-04,473.5,DMSO,C18H19N3O3S·C4H4O4,CN(CCOC1=CC=C(C=C1)CC2C(=O)NC(=O)S2)C3=CC=CC=N3.C(=CC(=O)O)C(=O)O,≥23.7 mg/mL in DMSO; insoluble in H2O; ≥19 mg/mL in EtOH with ultrasonic,Maleate,Metabolism,PPAR,"PPARγ agonist,high-affinity and selective,potent insulin sensitizer",https://www.apexbt.com/search.php?catalog=A4302,1
326,A4304,Rosiglitazone,122320-73-4,F08,L1021-04,357.43,DMSO,C18H19N3O3S,CN(CCOC1=CC=C(C=C1)CC2C(=O)NC(=O)S2)C3=CC=CC=N3,insoluble in EtOH; insoluble in H2O; ≥17.85 mg/mL in DMSO,Free Base,Metabolism,PPAR,Potent PPARγ agonist,https://www.apexbt.com/search.php?catalog=A4304,1
327,A4306,Ciprofibrate,52214-84-3,F09,L1021-04,289.15,DMSO,C13H14Cl2O3,CC(C(O)=O)(OC1=CC=C(C2CC2(Cl)Cl)C=C1)C,insoluble in H2O; ≥10.85 mg/mL in DMSO; ≥94.6 mg/mL in EtOH,,Metabolism,PPAR,PPARα agonist,https://www.apexbt.com/search.php?catalog=A4306,1
328,A4310,Rosiglitazone HCl,302543-62-0,F10,L1021-04,393.89,DMSO,C18H20ClN3O3S,CN(C1=CC=CC=N1)CCOC2=CC=C(CC3C(NC(S3)=O)=O)C=C2.Cl,≥39.4 mg/mL in DMSO; ≥2.81 mg/mL in H2O with gentle warming and ultrasonic; ≥51.2 mg/mL in EtOH with ultrasonic,,Metabolism,PPAR,PPARγ agonist,https://www.apexbt.com/search.php?catalog=A4310,1
329,A4313,Cobicistat (GS-9350),1004316-88-4,F11,L1021-04,776.02,DMSO,C40H53N7O5S2,CC(C1=NC(CN(C(NC(C(NC(CC2=CC=CC=C2)CCC(NC(OCC3=CN=CS3)=O)CC4=CC=CC=C4)=O)CCN5CCOCC5)=O)C)=CS1)C,insoluble in H2O; ≥150.9 mg/mL in DMSO; ≥102.4 mg/mL in EtOH with ultrasonic,,Metabolism,CYP3A/CYP450,Selective CYP3A inhibitor,https://www.apexbt.com/search.php?catalog=A4313,1
330,A4316,Ketoconazole,65277-42-1,G01,L1021-04,531.43,DMSO,C26H28Cl2N4O4,CC(=O)N1CCN(CC1)C2=CC=C(C=C2)OCC3COC(O3)(CN4C=CN=C4)C5=C(C=C(C=C5)Cl)Cl,≥23.4 mg/mL in DMSO; insoluble in H2O; ≥10 mg/mL in EtOH with ultrasonic,Free Base,Metabolism,P450,Inhibitor of cyclosporine oxidase and testosterone 6 beta-hydroxylase,https://www.apexbt.com/search.php?catalog=A4316,1
331,A4317,Apremilast (CC-10004),608141-41-9,G02,L1021-04,460.5,DMSO,C22H24N2O7S,CCOC1=C(C=CC(=C1)C(CS(=O)(=O)C)N2C(=O)C3=C(C2=O)C(=CC=C3)NC(=O)C)OC,≥23.05 mg/mL in DMSO; insoluble in H2O; insoluble in EtOH,Free Base,Metabolism,PDE,PDE4 inhibitor,https://www.apexbt.com/search.php?catalog=A4317,1
332,A4319,Roflumilast,162401-32-3,G03,L1021-04,403.21,DMSO,C17H14Cl2F2N2O3,C1CC1COC2=C(C=CC(=C2)C(=O)NC3=C(C=NC=C3Cl)Cl)OC(F)F,insoluble in H2O; ≥20.2 mg/mL in DMSO; ≥9.94 mg/mL in EtOH with ultrasonic,Free Base,Metabolism,PDE,PDE-4 inhibitor,https://www.apexbt.com/search.php?catalog=A4319,1
333,A4320,Voriconazole,137234-62-9,G04,L1021-04,349.31,DMSO,C16H14F3N5O,CC(C1=NC=NC=C1F)C(CN2C=NC=N2)(C3=C(C=C(C=C3)F)F)O,≥34.9 mg/mL in DMSO; insoluble in H2O; ≥45 mg/mL in EtOH with gentle warming and ultrasonic,Free Base,Metabolism,CYP3A/CYP450,CYP51 inhibitor,https://www.apexbt.com/search.php?catalog=A4320,1
334,A4321,Sildenafil Citrate,171599-83-0,G05,L1021-04,666.7,DMSO,C22H30N6O4S·C6H8O7,CCCC1=NN(C2=C1NC(=NC2=O)C3=C(C=CC(=C3)S(=O)(=O)N4CCN(CC4)C)OCC)C.C(C(=O)O)C(CC(=O)O)(C(=O)O)O,≥25.35 mg/mL in DMSO; insoluble in EtOH; ≥2.97 mg/mL in H2O with gentle warming and ultrasonic,Citrate,Metabolism,PDE,Treat erectile dysfunction and PAH,https://www.apexbt.com/search.php?catalog=A4321,1
335,A4322,Clarithromycin,81103-11-9,G06,L1021-04,747.95,DMSO,C38H69NO13,CCC1C(C(C(C(=O)C(CC(C(C(C(C(C(=O)O1)C)OC2CC(C(C(O2)C)O)(C)OC)C)OC3C(C(CC(O3)C)N(C)C)O)(C)OC)C)C)O)(C)O,≥31.2 mg/mL in DMSO; insoluble in H2O; ≥3.24 mg/mL in EtOH with gentle warming and ultrasonic,Free Base,Metabolism,CYP3A/CYP450,"CYP3A inhibitor, potent",https://www.apexbt.com/search.php?catalog=A4322,1
336,A4323,Vardenafil HCl Trihydrate,330808-88-3,G07,L1021-04,579.11,DMSO,C23H32N6O4S·HCl·3H2O,CCCC1=NC(=C2N1NC(=NC2=O)C3=C(C=CC(=C3)S(=O)(=O)N4CCN(CC4)CC)OCC)C,≥13.3 mg/mL in DMSO; ≥3.42 mg/mL in EtOH with gentle warming and ultrasonic; ≥95 mg/mL in H2O,,Metabolism,PDE,,https://www.apexbt.com/search.php?catalog=A4323,1
337,A4324,Pioglitazone HCl,112529-15-4,G08,L1021-04,392.9,DMSO,C19H20N2O3S·HCl,CCC1=CN=C(C=C1)CCOC2=CC=C(C=C2)CC3C(=O)NC(=O)S3.Cl,insoluble in H2O; ≥19.65 mg/mL in DMSO; ≥7.52 mg/mL in EtOH with gentle warming and ultrasonic,Hydrochloride,Metabolism,PPAR,PPARγ agonist,https://www.apexbt.com/search.php?catalog=A4324,1
338,A4327,Tadalafil,171596-29-5,G09,L1021-04,389.4,DMSO,C22H19N3O4,CN1CC(=O)N2C(C1=O)CC3=C(C2C4=CC5=C(C=C4)OCO5)NC6=CC=CC=C36,insoluble in H2O; insoluble in EtOH; ≥16.6 mg/mL in DMSO,Free Base,Metabolism,PDE,PDE5 inhibitor,https://www.apexbt.com/search.php?catalog=A4327,0
339,A4328,Rolipram,61413-54-5,G10,L1021-04,275.34,DMSO,C16H21NO3,COC1=C(C=C(C=C1)C2CC(=O)NC2)OC3CCCC3,insoluble in H2O; ≥13 mg/mL in DMSO; ≥24.65 mg/mL in EtOH with ultrasonic,Free Base,Metabolism,PDE,PDE4-inhibitor and an anti-inflammatory agent,https://www.apexbt.com/search.php?catalog=A4328,1
340,A4329,Cilomilast,153259-65-5,G11,L1021-04,343.42,DMSO,C20H25NO4,COC1=C(C=C(C=C1)C2(CCC(CC2)C(=O)O)C#N)OC3CCCC3,insoluble in H2O; ≥12.95 mg/mL in DMSO; ≥49.9 mg/mL in EtOH with gentle warming and ultrasonic,,Metabolism,PDE,Potent PDE4 inhibitor,https://www.apexbt.com/search.php?catalog=A4329,1
341,A4330,Isotretinoin,4759-48-2,H01,L1021-04,300.44,DMSO,C20H28O2,CC1=C(C(CCC1)(C)C)C=CC(=CC=CC(=CC(=O)O)C)C,insoluble in H2O; ≥13.8 mg/mL in DMSO; ≥24.3 mg/mL in EtOH with gentle warming and ultrasonic,Free Base,Metabolism,Dopamine β-hydroxylase,Dopamine β-hydroxylase activator,https://www.apexbt.com/search.php?catalog=A4330,1
342,A4334,Avanafil,330784-47-9,H02,L1021-04,483.95,DMSO,C23H26ClN7O3,COC1=C(C=C(C=C1)CNC2=NC(=NC=C2C(=O)NCC3=NC=CC=N3)N4CCCC4CO)Cl,insoluble in H2O; insoluble in EtOH; ≥17.6 mg/mL in DMSO,Free Base,Metabolism,PDE,PDE5 inhibitor,https://www.apexbt.com/search.php?catalog=A4334,0
343,A4336,Mycophenolate Mofetil,128794-94-5,H03,L1021-04,433.49,DMSO,C23H31NO7,CC1=C(C(=C(C2=C1COC2=O)O)CC=C(C)CCC(=O)OCCN3CCOCC3)OC,insoluble in H2O; ≥15.68 mg/mL in EtOH with ultrasonic; ≥16.25 mg/mL in DMSO,Free Base,Metabolism,Dehydrogenase,IMPDH inhibitor,https://www.apexbt.com/search.php?catalog=A4336,1
344,A4337,Cilostazol,73963-72-1,H04,L1021-04,369.46,DMSO,C20H27N5O2,C1CCC(CC1)N2C(=NN=N2)CCCCOC3=CC4=C(C=C3)NC(=O)CC4,insoluble in H2O; ≥15.4 mg/mL in DMSO; ≥3.95 mg/mL in EtOH with gentle warming and ultrasonic,Free Base,Metabolism,PDE,PDE3 inhibitor,https://www.apexbt.com/search.php?catalog=A4337,1
345,A4338,Rivaroxaban,366789-02-8,H05,L1021-04,435.88,DMSO,C19H18ClN3O5S,C1COCC(=O)N1C2=CC=C(C=C2)N3CC(OC3=O)CNC(=O)C4=CC=C(S4)Cl,insoluble in H2O; insoluble in EtOH; ≥13.9 mg/mL in DMSO with gentle warming,Free Base,Metabolism,Factor Xa,Factor Xa inhibitor,https://www.apexbt.com/search.php?catalog=A4338,1
346,A4340,Pimobendan,74150-27-9,H06,L1021-04,334.37,DMSO,C19H18N4O2,CC1CC(=O)NN=C1C2=CC3=C(C=C2)N=C(N3)C4=CC=C(C=C4)OC,insoluble in H2O; ≥16.2 mg/mL in DMSO; ≥19.48 mg/mL in EtOH with gentle warming and ultrasonic,Free Base,Metabolism,PDE,Selective PDE3 inhibitor.Ca2+ channel sensitizer,https://www.apexbt.com/search.php?catalog=A4340,1
347,A4341,Apixaban,503612-47-3,H07,L1021-04,459.5,DMSO,C25H25N5O4,COC1=CC=C(C=C1)N2C3=C(CCN(C3=O)C4=CC=C(C=C4)N5CCCCC5=O)C(=N2)C(=O)N,insoluble in H2O; ≥10.64 mg/mL in EtOH with gentle warming and ultrasonic; ≥11.5 mg/mL in DMSO,Free Base,Proteases,Thrombin,Factor Xa inhibitor,https://www.apexbt.com/search.php?catalog=A4341,1
348,A4342,Gimeracil,103766-25-2,H08,L1021-04,145.54,DMSO,C5H4ClNO2,C1=C(C(=CNC1=O)Cl)O,insoluble in H2O; ≥6.56 mg/mL in EtOH with gentle warming and ultrasonic; ≥6.6 mg/mL in DMSO,Free Base,Metabolism,Dehydrogenase,Dihydropyrimidine dehydrogenase inhibitor,https://www.apexbt.com/search.php?catalog=A4342,1
349,A4343,Dyphylline,479-18-5,H09,L1021-04,254.24,DMSO,C10H14N4O4,CN1C2=C(C(=O)N(C1=O)C)N(C=N2)CC(CO)O,≥17.17 mg/mL in H2O; ≥21.96 mg/mL in EtOH with gentle warming and ultrasonic; ≥7.8 mg/mL in DMSO,Free Base,Metabolism,PDE,Pan-PDE inhibitor,https://www.apexbt.com/search.php?catalog=A4343,1
350,A4344,Ozagrel,82571-53-7,H10,L1021-04,228.25,DMSO,C13H12N2O2,C1=CC(=CC=C1CN2C=CN=C2)C=CC(=O)O,≥10.8 mg/mL in DMSO; ≥13.23 mg/mL in EtOH with gentle warming and ultrasonic; ≥17.03 mg/mL in H2O,Free Base,Metabolism,Factor Xa,Thromboxane A2 synthetase inhibitor,https://www.apexbt.com/search.php?catalog=A4344,1
351,A4346,Aminophylline,317-34-0,H11,L1021-04,420.43,H2O,C16H24N10O4,CN1C2=C(C(=O)N(C1=O)C)NC=N2.CN1C2=C(C(=O)N(C1=O)C)NC=N2.C(CN)N,≥13.48 mg/mL in DMSO with gentle warming and ultrasonic; ≥14.45 mg/mL in H2O with gentle warming; ≥16.933 mg/mL in EtOH with gentle warming and ultrasonic,Ethylenediamine,Metabolism,PDE,Pan-PDE inhibitor,https://www.apexbt.com/search.php?catalog=A4346,1
352,A4347,Methotrexate,59-05-2,A01,L1021-05,454.44,DMSO,C20H22N8O5,CN(CC1=CN=C2C(=N1)C(=NC(=N2)N)N)C3=CC=C(C=C3)C(=O)NC(CCC(=O)O)C(=O)O,≥21.55 mg/mL in DMSO; insoluble in EtOH; insoluble in H2O,Free Base,Metabolism,DHFR,"Folate antagonist,inhibits DFHR",https://www.apexbt.com/search.php?catalog=A4347,1
353,A4348,Trilostane,13647-35-3,A02,L1021-05,329.43,DMSO,C20H27NO3,CC12CCC3C(C1CCC2O)CCC45C3(CC(=C(C4O5)O)C#N)C,insoluble in H2O; insoluble in EtOH; ≥16.35 mg/mL in DMSO,Free Base,Metabolism,Dehydrogenase,3β-HSD inhibitor,https://www.apexbt.com/search.php?catalog=A4348,0
354,A4349,S- (+)-Rolipram,85416-73-5,A03,L1021-05,275.34,DMSO,C16H21NO3,COC1=C(C=C(C=C1)C2CC(=O)NC2)OC3CCCC3,insoluble in H2O; ≥13.9 mg/mL in DMSO; ≥20.76 mg/mL in EtOH with gentle warming and ultrasonic,Free Base,Metabolism,PDE,CAMP-specific PDE4 inhibitor,https://www.apexbt.com/search.php?catalog=A4349,1
355,A4350,Pralatrexate,146464-95-1,A04,L1021-05,477.47,DMSO,C23H23N7O5,C#CCC(CC1=CN=C2C(=N1)C(=NC(=N2)N)N)C3=CC=C(C=C3)C(=O)NC(CCC(=O)O)C(=O)O,≥23.85 mg/mL in DMSO; insoluble in H2O; insoluble in EtOH,Free Base,Metabolism,DHFR,"Antifolate,a folate analog",https://www.apexbt.com/search.php?catalog=A4350,1
356,A4352,Anagrelide HCl,58579-51-4,A05,L1021-05,292.55,DMSO,C10H8Cl3N3O,C1C2=C(C=CC(=C2Cl)Cl)NC3=NC(=O)CN31.Cl,insoluble in EtOH; insoluble in H2O; ≥4.9 mg/mL in DMSO,Hydrochloride,Metabolism,PDE,Thrombocytopenic agent,https://www.apexbt.com/search.php?catalog=A4352,1
357,A4353,Pyrimethamine,58-14-0,A06,L1021-05,248.71,DMSO,C12H13ClN4,CCC1=C(C(=NC(=N1)N)N)C2=CC=C(C=C2)Cl,insoluble in H2O; ≥10 mg/mL in DMSO with gentle warming; ≥5.23 mg/mL in EtOH with ultrasonic,Free Base,Metabolism,DHFR,DHFR inhibitor,https://www.apexbt.com/search.php?catalog=A4353,1
358,A4357,Dorzolamide HCl,130693-82-2,A07,L1021-05,360.9,H2O,C10H16N2O4S3·HCl,CCNC1CC(S(=O)(=O)C2=C1C=C(S2)S(=O)(=O)N)C.Cl,insoluble in EtOH; ≥13 mg/mL in H2O; ≥18.67 mg/mL in DMSO with ultrasonic,Hydrochloride,Metabolism,Carbonic Anhydrase,Carbonic anhydrase inhibitor,https://www.apexbt.com/search.php?catalog=A4357,1
359,A4359,Brinzolamide,138890-62-7,A08,L1021-05,383.51,DMSO,C12H21N3O5S3,CCNC1CN(S(=O)(=O)C2=C1C=C(S2)S(=O)(=O)N)CCCOC,insoluble in H2O; ≥15.05 mg/mL in DMSO; ≥8.82 mg/mL in EtOH with gentle warming and ultrasonic,Free Base,Metabolism,Carbonic Anhydrase,CA II inhibitor,https://www.apexbt.com/search.php?catalog=A4359,0
360,A4360,Topiramate,97240-79-4,A09,L1021-05,339.36,DMSO,C12H21NO8S,CC1(OC2COC3(C(C2O1)OC(O3)(C)C)COS(=O)(=O)N)C,≥16.95 mg/mL in DMSO; ≥2.22 mg/mL in H2O with ultrasonic; ≥24.1 mg/mL in EtOH,Free Base,Metabolism,Carbonic Anhydrase,"GluR5 receptor antagonist,anticonvulsant",https://www.apexbt.com/search.php?catalog=A4360,1
361,A4362,Tioxolone,4991-65-5,A10,L1021-05,168.17,DMSO,C7H4O3S,OC1=CC(OC(S2)=O)=C2C=C1,≥63.2 mg/mL in DMSO; ≥2.33 mg/mL in H2O with gentle warming and ultrasonic; ≥22.7 mg/mL in EtOH with ultrasonic,,Metabolism,Carbonic Anhydrase,CAI inhibitor,https://www.apexbt.com/search.php?catalog=A4362,1
362,A4363,Fluvastatin Sodium,93957-55-2,A11,L1021-05,433.45,DMSO,C24H25FNNaO4,CC(C)N1C2=CC=CC=C2C(=C1C=CC(CC(CC(=O)[O-])O)O)C3=CC=C(C=C3)F.[Na+],≥16.83 mg/mL in EtOH; ≥18.15 mg/mL in DMSO; ≥8.22 mg/mL in H2O,Sodium,Metabolism,HMG-CoA Reductase,HMG-CoA reductase inhibitor,https://www.apexbt.com/search.php?catalog=A4363,1
363,A4364,Methazolamide,554-57-4,B01,L1021-05,236.27,DMSO,C5H8N4O3S2,CC(=O)N=C1N(N=C(S1)S(=O)(=O)N)C,≥11.18 mg/mL in EtOH with gentle warming and ultrasonic; ≥2.58 mg/mL in H2O with gentle warming and ultrasonic; ≥7.25 mg/mL in DMSO ,Free Base,Metabolism,Carbonic Anhydrase,Carbonic anhydrase inhibitor,https://www.apexbt.com/search.php?catalog=A4364,1
364,A4365,Lovastatin,75330-75-5,B02,L1021-05,404.54,DMSO,C24H36O5,CCC(C)C(=O)OC1CC(C=C2C1C(C(C=C2)C)CCC3CC(CC(=O)O3)O)C,insoluble in H2O; ≥18.6 mg/mL in EtOH with ultrasonic; ≥20.2 mg/mL in DMSO,Free Base,Metabolism,HMG-CoA Reductase,HMG-CoA reductase inhibitor,https://www.apexbt.com/search.php?catalog=A4365,1
365,A4366,Rasagiline Mesylate,161735-79-1,B03,L1021-05,267.34,DMSO,C12H13N·CH4O3S,CS(=O)(=O)O.C#CCNC1CCC2=CC=CC=C12,≥13.37 mg/mL in DMSO; ≥46 mg/mL in EtOH with ultrasonic; ≥95.8 mg/mL in H2O,Mesylate,Metabolism,MAO,Irreversible MAO-B inhibitor,https://www.apexbt.com/search.php?catalog=A4366,1
366,A4367,Atorvastatin Calcium,134523-03-8,B04,L1021-05,1155.34,DMSO,2(C33H34FN2O5)·Ca,CC(C)C1=C(C(=C(N1CCC(CC(CC(=O)[O-])O)O)C2=CC=C(C=C2)F)C3=CC=CC=C3)C(=O)NC4=CC=CC=C4.CC(C)C1=C(C(=C(N1CCC(CC(CC(=O)[O-])O)O)C2=CC=C(C=C2)F)C3=CC=CC=C3)C(=O)NC4=CC=CC=C4.[Ca+2],≥57.75 mg/mL in DMSO; insoluble in H2O; ≥2.94 mg/mL in EtOH with gentle warming and ultrasonic,Calcium,Metabolism,HMG-CoA Reductase,HMG-CoA reductase inhibitor,https://www.apexbt.com/search.php?catalog=A4367,1
367,A4368,Safinamide Mesylate,202825-46-5,B05,L1021-05,398.45,DMSO,C17H19FN2O2·CH4O3S,CC(C(=O)N)NCC1=CC=C(C=C1)OCC2=CC(=CC=C2)F.CS(=O)(=O)O,≥10.08 mg/mL in EtOH with gentle warming and ultrasonic; ≥16.1 mg/mL in DMSO; ≥84.6 mg/mL in H2O,Mesylate,Metabolism,MAO,"MAO-B inhibitor,potent,selective and reversible",https://www.apexbt.com/search.php?catalog=A4368,1
368,A4369,Pravastatin sodium,81131-70-6,B06,L1021-05,446.51,DMSO,C23H35O7·Na,CCC(C)C(=O)OC1CC(C=C2C1C(C(C=C2)C)CCC(CC(CC(=O)[O-])O)O)O.[Na+],≥100.4 mg/mL in EtOH with ultrasonic; ≥13.15 mg/mL in DMSO; ≥98.8 mg/mL in H2O,Free Base,Metabolism,HMG-CoA Reductase,"HMG-CoA reductase inhibitor,highly selective and competitive",https://www.apexbt.com/search.php?catalog=A4369,1
369,A4370,Moclobemide (Ro 111163),71320-77-9,B07,L1021-05,268.74,DMSO,C13H17ClN2O2,C1COCCN1CCNC(=O)C2=CC=C(C=C2)Cl,insoluble in H2O; ≥48.3 mg/mL in EtOH with ultrasonic; ≥9.85 mg/mL in DMSO,Free Base,Metabolism,MAO,Reversible inhibitor of MAO-A,https://www.apexbt.com/search.php?catalog=A4370,1
370,A4377,Evacetrapib (LY2484595),1186486-62-3,B08,L1021-05,638.65,DMSO,C31H36F6N6O2,CC1=CC(=C2C(=C1)C(CCCN2CC3CCC(CC3)C(=O)O)N(CC4=CC(=CC(=C4)C(F)(F)F)C(F)(F)F)C5=NN(N=N5)C)C,≥32.1 mg/mL in DMSO; insoluble in H2O; ≥50.4 mg/mL in EtOH with ultrasonic,Free Base,Metabolism,CETP,"CETP inhibitor,potent and selective",https://www.apexbt.com/search.php?catalog=A4377,1
371,A4378,Torcetrapib,262352-17-0,B09,L1021-05,600.47,DMSO,C26H25F9N2O4,CCC1CC(C2=C(N1C(=O)OCC)C=CC(=C2)C(F)(F)F)N(CC3=CC(=CC(=C3)C(F)(F)F)C(F)(F)F)C(=O)OC,≥22.4 mg/mL in DMSO; insoluble in H2O; ≥69 mg/mL in EtOH with gentle warming and ultrasonic,,Metabolism,CETP,CETP inhibitor,https://www.apexbt.com/search.php?catalog=A4378,1
372,A4379,Lonafarnib,193275-84-2,B10,L1021-05,638.82,DMSO,C27H31Br2ClN4O2,C1CN(CCC1CC(=O)N2CCC(CC2)C3C4=C(C=C(C=C4CCC5=CC(=CN=C35)Br)Cl)Br)C(=O)N,≥31.95 mg/mL in DMSO; insoluble in H2O; ≥96.4 mg/mL in EtOH with ultrasonic,Free Base,Metabolism,Transferase,"Ftase inhibitor,potent and selective",https://www.apexbt.com/search.php?catalog=A4379,1
373,A4383,Tolcapone,134308-13-7,B11,L1021-05,273.24,DMSO,C14H11NO5,CC1=CC=C(C=C1)C(=O)C2=CC(=C(C(=C2)O)O)[N+](=O)[O-],insoluble in H2O; ≥12 mg/mL in DMSO; ≥5.78 mg/mL in EtOH with gentle warming and ultrasonic,Free Base,Metabolism,Transferase,COMT inhibitor,https://www.apexbt.com/search.php?catalog=A4383,1
374,A4385,Ganetespib (STA-9090),888216-25-9,C01,L1021-05,364.4,DMSO,C20H20N4O3,CC(C)C1=CC(=C2NNC(=O)N2C3=CC4=C(C=C3)N(C=C4)C)C(=O)C=C1O,insoluble in H2O; ≥18.22 mg/mL in DMSO; ≥6.4 mg/mL in EtOH with gentle warming and ultrasonic,Free Base,Proteases,HSP,"Hsp90 inhibitor,non-geldanamycin",https://www.apexbt.com/search.php?catalog=A4385,1
375,A4390,Pemetrexed,150399-23-8,C02,L1021-05,471.37,H2O,C20H19N5Na2O6,C1=CC(=CC=C1CCC2=CNC3=C2C(=O)N=C(N3)N)C(=O)NC(CCC(=O)[O-])C(=O)[O-].[Na+].[Na+],insoluble in EtOH; ≥15.68 mg/mL in DMSO with gentle warming and ultrasonic; ≥30.67 mg/mL in H2O,Free Base,Metabolism,DHFR,"TS, DHFR,GARFT and AICARFT inhibitor",https://www.apexbt.com/search.php?catalog=A4390,1
376,A4393,Paclitaxel (Taxol),33069-62-4,C03,L1021-05,853.91,DMSO,C47H51NO14,CC1=C2C(C(=O)C3(C(CC4C(C3C(C(C2(C)C)(CC1OC(=O)C(C(C5=CC=CC=C5)NC(=O)C6=CC=CC=C6)O)O)OC(=O)C7=CC=CC=C7)(CO4)OC(=O)C)O)C)OC(=O)C,≥42.7 mg/mL in DMSO; insoluble in H2O; insoluble in H2O; ≥29.53 mg/mL in EtOH with ultrasonic; ≥31.6 mg/mL in EtOH with ultrasonic,Free Base,Cell Cycle/Checkpoint,Microtubule/Tubulin,Antineoplastic agent,https://www.apexbt.com/search.php?catalog=A4393,0
377,A4394,Docetaxel,114977-28-5,C04,L1021-05,807.88,DMSO,C43H53NO14,CC1=C2C(C(=O)C3(C(CC4C(C3C(C(C2(C)C)(CC1OC(=O)C(C(C5=CC=CC=C5)NC(=O)OC(C)(C)C)O)O)OC(=O)C6=CC=CC=C6)(CO4)OC(=O)C)O)C)O,≥40.4 mg/mL in DMSO; insoluble in H2O; ≥94.4 mg/mL in EtOH,Free Base,Cell Cycle/Checkpoint,Microtubule/Tubulin,Microtubulin disassembly inhibitor,https://www.apexbt.com/search.php?catalog=A4394,0
378,A4395,10-DAB (10-Deacetylbaccatin),32981-86-5,C05,L1021-05,544.59,DMSO,C29H36O10,CC1=C2C(C(=O)C3(C(CC4C(C3C(C(C2(C)C)(CC1O)O)OC(=O)C5=CC=CC=C5)(CO4)OC(=O)C)O)C)O,≥22.25 mg/mL in DMSO; insoluble in H2O; ≥3.96 mg/mL in EtOH with ultrasonic,Free Base,Cell Cycle/Checkpoint,Microtubule/Tubulin,Precursor of antitumor compound Palitaxel and Docetaxel,https://www.apexbt.com/search.php?catalog=A4395,0
379,A4448,Actinomycin D,50-76-0,C06,L1021-05,1255.43,DMSO,C62H86N12O16,CC1C(C(=O)NC(C(=O)N2CCCC2C(=O)N(CC(=O)N(C(C(=O)O1)C(C)C)C)C)C(C)C)NC(=O)C3=C4C(=C(C=C3)C)OC5=C(C(=O)C(=C(C5=N4)C(=O)NC6C(OC(=O)C(N(C(=O)CN(C(=O)C7CCCN7C(=O)C(NC6=O)C(C)C)C)C)C(C)C)C)N)C,≥62.75 mg/mL in DMSO; insoluble in H2O; insoluble in EtOH,,Apoptosis,Apoptosis Inducers,,https://www.apexbt.com/search.php?catalog=A4448,1
380,A4452,Mitomycin C,50-07-7,C07,L1021-05,334.33,DMSO,C15H18N4O5,CC1=C(C(=O)C2=C(C1=O)N3CC4C(C3(C2COC(=O)N)OC)N4)N,insoluble in H2O; insoluble in EtOH; ≥16.7 mg/mL in DMSO,Free Base,Apoptosis,Apoptosis Inducers,"Inhibits DNA synthesis,antibiotic and antitumor agent",https://www.apexbt.com/search.php?catalog=A4452,0
381,A4457,Streptozocin,18883-66-4,C08,L1021-05,265.22,DMSO,C8H15N3O7,CN(C(=O)NC1C(C(C(OC1O)CO)O)O)N=O,≥10.3 mg/mL in DMSO; ≥26.5 mg/mL in EtOH with gentle warming; ≥53.2 mg/mL in H2O,Free Base,Apoptosis,Apoptosis Inducers,Antibiotic and antitumor agent,https://www.apexbt.com/search.php?catalog=A4457,1
382,A4468,Cesium chloride,7647-17-8,C09,L1021-05,168.36,H2O,ClCs,[Cs+].[Cl-],insoluble in EtOH; insoluble in DMSO; ≥90.6 mg/mL in H2O,,Apoptosis,Other Apoptosis,,https://www.apexbt.com/search.php?catalog=A4468,1
383,A4473,Melphalan,148-82-3,C10,L1021-05,305.2,DMSO,C13H18Cl2N2O2,C1=CC(=CC=C1CC(C(=O)O)N)N(CCCl)CCCl,insoluble in H2O; insoluble in EtOH; ≥6.85 mg/mL in DMSO,Free Base,Apoptosis,Other Apoptosis,DNA alkylating agent,https://www.apexbt.com/search.php?catalog=A4473,1
384,A4601,Empagliflozin (BI 10773),864070-44-0,C11,L1021-05,450.91,DMSO,C23H27ClO7,C1COCC1OC2=CC=C(C=C2)CC3=C(C=CC(=C3)C4C(C(C(C(O4)CO)O)O)O)Cl,insoluble in H2O; ≥20.75 mg/mL in DMSO; ≥7.06 mg/mL in EtOH with ultrasonic,,Metabolism,SGLT,SGLT-2 inhibitor for oral treatment of type 2 diabetes,https://www.apexbt.com/search.php?catalog=A4601,1
385,A5010,Asenapine,85650-56-2,D01,L1021-05,401.84,DMSO,C17H16ClNO·C4H4O4,CN1CC2C(C1)C3=C(C=CC(=C3)Cl)OC4=CC=CC=C24,≥20.09 mg/mL in DMSO; ≥24.75 mg/mL in EtOH with ultrasonic; ≥3.025 mg/mL in H2O with ultrasonic,Free Base,Neuroscience,5-HT Receptor,Inhibits adrenergic receptor/5-HT receptor,https://www.apexbt.com/search.php?catalog=A5010,0
386,A5047,Ivacaftor (VX-770),873054-44-5,D02,L1021-05,392.49,DMSO,C24H28N2O3,CC(C)(C)C1=CC(=C(C=C1NC(=O)C2=CNC3=CC=CC=C3C2=O)O)C(C)(C)C,insoluble in H2O; ≥19.6 mg/mL in DMSO; ≥2.95 mg/mL in EtOH with ultrasonic,Free Base,Membrane Transporter/Ion Channel,CFTR,Potent CFTR potentiator,https://www.apexbt.com/search.php?catalog=A5047,1
387,A5059,Edaravone,89-25-8,D03,L1021-05,174.2,DMSO,C10H10N2O,CC1=NN(C(=O)C1)C2=CC=CC=C2,insoluble in H2O; ≥47.8 mg/mL in EtOH with ultrasonic; ≥6.45 mg/mL in DMSO,Free Base,Others,Others,A radical scavenger and antioxidant,https://www.apexbt.com/search.php?catalog=A5059,1
388,A5065,Bicalutamide,90357-06-5,D04,L1021-05,430.37,DMSO,C18H14F4N2O4S,CC(CS(=O)(=O)C1=CC=C(C=C1)F)(C(=O)NC2=CC(=C(C=C2)C#N)C(F)(F)F)O,≥21.5 mg/mL in DMSO; insoluble in H2O; ≥4.3 mg/mL in EtOH with ultrasonic,Free Base,Endocrinology and Hormones,Androgen Receptor,Androgen receptor antagonist,https://www.apexbt.com/search.php?catalog=A5065,1
389,A5066,Heparin sodium,9041-08-1,D05,L1021-05,6000-20000,H2O,(C12H16NS2Na3)20,CC(=O)NC1C(C(C(OC1O)COS(=O)(=O)O)OC2C(C(C(C(O2)C(=O)O)OC3C(C(C(C(O3)CO)OC4C(C(C(C(O4)C(=O)O)O)O)OS(=O)(=O)O)OS(=O)(=O)O)NS(=O)(=O)O)O)OS(=O)(=O)O)O.[Na+],insoluble in EtOH; insoluble in DMSO; ≥12.75 mg/mL in H2O,Free Base,Proteases,Thrombin,Antithrombin III activator,https://www.apexbt.com/search.php?catalog=A5066,0
390,A5124,Meropenem,96036-03-2,D06,L1021-05,383.46,DMSO,C17H25N3O5S,CC1C2C(C(=O)N2C(=C1SC3CC(NC3)C(=O)N(C)C)C(=O)O)C(C)O,insoluble in EtOH; ≥19.15 mg/mL in DMSO; ≥9.88 mg/mL in H2O with ultrasonic,Free Base,Microbiology & Virology,Antibiotic,β-lactam antibiotic of the carbapenem subclass,https://www.apexbt.com/search.php?catalog=A5124,1
391,A5133,Irinotecan,97682-44-5,D07,L1021-05,586.68,DMSO,C33H38N4O6,O=C(OC1)C(O)(CC)C2=C1C(N(CC3=C4N=C5C(C=C(OC(N6CCC(N7CCCCC7)CC6)=O)C=C5)=C3CC)C4=C2)=O,insoluble in H2O; ≥11.4 mg/mL in DMSO; ≥4.9 mg/mL in EtOH,Free Base,DNA Damage/DNA Repair,Topoisomerase,Topoisomerase I inhibitor,https://www.apexbt.com/search.php?catalog=A5133,1
392,A5143,Finasteride,98319-26-7,D08,L1021-05,372.54,DMSO,C23H36N2O2,CC12CCC3C(C1CCC2C(=O)NC(C)(C)C)CCC4C3(C=CC(=O)N4)C,insoluble in H2O; ≥14.65 mg/mL in DMSO; ≥76.4 mg/mL in EtOH,Free Base,Endocrinology and Hormones,5-alpha Reductase,Inhibitor of Type II 5α-reductase,https://www.apexbt.com/search.php?catalog=A5143,1
393,A5166,Ondansetron HCl,99614-01-4,D09,L1021-05,329.82,DMSO,C18H19N3O·HCl,CC1=NC=CN1CC2CCC3=C(C2=O)C4=CC=CC=C4N3C.Cl,insoluble in EtOH; insoluble in H2O; ≥25.5 mg/mL in DMSO,Hydrochloride,Neuroscience,5-HT Receptor,5-HT3 receptor antagonist,https://www.apexbt.com/search.php?catalog=A5166,1
394,A5173,Alfuzosin HCl,81403-68-1,D10,L1021-05,425.91,DMSO,C19H27N5O4·HCl,CN(CCCNC(=O)C1CCCO1)C2=NC3=CC(=C(C=C3C(=N2)N)OC)OC.Cl,≥19 mg/mL in DMSO; ≥3 mg/mL in EtOH with ultrasonic; ≥47.8 mg/mL in H2O,Hydrochloride,GPCR/G protein,Adrenergic Receptor,"α1 adrenoceptor antagonist,functionally uro-selective",https://www.apexbt.com/search.php?catalog=A5173,1
395,A5181,Linezolid,165800-03-3,D11,L1021-05,337.35,DMSO,C16H20FN3O4,CC(=O)NCC1CN(C(=O)O1)C2=CC(=C(C=C2)N3CCOCC3)F,≥16.85 mg/mL in DMSO; ≥2.48 mg/mL in H2O with gentle warming and ultrasonic; ≥9.5 mg/mL in EtOH with ultrasonic,Free Base,Microbiology & Virology,Antibiotic,Antibacterial reagent,https://www.apexbt.com/search.php?catalog=A5181,1
396,A5183,Clopidogrel,120202-66-6,E01,L1021-05,419.9,DMSO,C16H16ClNO2S·H2SO4,COC(=O)C(C1=CC=CC=C1Cl)N2CCC3=C(C2)C=CS3.OS(=O)(=O)O,≥20.995 mg/mL in DMSO; ≥48.6 mg/mL in H2O; ≥50 mg/mL in EtOH with ultrasonic,Sulfate,Neuroscience,P2 Receptor,P2Y12 receptor antagonist,https://www.apexbt.com/search.php?catalog=A5183,1
397,A5220,Vecuronium Bromide,50700-72-6,E02,L1021-05,637.73,DMSO,C34H57N2O4·Br,CC(=O)OC1CC2CCC3C(C2(CC1N4CCCCC4)C)CCC5(C3CC(C5OC(=O)C)[N+]6(CCCCC6)C)C.[Br-],≥31.89 mg/mL in DMSO; insoluble in H2O; ≥98.6 mg/mL in EtOH with ultrasonic,Bromide,Neuroscience,AChR,Nonpolarizing neuromuscular relaxant,https://www.apexbt.com/search.php?catalog=A5220,1
398,A5226,Tigecycline,220620-09-7,E03,L1021-05,585.65,DMSO,C29H39N5O8,CC(C)(C)NCC(=O)NC1=C(C2=C(CC3CC4C(C(=O)C(=C(C4(C(=O)C3=C2O)O)O)C(=O)N)N(C)C)C(=C1)N(C)C)O,≥29.3 mg/mL in DMSO; insoluble in EtOH; ≥32.47 mg/mL in H2O with ultrasonic,Free Base,Microbiology & Virology,Antibiotic,Glycylcycline antibiotic,https://www.apexbt.com/search.php?catalog=A5226,1
399,A5275,Tenofovir,147127-20-6,E04,L1021-05,287.21,DMSO,C9H14N5O4P,CC(CN1C=NC2=C1N=CN=C2N)OCP(=O)(O)O,insoluble in EtOH; insoluble in H2O; ≥4.38 mg/mL in DMSO with gentle warming,Free Base,Microbiology & Virology,Reverse Transcriptase,HIV reverse transcriptase inhibitor,https://www.apexbt.com/search.php?catalog=A5275,1
400,A5293,Risedronate Sodium,115436-72-1,E05,L1021-05,305.09,H2O,C7H10NNaO7P2,C1=CC(=CN=C1)CC(O)(P(=O)(O)O)P(=O)(O)[O-].[Na+],insoluble in EtOH; insoluble in DMSO; ≥10.17 mg/mL in H2O with gentle warming,,Others,Others,FPP synthase inhibitor,https://www.apexbt.com/search.php?catalog=A5293,1
401,A5294,Sumatriptan Succinate,103628-48-4,E06,L1021-05,413.49,DMSO,C14H21N3O2S·C4H6O4,CNS(=O)(=O)CC1=CC2=C(C=C1)NC=C2CCN(C)C.C(CC(=O)O)C(=O)O,insoluble in EtOH; ≥136.8 mg/mL in DMSO; ≥47.2 mg/mL in H2O,,Neuroscience,5-HT Receptor,5-HT1 receptor agonist,https://www.apexbt.com/search.php?catalog=A5294,1
402,A5300,Ranolazine 2HCl,95635-56-6,E07,L1021-05,500.46,DMSO,C24H33N3O4·2HCl,CC1=C(C(=CC=C1)C)NC(=O)CN2CCN(CC2)CC(COC3=CC=CC=C3OC)O.Cl.Cl,≥20.25 mg/mL in DMSO; ≥3.34 mg/mL in EtOH with ultrasonic; ≥47.2 mg/mL in H2O,Dihydrochloride,Membrane Transporter/Ion Channel,Calcium Channel,Partial fatty acid oxidation inhibitor,https://www.apexbt.com/search.php?catalog=A5300,1
403,A5316,Repaglinide,135062-02-1,E08,L1021-05,452.59,DMSO,C27H36N2O4,CCOC1=C(C=CC(=C1)CC(=O)NC(CC(C)C)C2=CC=CC=C2N3CCCCC3)C(=O)O,insoluble in H2O; ≥16.73 mg/mL in EtOH with ultrasonic; ≥17 mg/mL in DMSO,Free Base,Membrane Transporter/Ion Channel,Potassium Channel,Kir6 (KATP) channel blocker,https://www.apexbt.com/search.php?catalog=A5316,1
404,A5318,Prazosin HCl,19237-84-4,E09,L1021-05,419.86,DMSO,C19H21N5O4·HCl,COC1=C(C=C2C(=C1)C(=NC(=N2)N3CCN(CC3)C(=O)C4=CC=CO4)N)OC.Cl,insoluble in H2O; insoluble in EtOH; ≥6.99 mg/mL in DMSO,Free Base,GPCR/G protein,Adrenergic Receptor,α1 and α2B-adrenoceptor antagonist,https://www.apexbt.com/search.php?catalog=A5318,1
405,A5322,Tianeptine sodium,30123-17-2,E10,L1021-05,458.93,DMSO,C21H24ClN2NaO4S,CN1C2=CC=CC=C2C(C3=C(S1(=O)=O)C=C(C=C3)Cl)NCCCCCCC(=O)[O-].[Na+],≥22.95 mg/mL in DMSO; ≥16.27 mg/mL in EtOH with ultrasonic; ≥50.3 mg/mL in H2O with ultrasonic,Sodium Salt,Neuroscience,5-HT Receptor,"5-HT uptake facilitator,selective,antidepressant",https://www.apexbt.com/search.php?catalog=A5322,1
406,A5323,Moxifloxacin HCl,186826-86-8,E11,L1021-05,437.89,DMSO,C21H24FN3O4·HCl,COC1=C2C(=CC(=C1N3CC4CCCNC4C3)F)C(=O)C(=CN2C5CC5)C(=O)O.Cl,insoluble in EtOH; ≥19.15 mg/mL in DMSO; ≥25.4 mg/mL in H2O with gentle warming,Hydrochloride,DNA Damage/DNA Repair,Topoisomerase,Fluoroquinolone antibiotic,https://www.apexbt.com/search.php?catalog=A5323,1
407,A5331,"TSU-68 (SU6668,Orantinib)",252916-29-3,F01,L1021-05,310.35,DMSO,C18H18N2O3,CC1=C(NC(=C1CCC(=O)O)C)C=C2C3=CC=CC=C3NC2=O,insoluble in EtOH; insoluble in H2O; ≥15.5 mg/mL in DMSO,Free Base,Tyrosine Kinase,VEGFR,"PDGFR/Flk-1/FGFR1 inhibitor,potent and competitive",https://www.apexbt.com/search.php?catalog=A5331,1
408,A5343,Ispinesib (SB-715992),336113-53-2,F02,L1021-05,517.06,DMSO,C30H33ClN4O2,CC1=CC=C(C=C1)C(=O)N(CCCN)C(C2=NC3=C(C=CC(=C3)Cl)C(=O)N2CC4=CC=CC=C4)C(C)C,≥25.85 mg/mL in DMSO; insoluble in H2O; ≥48.4 mg/mL in EtOH,Free Base,Cell Cycle/Checkpoint,Ksp,Kinesin spindle protein (KSP)inhibitor,https://www.apexbt.com/search.php?catalog=A5343,1
409,A5346,Marbofloxacin,115550-35-1,F03,L1021-05,362.36,DMSO,C17H19FN4O4,FC1=C(C2=C(C3=C1[H])N(C([H])=C(C(O[H])=O)C3=O)N(C([H])([H])[H])C([H])([H])O2)N4C([H])([H])C([H])([H])N(C([H])([H])[H])C([H])([H])C4([H])[H],insoluble in EtOH; insoluble in H2O; ≥6.18 mg/mL in DMSO with gentle warming,Free Base,Microbiology & Virology,Antibiotic,Fluoroquinolone antibiotic for veterinary use,https://www.apexbt.com/search.php?catalog=A5346,1
410,A5350,Ziprasidone HCl,122883-93-6,F04,L1021-05,449.4,DMSO,C21H21ClN4OS·HCl,C1CN(CCN1CCC2=C(C=C3C(=C2)CC(=O)N3)Cl)C4=NSC5=CC=CC=C54.Cl,≥22.47 mg/mL in DMSO; insoluble in H2O; insoluble in EtOH,Hydrochloride,Neuroscience,5-HT Receptor,Serotonin and dopamine receptor antagonist,https://www.apexbt.com/search.php?catalog=A5350,1
411,A5354,Zonisamide,68291-97-4,F05,L1021-05,212.23,DMSO,C8H8N2O3S,C1=CC=C2C(=C1)C(=NO2)CS(=O)(=O)N,insoluble in H2O; ≥8.35 mg/mL in DMSO; ≥9.48 mg/mL in EtOH with gentle warming and ultrasonic,Free Base,Membrane Transporter/Ion Channel,Calcium Channel,Antiepileptic with anticonvulsant and mechanistic effect,https://www.apexbt.com/search.php?catalog=A5354,1
412,A5355,Venlafaxine,99300-78-4,F06,L1021-05,313.86,DMSO,C17H27NO2·HCl,CN(C)CC(C1=CC=C(C=C1)OC)C2(CCCCC2)O.Cl,≥28.65 mg/mL in DMSO; ≥56.5 mg/mL in H2O; ≥59.7 mg/mL in EtOH,Hydrochloride,Neuroscience,5-HT Receptor,Dual serotonin/noradrenalin re-uptake inhibitor,https://www.apexbt.com/search.php?catalog=A5355,1
413,A5375,Tranilast,53902-12-8,F07,L1021-05,327.33,DMSO,C18H17NO5,COC1=C(C=C(C=C1)C=CC(=O)NC2=CC=CC=C2C(=O)O)OC,≥32.7 mg/mL in DMSO; insoluble in H2O; insoluble in EtOH,Free Base,GPCR/G protein,Angiotensin Receptor,Angiogenesis inhibitor,https://www.apexbt.com/search.php?catalog=A5375,1
414,A5384,Zileuton,111406-87-2,F08,L1021-05,236.29,DMSO,C11H12N2O2S,CC(C1=CC2=CC=CC=C2S1)N(C(=O)N)O,insoluble in H2O; ≥12.73 mg/mL in EtOH; ≥13.3 mg/mL in DMSO,Free Base,Immunology/Inflammation,5-Lipoxygenase,"5-lipoxygenase (5-LOX) inhibitor, orally active",https://www.apexbt.com/search.php?catalog=A5384,1
415,A5391,Varenicline Tartrate,375815-87-5,F09,L1021-05,361.35,DMSO,C13H13N3·C4H6O6,O=C([C@]([C@@](C(O[H])=O)([H])O[H])([H])O[H])O[H].[H][C@@]12C([H])([H])C(C([H])([H])N([H])C2([H])[H])([H])C3=C([H])C4=NC([H])=C([H])N=C4C([H])=C13,insoluble in EtOH; ≥18.07 mg/mL in DMSO; ≥96.2 mg/mL in H2O,Tartrate,Neuroscience,AChR,"Subtype-selective agonist of α4β2 nicotinic receptors,orally active",https://www.apexbt.com/search.php?catalog=A5391,0
416,A5399,Iloperidone,133454-47-4,F10,L1021-05,426.48,DMSO,C24H27FN2O4,CC(=O)C1=CC(=C(C=C1)OCCCN2CCC(CC2)C3=NOC4=C3C=CC(=C4)F)OC,≥21.32 mg/mL in DMSO; insoluble in EtOH; insoluble in H2O,Free Base,Neuroscience,5-HT Receptor,Dopamine (D2) and serotonin (5HT2) receptor antagonist,https://www.apexbt.com/search.php?catalog=A5399,1
417,A5413,HMN-214,173529-46-9,F11,L1021-05,424.47,DMSO,C22H20N2O5S,CC(=O)N(C1=CC=CC=C1C=CC2=CC=[N+](C=C2)[O-])S(=O)(=O)C3=CC=C(C=C3)OC,≥21.2 mg/mL in DMSO; insoluble in H2O; insoluble in EtOH,,Cell Cycle/Checkpoint,PLK,"Plk inhibitor,broad-spectrum anti-tumor agent",https://www.apexbt.com/search.php?catalog=A5413,1
418,A5424,Fludarabine,21679-14-1,G01,L1021-05,285.23,DMSO,C10H12FN5O4,C1=NC2=C(N1C3C(C(C(O3)CO)O)O)N=C(N=C2N)F,insoluble in H2O; insoluble in EtOH; ≥9.25 mg/mL in DMSO,Free Base,DNA Damage/DNA Repair,DNA Synthesis,DNA synthsis inhibitor,https://www.apexbt.com/search.php?catalog=A5424,1
419,A5467,Ponatinib (AP24534),943319-70-8,G02,L1021-05,532.56,DMSO,C29H27F3N6O,CC1=C(C=C(C=C1)C(=O)NC2=CC(=C(C=C2)CN3CCN(CC3)C)C(F)(F)F)C#CC4=CN=C5N4N=CC=C5,≥53.3 mg/mL in DMSO; insoluble in H2O; insoluble in EtOH,,TGF-β / Smad Signaling,Bcr-Abl,"pan-BCR-ABL inhibitor,multi-kinase inhibitor",https://www.apexbt.com/search.php?catalog=A5467,1
420,A5489,Zibotentan (ZD4054),186497-07-4,G03,L1021-05,424.43,DMSO,C19H16N6O4S,CC1=CN=C(C(=N1)OC)NS(=O)(=O)C2=C(N=CC=C2)C3=CC=C(C=C3)C4=NN=CO4,insoluble in EtOH; insoluble in H2O; ≥7.2 mg/mL in DMSO,Free Base,GPCR/G protein,Endothelin Receptor,"ETA receptor antagonist,potent and specific",https://www.apexbt.com/search.php?catalog=A5489,1
421,A5511,Ofloxacin,82419-36-1,G04,L1021-05,361.37,DMSO,C18H20FN3O4,FC1=C(C2=C(C3=C1[H])N(C([H])=C(C(O[H])=O)C3=O)C(C([H])([H])[H])([H])C([H])([H])O2)N4C([H])([H])C([H])([H])N(C([H])([H])[H])C([H])([H])C4([H])[H],insoluble in H2O; insoluble in EtOH; ≥12.03 mg/mL in DMSO with gentle warming,,DNA Damage/DNA Repair,Topoisomerase,"Fluoroquinolones,antibiotics",https://www.apexbt.com/search.php?catalog=A5511,1
422,A5559,Cefaclor,53994-73-3,G05,L1021-05,367.81,H2O,C15H14ClN3O4S,C1C(=C(N2C(S1)C(C2=O)NC(=O)C(C3=CC=CC=C3)N)C(=O)O)Cl,insoluble in EtOH; insoluble in DMSO; ≥3.68 mg/mL in H2O with gentle warming and ultrasonic,,Microbiology & Virology,Antibiotic,Cephalosporin antibiotic inhibiting cell wall synthesis.,https://www.apexbt.com/search.php?catalog=A5559,1
423,A5566,LY2228820,862507-23-1,G06,L1021-05,612.74,DMSO,C24H29FN6·2CH4O3S,CC(C)(C)CN1C2=C(C=CC(=N2)C3=C(N=C(N3)C(C)(C)C)C4=CC=C(C=C4)F)N=C1N.CS(=O)(=O)O.CS(=O)(=O)O,≥30.65 mg/mL in DMSO; ≥45 mg/mL in H2O with ultrasonic; ≥9.9 mg/mL in EtOH with ultrasonic,Mesylate,MAPK Signaling,p38,P38 MAP kinase inhibitor,https://www.apexbt.com/search.php?catalog=A5566,1
424,A5573,Pimasertib (AS-703026),1236699-92-5,G07,L1021-05,431.2,DMSO,C15H15FIN3O3,C1=CC(=C(C=C1I)F)NC2=C(C=CN=C2)C(=O)NCC(CO)O,≥21.55 mg/mL in DMSO; insoluble in H2O; ≥10.36 mg/mL in EtOH with ultrasonic,Free Base,MAPK Signaling,MEK1/2,MEK1/2 inhibitor,https://www.apexbt.com/search.php?catalog=A5573,1
425,A5618,Daclatasvir (BMS-790052),1009119-64-5,G08,L1021-05,738.88,DMSO,C40H50N8O6,CC(C)C(C(=O)N1CCCC1C2=NC=C(N2)C3=CC=C(C=C3)C4=CC=C(C=C4)C5=CN=C(N5)C6CCCN6C(=O)C(C(C)C)NC(=O)OC)NC(=O)OC,≥36.6 mg/mL in DMSO; insoluble in H2O; ≥23.33 mg/mL in EtOH with ultrasonic,Free Base,Proteases,HCV Protease,HCV NS5A inhibitor,https://www.apexbt.com/search.php?catalog=A5618,1
426,A5634,SAR245409 (XL765),1349796-36-6,G09,L1021-05,599.66,DMSO,C31H29N5O6S,CC1=C(C=C(C=C1)C(=O)NC2=CC=C(C=C2)S(=O)(=O)NC3=NC4=CC=CC=C4N=C3NC5=CC(=CC(=C5)OC)OC)OC,insoluble in H2O; insoluble in EtOH; ≥15 mg/mL in DMSO,Free Base,PI3K/Akt/mTOR Signaling,PI3K,mTOR/PI3K inhibitor,https://www.apexbt.com/search.php?catalog=A5634,1
427,A5639,BIRB 796 (Doramapimod),285983-48-4,G10,L1021-05,527.66,DMSO,C31H37N5O3,CC1=CC=C(C=C1)N2C(=CC(=N2)C(C)(C)C)NC(=O)NC3=CC=C(C4=CC=CC=C43)OCCN5CCOCC5,≥26.4 mg/mL in DMSO; insoluble in H2O; ≥11.24 mg/mL in EtOH with ultrasonic,Free Base,MAPK Signaling,p38,"P38 MAPK inhibitor,cell permeable and highly selective",https://www.apexbt.com/search.php?catalog=A5639,1
428,A5710,Tazarotene,118292-40-3,G11,L1021-05,351.46,DMSO,C21H21NO2S,CCOC(=O)C1=CN=C(C=C1)C#CC2=CC3=C(C=C2)SCCC3(C)C,insoluble in H2O; ≥11.1 mg/mL in EtOH with ultrasonic; ≥14.85 mg/mL in DMSO,Free Base,Others,RARs,Topical retinoid;antiproliferative;inducer of TIG3 tumor suppressor,https://www.apexbt.com/search.php?catalog=A5710,1
429,A5734,Fasudil (HA-1077) HCl,105628-07-7,H01,L1021-05,327.83,DMSO,C14H17N3O2S·HCl,C1CNCCN(C1)S(=O)(=O)C2=CC=CC3=C2C=CN=C3.Cl,≥16.4 mg/mL in DMSO; ≥4.81 mg/mL in EtOH with ultrasonic; ≥50 mg/mL in H2O,Hydrochloride,TGF-β / Smad Signaling,ROCK,Protein kinase inhibitor,https://www.apexbt.com/search.php?catalog=A5734,1
430,A5770,Sulfasalazine,599-79-1,H02,L1021-05,398.39,DMSO,C18H14N4O5S,C1=CC=NC(=C1)NS(=O)(=O)C2=CC=C(C=C2)NN=C3C=CC(=O)C(=C3)C(=O)O,insoluble in ETOH; insoluble in H2O; ≥17.7 mg/mL in DMSO,Free Base,Others,Others,NF-κB activation inhibitor,https://www.apexbt.com/search.php?catalog=A5770,1
431,A5786,Natamycin,7681-93-8,H03,L1021-05,665.73,DMSO,C33H47NO13,CC1CC=CC=CC=CC=CC(CC2C(C(CC(O2)(CC(CC3C(O3)C=CC(=O)O1)O)O)O)C(=O)O)OC4C(C(C(C(O4)C)O)N)O,insoluble in EtOH; insoluble in H2O; ≥16.43 mg/mL in DMSO with gentle warming,Free Base,Microbiology & Virology,Antibiotic,Antifungal macrolide polyene,https://www.apexbt.com/search.php?catalog=A5786,0
432,A5790,Cidofovir,113852-37-2,H04,L1021-05,279.19,H2O,C8H14N3O6P,C1=CN(C(=O)N=C1N)CC(CO)OCP(=O)(O)O,insoluble in EtOH; insoluble in DMSO; ≥13.95 mg/mL in H2O with gentle warming,,Microbiology & Virology,CMV,Anti-CMV drug;inhibitor of viral DNA syntheis,https://www.apexbt.com/search.php?catalog=A5790,1
433,A5791,Ibuprofen Lysine,57469-77-9,H05,L1021-05,352.47,H2O,C19H32N2O4,CC(C)CC1=CC=C(C=C1)C(C)C(=O)O.C(CCN)CC(C(=O)O)N,insoluble in EtOH; insoluble in DMSO; ≥17.62 mg/mL in H2O,Free Base,Neuroscience,COX,COX inhibitor,https://www.apexbt.com/search.php?catalog=A5791,1
434,A5793,Quizartinib (AC220),950769-58-1,H06,L1021-05,560.67,DMSO,C29H32N6O4S,CC(C)(C)C1=CC(=NO1)NC(=O)NC2=CC=C(C=C2)C3=CN4C5=C(C=C(C=C5)OCCN6CCOCC6)SC4=N3,≥28.03 mg/mL in DMSO; insoluble in EtOH; insoluble in H2O,Free Base,Tyrosine Kinase,FLT3,"FLT3 inhibitor,potent and selective",https://www.apexbt.com/search.php?catalog=A5793,1
435,A5854,Dapagliflozin,461432-26-8,H07,L1021-05,408.87,DMSO,C21H25ClO6,CCOC1=CC=C(C=C1)CC2=C(C=CC(=C2)C3C(C(C(C(O3)CO)O)O)O)Cl,insoluble in H2O; ≥116.6 mg/mL in EtOH; ≥15.1 mg/mL in DMSO,Free Base,Metabolism,SGLT,"SGLT2 inhibitor,potent and selective",https://www.apexbt.com/search.php?catalog=A5854,1
436,A5926,Febuxostat,144060-53-7,H08,L1021-05,316.37,DMSO,C16H16N2O3S,CC1=C(SC(=N1)C2=CC(=C(C=C2)OCC(C)C)C#N)C(=O)O,insoluble in H2O; ≥15.55 mg/mL in DMSO; ≥15.95 mg/mL in EtOH with ultrasonic,,Others,XAO,non-purine selective inhibitor of xanthine oxidase,https://www.apexbt.com/search.php?catalog=A5926,1
437,A5931,Aztreonam,78110-38-0,H09,L1021-05,435.43,DMSO,C13H17N5O8S2,CC1C(C(=O)N1S(=O)(=O)O)NC(=O)C(=NOC(C)(C)C(=O)O)C2=CSC(=N2)N,insoluble in EtOH; ≥10.24 mg/mL in H2O with ultrasonic; ≥18.9 mg/mL in DMSO,Free Base,Microbiology & Virology,Antibiotic,"Monobactam antibiotic,selectively active against Gram-negative aerobic bacteria",https://www.apexbt.com/search.php?catalog=A5931,1
438,A5932,Candesartan,139481-59-7,H10,L1021-05,440.45,DMSO,C24H20N6O3,CCOC1=NC2=CC=CC(=C2N1CC3=CC=C(C=C3)C4=CC=CC=C4C5=NNN=N5)C(=O)O,insoluble in H2O; ≥14.65 mg/mL in DMSO; ≥3.45 mg/mL in EtOH with ultrasonic,Free Base,Endocrinology and Hormones,RAAS,Angiotensin II receptor 1 (AT1) antagonist,https://www.apexbt.com/search.php?catalog=A5932,1
439,A5970,Irbesartan,138402-11-6,H11,L1021-05,428.53,DMSO,C25H28N6O,CCCCC1=NC2(CCCC2)C(=O)N1CC3=CC=C(C=C3)C4=CC=CC=C4C5=NNN=N5,insoluble in H2O; ≥11.49 mg/mL in EtOH with ultrasonic; ≥17.4 mg/mL in DMSO,Free Base,GPCR/G protein,Angiotensin Receptor,Angiotensin II inhibitor,https://www.apexbt.com/search.php?catalog=A5970,1
440,A6743,H-D-Ser-OH,312-84-5,A01,L1021-06,105.09,H2O,C3H7NO3,C(C(C(=O)O)N)O,insoluble in DMSO; insoluble in EtOH; ≥93 mg/mL in H2O,,Others,Others,Endogenous ligand for the glycine site of the N-methyl D-aspartate receptor (NMDAR),https://www.apexbt.com/search.php?catalog=A6743,1
441,A7132,H-Cys-OH,52-90-4,A02,L1021-06,121.2,H2O,C3H7NO2S,C(C(C(=O)O)N)S,insoluble in EtOH; insoluble in DMSO; ≥40.3 mg/mL in H2O,,Amino Acids & Building Blocks,Amino Acids and Derivatives,,https://www.apexbt.com/search.php?catalog=A7132,1
442,A7291,H-Ser-OH,56-45-1,A03,L1021-06,105.1,H2O,C3H7NO3,C(C(C(=O)O)N)O,insoluble in DMSO; insoluble in EtOH; ≥107 mg/mL in H2O,,Amino Acids & Building Blocks,Amino Acids and Derivatives,,https://www.apexbt.com/search.php?catalog=A7291,1
443,A7486,H-Cit-OH,372-75-8,A04,L1021-06,175.2,H2O,C6H13N3O3,C(CC(C(=O)O)N)CNC(=O)N,insoluble in EtOH; insoluble in DMSO; ≥17.5 mg/mL in H2O,,Amino Acids & Building Blocks,Unusual Amino Acids,,https://www.apexbt.com/search.php?catalog=A7486,1
444,A8010,Biotin,58-85-5,A05,L1021-06,244.31,DMSO,C10H16N2O3S,C1C2C(C(S1)CCCCC(=O)O)NC(=O)N2,≥24.4 mg/mL in DMSO; insoluble in H2O; insoluble in EtOH,,Labels and tags,Biotinylation Reagents,Lysine probe coupled to mass spectrometry detection,https://www.apexbt.com/search.php?catalog=A8010,1
445,A8019,Perindopril Erbumine,107133-36-8,A06,L1021-06,441.6,DMSO,C19H32N2O5·C4H11N,CCCC(C(=O)OCC)NC(C)C(=O)N1C2CCCCC2CC1C(=O)O.CC(C)(C)N,≥111.4 mg/mL in H2O; ≥15.7 mg/mL in EtOH; ≥8.58 mg/mL in DMSO with ultrasonic,t-Butylamine,Endocrinology and Hormones,RAAS,ACE inhibitor,https://www.apexbt.com/search.php?catalog=A8019,1
446,A8164,Cyclo (-RGDfK),161552-03-0,A07,L1021-06,603.7,DMSO,C27H41N9O7,C1C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)N1)CCCN=C(N)N)CCCCN)CC2=CC=CC=C2)CC(=O)O,≥30.19 mg/mL in DMSO; insoluble in EtOH; ≥59.2 mg/mL in H2O,,Angiogenesis,Integrin,Inhibitor of αvβ3 integrin,https://www.apexbt.com/search.php?catalog=A8164,1
447,A8167,Rapamycin (Sirolimus),53123-88-9,A08,L1021-06,914.18,DMSO,C51H79NO13,CC1CCC2CC(C(=CC=CC=CC(CC(C(=O)C(C(C(=CC(C(=O)CC(OC(=O)C3CCCCN3C(=O)C(=O)C1(O2)O)C(C)CC4CCC(C(C4)OC)O)C)C)O)OC)C)C)C)OC,≥45.7 mg/mL in DMSO; insoluble in H2O; ≥58.9 mg/mL in EtOH with ultrasonic,Free Base,PI3K/Akt/mTOR Signaling,mTOR,Original antifungal antibiotic,https://www.apexbt.com/search.php?catalog=A8167,0
448,A8169,Everolimus (RAD001),159351-69-6,A09,L1021-06,958.22,DMSO,C53H83NO14,CC1CCC2CC(C(=CC=CC=CC(CC(C(=O)C(C(C(=CC(C(=O)CC(OC(=O)C3CCCCN3C(=O)C(=O)C1(O2)O)C(C)CC4CCC(C(C4)OC)OCCO)C)C)O)OC)C)C)C)OC,≥47.91 mg/mL in DMSO; insoluble in H2O; ≥122 mg/mL in EtOH,Free Base,PI3K/Akt/mTOR Signaling,mTOR,MTOR inhibitor,https://www.apexbt.com/search.php?catalog=A8169,0
449,A8171,"Entinostat (MS-275,SNDX-275)",209783-80-2,A10,L1021-06,376.4,DMSO,C21H20N4O3,C1=CC=C(C(=C1)N)NC(=O)C2=CC=C(C=C2)CNC(=O)OCC3=CN=CC=C3,insoluble in H2O; ≥18.8 mg/mL in DMSO; ≥7.4 mg/mL in EtOH with ultrasonic,Free Base,DNA Damage/DNA Repair,HDAC,HDAC1 and HDAC3 inhibitor,https://www.apexbt.com/search.php?catalog=A8171,1
450,A8173,"Romidepsin (FK228, depsipeptide)",128517-07-7,A11,L1021-06,540.7,DMSO,C24H36N4O6S2,CC=C1C(=O)NC(C(=O)OC2CC(=O)NC(C(=O)NC(CSSCCC=C2)C(=O)N1)C(C)C)C(C)C,≥27.04 mg/mL in DMSO; insoluble in H2O; ≥35.27 mg/mL in EtOH with ultrasonic,Free Base,DNA Damage/DNA Repair,HDAC,"HDAC1/HDAC2 inhibitor,potent and selective",https://www.apexbt.com/search.php?catalog=A8173,1
451,A8178,Panobinostat (LBH589),404950-80-7,B01,L1021-06,349.43,DMSO,C21H23N3O2,CC1=C(C2=CC=CC=C2N1)CCNCC3=CC=C(C=C3)C=CC(=O)NO,insoluble in H2O; insoluble in EtOH; ≥17.47 mg/mL in DMSO,Free Base,DNA Damage/DNA Repair,HDAC,HDAC inhibitor,https://www.apexbt.com/search.php?catalog=A8178,1
452,A8184,AICAR,2627-69-2,B02,L1021-06,258.23,DMSO,C9H14N4O5,CC(C=C(C)C=CC(=O)NO)C(=O)C1=CC=C(C=C1)N(C)C,insoluble in EtOH; ≥12.9 mg/mL in DMSO; ≥52.9 mg/mL in H2O,,PI3K/Akt/mTOR Signaling,AMPK,AMPK activator,https://www.apexbt.com/search.php?catalog=A8184,1
453,A8190,Semagacestat (LY450139),425386-60-3,B03,L1021-06,361.44,DMSO,C19H27N3O4,CC(C)C(C(=O)NC(C)C(=O)NC1C2=CC=CC=C2CCN(C1=O)C)O,insoluble in H2O; ≥18.05 mg/mL in DMSO; ≥40.3 mg/mL in EtOH with ultrasonic,Free Base,Neuroscience,Amyloid β,γ-secretase inhibitor,https://www.apexbt.com/search.php?catalog=A8190,1
454,A8192,Staurosporine,62996-74-1,B04,L1021-06,466.53,DMSO,C28H26N4O3,O=C(NC1)C2=C1C3=C(C4=C2C5=C(C=CC=C5)N4[C@H]6C[C@@H](NC)[C@@H](OC)[C@]7(C)O6)N7C8=CC=CC=C83,insoluble in H2O; insoluble in EtOH; ≥11.66 mg/mL in DMSO,,Tyrosine Kinase,Broad Spectrum Protein Kinase Inhibitor,"Protein kinase inhibitor,potent and cell permeable",https://www.apexbt.com/search.php?catalog=A8192,0
455,A8194,ABT-199,1257044-40-8,B05,L1021-06,868.44,DMSO,C45H50ClN7O7S,CC1(CCC(=C(C1)C2=CC=C(C=C2)Cl)CN3CCN(CC3)C4=CC(=C(C=C4)C(=O)NS(=O)(=O)C5=CC(=C(C=C5)NCC6CCOCC6)[N+](=O)[O-])OC7=CN=C8C(=C7)C=CN8)C,≥43.42 mg/mL in DMSO; insoluble in EtOH; insoluble in H2O,,Apoptosis,Bcl-2 Family,"Bcl-2 inhibitor,potent and selective",https://www.apexbt.com/search.php?catalog=A8194,1
456,A8200,DAPT (GSI-IX),208255-80-5,B06,L1021-06,432.46,DMSO,C23H26F2N2O4,CC(C(=O)NC(C1=CC=CC=C1)C(=O)OC(C)(C)C)NC(=O)CC2=CC(=CC(=C2)F)F,≥21.62 mg/mL in DMSO; insoluble in H2O; ≥16.36 mg/mL in EtOH with ultrasonic,Free Base,Neuroscience,Amyloid β,"γ-secretase inhibitor,potent and specific",https://www.apexbt.com/search.php?catalog=A8200,1
457,A8201,Amprenavir (agenerase),161814-49-9,B07,L1021-06,505.63,DMSO,C25H35N3O6S,CC(C)CN(CC(C(CC1=CC=CC=C1)NC(=O)OC2CCOC2)O)S(=O)(=O)C3=CC=C(C=C3)N,insoluble in H2O; ≥14.85 mg/mL in EtOH; ≥25 mg/mL in EtOH with ultrasonic,Free Base,Proteases,HIV Protease,HIV-1 protease inhibitor,https://www.apexbt.com/search.php?catalog=A8201,1
458,A8202,Abiraterone acetate,154229-18-2,B08,L1021-06,391.55,DMSO,C26H33NO2,CC(=O)OC1CCC2(C3CCC4(C(C3CC=C2C1)CC=C4C5=CN=CC=C5)C)C,insoluble in H2O; ≥11.22 mg/mL in DMSO with gentle warming and ultrasonic; ≥15.7 mg/mL in EtOH,acetate,Metabolism,P450,Cytochrome p450 17a1 inhibitor,https://www.apexbt.com/search.php?catalog=A8202,1
459,A8203,Ritonavir,155213-67-5,B09,L1021-06,720.9,DMSO,C37H48N6O5S2,CC(C)C1=NC(=CS1)CN(C)C(=O)NC(C(C)C)C(=O)NC(CC2=CC=CC=C2)CC(C(CC3=CC=CC=C3)NC(=O)OCC4=CN=CS4)O,≥26 mg/mL in DMSO with gentle warming; insoluble in H2O; ≥9.02 mg/mL in EtOH,Free Base,Proteases,HIV Protease,HIV protease inhibitor,https://www.apexbt.com/search.php?catalog=A8203,1
460,A8204,Lopinavir,192725-17-0,B10,L1021-06,628.81,DMSO,C37H48N4O5,CC1=C(C(=CC=C1)C)OCC(=O)NC(CC2=CC=CC=C2)C(CC(CC3=CC=CC=C3)NC(=O)C(C(C)C)N4CCCNC4=O)O,≥31.45 mg/mL in DMSO; insoluble in H2O; ≥48.3 mg/mL in EtOH,Free Base,Proteases,HIV Protease,"HIV protease inhibitor,highly potent",https://www.apexbt.com/search.php?catalog=A8204,1
461,A8205,Atazanavir,198904-31-3,B11,L1021-06,704.9,DMSO,C38H52N6O7,CC(C)(C)C(C(=O)NC(CC1=CC=CC=C1)C(CN(CC2=CC=C(C=C2)C3=CC=CC=N3)NC(=O)C(C(C)(C)C)NC(=O)OC)O)NC(=O)OC,≥28.6 mg/mL in DMSO; insoluble in H2O; ≥9.9 mg/mL in EtOH with ultrasonic,Free Base,Proteases,HIV Protease,"HIV protease inhibitor,highly potent",https://www.apexbt.com/search.php?catalog=A8205,1
462,A8206,Darunavir,206361-99-1,C01,L1021-06,547.66,DMSO,C27H37N3O7S,CC(C)CN(CC(C(CC1=CC=CC=C1)NC(=O)OC2COC3C2CCO3)O)S(=O)(=O)C4=CC=C(C=C4)N,≥22.65 mg/mL in DMSO; insoluble in H2O; ≥4.94 mg/mL in EtOH with ultrasonic,Ethanolate,Proteases,HIV Protease,HIV-1 protease inhibitor,https://www.apexbt.com/search.php?catalog=A8206,0
463,A8207,AZD6244 (Selumetinib),606143-52-6,C02,L1021-06,457.69,DMSO,C17H15BrClFN4O3,CN1C=NC2=C1C=C(C(=C2F)NC3=C(C=C(C=C3)Br)Cl)C(=O)NOCCO,≥22.88 mg/mL in DMSO; insoluble in H2O; insoluble in EtOH,Free Base,MAPK Signaling,MEK1/2,MEK inhibitor,https://www.apexbt.com/search.php?catalog=A8207,1
464,A8210,GDC-0941,957054-30-7,C03,L1021-06,513.64,DMSO,C23H27N7O3S2,CS(=O)(=O)N1CCN(CC1)CC2=CC3=C(S2)C(=NC(=N3)C4=C5C=NNC5=CC=C4)N6CCOCC6,≥25.7 mg/mL in DMSO; insoluble in H2O; ≥3.59 mg/mL in EtOH with gentle warming and ultrasonic,Free Base,PI3K/Akt/mTOR Signaling,PI3K,"PI3K inhibitor,potent and selective",https://www.apexbt.com/search.php?catalog=A8210,1
465,A8218,Lapatinib,231277-92-2,C04,L1021-06,581.06,DMSO,C29H26ClFN4O4S,CS(=O)(=O)CCNCC1=CC=C(O1)C2=CC3=C(C=C2)N=CN=C3NC4=CC(=C(C=C4)OCC5=CC(=CC=C5)F)Cl,≥29.05 mg/mL in DMSO; insoluble in H2O; insoluble in EtOH,Free Base,JAK/STAT Signaling,EGFR,"EGFR/HER2 inhibitor,potent,selective and reversible",https://www.apexbt.com/search.php?catalog=A8218,1
466,A8219,Gefitinib (ZD1839),184475-35-2,C05,L1021-06,446.90,DMSO,C22H24ClFN4O3,COC1=C(C=C2C(=C1)N=CN=C2NC3=CC(=C(C=C3)F)Cl)OCCCN4CCOCC4,≥22.34 mg/mL in DMSO; insoluble in H2O; ≥2.48 mg/mL in EtOH with ultrasonic,Free Base,JAK/STAT Signaling,EGFR,Selective EGFR inhibitor,https://www.apexbt.com/search.php?catalog=A8219,1
467,A8221,EPZ-6438,1403254-99-8,C06,L1021-06,572.74,DMSO,C34H44N4O4,CCN(C1CCOCC1)C2=CC(=CC(=C2C)C(=O)NCC3=C(C=C(NC3=O)C)C)C4=CC=C(C=C4)CN5CCOCC5,≥28.64 mg/mL in DMSO; insoluble in EtOH; insoluble in H2O,,Chromatin/Epigenetics,Histone Methyltransferase,"EZH2 inhibitor,potent and selective",https://www.apexbt.com/search.php?catalog=A8221,1
468,A8232,Nilotinib(AMN-107),641571-10-0,C07,L1021-06,529.53,DMSO,C28H22F3N7O,CC1=C(C=C(C=C1)C(=O)NC2=CC(=CC(=C2)N3C=C(N=C3)C)C(F)(F)F)NC4=NC=CC(=N4)C5=CN=CC=C5,≥26.5 mg/mL in DMSO; insoluble in H2O; ≥5 mg/mL in EtOH with gentle warming and ultrasonic,Free Base,TGF-β / Smad Signaling,Bcr-Abl,"Bcr-Abl kinase inhibitor,selective",https://www.apexbt.com/search.php?catalog=A8232,1
469,A8234,Erlotinib Hydrochloride,183319-69-9,C08,L1021-06,429.91,DMSO,C22H24ClN3O4,COCCOC1=C(C=C2C(=C1)C(=NC=N2)NC3=CC=CC(=C3)C#C)OCCOC.Cl,insoluble in H2O; insoluble in EtOH; ≥6.44 mg/mL in DMSO with gentle warming,Hydrochloride,JAK/STAT Signaling,EGFR,Selective EGFR inhibitor,https://www.apexbt.com/search.php?catalog=A8234,1
470,A8235,Embelin,550-24-3,C09,L1021-06,294.39,DMSO,C17H26O4,CCCCCCCCCCCC1=C(C(=O)C=C(C1=O)O)O,insoluble in H2O; ≥4.23 mg/mL in EtOH with ultrasonic; ≥9.6 mg/mL in DMSO,,Apoptosis,IAP,"XIAP inhibitor,cell-permeable",https://www.apexbt.com/search.php?catalog=A8235,1
471,A8236,Regorafenib,755037-03-7,C10,L1021-06,482.82,DMSO,C21H15ClF4N4O3,O=C(NC)C1=CC(OC2=CC=C(NC(NC3=CC=C(Cl)C(C(F)(F)F)=C3)=O)C(F)=C2)=CC=N1,≥25.04 mg/mL in DMSO; insoluble in H2O; ≥6.25 mg/mL in EtOH with ultrasonic,Free Base,Tyrosine Kinase,c-RET,Inhibitor of VEGFR/PDGFR/FGFR/mutant kit/RET/Raf-1,https://www.apexbt.com/search.php?catalog=A8236,1
472,A8245,Sorafenib Tosylate,475207-59-1,C11,L1021-06,637.03,DMSO,C21H16ClF3N4O3·C7H8O3S,CC1=CC=C(C=C1)S(=O)(=O)O.CNC(=O)C1=NC=CC(=C1)OC2=CC=C(C=C2)NC(=O)NC3=CC(=C(C=C3)Cl)C(F)(F)F,≥31.85 mg/mL in DMSO; insoluble in H2O; ≥4.15 mg/mL in EtOH with ultrasonic,Tosylate,Tyrosine Kinase,PDGFR,,https://www.apexbt.com/search.php?catalog=A8245,1
473,A8247,Afatinib (BIBW2992),439081-18-2,D01,L1021-06,485.94,DMSO,C24H25ClFN5O3,CN(C)CC=CC(=O)NC1=C(C=C2C(=C1)C(=NC=N2)NC3=CC(=C(C=C3)F)Cl)OC4CCOC4,≥24.3 mg/mL in DMSO; insoluble in H2O; ≥42.1 mg/mL in EtOH with ultrasonic,Free Base,JAK/STAT Signaling,EGFR,Irreversible EGFR/HER2 inhibitor,https://www.apexbt.com/search.php?catalog=A8247,1
474,A8252,Nintedanib (BIBF 1120),656247-17-5,D02,L1021-06,539.62,DMSO,C31H33N5O4,CN1CCN(CC1)CC(=O)N(C)C2=CC=C(C=C2)NC(=C3C4=C(C=C(C=C4)C(=O)OC)NC3=O)C5=CC=CC=C5,insoluble in H2O; insoluble in EtOH; ≥5.34 mg/mL in DMSO,Free Base,Tyrosine Kinase,PDGFR,VEGFR/PDGFR/FGFR inhibitor,https://www.apexbt.com/search.php?catalog=A8252,1
475,A8255,Sunitinib malate,341031-54-7,D03,L1021-06,532.56,DMSO,C22H27FN4O2·C4H6O5,CCN(CC)CCNC(=O)C1=C(NC(=C1C)C=C2C3=C(C=CC(=C3)F)NC2=O)C.C(C(C(=O)O)O)C(=O)O,≥26.65 mg/mL in DMSO; insoluble in EtOH; ≥4.6 mg/mL in H2O with ultrasonic,Malate,Tyrosine Kinase,VEGFR,VEGFR/PDGFRβ/ KIT/ FLT3/RET/CSF-1R inhibitor,https://www.apexbt.com/search.php?catalog=A8255,1
476,A8307,Crenolanib (CP-868596),670220-88-9,D04,L1021-06,443.54,DMSO,C26H29N5O2,CC1(COC1)COC2=CC3=C(C=C2)N(C=N3)C4=NC5=C(C=CC=C5N6CCC(CC6)N)C=C4,≥22.2 mg/mL in DMSO; insoluble in H2O; ≥2.5 mg/mL in EtOH with ultrasonic,Free Base,Tyrosine Kinase,PDGFR,"PDGFR-β inhibitor,potent and selective",https://www.apexbt.com/search.php?catalog=A8307,1
477,A8309,Perifosine,157716-52-4,D05,L1021-06,461.67,H2O,C25H52NO4P,CCCCCCCCCCCCCCCCCCOP(=O)([O-])OC1CC[N+](CC1)(C)C,insoluble in DMSO; ≥5.55 mg/mL in EtOH with ultrasonic; ≥5.94 mg/mL in H2O with ultrasonic,,PI3K/Akt/mTOR Signaling,Akt,,https://www.apexbt.com/search.php?catalog=A8309,1
478,A8311,Maraviroc,376348-65-1,D06,L1021-06,513.67,DMSO,C29H41F2N5O,CC1=NN=C(N1C2CC3CCC(C2)N3CCC(C4=CC=CC=C4)NC(=O)C5CCC(CC5)(F)F)C(C)C,≥25.7 mg/mL in DMSO; insoluble in H2O; ≥48 mg/mL in EtOH,Free Base,Microbiology & Virology,HIV,"Selective CCR5 antagonist,antiretroviral agent",https://www.apexbt.com/search.php?catalog=A8311,1
479,A8314,Temsirolimus,162635-04-3,D07,L1021-06,1030.29,DMSO,C56H87NO16,CC1CCC2CC(C(=CC=CC=CC(CC(C(=O)C(C(C(=CC(C(=O)CC(OC(=O)C3CCCCN3C(=O)C(=O)C1(O2)O)C(C)CC4CCC(C(C4)OC)OC(=O)C(C)(CO)CO)C)C)O)OC)C)C)C)OC,≥51.5 mg/mL in DMSO; insoluble in H2O; ≥11.2 mg/mL in EtOH,Free Base,PI3K/Akt/mTOR Signaling,mTOR,MTOR inhibitor,https://www.apexbt.com/search.php?catalog=A8314,0
480,A8316,PD 0332991 (Palbociclib) HCl,827022-32-2,D08,L1021-06,483.99,H2O,C24H30ClN7O2,O=C1N(C2=NC(NC3=NC=C(C=C3)N4CCNCC4)=NC=C2C(C)=C1C(C)=O)C5CCCC5.Cl,≥14.48 mg/mL in H2O; ≥2.42 mg/mL in DMSO; ≥2.79 mg/mL in EtOH with gentle warming and ultrasonic,Hydrochloride,Cell Cycle/Checkpoint,Cyclin-Dependent Kinases,"CDK4/6 inhibitor,highly selective",https://www.apexbt.com/search.php?catalog=A8316,1
481,A8317,Fludarabine Phosphate (Fludara),75607-67-9,D09,L1021-06,365.21,DMSO,C10H13FN5O7P,C1=NC2=C(N1C3C(C(C(O3)COP(=O)(O)O)O)O)N=C(N=C2N)F,insoluble in EtOH; ≥17.6 mg/mL in DMSO; ≥6.7 mg/mL in H2O with gentle warming and ultrasonic,Phosphate,DNA Damage/DNA Repair,DNA Synthesis,Inhibits STAT1 activation and DNA synthesis,https://www.apexbt.com/search.php?catalog=A8317,1
482,A8319,"Dacomitinib (PF299804, PF299)",1110813-31-4,D10,L1021-06,469.94,DMSO,C24H25ClFN5O2,COC1=C(C=C2C(=C1)N=CN=C2NC3=CC(=C(C=C3)F)Cl)NC(=O)C=CCN4CCCCC4,≥23.5 mg/mL in DMSO; insoluble in H2O; ≥8.76 mg/mL in EtOH with gentle warming and ultrasonic,Free Base,JAK/STAT Signaling,EGFR,HER inhibitor,https://www.apexbt.com/search.php?catalog=A8319,1
483,A8321,Cisplatin,15663-27-1,D11,L1021-06,300.05,DMSO,Cl2H6N2Pt,N.N.Cl[Pt+2]Cl,insoluble in EtOH; insoluble in H2O; ≥12.5 mg/mL in DMF,Free Base,Apoptosis,Caspase,"Inhibits DNA synthesis,chemotherapy drug",https://www.apexbt.com/search.php?catalog=A8321,1
484,A8322,Neratinib (HKI-272),698387-09-6,E01,L1021-06,557.04,DMSO,C30H29ClN6O3,CCOC1=C(C=C2C(=C1)N=CC(=C2NC3=CC(=C(C=C3)OCC4=CC=CC=N4)Cl)C#N)NC(=O)C=CCN(C)C,insoluble in H2O; ≥13.93 mg/mL in DMSO with gentle warming; ≥2.52 mg/mL in EtOH with gentle warming,,JAK/STAT Signaling,EGFR,"HER2/EGFR inhibitor,potent and irreversible",https://www.apexbt.com/search.php?catalog=A8322,1
485,A8325,Tivantinib (ARQ 197),905854-02-6,E02,L1021-06,369.42,DMSO,C23H19N3O2,O=C([C@H](C(C1=CC=C2)=CN3C1=C2CCC3)[C@@H]4C5=CNC6=CC=CC=C56)NC4=O,≥18.47 mg/mL in DMSO; ≥2.29 mg/mL in H2O with gentle warming; ≥4.32 mg/mL in EtOH,Free Base,Tyrosine Kinase,c-MET,"C-Met inhibitor,non-ATP-competitive",https://www.apexbt.com/search.php?catalog=A8325,0
486,A8327,Verteporfin,129497-78-5,E03,L1021-06,718.79,DMSO,C41H42N4O8,CC1=C(C2=CC3=NC(=CC4=C(C(=C(N4)C=C5C6(C(C(=CC=C6C(=N5)C=C1N2)C(=O)OC)C(=O)OC)C)C)CCC(=O)OC)C(=C3C)CCC(=O)O)C=C.CC1=C(C2=CC3=NC(=CC4=C(C(=C(N4)C=C5C6(C(C(=CC=C6C(=N5)C=C1N2)C(=O)OC)C(=O)OC)C)C)CCC(=O)O)C(=C3C)CCC(=O)OC)C=C,insoluble in EtOH; insoluble in H2O; ≥18.3 mg/mL in DMSO,,Others,Others,Photosensitizer used in photodynamic therapy,https://www.apexbt.com/search.php?catalog=A8327,0
487,A8328,LDK378,1032900-25-6,E04,L1021-06,558.14,DMSO,C28H36ClN5O3S,CC1=CC(=C(C=C1C2CCNCC2)OC(C)C)NC3=NC=C(C(=N3)NC4=CC=CC=C4S(=O)(=O)C(C)C)Cl,insoluble in H2O; ≥13.95 mg/mL in DMSO; ≥4.62 mg/mL in EtOH with gentle warming,Free Base,Tyrosine Kinase,ALK,Potent ALK inhibitor,https://www.apexbt.com/search.php?catalog=A8328,1
488,A8330,CX-4945 (Silmitasertib),1009820-21-6,E05,L1021-06,349.77,DMSO,C19H12ClN3O2,C1=CC(=CC(=C1)Cl)NC2=C3C=CN=CC3=C4C=CC(=CC4=N2)C(=O)O,insoluble in H2O; insoluble in EtOH; ≥8.74 mg/mL in DMSO,Free Base,PI3K/Akt/mTOR Signaling,CK2,CK2 inhibitor,https://www.apexbt.com/search.php?catalog=A8330,1
489,A8331,Bleomycin Sulfate,9041-93-4,E06,L1021-06,1512.6,DMSO,C55H85N17O25S4,CC1=C(N=C(N=C1N)C(CC(=O)N)NCC(C(=O)N)N)C(=O)NC(C(C2=CN=CN2)OC3C(C(C(C(O3)CO)O)O)OC4C(C(C(C(O4)CO)O)OC(=O)N)O)C(=O)NC(C)C(C(C)C(=O)NC(C(C)O)C(=O)NCCC5=NC(=CS5)C6=NC(=CS6)C(=O)NCCC[S+](C)C)O.OS(=O)(=O)[O-],≥125 mg/mL in DMSO with gentle warming; insoluble in EtOH; ≥151.3 mg/mL in H2O with ultrasonic,Sulfate,DNA Damage/DNA Repair,DNA Synthesis,"Chemotherapy agent, induces DNA strand break",https://www.apexbt.com/search.php?catalog=A8331,0
490,A8332,R788 disodium,1025687-58-4,E07,L1021-06,624.42,DMSO,C23H24FN6Na2O9P,CC1(C(=O)N(C2=C(O1)C=CC(=N2)NC3=NC(=NC=C3F)NC4=CC(=C(C(=C4)OC)OC)OC)COP(=O)([O-])[O-])C.[Na+].[Na+],≥62.4 mg/mL in DMSO with gentle warming; insoluble in EtOH; ≥2.53 mg/mL in H2O with gentle warming,,Tyrosine Kinase,Spleen Tyrosine Kinase (Syk),"Syk inhibitor,ATP competitive and potent",https://www.apexbt.com/search.php?catalog=A8332,1
491,A8333,Canagliflozin,842133-18-0,E08,L1021-06,444.52,DMSO,C24H25FO5S,CC1=C(C=C(C=C1)C2C(C(C(C(O2)CO)O)O)O)CC3=CC=C(S3)C4=CC=C(C=C4)F,≥22.25 mg/mL in DMSO; insoluble in H2O; ≥49.5 mg/mL in EtOH,Free Base,Metabolism,SGLT,"SGLT2 inhibitor,potent and selective",https://www.apexbt.com/search.php?catalog=A8333,1
492,A8334,Linsitinib,867160-71-2,E09,L1021-06,421.51,DMSO,C26H23N5O,CC1(CC(C1)C2=NC(=C3N2C=CN=C3N)C4=CC5=C(C=C4)C=CC(=N5)C6=CC=CC=C6)O,≥21.08 mg/mL in DMSO; insoluble in H2O; ≥2.88 mg/mL in EtOH with gentle warming and ultrasonic,Free Base,Tyrosine Kinase,Insulin Receptor,"IGF1R/IR inhibitor,potent and novel",https://www.apexbt.com/search.php?catalog=A8334,1
493,A8335,Palbociclib (PD0332991) Isethionate,827022-33-3,E10,L1021-06,573.66,DMSO,C24H29N7O2·C2H6O4S,CC1=C(C(=O)N(C2=NC(=NC=C12)NC3=NC=C(C=C3)N4CCNCC4)C5CCCC5)C(=O)C.C(CS(=O)(=O)O)O,≥28.7 mg/mL in DMSO; insoluble in EtOH; ≥26.8 mg/mL in H2O,,Cell Cycle/Checkpoint,Cyclin-Dependent Kinases,"CDK4/6 inhibitor,highly selective",https://www.apexbt.com/search.php?catalog=A8335,1
494,A8346,BYL-719,1217486-61-7,E11,L1021-06,441.47,DMSO,C19H22F3N5O2S,CC1=C(SC(=N1)NC(=O)N2CCCC2C(=O)N)C3=CC(=NC=C3)C(C)(C)C(F)(F)F,≥22.07 mg/mL in DMSO; insoluble in H2O; insoluble in EtOH,Free Base,PI3K/Akt/mTOR Signaling,PI3K,Selective PI3Kα inhibitor,https://www.apexbt.com/search.php?catalog=A8346,1
495,A8347,Pazopanib Hydrochloride,635702-64-6,F01,L1021-06,473.98,DMSO,C21H24ClN7O2S,CC1=C(C=C(C=C1)NC2=NC=CC(=N2)N(C)C3=CC4=NN(C(=C4C=C3)C)C)S(=O)(=O)N.Cl,≥11.1 mg/mL in H2O; ≥11.85 mg/mL in DMSO; ≥2.88 mg/mL in EtOH,,Tyrosine Kinase,VEGFR,,https://www.apexbt.com/search.php?catalog=A8347,1
496,A8348,LY2157299,700874-72-2,F02,L1021-06,369.42,DMSO,C22H19N5O,CC1=CC=CC(=N1)C2=NN3CCCC3=C2C4=C5C=C(C=CC5=NC=C4)C(=O)N,insoluble in H2O; ≥18.45 mg/mL in DMSO; ≥26.15 mg/mL in EtOH,Free Base,TGF-β / Smad Signaling,TGF-βR1(ALK5),"TGF-βR1 inhibitor,potent and selective",https://www.apexbt.com/search.php?catalog=A8348,1
497,A8351,VX-809,936727-05-8,F03,L1021-06,452.41,DMSO,C24H18F2N2O5,CC1=C(N=C(C=C1)NC(=O)C2(CC2)C3=CC4=C(C=C3)OC(O4)(F)F)C5=CC(=CC=C5)C(=O)O,≥22.6 mg/mL in DMSO; insoluble in H2O; ≥4.91 mg/mL in EtOH with gentle warming,Free Base,Membrane Transporter/Ion Channel,CFTR,CFTR corrector,https://www.apexbt.com/search.php?catalog=A8351,1
498,A8355,Arsonic acid,97-44-9,F04,L1021-06,275.09,DMSO,C8H10AsNO5,CC(=O)NC1=C(C=CC(=C1)[As](=O)(O)O)O,insoluble in H2O; insoluble in EtOH; ≥12.95 mg/mL in DMSO with gentle warming,Free Base,Others,Others,An organoarsenic compound,https://www.apexbt.com/search.php?catalog=A8355,1
499,A8356,Acetylcysteine,616-91-1,F05,L1021-06,163.19,DMSO,C5H9NO3S,CC(=O)NC(CS)C(=O)O,≥44.6 mg/mL in H2O; ≥53.3 mg/mL in EtOH; ≥8.16 mg/mL in DMSO,,Neuroscience,AChR,Antioxidant;mucolytic agent,https://www.apexbt.com/search.php?catalog=A8356,1
500,A8358,Albendazole,54965-21-8,F06,L1021-06,265.33,DMSO,C12H15N3O2S,CCCSC1=CC2=C(C=C1)N=C(N2)NC(=O)OC,insoluble in EtOH; insoluble in H2O; ≥8.75 mg/mL in DMSO,Free Base,Microbiology & Virology,Antibiotic,treatment of a variety of parasitic worm infestations,https://www.apexbt.com/search.php?catalog=A8358,1
501,A8359,Alendronate sodium,129318-43-0,F07,L1021-06,271.08,H2O,C4H12NNaO7P2,C(CC(O)(P(=O)(O)O)P(=O)(O)[O-])CN.[Na+],insoluble in DMSO; insoluble in EtOH; ≥15 mg/mL in H2O with gentle warming,Sodium,Others,Others,Osteoclast-mediated bone resorption inhibitor,https://www.apexbt.com/search.php?catalog=A8359,1
502,A8360,Allopurinol,315-30-0,F08,L1021-06,136.11,DMSO,C5H4N4O,C1=C2C(=NC=NC2=O)NN1,insoluble in H2O; insoluble in EtOH; ≥5.15 mg/mL in DMSO with gentle warming,Free Base,Others,XAO,Xanthine oxidase inhibitor,https://www.apexbt.com/search.php?catalog=A8360,1
503,A8362,Arbidol HCl,131707-23-8,F09,L1021-06,513.88,DMSO,C22H25BrN2O3S·HCl,CCOC(=O)C1=C(N(C2=CC(=C(C(=C21)CN(C)C)O)Br)C)CSC3=CC=CC=C3.Cl,≥19.85 mg/mL in DMSO; ≥2.55 mg/mL in H2O with gentle warming; ≥45.1 mg/mL in EtOH,hydrochloride,Microbiology & Virology,Influenza A virus,Antiviral chemical agent,https://www.apexbt.com/search.php?catalog=A8362,1
504,A8363,Argatroban,74863-84-6,F10,L1021-06,508.63,DMSO,C23H36N6O5S,CC1CCN(C(C1)C(=O)O)C(=O)C(CCCN=C(N)N)NS(=O)(=O)C2=CC=CC3=C2NCC(C3)C,≥25.25 mg/mL in DMSO; insoluble in H2O; ≥2.97 mg/mL in EtOH with gentle warming,Free Base,Proteases,Thrombin,Thrombin mediated fibrinogen cleavage inhibitor,https://www.apexbt.com/search.php?catalog=A8363,0
505,A8364,ARN-509,956104-40-8,F11,L1021-06,477.43,DMSO,C21H15F4N5O2S,CNC(=O)C1=C(C=C(C=C1)N2C(=S)N(C(=O)C23CCC3)C4=CN=C(C(=C4)C(F)(F)F)C#N)F,≥23.85 mg/mL in DMSO; insoluble in H2O; ≥7.33 mg/mL in EtOH,,Endocrinology and Hormones,Androgen Receptor,,https://www.apexbt.com/search.php?catalog=A8364,1
506,A8369,Atropine sulfate monohydrate,5908-99-6,G01,L1021-06,694.83,DMSO,2(C17H23NO3)·H2O·H2SO4,CN1C2CCC1CC(C2)OC(=O)C(CO)C3=CC=CC=C3.CN1C2CCC1CC(C2)OC(=O)C(CO)C3=CC=CC=C3.O.OS(=O)(=O)O,≥34.74 mg/mL in DMSO; ≥56.5 mg/mL in H2O; ≥59.7 mg/mL in EtOH,sulfate,Neuroscience,AChR,MAChRs antagonist,https://www.apexbt.com/search.php?catalog=A8369,1
507,A8370,Axitinib (AG 013736),319460-85-0,G02,L1021-06,386.47,DMSO,C22H18N4OS,CNC(=O)C1=CC=CC=C1SC2=CC3=C(C=C2)C(=NN3)C=CC4=CC=CC=N4,insoluble in H2O; ≥19.3 mg/mL in DMSO; ≥3.52 mg/mL in EtOH,Free Base,Tyrosine Kinase,VEGFR,VEGFR1/ c-Kit inhibitor,https://www.apexbt.com/search.php?catalog=A8370,1
508,A8376,Bephenium Hydroxynaphthoate,3818-50-6,G03,L1021-06,443.53,DMSO,C28H29NO4,C[N+](C)(CCOC1=CC=CC=C1)CC2=CC=CC=C2.C1=CC=C2C=C(C(=CC2=C1)C(=O)O)[O-],insoluble in H2O; insoluble in EtOH; ≥20.85 mg/mL in DMSO,hydroxynaphthoa,Others,Others,Anthelmintic agent,https://www.apexbt.com/search.php?catalog=A8376,1
509,A8377,Betacarotene,7235-40-7,G04,L1021-06,536.87,EtOH,C40H56,CC1=C(C(CCC1)(C)C)C=CC(=CC=CC(=CC=CC=C(C)C=CC=C(C)C=CC2=C(CCCC2(C)C)C)C)C,insoluble in H2O; insoluble in DMSO; ≥9.6 mg/mL in EtOH,,Others,Others,,https://www.apexbt.com/search.php?catalog=A8377,1
510,A8378,Betamethasone Dipropionate,5593-20-4,G05,L1021-06,504.59,DMSO,C28H37FO7,CCC(=O)OCC(=O)C1(C(CC2C1(CC(C3(C2CCC4=CC(=O)C=CC43C)F)O)C)C)OC(=O)CC,≥22.75 mg/mL in DMSO; insoluble in H2O; ≥31.03 mg/mL in EtOH with ultrasonic,Free Base,Others,Others,Glucocorticoid receptor agonist,https://www.apexbt.com/search.php?catalog=A8378,1
511,A8379,Betamethasone Valerate,2152-44-5,G06,L1021-06,476.58,DMSO,C27H37FO6,CCCCC(=O)OC1(C(CC2C1(CC(C3(C2CCC4=CC(=O)C=CC43C)F)O)C)C)C(=O)CO,insoluble in H2O; ≥19.2 mg/mL in DMSO; ≥28.1 mg/mL in EtOH,Valerate,Others,Others,anti-inflammatory corticosteroid,https://www.apexbt.com/search.php?catalog=A8379,1
512,A8380,Bexarotene,153559-49-0,G07,L1021-06,348,DMSO,C24H28O2,CC1=CC2=C(C=C1C(=C)C3=CC=C(C=C3)C(=O)O)C(CCC2(C)C)(C)C,insoluble in H2O; ≥10.35 mg/mL in DMSO; ≥11.34 mg/mL in EtOH,Free Base,Others,Retinoid X Receptors,Retinoid Receptor agonist,https://www.apexbt.com/search.php?catalog=A8380,1
513,A8381,BIBR-1048,211915-06-9,G08,L1021-06,627.73,DMSO,C34H41N7O5,CCCCCCOC(=O)N=C(C1=CC=C(C=C1)NCC2=NC3=C(N2C)C=CC(=C3)C(=O)N(CCC(=O)OCC)C4=CC=CC=N4)N,≥30 mg/mL in DMSO; insoluble in H2O; ≥22.13 mg/mL in EtOH,Free Base,Proteases,Thrombin,Thrombin inhibitor,https://www.apexbt.com/search.php?catalog=A8381,1
514,A8384,Blonanserin,132810-10-7,G09,L1021-06,367.5,DMSO,C23H30FN3,CCN1CCN(CC1)C2=NC3=C(CCCCCC3)C(=C2)C4=CC=C(C=C4)F,insoluble in H2O; ≥17.67 mg/mL in EtOH; ≥9.19 mg/mL in DMSO,,Neuroscience,5-HT Receptor,,https://www.apexbt.com/search.php?catalog=A8384,1
515,A8386,Busulfan,55-98-1,G10,L1021-06,246.3,DMSO,C6H14O6S2,CS(=O)(=O)OCCCCOS(=O)(=O)C,≥12.3 mg/mL in DMSO; ≥2.35 mg/mL in H2O with gentle warming; ≥2.82 mg/mL in EtOH with gentle warming,Free Base,DNA Damage/DNA Repair,DNA Alkylating,DNA alkylating agent,https://www.apexbt.com/search.php?catalog=A8386,1
516,A8387,Calcium Gluceptate,17140-60-2,G11,L1021-06,490.42,H2O,C14H26CaO16,C(C(C(C(C(C(C(=O)[O-])O)O)O)O)O)O.C(C(C(C(C(C(C(=O)[O-])O)O)O)O)O)O.[Ca+2],insoluble in EtOH; ≥4.90 mg/mL in DMSO with gentle warming; ≥89.2 mg/mL in H2O,Gluceptate,Others,Others,Calcium supplement,https://www.apexbt.com/search.php?catalog=A8387,1
517,A8388,Carbadox,6804-07-5,H01,L1021-06,262.22,DMSO,C11H10N4O4,COC(=O)N=NC=C1C=[N+](C2=CC=CC=C2N1O)[O-],insoluble in H2O; insoluble in EtOH; ≥3.78 mg/mL in DMSO with gentle warming,Free Base,Others,Others,antibiotic,https://www.apexbt.com/search.php?catalog=A8388,1
518,A8389,Carbenoxolone disodium,7421-40-1,H02,L1021-06,614.72,DMSO,C34H48Na2O7,CC1(C2CCC3(C(C2(CCC1OC(=O)CCC(=O)[O-])C)C(=O)C=C4C3(CCC5(C4CC(CC5)(C)C(=O)[O-])C)C)C)C.[Na+].[Na+],≥30.74 mg/mL in DMSO; ≥39.1 mg/mL in EtOH; ≥55.1 mg/mL in H2O,disodium,Neuroscience,Gap Junction,11β-HSD inhibitor,https://www.apexbt.com/search.php?catalog=A8389,1
519,A8390,Casanthranol,8024-48-4,H03,L1021-06,434.39,DMSO,C21H22O10,C1=CC2=C(C(=C1)O)C(=O)C3=C(C=C(C=C3C2OC4C(C(C(C(O4)CO)O)O)O)CO)O,insoluble in H2O; insoluble in EtOH; ≥20.45 mg/mL in DMSO,,Others,Others,,https://www.apexbt.com/search.php?catalog=A8390,1
520,A8391,Cefdinir,91832-40-5,H04,L1021-06,395.41,DMSO,C14H13N5O5S2,C=CC1=C(N2C(C(C2=O)NC(=O)C(=NO)C3=CSC(=N3)N)SC1)C(=O)O,insoluble in EtOH; insoluble in H2O; ≥19.55 mg/mL in DMSO,Free Base,Microbiology & Virology,Antibiotic,Third generation cephalosporin antibiotic,https://www.apexbt.com/search.php?catalog=A8391,1
521,A8392,Cefoperazone,62893-19-0,H05,L1021-06,645.66,DMSO,C25H27N9O8S2,CCN1CCN(C(=O)C1=O)C(=O)NC(C2=CC=C(C=C2)O)C(=O)NC3C4N(C3=O)C(=C(CS4)CSC5=NN=NN5C)C(=O)O,≥64.6 mg/mL in DMSO; insoluble in H2O; insoluble in EtOH,Free Base,Microbiology & Virology,Antibiotic,Third-generation cephalosporin antibiotic,https://www.apexbt.com/search.php?catalog=A8392,1
522,A8393,CH5424802,1256580-46-7,H06,L1021-06,482.62,DMSO,C30H34N4O2,CCC1=C(C=C2C(=C1)C(=O)C3=C(C2(C)C)NC4=C3C=CC(=C4)C#N)N5CCC(CC5)N6CCOCC6,insoluble in H2O; ≥2.72 mg/mL in EtOH with gentle warming; ≥4.83 mg/mL in DMSO with gentle warming and ultrasonic,,Tyrosine Kinase,ALK,"ALK inhibitor,potent and ATP-competitive",https://www.apexbt.com/search.php?catalog=A8393,1
523,A8397,Chlorothiazide,58-94-6,H07,L1021-06,295.72,DMSO,C7H6ClN3O4S2,ClC1=C(C=C2S(=O)(NC=NC2=C1)=O)S(=O)(N)=O,insoluble in H2O; insoluble in EtOH; ≥14.85 mg/mL in DMSO,Free Base,Others,Others,Carbonic anhydrase inhibitor,https://www.apexbt.com/search.php?catalog=A8397,1
524,A8398,Chlorprothixene,113-59-7,H08,L1021-06,315.87,EtOH,C18H18ClNS,CN(C)CCC=C1C2=CC=CC=C2SC3=C1C=C(C=C3)Cl,insoluble in H2O; ≥13.43 mg/mL in DMSO; ≥15.79 mg/mL in EtOH,Free Base,Neuroscience,Dopamine Receptor,Dopamine receptor antagonist,https://www.apexbt.com/search.php?catalog=A8398,1
525,A8401,Clotrimazole,23593-75-1,H09,L1021-06,344.84,DMSO,C22H17ClN2,C1=CC=C(C=C1)C(C2=CC=CC=C2)(C3=CC=CC=C3Cl)N4C=CN=C4,insoluble in H2O; ≥15.1 mg/mL in EtOH; ≥28.1 mg/mL in DMSO,Free Base,Microbiology & Virology,Antibiotic,antifungal compound,https://www.apexbt.com/search.php?catalog=A8401,1
526,A8402,Conivaptan HCl,168626-94-6,H10,L1021-06,535.04,DMSO,C32H26N4O2·HCl,CC1=NC2=C(N1)CCN(C3=CC=CC=C32)C(=O)C4=CC=C(C=C4)NC(=O)C5=CC=CC=C5C6=CC=CC=C6.Cl,insoluble in H2O; ≥10.22 mg/mL in EtOH; ≥14.8 mg/mL in DMSO,HCl,GPCR/G protein,Vasopressin Receptor,Vasopressin receptor antagonist,https://www.apexbt.com/search.php?catalog=A8402,1
527,A8404,Cyproterone Acetate,427-51-0,H11,L1021-06,416.94,DMSO,C24H29ClO4,ClC1=C([H])C(C(C([H])([H])C2([H])[H])([H])C(C2(C(C([H])([H])[H])=O)OC(C([H])([H])[H])=O)(C([H])([H])[H])C([H])([H])C3([H])[H])([H])C3([H])C(C1=C([H])C4=O)(C([H])([H])[H])C5([H])C4([H])C5([H])[H],insoluble in H2O; ≥14.7 mg/mL in DMSO; ≥20.55 mg/mL in EtOH,Acetate,Endocrinology and Hormones,Androgen Receptor,Androgen receptor antagonist,https://www.apexbt.com/search.php?catalog=A8404,1
528,A8405,Cytarabine,147-94-4,A01,L1021-07,243.2,H2O,C9H13N3O5,C1=CN(C(=O)N=C1N)C2C(C(C(O2)CO)O)O,insoluble in EtOH; ≥28.6 mg/mL in H2O; ≥7.65 mg/mL in H2O,Free Base,DNA Damage/DNA Repair,DNA Synthesis,"cytotoxic agent, blocks DNA synthesis",https://www.apexbt.com/search.php?catalog=A8405,1
529,A8406,Dextrose (D-glucose),50-99-7,A02,L1021-07,180.16,DMSO,C6H12O6,C(C1C(C(C(C(O1)O)O)O)O)O,≥2.6 mg/mL in EtOH with gentle warming and ultrasonic; ≥13.85 mg/mL in DMSO; ≥44.3 mg/mL in H2O,Free Base,Others,Others,Simple sugar (monosaccharide),https://www.apexbt.com/search.php?catalog=A8406,1
530,A8407,Dibucaine (Cinchocaine) HCl,61-12-1,A03,L1021-07,379.92,DMSO,C20H29N3O2·HCl,CCCCOC1=NC2=CC=CC=C2C(C(NCCN(CC)CC)=O)=C1.Cl,≥11.9 mg/mL in DMSO; ≥40.2 mg/mL in H2O; ≥41.4 mg/mL in EtOH,Free Base,Membrane Transporter/Ion Channel,Sodium Channel,Sodium channel inhibitor,https://www.apexbt.com/search.php?catalog=A8407,1
531,A8408,Dichlorphenamide,120-97-8,A04,L1021-07,305.16,DMSO,C6H6Cl2N2O4S2,C1=C(C=C(C(=C1S(=O)(=O)N)Cl)Cl)S(=O)(=O)N,insoluble in H2O; ≥15.3 mg/mL in DMSO; ≥15.6 mg/mL in EtOH with ultrasonic,,Metabolism,Carbonic Anhydrase,,https://www.apexbt.com/search.php?catalog=A8408,1
532,A8409,Dicyclomine HCl,67-92-5,A05,L1021-07,345.95,DMSO,C19H35NO2·HCl,CCN(CC)CCOC(=O)C1(CCCCC1)C2CCCCC2.Cl,≥16.05 mg/mL in DMSO with gentle warming; ≥31.25 mg/mL in H2O; ≥65.5 mg/mL in EtOH,Hydrochloride,Others,Others,Anticholinergic drug,https://www.apexbt.com/search.php?catalog=A8409,1
533,A8410,Didanosine,69655-05-6,A06,L1021-07,236.23,DMSO,C10H12N4O3,C1CC(OC1CO)N2C=NC3=C2NC=NC3=O,insoluble in H2O; insoluble in EtOH; ≥10.3 mg/mL in DMSO,Free Base,Microbiology & Virology,Reverse Transcriptase,Reverse transcriptase inhibitor,https://www.apexbt.com/search.php?catalog=A8410,1
534,A8411,Difloxacin HCl,98106-17-3,A07,L1021-07,435.86,DMSO,C21H19F2N3O3 HCl,CN1CCN(CC1)C2=C(C=C3C(=C2)N(C=C(C3=O)C(=O)O)C4=CC=C(C=C4)F)F,insoluble in EtOH; ≥7.36 mg/mL in H2O with ultrasonic; ≥9.15 mg/mL in DMSO with gentle warming,hydrochloride,Others,Others,quinolone antimicrobial antibiotic,https://www.apexbt.com/search.php?catalog=A8411,1
535,A8412,Dinaciclib (SCH727965),779353-01-4,A08,L1021-07,396.49,DMSO,C21H28N6O2,CCC1=C2N=C(C=C(N2N=C1)NCC3=C[N+](=CC=C3)[O-])N4CCCCC4CCO,insoluble in H2O; ≥10.22 mg/mL in EtOH; ≥17.15 mg/mL in DMSO,Free Base,Cell Cycle/Checkpoint,Cyclin-Dependent Kinases,Potent CDK inhibitor,https://www.apexbt.com/search.php?catalog=A8412,1
536,A8413,Diperodon HCl,537-12-2,A09,L1021-07,433.93,DMSO,C22H27N3O4·HCl,O=C(NC1=CC=CC=C1)OC(COC(NC2=CC=CC=C2)=O)CN3CCCCC3.Cl,insoluble in H2O; ≥16.8 mg/mL in DMSO; ≥19.9 mg/mL in EtOH,hydrochloride,Others,Others,Local anaesthetics,https://www.apexbt.com/search.php?catalog=A8413,1
537,A8414,Diphemanil Methylsulfate,62-97-5,A10,L1021-07,389.51,DMSO,C20H24N·CH3O4S,C[N+]1(CCC(=C(C2=CC=CC=C2)C3=CC=CC=C3)CC1)C.COS(=O)(=O)[O-],≥10.7 mg/mL in EtOH; ≥7.7 mg/mL in H2O; ≥9.74 mg/mL in DMSO,Methylsulfate,Neuroscience,AChR,AChR antagonist,https://www.apexbt.com/search.php?catalog=A8414,1
538,A8415,Diphenylpyraline HCl,132-18-3,A11,L1021-07,317.85,DMSO,C19H23NO·HCl,CN1CCC(CC1)OC(C2=CC=CC=C2)C3=CC=CC=C3.Cl,≥12.85 mg/mL in H2O; ≥42 mg/mL in DMSO; ≥54.7 mg/mL in EtOH,hydrochloride,Others,Others,Histamine receptor antagonist,https://www.apexbt.com/search.php?catalog=A8415,1
539,A8416,Docosanol (Abreua),661-19-8,B01,L1021-07,326.6,EtOH,C22H46O,CCCCCCCCCCCCCCCCCCCCCCO,insoluble in DMSO; insoluble in H2O; ≥11.9 mg/mL in EtOH with gentle warming,Free Base,Others,Others,Saturated fatty alcohol,https://www.apexbt.com/search.php?catalog=A8416,1
540,A8417,Dofetilide,115256-11-6,B02,L1021-07,441.56,DMSO,C19H27N3O5S2,CN(CCC1=CC=C(C=C1)NS(=O)(=O)C)CCOC2=CC=C(C=C2)NS(=O)(=O)C,≥21.15 mg/mL in DMSO; insoluble in EtOH; insoluble in H2O,Free Base,Membrane Transporter/Ion Channel,Potassium Channel,Potassium channel inhibitor,https://www.apexbt.com/search.php?catalog=A8417,1
541,A8418,Dovitinib Dilactic acid,852433-84-2,B03,L1021-07,572.59,DMSO,C21H21FN6O·2C3H6O3,CC(C(=O)O)O.CC(C(=O)O)O.CN1CCN(CC1)C2=CC3=C(C=C2)NC(=C4C(=C5C(=NC4=O)C=CC=C5F)N)N3,≥57.3 mg/mL in DMSO; insoluble in EtOH; ≥14.7 mg/mL in H2O,Dilactic Acid,Tyrosine Kinase,VEGFR,FLT3 inhibitor,https://www.apexbt.com/search.php?catalog=A8418,1
542,A8419,Doxapram HCl,7081-53-0,B04,L1021-07,432.98,DMSO,C24H30N2O2·HCl·H2O,CCN1CC(CCN2CCOCC2)C(C3=CC=CC=C3)(C4=CC=CC=C4)C1=O.O.Cl,≥20.05 mg/mL in DMSO with gentle warming; ≥14.27 mg/mL in H2O with ultrasonic; ≥14.6 mg/mL in EtOH,hydrochloride,Others,Others,Potassium channel inhibitor,https://www.apexbt.com/search.php?catalog=A8419,1
543,A8420,Doxycycline HCl,10592-13-9,B05,L1021-07,480.9,DMSO,C22H24N2O8.HCl,CC1C2C(C3C(C(=O)C(=C(C3(C(=O)C2=C(C4=C1C=CC=C4O)O)O)O)C(=O)N)N(C)C)O.Cl,>16.4mg/mL in DMSO,,Proteases,MMP,Tetracycline antibiotic;MMP inhibitor;cell selection reagent,https://www.apexbt.com/search.php?catalog=A8420,1
544,A8421,Duloxetine HCl,136434-34-9,B06,L1021-07,333.88,DMSO,C18H19NOS·HCl,CNCCC(C1=CC=CS1)OC2=CC=CC3=CC=CC=C32.Cl,insoluble in H2O; ≥16.69 mg/mL in DMSO; ≥27.75 mg/mL in EtOH with ultrasonic,hydrochloride,Neuroscience,5-HT Receptor,5-HT receptor inhibitor,https://www.apexbt.com/search.php?catalog=A8421,1
545,A8422,Emtricitabine,143491-57-0,B07,L1021-07,247.25,DMSO,C8H10FN3O3S,C1C(OC(S1)CO)N2C=C(C(=NC2=O)N)F,≥10.4 mg/mL in DMSO; ≥50.1 mg/mL in H2O; ≥9.38 mg/mL in EtOH with ultrasonic,Free Base,Microbiology & Virology,Reverse Transcriptase,Reverse transcriptase inhibitor,https://www.apexbt.com/search.php?catalog=A8422,1
546,A8423,Enoxacin (Penetrex),74011-58-8,B08,L1021-07,320.32,DMSO,C15H17FN4O3,CCN1C=C(C(=O)C2=CC(=C(N=C21)N3CCNCC3)F)C(=O)O,insoluble in H2O; insoluble in EtOH; ≥18.4 mg/mL in DMSO,Free Base,Microbiology & Virology,Antibiotic,Topoisomerase inhibitor,https://www.apexbt.com/search.php?catalog=A8423,1
547,A8424,Eplerenone,107724-20-9,B09,L1021-07,414.49,DMSO,C24H30O6,CC12CCC(=O)C=C1CC(C3C24C(O4)CC5(C3CCC56CCC(=O)O6)C)C(=O)OC,insoluble in H2O; insoluble in EtOH; ≥4.6 mg/mL in DMSO with gentle warming,,Others,Mineralocorticoid Receptor,Mineralocorticoid receptor antagonists,https://www.apexbt.com/search.php?catalog=A8424,0
548,A8425,Estradiol,50-28-2,B10,L1021-07,272.38,DMSO,C18H24O2,CC12CCC3C(C1CCC2O)CCC4=C3C=CC(=C4)O,insoluble in H2O; ≥11.25 mg/mL in EtOH; ≥13.5 mg/mL in DMSO,Free Base,Endocrinology and Hormones,Estrogen/progestogen Receptor,Sex hormone,https://www.apexbt.com/search.php?catalog=A8425,1
549,A8426,Estrone,53-16-7,B11,L1021-07,270.37,DMSO,C18H22O2,CC12CCC3C(C1CCC2=O)CCC4=C3C=CC(=C4)O,insoluble in H2O; ≥9.2 mg/mL in EtOH with gentle warming and ultrasonic; ≥9.75 mg/mL in DMSO,Free Base,Endocrinology and Hormones,Estrogen/progestogen Receptor,Estrogenic hormone,https://www.apexbt.com/search.php?catalog=A8426,1
550,A8427,Ethambutol HCl,1070-11-7,C01,L1021-07,277.23,DMSO,C10H24N2O2·2HCl,CCC(CO)NCCNC(CC)CO.Cl.Cl,≥12.65 mg/mL in DMSO,Dihydrochloride,Others,Others,Antitubercular agent,https://www.apexbt.com/search.php?catalog=A8427,1
551,A8428,Ethinyl Estradiol,57-63-6,C02,L1021-07,296.4,DMSO,C20H24O2,CC12CCC3C(C1CCC2(C#C)O)CCC4=C3C=CC(=C4)O,≥8.7 mg/mL in DMSO,Free Base,Endocrinology and Hormones,Estrogen/progestogen Receptor,Oral contraceptive,https://www.apexbt.com/search.php?catalog=A8428,1
552,A8429,Ethionamide,536-33-4,C03,L1021-07,166.24,DMSO,C8H10N2S,CCC1=NC=CC(=C1)C(=S)N,≥7.65 mg/mL in DMSO,Free Base,Microbiology & Virology,Antibiotic,Anti-tuberculosis antibiotic,https://www.apexbt.com/search.php?catalog=A8429,1
553,A8430,Ezetimibe,163222-33-1,C04,L1021-07,409.4,DMSO,C24H21F2NO3,C1=CC(=CC=C1C2C(C(=O)N2C3=CC=C(C=C3)F)CCC(C4=CC=C(C=C4)F)O)O,≥20.45 mg/mL in DMSO,Free Base,Metabolism,Cholesterol absorption,Cholesterol transport inhibitor,https://www.apexbt.com/search.php?catalog=A8430,1
554,A8431,Famprofazone,22881-35-2,C05,L1021-07,377.52,DMSO,C24H31N3O,CC(C)C1=C(N(N(C1=O)C2=CC=CC=C2)C)CN(C)C(C)CC3=CC=CC=C3,insoluble in H2O; ≥17.35 mg/mL in DMSO with gentle warming; ≥26.45 mg/mL in EtOH,Free Base,Others,Others,Non-steroidal anti-inflammatory agent,https://www.apexbt.com/search.php?catalog=A8431,1
555,A8432,Fenticonazole Nitrate,73151-29-8,C06,L1021-07,518.41,DMSO,C24H20Cl2N2OS·HNO3,C1=CC=C(C=C1)SC2=CC=C(C=C2)COC(CN3C=CN=C3)C4=C(C=C(C=C4)Cl)Cl.[N+](=O)(O)[O-],≥25.4 mg/mL in DMSO; insoluble in H2O; ≥22.25 mg/mL in EtOH,Nitrate,Microbiology & Virology,Anti-infection,Antifungal drug,https://www.apexbt.com/search.php?catalog=A8432,1
556,A8433,Flucytosine,2022-85-7,C07,L1021-07,129.09,DMSO,C4H4FN3O,C1=NC(=O)NC(=C1F)N,insoluble in EtOH; ≥18.8 mg/mL in H2O; ≥6.4 mg/mL in DMSO,Free Base,Microbiology & Virology,Antibiotic,Antifungal drug,https://www.apexbt.com/search.php?catalog=A8433,1
557,A8434,Flurbiprofen,5104-49-4,C08,L1021-07,244.26,DMSO,C15H13FO2,CC(C1=CC(=C(C=C1)C2=CC=CC=C2)F)C(=O)O,insoluble in H2O; ≥11.35 mg/mL in DMSO; ≥51.2 mg/mL in EtOH,,Immunology/Inflammation,PGE synthase,Cyclooxygenase inhibitors,https://www.apexbt.com/search.php?catalog=A8434,1
558,A8435,Furosemide,54-31-9,C09,L1021-07,330.74,DMSO,C12H11ClN2O5S,C1=COC(=C1)CNC2=CC(=C(C=C2C(=O)O)S(=O)(=O)N)Cl,insoluble in H2O; ≥13.35 mg/mL in EtOH; ≥14.9 mg/mL in DMSO,Free Base,Membrane Transporter/Ion Channel,NKCC,GABAA receptors antagonist,https://www.apexbt.com/search.php?catalog=A8435,1
559,A8436,Gabapentin,60142-96-3,C10,L1021-07,171.24,H2O,C9H17NO2,C1CCC(CC1)(CC(=O)O)CN,≥2.6 mg/mL in EtOH; ≥25.85 mg/mL in H2O; ≥8.56 mg/mL in DMSO,Free Base,Neuroscience,GABA Receptor,GABA enhancer,https://www.apexbt.com/search.php?catalog=A8436,1
560,A8437,Gemcitabine,95058-81-4,C11,L1021-07,263.2,DMSO,C9H11F2N3O4,C1=CN(C(=O)N=C1N)C2C(C(C(O2)CO)O)(F)F,≥11.75 mg/mL in H2O with gentle warming; ≥24.8 mg/mL in DMSO; ≥7.54 mg/mL in EtOH with ultrasonic,Free Base,DNA Damage/DNA Repair,DNA Synthesis,inhibitor of DNA synthesis,https://www.apexbt.com/search.php?catalog=A8437,1
561,A8438,Glipizide,29094-61-9,D01,L1021-07,445.54,DMSO,C21H27N5O4S,CC1=NC=C(N=C1)C(=O)NCCC2=CC=C(C=C2)S(=O)(=O)NC(=O)NC3CCCCC3,insoluble in H2O; ≥16.8 mg/mL in DMSO; ≥2.57 mg/mL in EtOH with gentle warming,Free Base,Membrane Transporter/Ion Channel,Potassium Channel,Oral anti-diabetic medication,https://www.apexbt.com/search.php?catalog=A8438,1
562,A8442,Guaifenesin,93-14-1,D02,L1021-07,198.22,DMSO,C10H14O4,COC1=CC=CC=C1OCC(CO)O,≥12.35 mg/mL in H2O; ≥50 mg/mL in EtOH; ≥8.05 mg/mL in DMSO,Free Base,Others,Others,Expectorant agent,https://www.apexbt.com/search.php?catalog=A8442,1
563,A8443,Guanethidine Sulfate,60-02-6,D03,L1021-07,494.7,H2O,C20H44N8·H2O4S,OS(O)(=O)=O.N=C(N)NCCN1CCCCCCC1.N=C(N)NCCN2CCCCCCC2,insoluble in DMSO; insoluble in EtOH; ≥159.4 mg/mL in H2O,,Others,Others,,https://www.apexbt.com/search.php?catalog=A8443,1
564,A8446,Ibuprofen,15687-27-1,D04,L1021-07,206.28,DMSO,C13H18O2,CC(C)CC1=CC=C(C=C1)C(C)C(=O)O,insoluble in H2O; ≥10.31 mg/mL in DMSO; ≥50.2 mg/mL in EtOH,Free Base,Neuroscience,COX,inhibitor of cyclooxygenase 1 and cyclooxygenase 2,https://www.apexbt.com/search.php?catalog=A8446,1
565,A8447,Imidapril HCl,89396-94-1,D05,L1021-07,441.91,DMSO,C20H27N3O6·HCl,CCOC(=O)C(CCC1=CC=CC=C1)NC(C)C(=O)N2C(CN(C2=O)C)C(=O)O.Cl,insoluble in H2O; ≥16.5 mg/mL in DMSO; ≥25.35 mg/mL in EtOH with ultrasonic,hydrochloride,Endocrinology and Hormones,RAAS,RAAS inhibitor,https://www.apexbt.com/search.php?catalog=A8447,1
566,A8449,Indomethacin,53-86-1,D06,L1021-07,357.79,DMSO,C19H16ClNO4,CC1=C(C2=C(N1C(=O)C3=CC=C(C=C3)Cl)C=CC(=C2)OC)CC(=O)O,insoluble in H2O; ≥16.97 mg/mL in EtOH with ultrasonic; ≥17.89 mg/mL in DMSO,Free Base,Neuroscience,COX,Cox inhibitor,https://www.apexbt.com/search.php?catalog=A8449,1
567,A8451,Ipratropium Bromide,22254-24-6,D07,L1021-07,412.37,DMSO,C20H30BrNO3,CC(C)[N+]1(C2CCC1CC(C2)OC(=O)C(CO)C3=CC=CC=C3)C.[Br-],insoluble in H2O; ≥20.62 mg/mL in DMSO; ≥24.65 mg/mL in EtOH with ultrasonic,Bromide,Neuroscience,AChR,AChR antagonist,https://www.apexbt.com/search.php?catalog=A8451,1
568,A8452,ODM-201,1297538-32-9,D08,L1021-07,398.85,DMSO,C19H19ClN6O2,CC(CN1C=CC(=N1)C2=CC(=C(C=C2)C#N)Cl)NC(=O)C3=NNC(=C3)C(C)O,insoluble in H2O; ≥12.7 mg/mL in EtOH with ultrasonic; ≥19.95 mg/mL in DMSO,,Endocrinology and Hormones,Androgen Receptor,,https://www.apexbt.com/search.php?catalog=A8452,0
569,A8453,Isradipine (Dynacirc),75695-93-1,D09,L1021-07,371.39,DMSO,C19H21N3O5,CC1=C(C(C(=C(N1)C)C(=O)OC(C)C)C2=CC=CC3=NON=C32)C(=O)OC,≥12.55 mg/mL in DMSO; ≥16.43 mg/mL in EtOH with ultrasonic; ≥2.71 mg/mL in H2O with gentle warming and ultrasonic,Free Base,Membrane Transporter/Ion Channel,Calcium Channel,Calcium channel blocker,https://www.apexbt.com/search.php?catalog=A8453,1
570,A8454,Istradefylline (KW-6002),155270-99-8,D10,L1021-07,384.43,DMSO,C20H24N4O4,CCN1C2=C(C(=O)N(C1=O)CC)N(C(=N2)C=CC3=CC(=C(C=C3)OC)OC)C,insoluble in H2O; insoluble in EtOH; ≥8.78 mg/mL in DMSO with gentle warming,,GPCR/G protein,Adenosine Receptor,Selective A2A receptor antagonist,https://www.apexbt.com/search.php?catalog=A8454,1
571,A8455,Nilvadipine,75530-68-6,D11,L1021-07,385.37,DMSO,C19H19N3O6,CC1=C(C(C(=C(N1)C#N)C(=O)OC)C2=CC(=CC=C2)[N+](=O)[O-])C(=O)OC(C)C,insoluble in H2O; ≥12.4 mg/mL in DMSO; ≥37.13 mg/mL in EtOH with ultrasonic,Free Base,Membrane Transporter/Ion Channel,Calcium Channel,Calcium channel inhibitor,https://www.apexbt.com/search.php?catalog=A8455,1
572,A8458,Lamivudine,134678-17-4,E01,L1021-07,229.26,DMSO,C8H11N3O3S,C1C(OC(S1)CO)N2C=CC(=NC2=O)N,≥10.5 mg/mL in DMSO; ≥11.4 mg/mL in EtOH with ultrasonic; ≥89.4 mg/mL in H2O with ultrasonic,Free Base,Microbiology & Virology,Reverse Transcriptase,Nucleoside analog reverse transcriptase inhibitor,https://www.apexbt.com/search.php?catalog=A8458,1
573,A8459,Laquinimod (ABR-215062),248281-84-7,E02,L1021-07,356.8,DMSO,C19H17ClN2O3,CCN(C1=CC=CC=C1)C(=O)C2=C(C3=C(C=CC=C3Cl)N(C2=O)C)O,insoluble in H2O; ≥17.25 mg/mL in DMSO; ≥3.94 mg/mL in EtOH with ultrasonic,,Others,Others,"Immunomodulator,orally-available,quinolinone-based and broad spectrum",https://www.apexbt.com/search.php?catalog=A8459,1
574,A8460,Levodopa,59-92-7,E03,L1021-07,197.19,H2O,C9H11NO4,C1=CC(=C(C=C1CC(C(=O)O)N)O)O,insoluble in DMSO; insoluble in EtOH; ≥6.57 mg/mL in H2O with gentle warming,,Neuroscience,Dopamine Receptor,,https://www.apexbt.com/search.php?catalog=A8460,1
575,A8461,L-Glutamine,56-85-9,E04,L1021-07,146.14,H2O,C5H10N2O3,C(CC(=O)N)C(C(=O)O)N,insoluble in EtOH; insoluble in DMSO; ≥6.2 mg/mL in H2O,,GPCR/G protein,mGluR,Non-essential amino acid,https://www.apexbt.com/search.php?catalog=A8461,1
576,A8462,Lithium Citrate,6080-58-6,E05,L1021-07,281.98,DMSO,C6H5O7·4H2O·3Li,[Li+].[Li+].[Li+].C(C(=O)[O-])C(CC(=O)[O-])(C(=O)[O-])O.O.O.O.O,insoluble in EtOH; ≥14.1 mg/mL in DMSO with gentle warming and ultrasonic; ≥83.6 mg/mL in H2O with ultrasonic,,Others,Others,Mood stabilizer,https://www.apexbt.com/search.php?catalog=A8462,1
577,A8463,Lithocholic Acid,434-13-9,E06,L1021-07,376.57,DMSO,C24H40O3,CC(CCC(=O)O)C1CCC2C1(CCC3C2CCC4C3(CCC(C4)O)C)C,insoluble in H2O; ≥12.95 mg/mL in DMSO; ≥26.6 mg/mL in EtOH with ultrasonic,Free Base,Others,Others,"Activator of vitamin D receptor,PXR and FXR",https://www.apexbt.com/search.php?catalog=A8463,1
578,A8466,Meloxicam (Mobic),71125-38-7,E07,L1021-07,351.4,DMSO,C14H13N3O4S2,CC1=CN=C(S1)NC(=O)C2=C(C3=CC=CC=C3S(=O)(=O)N2C)O,insoluble in H2O; insoluble in EtOH; ≥17.57 mg/mL in DMSO,Free Base,Neuroscience,COX,Nonsteroidal anti-inflammatory drug,https://www.apexbt.com/search.php?catalog=A8466,1
579,A8467,Mepenzolate Bromide,76-90-4,E08,L1021-07,420.34,DMSO,C21H26BrNO3,OC(C1=CC=CC=C1)(C(OC2CCC[N+](C)(C)C2)=O)C3=CC=CC=C3.[Br-],≥10.02 mg/mL in EtOH with ultrasonic; ≥20.65 mg/mL in DMSO; ≥6.59 mg/mL in H2O with ultrasonic,bromide,Others,Others,mAChR antagonist,https://www.apexbt.com/search.php?catalog=A8467,1
580,A8468,Mepiroxol,6968-72-5,E09,L1021-07,125.13,DMSO,C6H7NO2,C1=CC(=C[N+](=C1)[O-])CO,≥45.3 mg/mL in EtOH; ≥5.45 mg/mL in DMSO; ≥51.9 mg/mL in H2O,Free Base,Others,Others,Antihyperlipidemic drug,https://www.apexbt.com/search.php?catalog=A8468,1
581,A8469,Mesna,19767-45-4,E10,L1021-07,164.18,DMSO,C2H5NaO3S2,C(CS(=O)(=O)[O-])S.[Na+],≥2.25 mg/mL in EtOH with gentle warming; ≥48.4 mg/mL in H2O; ≥8.05 mg/mL in DMSO,Free Base,Others,Others,Chemotherapy adjuvant;potential antioxidant,https://www.apexbt.com/search.php?catalog=A8469,1
582,A8470,Mestranol,72-33-3,E11,L1021-07,310.44,DMSO,C21H26O2,CC12CCC3C(C1CCC2(C#C)O)CCC4=C3C=CC(=C4)OC,insoluble in H2O; ≥12.4 mg/mL in DMSO; ≥20.25 mg/mL in EtOH,Free Base,Endocrinology and Hormones,Estrogen/progestogen Receptor,Estrogen used in contraceptives,https://www.apexbt.com/search.php?catalog=A8470,0
583,A8471,Meticrane,1084-65-7,F01,L1021-07,275.34,DMSO,C10H13NO4S2,CC1=C(C=C2C(=C1)CCCS2(=O)=O)S(=O)(=O)N,insoluble in H2O; insoluble in EtOH; ≥12.45 mg/mL in DMSO,Free Base,Others,Others,Peripheral-type benzodiazepine receptor (PBR) inhibitor,https://www.apexbt.com/search.php?catalog=A8471,1
584,A8472,Methimazole,60-56-0,F02,L1021-07,114.17,DMSO,C4H6N2S,CN1C=CN=C1S,≥49.1 mg/mL in H2O; ≥5.8 mg/mL in DMSO; ≥52.4 mg/mL in EtOH,Free Base,Others,Others,ICAM-1 inhibitor,https://www.apexbt.com/search.php?catalog=A8472,1
585,A8473,Methyocarbamol,532-03-6,F03,L1021-07,241.24,DMSO,C11H15NO5,COC1=CC=CC=C1OCC(COC(=O)N)O,≥15.65 mg/mL in DMSO; ≥59.7 mg/mL in EtOH; ≥7.7 mg/mL in H2O,Free Base,Others,Others,Carbonic anhydrase inhibitor,https://www.apexbt.com/search.php?catalog=A8473,1
586,A8474,Mirabegron (YM178),223673-61-8,F04,L1021-07,396.51,DMSO,C21H24N4O2S,C1=CC=C(C=C1)C(CNCCC2=CC=C(C=C2)NC(=O)CC3=CSC(=N3)N)O,insoluble in H2O; ≥16.13 mg/mL in EtOH; ≥19.83 mg/mL in DMSO,Free Base,GPCR/G protein,Adrenergic Receptor,Selective β3-adrenoceptor agonist,https://www.apexbt.com/search.php?catalog=A8474,1
587,A8475,Mitotane (Lsodren),53-19-0,F05,L1021-07,320.04,DMSO,C14H10Cl4,C1=CC=C(C(=C1)C(C2=CC=C(C=C2)Cl)C(Cl)Cl)Cl,insoluble in H2O; ≥12.5 mg/mL in DMSO; ≥25.85 mg/mL in EtOH,Free Base,Others,Others,Antineoplastic agents against adrenocortical carcinoma,https://www.apexbt.com/search.php?catalog=A8475,1
588,A8478,Monobenzone,103-16-2,F06,L1021-07,200.23,DMSO,C13H12O2,C1=CC=C(C=C1)COC2=CC=C(C=C2)O,insoluble in H2O; ≥55.8 mg/mL in EtOH; ≥9.8 mg/mL in DMSO,Free Base,Others,Others,Skin depigmenting agent,https://www.apexbt.com/search.php?catalog=A8478,1
589,A8479,Noscapine HCl,912-60-7,F07,L1021-07,449.88,DMSO,C22H23NO7·HCl,CN1CCC2=CC3=C(C(=C2C1C4C5=C(C(=C(C=C5)OC)OC)C(=O)O4)OC)OCO3.Cl,insoluble in H2O; ≥10.38 mg/mL in EtOH with gentle warming; ≥18.47 mg/mL in DMSO,hydrochloride,Others,Others,Multi-action opioid alkaloid,https://www.apexbt.com/search.php?catalog=A8479,1
590,A8481,Nevirapine,129618-40-2,F08,L1021-07,266.3,DMSO,C15H14N4O,CC1=C2C(=NC=C1)N(C3=C(C=CC=N3)C(=O)N2)C4CC4,insoluble in H2O; ≥13.3 mg/mL in DMSO; ≥3.02 mg/mL in EtOH with gentle warming,Free Base,Microbiology & Virology,Reverse Transcriptase,Non-nucleoside reverse transcriptase inhibitor,https://www.apexbt.com/search.php?catalog=A8481,1
591,A8482,Nicotine Difartrate,65-31-6,F09,L1021-07,462.46,DMSO,C18H26N2O12,CN1CCCC1C2=CN=CC=C2.C(C(C(=O)O)O)(C(=O)O)O.C(C(C(=O)O)O)(C(=O)O)O,insoluble in EtOH; ≥16.1 mg/mL in DMSO; ≥35.5 mg/mL in H2O,ditartrate,Others,Others,Nicotinic acetylcholine receptor (nAChR) agonist,https://www.apexbt.com/search.php?catalog=A8482,1
592,A8483,Nifenazone,2139-47-1,F10,L1021-07,308.33,DMSO,C17H16N4O2,CC1=C(C(=O)N(N1C)C2=CC=CC=C2)NC(=O)C3=CN=CC=C3,Soluble in DMSO,Free Base,Others,Others,Analgesic,https://www.apexbt.com/search.php?catalog=A8483,1
593,A8484,Nimodipine,66085-59-4,F11,L1021-07,418.45,DMSO,C21H26N2O7,CC1=C(C(C(=C(N1)C)C(=O)OC(C)C)C2=CC(=CC=C2)[N+](=O)[O-])C(=O)OCCOC,≥41.8 mg/mL in EtOH; insoluble in H2O; ≥108 mg/mL in DMSO,Free Base,Ubiquitination/Proteasome,Autophagy,Calcium Channel inhibitor & Autophagy activator,https://www.apexbt.com/search.php?catalog=A8484,1
594,A8485,Nitazoxanide,55981-09-4,G01,L1021-07,307.28,DMSO,C12H9N3O5S,CC(=O)OC1=CC=CC=C1C(=O)NC2=NC=C(S2)[N+](=O)[O-],insoluble in H2O; insoluble in EtOH; ≥13.25 mg/mL in DMSO,Free Base,Others,Others,Antiprotozoal agent,https://www.apexbt.com/search.php?catalog=A8485,1
595,A8486,Nitrofurazone,59-87-0,G02,L1021-07,198.14,DMSO,C6H6N4O4,C1=C(OC(=C1)[N+](=O)[O-])C=NNC(=O)N,insoluble in EtOH; insoluble in H2O; ≥9.6 mg/mL in DMSO,Free Base,Microbiology & Virology,Antibiotic,Antibiotic,https://www.apexbt.com/search.php?catalog=A8486,1
596,A8490,Olsalazine Sodium,6054-98-4,G03,L1021-07,346.2,H2O,C14H8N2O6·2Na,C1=CC(=C(C=C1NN=C2C=CC(=O)C(=C2)C(=O)O)C(=O)[O-])[O-].[Na+].[Na+],insoluble in DMSO; insoluble in EtOH; ≥17.2 mg/mL in H2O,Free Base,Microbiology & Virology,Antibiotic,Anti-inflammatory prodrug,https://www.apexbt.com/search.php?catalog=A8490,1
597,A8492,Orlistat,96829-58-2,G04,L1021-07,495.73,DMSO,C29H53NO5,CCCCCCCCCCCC(CC1C(C(=O)O1)CCCCCC)OC(=O)C(CC(C)C)NC=O,insoluble in H2O; ≥17.4 mg/mL in DMSO; ≥26.8 mg/mL in EtOH,Free Base,Others,Others,Lipase inhibitor for obesity treatment,https://www.apexbt.com/search.php?catalog=A8492,1
598,A8493,Oxeladin Citrate,52432-72-1,G05,L1021-07,527.6,DMSO,C20H33NO3·C6H8O7,CCC(CC)(C1=CC=CC=C1)C(=O)OCCOCCN(CC)CC.C(C(=O)O)C(CC(=O)O)(C(=O)O)O,≥25 mg/mL in DMSO; ≥24.75 mg/mL in H2O; ≥25.85 mg/mL in EtOH,citrate,Others,Others,Cough suppressant,https://www.apexbt.com/search.php?catalog=A8493,1
599,A8494,Oxethazaine,126-27-2,G06,L1021-07,467.64,DMSO,C28H41N3O3,CC(C)(CC1=CC=CC=C1)N(C)C(=O)CN(CCO)CC(=O)N(C)C(C)(C)CC2=CC=CC=C2,≥23.15 mg/mL in DMSO; insoluble in H2O; ≥50 mg/mL in EtOH,Free Base,Others,Others,Topical anesthetic,https://www.apexbt.com/search.php?catalog=A8494,1
600,A8495,Oxybutynin,5633-20-5,G07,L1021-07,357.49,DMSO,C22H31NO3,CCN(CC)CC#CCOC(=O)C(C1CCCCC1)(C2=CC=CC=C2)O,insoluble in H2O; ≥17.87 mg/mL in DMSO; ≥48.5 mg/mL in EtOH,Free Base,Neuroscience,AChR,AChR antagonist,https://www.apexbt.com/search.php?catalog=A8495,1
601,A8496,Paliperidone,144598-75-4,G08,L1021-07,426.48,DMSO,C23H27FN4O3,CC1=C(C(=O)N2CCCC(C2=N1)O)CCN3CCC(CC3)C4=NOC5=C4C=CC(=C5)F,insoluble in H2O; insoluble in EtOH; ≥10.662 mg/mL in DMSO with gentle warming,,Neuroscience,Dopamine Receptor,Dopamine receptor antagonist,https://www.apexbt.com/search.php?catalog=A8496,1
602,A8497,Pasiniazid,2066-89-9,G09,L1021-07,290.27,DMSO,C6H7N3O·C7H7NO3,C1=CC(=C(C=C1N)O)C(=O)O.C1=CN=CC=C1C(=O)NN,insoluble in H2O; ≥14.5 mg/mL in EtOH; ≥22.75 mg/mL in DMSO,Isonicotinic,Others,Others,Anti-TB and anti-leprosy drug,https://www.apexbt.com/search.php?catalog=A8497,1
603,A8502,Piromidic Acid,19562-30-2,G10,L1021-07,288.32,DMSO,C14H16N4O3,CCN1C=C(C(=O)C2=CN=C(N=C21)N3CCCC3)C(=O)O,insoluble in H2O; insoluble in EtOH; ≥2.88 mg/mL in DMF with gentle warming; ≥3 mg/mL in DMSO with gentle warming,,Others,Others,Quinolone antibiotic,https://www.apexbt.com/search.php?catalog=A8502,1
604,A8503,Piroxicam,36322-90-4,G11,L1021-07,331.35,DMSO,C15H13N3O4S,CN1C(=C(C2=CC=CC=C2S1(=O)=O)O)C(=O)NC3=CC=CC=N3,insoluble in H2O; insoluble in EtOH; ≥16.57 mg/mL in DMSO,Free Base,Neuroscience,COX,Prostaglandin synthesis/Coxinhibitor,https://www.apexbt.com/search.php?catalog=A8503,1
605,A8504,Pitavastatin Calcium,147526-32-7,H01,L1021-07,880.98,DMSO,C50H46CaF2N2O8,C1CC1C2=NC3=CC=CC=C3C(=C2C=CC(CC(CC(=O)[O-])O)O)C4=CC=C(C=C4)F.C1CC1C2=NC3=CC=CC=C3C(=C2C=CC(CC(CC(=O)[O-])O)O)C4=CC=C(C=C4)F.[Ca+2],≥34.85 mg/mL in DMSO; insoluble in EtOH; insoluble in H2O,Calcium,Metabolism,HMG-CoA Reductase,Enzyme HMGCR inhibitor,https://www.apexbt.com/search.php?catalog=A8504,1
606,A8506,Potassium Canrenoate,2181-04-6,H02,L1021-07,396.56,H2O,C22H29KO4,CC12CCC(=O)C=C1C=CC3C2CCC4(C3CCC4(CCC(=O)[O-])O)C.[K+],insoluble in EtOH; insoluble in DMSO; ≥117.4 mg/mL in H2O,,Others,Others,Aldosterone antagonist,https://www.apexbt.com/search.php?catalog=A8506,1
607,A8507,Pridinol Methanesulfonate,6856-31-1,H03,L1021-07,391.52,DMSO,C21H29NO4S,CS(=O)(=O)O.C1CCN(CC1)CCC(C2=CC=CC=C2)(C3=CC=CC=C3)O,≥10.96 mg/mL in H2O with ultrasonic; ≥16.95 mg/mL in DMSO; ≥40.53 mg/mL in EtOH with ultrasonic,Methanesulfonat,Others,Others,Anticholinergic / antiparkinsonian agent,https://www.apexbt.com/search.php?catalog=A8507,1
608,A8508,Prochlorperazine,58-38-8,H04,L1021-07,373.94,DMSO,C20H24ClN3S,CN(CC1)CCN1CCCN2C3=CC=CC=C3SC4=C2C=C(Cl)C=C4,insoluble in H2O; ≥16.5 mg/mL in DMSO; ≥58.5 mg/mL in EtOH,Free Base,Others,Others,Dopamine (D2) receptor antagonist,https://www.apexbt.com/search.php?catalog=A8508,1
609,A8509,Progesterone,57-83-0,H05,L1021-07,314.46,DMSO,C21H30O2,CC(=O)C1CCC2C1(CCC3C2CCC4=CC(=O)CCC34C)C,insoluble in H2O; ≥14.65 mg/mL in DMSO; ≥47.3 mg/mL in EtOH,Free Base,Endocrinology and Hormones,Estrogen/progestogen Receptor,Progesterone,https://www.apexbt.com/search.php?catalog=A8509,1
610,A8510,Ranolazine,95635-55-5,H06,L1021-07,427.54,DMSO,C24H33N3O4,CC1=C(C(=CC=C1)C)NC(=O)CN2CCN(CC2)CC(COC3=CC=CC=C3OC)O,insoluble in H2O; ≥13.18 mg/mL in EtOH with ultrasonic; ≥17.4 mg/mL in DMSO,Free Base,Others,Others,Anti-ischemic,https://www.apexbt.com/search.php?catalog=A8510,1
611,A8512,Rifaximin (Xifaxan),80621-81-4,H07,L1021-07,785.88,DMSO,C43H51N3O11,CC1C=CC=C(C(=O)NC2=C(C3=C(C4=C(C(=C3O)C)OC(C4=O)(OC=CC(C(C(C(C(C(C1O)C)O)C)OC(=O)C)C)OC)C)C5=C2N6C=CC(=CC6=N5)C)O)C,≥83.33 mg/mL in DMSO; insoluble in H2O; ≥30 mg/mL in EtOH with ultrasonic,Free Base,DNA Damage/DNA Repair,DNA Synthesis,"RNA synthesis inhibitor, PXR activator",https://www.apexbt.com/search.php?catalog=A8512,0
612,A8513,Riluzole,1744-22-5,H08,L1021-07,234.2,DMSO,C8H5F3N2OS,C1=CC2=C(C=C1OC(F)(F)F)SC(=N2)N,≥23.4 mg/mL in DMSO; insoluble in EtOH; insoluble in H2O,Free Base,Membrane Transporter/Ion Channel,Sodium Channel,Sodium channel protein inhibitor,https://www.apexbt.com/search.php?catalog=A8513,1
613,A8514,Risperidone,106266-06-2,H09,L1021-07,410.48,DMSO,C23H27FN4O2,CC1=C(C(=O)N2CCCCC2=N1)CCN3CCC(CC3)C4=NOC5=C4C=CC(=C5)F,insoluble in H2O; ≥11.49 mg/mL in EtOH with ultrasonic; ≥6.84 mg/mL in DMSO with gentle warming,Free Base,Neuroscience,5-HT Receptor,SR-2A inhibitor,https://www.apexbt.com/search.php?catalog=A8514,1
614,A8515,Rivastigmine Tartrate,129101-54-8,H10,L1021-07,400.42,DMSO,C14H22N2O2·C4H6O6,CCN(C)C(=O)OC1=CC=CC(=C1)C(C)N(C)C.C(C(C(=O)O)O)(C(=O)O)O,≥20.02 mg/mL in DMSO; ≥45.3 mg/mL in H2O; ≥79.4 mg/mL in EtOH,Tartrate,Neuroscience,AChR,AChR inhibitor,https://www.apexbt.com/search.php?catalog=A8515,1
615,A8516,Rizatriptan Benzoate,145202-66-0,H11,L1021-07,391.47,DMSO,C15H19N5·C7H6O2,CN(C)CCC1=CNC2=C1C=C(C=C2)CN3C=NC=N3.C1=CC=C(C=C1)C(=O)O,≥4.12 mg/mL in EtOH with ultrasonic; ≥48.9 mg/mL in H2O with ultrasonic; ≥9.79 mg/mL in DMSO,Benzoate,Neuroscience,5-HT Receptor,5-HT Receptor agonist,https://www.apexbt.com/search.php?catalog=A8516,1
616,A8518,Rosuvastatin Calcium,147098-20-2,A01,L1021-08,1001.14,DMSO,C44H54F2N6O12S2 Ca,CC(C)C1=NC(=NC(=C1C=CC(CC(CC(=O)[O-])O)O)C2=CC=C(C=C2)F)N(C)S(=O)(=O)C.CC(C)C1=NC(=NC(=C1C=CC(CC(CC(=O)[O-])O)O)C2=CC=C(C=C2)F)N(C)S(=O)(=O)C.[Ca+2],≥28.55 mg/mL in DMSO; insoluble in H2O; insoluble in EtOH,Free Base,Endocrinology and Hormones,RAAS,HMG-CoA reductase inhibitor,https://www.apexbt.com/search.php?catalog=A8518,1
617,A8521,Silodosin,160970-54-7,A02,L1021-08,495.53,DMSO,C25H32F3N3O4,CC(CC1=CC2=C(C(=C1)C(=O)N)N(CC2)CCCO)NCCOC3=CC=CC=C3OCC(F)(F)F,≥24.78 mg/mL in DMSO; insoluble in H2O; ≥45.5 mg/mL in EtOH with ultrasonic,Free Base,GPCR/G protein,Adrenergic Receptor,α1-adrenoceptor antagonist,https://www.apexbt.com/search.php?catalog=A8521,1
618,A8522,Simvastatin (Zocor),79902-63-9,A03,L1021-08,418.6,DMSO,C25H38O5,CCC(C)(C)C(=O)OC1CC(C=C2C1C(C(C=C2)C)CCC3CC(CC(=O)O3)O)C,insoluble in H2O; ≥102 mg/mL in EtOH with ultrasonic; ≥20.95 mg/mL in DMSO,Free Base,Metabolism,HMG-CoA Reductase,HMGCR (HMG-CoA reductase) inhibitor,https://www.apexbt.com/search.php?catalog=A8522,1
619,A8523,Sodium 4-amiropparaty Hyalrate,94-16-6,A04,L1021-08,216.17,DMSO,C9H9N2NaO3,C1=CC(=CC=C1C(=O)NCC(=O)[O-])N.[Na+],≥10.56 mg/mL in EtOH with ultrasonic; ≥129.6 mg/mL in H2O; ≥6.5 mg/mL in DMSO,Sodium,Others,Others,Sodium 4-amiropparaty Hyalrate,https://www.apexbt.com/search.php?catalog=A8523,1
620,A8525,Sotrastaurin (AEB071),425637-18-9,A05,L1021-08,438.48,DMSO,C25H22N6O2,CN1CCN(CC1)C2=NC3=CC=CC=C3C(=N2)C4=C(C(=O)NC4=O)C5=CNC6=CC=CC=C65,≥21.9 mg/mL in DMSO; insoluble in H2O; ≥2.55 mg/mL in EtOH with ultrasonic,Free Base,TGF-β / Smad Signaling,PKC,PKC inhibitor,https://www.apexbt.com/search.php?catalog=A8525,1
621,A8527,Sulfadiazine,68-35-9,A06,L1021-08,250.28,DMSO,C10H10N4O2S,C1=CN=C(N=C1)NS(=O)(=O)C2=CC=C(C=C2)N,insoluble in EtOH; insoluble in H2O; ≥7.55 mg/mL in DMSO,Free Base,Microbiology & Virology,Antibiotic,Sulfonamide antibiotic,https://www.apexbt.com/search.php?catalog=A8527,1
622,A8529,Tebipenempivoxil,161715-24-8,A07,L1021-08,497.63,DMSO,C22H31N3O6S2,CC1C2C(C(=O)N2C(=C1SC3CN(C3)C4=NCCS4)C(=O)OCOC(=O)C(C)(C)C)C(C)O,insoluble in H2O; ≥17.25 mg/mL in DMSO; ≥36.27 mg/mL in EtOH with ultrasonic,Free Base,Microbiology & Virology,Anti-infection,Carbapenem antibiotic,https://www.apexbt.com/search.php?catalog=A8529,1
623,A8530,Telbivudine,3424-98-4,A08,L1021-08,242.23,DMSO,C10H14N2O5,CC1=CN(C(=O)NC1=O)C2CC(C(O2)CO)O,insoluble in EtOH; ≥11.85 mg/mL in DMSO; ≥9.24 mg/mL in H2O with ultrasonic,Free Base,Microbiology & Virology,HBV,Reverse Transcriptase inhibitor,https://www.apexbt.com/search.php?catalog=A8530,1
624,A8531,Telmisattan,144701-48-4,A09,L1021-08,514.62,DMSO,C33H30N4O2,CCCC1=NC2=C(C=C(C=C2N1CC3=CC=C(C=C3)C4=CC=CC=C4C(=O)O)C5=NC6=CC=CC=C6N5C)C,insoluble in H2O; insoluble in EtOH; ≥9.6 mg/mL in DMSO with gentle warming,Free Base,Endocrinology and Hormones,RAAS,Angiotensin II receptor antagonist,https://www.apexbt.com/search.php?catalog=A8531,1
625,A8532,Teniposide,29767-20-2,A10,L1021-08,656.7,DMSO,C32H32O13S,COC1=CC(=CC(=C1O)OC)C2C3C(COC3=O)C(C4=CC5=C(C=C24)OCO5)OC6C(C(C7C(O6)COC(O7)C8=CC=CS8)O)O,≥23.65 mg/mL in DMSO; insoluble in H2O; insoluble in EtOH,Free Base,DNA Damage/DNA Repair,Topoisomerase,Topoisomerase inhibitor,https://www.apexbt.com/search.php?catalog=A8532,1
626,A8533,Terbinafine,91161-71-6,A11,L1021-08,291.43,DMSO,C21H25N,CC(C)(C)C#CC=CCN(C)CC1=CC=CC2=CC=CC=C21,insoluble in H2O; ≥11.9 mg/mL in DMSO; ≥67.2 mg/mL in EtOH with ultrasonic,Free Base,Microbiology & Virology,Antibiotic,Allylamine antifungal agent,https://www.apexbt.com/search.php?catalog=A8533,1
627,A8534,Terfenadine,50679-08-8,B01,L1021-08,471.67,DMSO,C32H41NO2,CC(C)(C)C1=CC=C(C=C1)C(CCCN2CCC(CC2)C(C3=CC=CC=C3)(C4=CC=CC=C4)O)O,insoluble in H2O; ≥18 mg/mL in DMSO; ≥8.06 mg/mL in EtOH with ultrasonic,Free Base,Others,Others,Histamine H1-receptor antagonist,https://www.apexbt.com/search.php?catalog=A8534,1
628,A8536,Thiabendazole,148-79-8,B02,L1021-08,201.25,DMSO,C10H7N3S,C1=CC=C2C(=C1)NC(=N2)C3=CSC=N3,insoluble in H2O; insoluble in EtOH; ≥8.7 mg/mL in DMSO ,Free Base,Others,Others,Fungicide,https://www.apexbt.com/search.php?catalog=A8536,1
629,A8537,Thioridazine HCl,130-61-0,B03,L1021-08,407,DMSO,C21H26N2S2·HCl,CN1CCCCC1CCN2C3=CC=CC=C3SC4=C2C=C(C=C4)SC.Cl,≥12.25 mg/mL in EtOH with ultrasonic; ≥20.35 mg/mL in DMSO; ≥6.78 mg/mL in H2O with ultrasonic,Hydrochloride,Others,Others,Calcium channel protein inhibitor,https://www.apexbt.com/search.php?catalog=A8537,1
630,A8538,Tiopronin (Thiola),1953-02-2,B04,L1021-08,163.19,DMSO,C5H9NO3S,CC(C(=O)NCC(=O)O)S,≥110.6 mg/mL in H2O; ≥120.6 mg/mL in EtOH; ≥6.8 mg/mL in DMSO,Free Base,Others,Others,Drug for cystinuria treatment,https://www.apexbt.com/search.php?catalog=A8538,1
631,A8539,Tretinoin (Aberela),302-79-4,B05,L1021-08,300.4,DMSO,C20H28O2,CC1=C(C(CCC1)(C)C)C=CC(=CC=CC(=CC(=O)O)C)C,insoluble in H2O; ≥11.9 mg/mL in DMSO; ≥5.77 mg/mL in EtOH with ultrasonic,Free Base,Others,RARs,"retinoic acid, treats acne vulgaris and keratosis pilaris",https://www.apexbt.com/search.php?catalog=A8539,1
632,A8540,Triamcinolone Acetonide,76-25-5,B06,L1021-08,434.5,DMSO,C24H31FO6,CC1(OC2CC3C4CCC5=CC(=O)C=CC5(C4(C(CC3(C2(O1)C(=O)CO)C)O)F)C)C,insoluble in H2O; ≥14.25 mg/mL in DMSO; ≥8.08 mg/mL in EtOH with ultrasonic,Free Base,Others,Others,Antiinflammatory steroid,https://www.apexbt.com/search.php?catalog=A8540,0
633,A8541,Triciribine,35943-35-2,B07,L1021-08,320.3,DMSO,C13H16N6O4,CN1C2=NC=NC3=C2C(=CN3C4C(C(C(O4)CO)O)O)C(=N1)N,insoluble in H2O; insoluble in EtOH; ≥118.4 mg/mL in DMSO,,PI3K/Akt/mTOR Signaling,Akt,"Akt inhibitor,highly selective",https://www.apexbt.com/search.php?catalog=A8541,0
634,A8542,Triflurdine (Viroptic),70-00-8,B08,L1021-08,296.2,DMSO,C10H11F3N2O5,C1C(C(OC1N2C=C(C(=O)NC2=O)C(F)(F)F)CO)O,≥14.45 mg/mL in DMSO; ≥17.03 mg/mL in EtOH with ultrasonic; ≥3.72 mg/mL in H2O with ultrasonic,Free Base,Apoptosis,Thymidylate Synthase,Anti-herpesvirus antiviral drug,https://www.apexbt.com/search.php?catalog=A8542,1
635,A8543,Vitamin D2 (Ergocalciferol),50-14-6,B09,L1021-08,396.65,EtOH,C28H44O,CC(C)C(C)C=CC(C)C1CCC2C1(CCCC2=CC=C3CC(CCC3=C)O)C,insoluble in H2O; ≥11.83 mg/mL in DMSO with ultrasonic; ≥16.8 mg/mL in EtOH,Free Base,Others,Others,DNA Polymerase inhibitor,https://www.apexbt.com/search.php?catalog=A8543,1
636,A8548,Fingolimod (FTY720),162359-56-0,B10,L1021-08,343.94,DMSO,C19H34ClNO2,CCCCCCCCC1=CC=C(C=C1)CCC(CO)(CO)N.Cl,≥15.3 mg/mL in EtOH; ≥17.2 mg/mL in DMSO; ≥31.3 mg/mL in H2O with ultrasonic,,GPCR/G protein,S1P receptor,S1P receptors agonist,https://www.apexbt.com/search.php?catalog=A8548,1
637,A8549,LY335979 (Zosuquidar 3HCL),167465-36-3,B11,L1021-08,637.0,DMSO,C32H34Cl3F2N3O2,C1CN(CCN1CC(COC2=CC=CC3=C2C=CC=N3)O)C4C5=CC=CC=C5C6C(C6(F)F)C7=CC=CC=C47.Cl.Cl.Cl,insoluble in EtOH; ≥17.1 mg/mL in DMSO; ≥31.9 mg/mL in H2O,,Membrane Transporter/Ion Channel,P-gp,Pgp (P-glycoprotein) inhibitor,https://www.apexbt.com/search.php?catalog=A8549,0
638,A8553,PTC124 (Ataluren),775304-57-9,C01,L1021-08,284.24,DMSO,C15H9FN2O3,C1=CC=C(C(=C1)C2=NC(=NO2)C3=CC(=CC=C3)C(=O)O)F,insoluble in H2O; ≥10.6 mg/mL in DMSO; ≥2.37 mg/mL in EtOH with gentle warming,,Membrane Transporter/Ion Channel,CFTR,CFTR-G542X nonsense allele inhibitor,https://www.apexbt.com/search.php?catalog=A8553,1
639,A8555,Vandetanib (ZD6474),443913-73-3,C02,L1021-08,475.35,DMSO,C22H24BrFN4O2,CN1CCC(CC1)COC2=C(C=C3C(=C2)N=CN=C3NC4=C(C=C(C=C4)Br)F)OC,insoluble in H2O; ≥11.88 mg/mL in DMSO with gentle warming; ≥8.74 mg/mL in EtOH,,Tyrosine Kinase,VEGFR,VEGFR2/EGFR antagonist,https://www.apexbt.com/search.php?catalog=A8555,1
640,A8556,GSK2126458,1086062-66-9,C03,L1021-08,505.5,DMSO,C25H17F2N5O3S,COC1=C(C=C(C=N1)C2=CC3=C(C=CN=C3C=C2)C4=CN=NC=C4)NS(=O)(=O)C5=C(C=C(C=C5)F)F,≥25.3 mg/mL in DMSO; insoluble in H2O; ≥2.29 mg/mL in EtOH,Free Base,PI3K/Akt/mTOR Signaling,mTOR,PI3K/mTOR inhibitor,https://www.apexbt.com/search.php?catalog=A8556,1
641,A8558,BI6727 (Volasertib),755038-65-4,C04,L1021-08,618.83,DMSO,C34H50N8O3,CCC1C(=O)N(C2=CN=C(N=C2N1C(C)C)NC3=C(C=C(C=C3)C(=O)NC4CCC(CC4)N5CCN(CC5)CC6CC6)OC)C,insoluble in H2O; ≥10.31 mg/mL in DMSO; ≥56.1 mg/mL in EtOH,Free Base,Cell Cycle/Checkpoint,PLK,"Plk inhibitor,highly potent",https://www.apexbt.com/search.php?catalog=A8558,1
642,A8623,TOK-001,851983-85-2,C05,L1021-08,388.56,DMSO,C26H32N2O,CC12CCC(CC1=CCC3C2CCC4(C3CC=C4N5C=NC6=CC=CC=C65)C)O,insoluble in H2O; ≥12.4 mg/mL in DMSO; ≥26.5 mg/mL in EtOH,,Endocrinology and Hormones,Androgen Receptor,CYP17 inhibitor and androgen receptor (AR) antagonist,https://www.apexbt.com/search.php?catalog=A8623,1
643,A8628,Chloroquine diphosphate,50-63-5,C06,L1021-08,515.86,H2O,C18H26ClN3·2H3PO4,CCN(CC)CCCC(C)NC1=C2C=CC(=CC2=NC=C1)Cl.OP(=O)(O)O.OP(=O)(O)O,insoluble in DMSO; insoluble in EtOH; ≥106.06 mg/mL in H2O,Phosphate,Ubiquitination/Proteasome,Autophagy,"Antimalarial drug,TLR7 TLR9 inhibitor",https://www.apexbt.com/search.php?catalog=A8628,1
644,A8639,Deferasirox,201530-41-8,C07,L1021-08,373.37,DMSO,C21H15N3O4,O=C(O)C1=CC=C(N2C(C3=CC=CC=C3O)=NC(C4=CC=CC=C4O)=N2)C=C1,insoluble in H2O; ≥11.9 mg/mL in DMSO; ≥2.94 mg/mL in EtOH with ultrasonic,Free Base,Cell Cycle/Checkpoint,Cyclin-Dependent Kinases,Oral iron chelator,https://www.apexbt.com/search.php?catalog=A8639,1
645,A8641,LEE011,1211441-98-3,C08,L1021-08,434.54,DMSO,C23H30N8O,CN(C)C(=O)C1=CC2=CN=C(N=C2N1C3CCCC3)NC4=NC=C(C=C4)N5CCNCC5,insoluble in H2O; insoluble in EtOH; ≥10.88 mg/mL in DMSO,Free Base,Cell Cycle/Checkpoint,Cyclin-Dependent Kinases,CDK4/6 inhibitor,https://www.apexbt.com/search.php?catalog=A8641,1
646,A8644,Acyclovir,59277-89-3,C09,L1021-08,225.21,DMSO,C8H11N5O3,C1=NC2=C(N1COCCO)NC(=NC2=O)N,insoluble in H2O; insoluble in EtOH; ≥11.4 mg/mL in DMSO,Free Base,DNA Damage/DNA Repair,DNA Synthesis,Antiviral agent,https://www.apexbt.com/search.php?catalog=A8644,1
647,A8647,Capecitabine,154361-50-9,C10,L1021-08,359.35,DMSO,C15H22FN3O6,CCCCCOC(=O)NC1=NC(=O)N(C=C1F)C2C(C(C(O2)C)O)O,≥10.97 mg/mL in H2O with ultrasonic; ≥17.95 mg/mL in DMSO; ≥66.9 mg/mL in EtOH,Free Base,DNA Damage/DNA Repair,DNA Synthesis,"DNA, RNA and protein synthesis inhibitor",https://www.apexbt.com/search.php?catalog=A8647,1
648,A8648,Oxaliplatin,61825-94-3,C11,L1021-08,397.29,DMSO,C8H14N2O4Pt,C1CCC(C(C1)N)N.C(=O)(C(=O)[O-])[O-].[Pt+2],insoluble in EtOH; ≥37.25 mg/mL in DMSO; ≥3.94 mg/mL in H2O with gentle warming,,DNA Damage/DNA Repair,DNA Synthesis,Antitumor agent,https://www.apexbt.com/search.php?catalog=A8648,1
649,A8650,Saxagliptin,361442-04-8,D01,L1021-08,315.41,DMSO,C18H25N3O2,C1C2CC2N(C1C#N)C(=O)C(C34CC5CC(C3)CC(C5)(C4)O)N,≥123 mg/mL in EtOH; ≥14.85 mg/mL in DMSO; ≥8.32 mg/mL in H2O with ultrasonic,,Proteases,DPP-4,Selective DPP4 inhibitor,https://www.apexbt.com/search.php?catalog=A8650,1
650,A8651,LY2940680,1258861-20-9,D02,L1021-08,512.5,DMSO,C26H24F4N6O,CN1C(=CC=N1)C2=NN=C(C3=CC=CC=C32)N4CCC(CC4)N(C)C(=O)C5=C(C=C(C=C5)F)C(F)(F)F,insoluble in H2O; ≥5.2 mg/mL in EtOH with ultrasonic; ≥51.3 mg/mL in DMSO with gentle warming and ultrasonic,,Stem Cell,Hedgehog,"Hedgehog/SMO antagonist,inhibits Hh signaling",https://www.apexbt.com/search.php?catalog=A8651,1
651,A8660,Cilengitide,188968-51-6,D03,L1021-08,588.66,DMSO,C27H40N8O7,CC(C)C1C(=O)NC(C(=O)NCC(=O)NC(C(=O)NC(C(=O)N1C)CC2=CC=CC=C2)CC(=O)O)CCCN=C(N)N,≥29.43 mg/mL in DMSO; insoluble in H2O; ≥22.56 mg/mL in H2O,Free Base,Angiogenesis,Integrin,Integrin inhibitor for αvβ3 and αvβ5,https://www.apexbt.com/search.php?catalog=A8660,1
652,A8686,VX-745,209410-46-8,D04,L1021-08,436.27,DMSO,C19H9Cl2F2N3OS,C1=CC(=C(C(=C1)Cl)C2=C3C=CC(=NN3C=NC2=O)SC4=C(C=C(C=C4)F)F)Cl,≥21.8 mg/mL in DMSO; insoluble in H2O; ≥2.1 mg/mL in EtOH with gentle warming and ultrasonic,,MAPK Signaling,p38,,https://www.apexbt.com/search.php?catalog=A8686,1
653,A8701,Mesoridazine Besylate,32672-69-8,D05,L1021-08,544.75,DMSO,C27H32N2O4S3,CN1CCCCC1CCN2C3=CC=CC=C3SC4=C2C=C(C=C4)S(=O)C.C1=CC=C(C=C1)S(=O)(=O)O,≥21.5 mg/mL in DMSO; insoluble in H2O; ≥19.55 mg/mL in EtOH,besylate,Others,Others,Phenothiazine dopamine receptor anatagonist,https://www.apexbt.com/search.php?catalog=A8701,0
654,A8704,Stiripentol,49763-96-4,D06,L1021-08,234.29,DMSO,C14H18O3,OC(C(C)(C)C)/C=C/C1=CC2=C(OCO2)C=C1,insoluble in H2O; ≥46.7 mg/mL in EtOH; ≥9.9 mg/mL in DMSO,,Metabolism,Dehydrogenase,,https://www.apexbt.com/search.php?catalog=A8704,1
655,A8710,ETC-1002,738606-46-7,D07,L1021-08,344.49,DMSO,C19H36O5,OC(C(C)(C)CCCCCC(O)CCCCCC(C)(C)C(O)=O)=O,insoluble in H2O; ≥97.6 mg/mL in DMSO; ≥42.5 mg/mL in EtOH,,Others,ATP citrate lyase,ACL inhibitor and AMPK activator,https://www.apexbt.com/search.php?catalog=A8710,1
656,A8802,(S)-Crizotinib,877399-52-5; 1374356-45-2,D08,L1021-08,450.34,DMSO,C21H22Cl2FN5O,CC(C1=C(C=CC(=C1Cl)F)Cl)OC2=C(N=CC(=C2)C3=CN(N=C3)C4CCNCC4)N,≥33.33 mg/mL in DMSO; insoluble in H2O; ≥8.58 mg/mL in EtOH with ultrasonic,,DNA Damage/DNA Repair,MTH1,Potent MTH1 inhibitor,https://www.apexbt.com/search.php?catalog=A8802,1
657,A8809,Vorapaxar,618385-01-6,D09,L1021-08,492.58,DMSO,C29H33FN2O4,CCOC(=O)NC1CCC2C(C1)CC3C(C2C=CC4=NC=C(C=C4)C5=CC(=CC=C5)F)C(OC3=O)C,≥24.65 mg/mL in DMSO; insoluble in H2O; ≥10.64 mg/mL in EtOH with ultrasonic,Free Base,Others,Others,"PAR-1 antagonist,potent and orally active",https://www.apexbt.com/search.php?catalog=A8809,1
658,A8893,Rucaparib (free base),283173-50-2,D10,L1021-08,323.36,DMSO,C19H18FN3O,FC1=CC2=C3C(CCNC2=O)=C(C4=CC=C(CNC)C=C4)NC3=C1,insoluble in H2O; insoluble in EtOH; ≥16.15 mg/mL in DMSO,,Chromatin/Epigenetics,PARP,Potent PARP inhibitor,https://www.apexbt.com/search.php?catalog=A8893,1
659,B1006,Vilanterol trifenatate,503070-58-4,D11,L1021-08,774.77,DMSO,C44H49Cl2NO7,C1=CC=C(C=C1)C(C2=CC=CC=C2)(C3=CC=CC=C3)C(=O)O.C1=CC(=C(C(=C1)Cl)COCCOCCCCCCNCC(C2=CC(=C(C=C2)O)CO)O)Cl,insoluble in H2O; ≥158.4 mg/mL in DMSO; ≥7.84 mg/mL in ETOH with gentle warming and ultrasonic,,GPCR/G protein,Adrenergic Receptor,β2-AR agonist,https://www.apexbt.com/search.php?catalog=B1006,1
660,B1011,Bafetinib (INNO-406),859212-16-1,E01,L1021-08,576.62,DMSO,C30H31F3N8O,CC1=C(C=C(C=C1)NC(=O)C2=CC(=C(C=C2)CN3CCC(C3)N(C)C)C(F)(F)F)NC4=NC=C(C=N4)C5=CN=CN=C5,≥57.7 mg/mL in DMSO; insoluble in EtOH; insoluble in H2O,,TGF-β / Smad Signaling,Bcr-Abl,Bcr-Abl/Lyn tyrosine kinase inhibitor,https://www.apexbt.com/search.php?catalog=B1011,1
661,B1027,2-Deoxy-D-glucose,154-17-6,E02,L1021-08,164.16,DMSO,C6H12O5,[H][C@]([C@](C1([H])[H])([H])O[H])([C@](C([H])([H])O[H])([H])OC1([H])O[H])O[H],≥105 mg/mL in H2O; ≥2.37 mg/mL in EtOH with gentle warming and ultrasonic; ≥8.2 mg/mL in DMSO,,Others,Hexokinase,,https://www.apexbt.com/search.php?catalog=B1027,0
662,B1037,Alvelestat,848141-11-7,E03,L1021-08,545.53,DMSO,C25H22F3N5O4S,CC(N1C2=CC=CC(C(F)(F)F)=C2)=C(C3=CC=NN3C)C=C(C1=O)C(NCC4=NC=C(S(C)(=O)=O)C=C4)=O,≥27.3 mg/mL in DMSO; insoluble in H2O; insoluble in EtOH,Free Base,Proteases,Elastase,NE inhibitor,https://www.apexbt.com/search.php?catalog=B1037,1
663,B1045,Sunitinib,557795-19-4,E04,L1021-08,398.47,DMSO,C22H27FN4O2,CCN(CC)CCNC(=O)C1=C(NC(=C1C)C=C2C3=C(C=CC(=C3)F)NC2=O)C,insoluble in H2O; ≥19.9 mg/mL in DMSO with gentle warming; ≥3.16 mg/mL in EtOH with gentle warming,Free Base,Tyrosine Kinase,PDGFR,RTK inhibitor,https://www.apexbt.com/search.php?catalog=B1045,1
664,B1049,Ulipristal acetate,126784-99-4,E05,L1021-08,475.62,DMSO,C30H37NO4,CC(=O)C1(CCC2C1(CC(C3=C4CCC(=O)C=C4CCC23)C5=CC=C(C=C5)N(C)C)C)OC(=O)C,≥21.3 mg/mL in DMSO with gentle warming; insoluble in H2O; ≥23.23 mg/mL in EtOH,acetate,Endocrinology and Hormones,Estrogen/progestogen Receptor,Novel selective progesterone receptor modulator (SPRM),https://www.apexbt.com/search.php?catalog=B1049,1
665,B1050,Delavirdine mesylate,147221-93-0,E06,L1021-08,552.67,DMSO,C23H32N6O6S2,CC(C)NC1=C(N=CC=C1)N2CCN(CC2)C(=O)C3=CC4=C(N3)C=CC(=C4)NS(=O)(=O)C.CS(=O)(=O)O,insoluble in H2O; insoluble in EtOH; ≥58.3 mg/mL in DMSO,,Microbiology & Virology,Reverse Transcriptase,Non-nucleoside reverse transcriptase inhibitor,https://www.apexbt.com/search.php?catalog=B1050,1
666,B1054,Resiquimod (R-848),144875-48-9,E07,L1021-08,314.38,DMSO,C17H22N4O2,CCOCC1=NC2=C(N1CC(C)(C)O)C3=CC=CC=C3N=C2N,insoluble in H2O; ≥12.65 mg/mL in EtOH with ultrasonic; ≥15.85 mg/mL in DMSO,,Immunology/Inflammation,TLR,,https://www.apexbt.com/search.php?catalog=B1054,1
667,B1059,Mosapride,112885-41-3,E08,L1021-08,421.89,DMSO,C21H25ClFN3O3,CCOC1=CC(=C(C=C1C(=O)NCC2CN(CCO2)CC3=CC=C(C=C3)F)Cl)N,insoluble in H2O; insoluble in EtOH; ≥75.3 mg/mL in DMSO,,Neuroscience,5-HT Receptor,Selective 5HT4 agonist,https://www.apexbt.com/search.php?catalog=B1059,1
668,B1063,Tizanidine,51322-75-9,E09,L1021-08,253.71,DMSO,C9H8ClN5S,ClC1=C(NC2=NCCN2)C3=NSN=C3C=C1,insoluble in H2O; ≥11.45 mg/mL in DMSO; ≥9.44 mg/mL in EtOH with gentle warming and ultrasonic,Free Base,GPCR/G protein,Adrenergic Receptor,α2 adrenergic agonist,https://www.apexbt.com/search.php?catalog=B1063,1
669,B1070,AHU-377(Sacubitril),149709-62-6,E10,L1021-08,411.49,DMSO,C24H29NO5,CCOC(=O)C(C)CC(CC1=CC=C(C=C1)C2=CC=CC=C2)NC(=O)CCC(=O)O,≥41.1 mg/mL in DMSO; ≥21.45 mg/mL in H2O with ultrasonic; ≥26.85 mg/mL in EtOH with ultrasonic,,GPCR/G protein,Angiotensin Receptor,,https://www.apexbt.com/search.php?catalog=B1070,1
670,B1072,Losartan,114798-26-4,E11,L1021-08,422.91,DMSO,C22H23ClN6O,CCCCC1=NC(=C(N1CC2=CC=C(C=C2)C3=CC=CC=C3C4=NNN=N4)CO)Cl,≥2.48 mg/mL in H2O with gentle warming and ultrasonic; ≥2.9 mg/mL in EtOH with gentle warming; ≥84.6 mg/mL in DMSO,,GPCR/G protein,Angiotensin Receptor,Angiotensin II receptor antagonist,https://www.apexbt.com/search.php?catalog=B1072,1
671,B1076,Doripenem,148016-81-3,F01,L1021-08,420.5,DMSO,C15H24N4O6S2,CC1C2C(C(=O)N2C(=C1SC3CC(NC3)CNS(=O)(=O)N)C(=O)O)C(C)O,≥20.1 mg/mL in DMSO with gentle warming; ≥13.1 mg/mL in H2O with ultrasonic; ≥3.37 mg/mL in EtOH with gentle warming and ultrasonic,Free Base,Microbiology & Virology,Antibiotic,Ultra-broad spectrum injectable antibiotic,https://www.apexbt.com/search.php?catalog=B1076,1
672,B1092,Salicylic acid,69-72-7,F02,L1021-08,138.12,DMSO,C7H6O3,C1=CC=C(C(=C1)C(=O)O)O,insoluble in H2O; ≥52.6 mg/mL in EtOH; ≥6.91 mg/mL in DMSO,Free Base,Neuroscience,COX,COX inhibitor,https://www.apexbt.com/search.php?catalog=B1092,1
673,B1100,Cytarabine hydrochloride,69-74-9,F03,L1021-08,279.68,DMSO,C9H14ClN3O5,C1=CN(C(=O)N=C1N)C2C(C(C(O2)CO)O)O.Cl,insoluble in EtOH; ≥14.2 mg/mL in DMSO; ≥64.2 mg/mL in H2O,Hydrochloride,DNA Damage/DNA Repair,DNA Synthesis,DNA synthsis inhibitor,https://www.apexbt.com/search.php?catalog=B1100,1
674,B1102,Brexpiprazole,913611-97-9,F04,L1021-08,433.57,DMSO,C25H27N3O2S,C1CN(CCN1CCCCOC2=CC3=C(C=C2)C=CC(=O)N3)C4=C5C=CSC5=CC=C4,≥21.68 mg/mL in DMSO with gentle warming; insoluble in EtOH; insoluble in H2O,Free Base,Neuroscience,Dopamine Receptor,"5-HT2A, α1B-, and α2C-adrenergic receptors antagonist",https://www.apexbt.com/search.php?catalog=B1102,1
675,B1104,AZD-9291,1421373-65-0,F05,L1021-08,499.61,DMSO,C28H33N7O2,CN1C=C(C2=NC(NC3=C(OC)C=C(N(CCN(C)C)C)C(NC(C=C)=O)=C3)=NC=C2)C4=C1C=CC=C4,≥24.98 mg/mL in DMSO; insoluble in H2O; ≥8.09 mg/mL in EtOH with ultrasonic,Free Base,JAK/STAT Signaling,EGFR,Mutated forms EGFR inhibitor,https://www.apexbt.com/search.php?catalog=B1104,1
676,B1106,VRT752271,869886-67-9,F06,L1021-08,433.33,DMSO,C21H22Cl2N4O2,CC(C)NC1=NC=C(C(=C1)C2=CNC(=C2)C(=O)NC(CO)C3=CC(=CC=C3)Cl)Cl,≥43.3 mg/mL in DMSO; insoluble in H2O; ≥2.51 mg/mL in EtOH with gentle warming and ultrasonic,,MAPK Signaling,ERK,ERK1/ERK2 inhibitor,https://www.apexbt.com/search.php?catalog=B1106,1
677,B1114,T 705,259793-96-9,F07,L1021-08,157.1,DMSO,C5H4FN3O2,C1=C(N=C(C(=O)N1)C(=O)N)F,≥2.9 mg/mL in H2O with ultrasonic; ≥6.2 mg/mL in DMSO; ≥8.78 mg/mL in EtOH with ultrasonic,,Microbiology & Virology,HCV,Potent and selective RNA-dependent RNA polymerase inhibitor,https://www.apexbt.com/search.php?catalog=B1114,1
678,B1119,Efavirenz,154598-52-4,F08,L1021-08,315.68,DMSO,C14H9ClF3NO2,C1CC1C#CC2(C3=C(C=CC(=C3)Cl)NC(=O)O2)C(F)(F)F,insoluble in H2O; ≥15.55 mg/mL in DMSO; ≥48.1 mg/mL in EtOH,Free Base,Microbiology & Virology,HIV,Reverse transcriptase inhibitor,https://www.apexbt.com/search.php?catalog=B1119,1
679,B1122,Nelfinavir,159989-64-7,F09,L1021-08,567.78,DMSO,C32H45N3O4S,CC1=C(C=CC=C1O)C(=O)NC(CSC2=CC=CC=C2)C(CN3CC4CCCCC4CC3C(=O)NC(C)(C)C)O,insoluble in H2O; ≥16.1 mg/mL in DMSO with ultrasonic; ≥20.45 mg/mL in EtOH,Free Base,Proteases,HIV Integrase,HIV-1 protease inhibitor,https://www.apexbt.com/search.php?catalog=B1122,1
680,B1123,Rosuvastatin,287714-41-4,F10,L1021-08,481.54,DMSO,C22H28FN3O6S,CC(C)C1=NC(=NC(=C1C=CC(CC(CC(=O)O)O)O)C2=CC=C(C=C2)F)N(C)S(=O)(=O)C,≥48.2 mg/mL in DMSO; ≥10.78 mg/mL in H2O with ultrasonic; ≥12.4 mg/mL in EtOH with ultrasonic,,Metabolism,HMG-CoA Reductase,Competitive inhibitor of HMG-CoA reductase,https://www.apexbt.com/search.php?catalog=B1123,1
681,B1124,Pitavastatin,147511-69-1,F11,L1021-08,421.46,DMSO,C25H24FNO4,C1CC1C2=NC3=CC=CC=C3C(=C2C=CC(CC(CC(=O)O)O)O)C4=CC=C(C=C4)F,≥10.56 mg/mL in H2O with ultrasonic; ≥14.35 mg/mL in DMSO; ≥8.46 mg/mL in EtOH with ultrasonic,Free Base,Metabolism,HMG-CoA Reductase,HMG-CoA reductase inhibitor,https://www.apexbt.com/search.php?catalog=B1124,1
682,B1125,Pravastatin,81093-37-0,G01,L1021-08,424.53,DMSO,C23H36O7,CCC(C)C(=O)OC1CC(C=C2C1C(C(C=C2)C)CCC(CC(CC(=O)O)O)O)O,≥14.05 mg/mL in DMSO,,Metabolism,HMG-CoA Reductase,,https://www.apexbt.com/search.php?catalog=B1125,1
683,B1130,GLPG0634,1206161-97-8,G02,L1021-08,425.5,DMSO,C21H23N5O3S,C1CC1C(=O)NC2=NN3C(=N2)C=CC=C3C4=CC=C(C=C4)CN5CCS(=O)(=O)CC5,≥21.3 mg/mL in DMSO; insoluble in EtOH; insoluble in H2O,Free Base,JAK/STAT Signaling,JAK,JAK1 inhibitor,https://www.apexbt.com/search.php?catalog=B1130,1
684,B1134,Oxybutynin chloride,1508-65-2,G03,L1021-08,393.95,DMSO,C22H32ClNO3,CCN(CC)CC#CCOC(=O)C(C1CCCCC1)(C2=CC=CC=C2)O.Cl,≥19.7 mg/mL in DMSO; ≥70.8 mg/mL in EtOH; ≥73.3 mg/mL in H2O,Chloride,Neuroscience,AChR,Anticholinergic medication,https://www.apexbt.com/search.php?catalog=B1134,1
685,B1147,Orotic acid,65-86-1,G04,L1021-08,156.1,DMSO,C5H4N2O4,C1=C(NC(=O)NC1=O)C(=O)O,insoluble in H2O; insoluble in EtOH; ≥15.6 mg/mL in DMSO with gentle warming,,DNA Damage/DNA Repair,Nucleoside Antimetabolite/Analogue,Pyrimidinecarboxylic acid,https://www.apexbt.com/search.php?catalog=B1147,1
686,B1157,sn-Glycero-3-phosphocholine,28319-77-9,G05,L1021-08,257.22,H2O,C8H20NO6P,C[N+](C)(C)CCOP(=O)([O-])OCC(CO)O,insoluble in DMSO; ≥11.2 mg/mL in H2O; ≥3.25 mg/mL in EtOH,,Others,Others,Nootropic phospholipid,https://www.apexbt.com/search.php?catalog=B1157,1
687,B1192,Topiroxostat,577778-58-6,G06,L1021-08,248.24,DMSO,C13H8N6,C1=CN=CC=C1C2=NC(=NN2)C3=CC(=NC=C3)C#N,insoluble in EtOH; insoluble in H2O; ≥10.7 mg/mL in DMSO,,Others,XAO,Xanthine oxidoreductase (XOR) inhibitor,https://www.apexbt.com/search.php?catalog=B1192,1
688,B1198,Cisapride,81098-60-4,G07,L1021-08,465.95,DMSO,C23H29ClFN3O4,COC1CN(CCC1NC(=O)C2=CC(=C(C=C2OC)N)Cl)CCCOC3=CC=C(C=C3)F,≥23.3 mg/mL in DMSO; insoluble in H2O; ≥3.47 mg/mL in EtOH,,Neuroscience,5-HT Receptor,5-HT4 receptor agonist,https://www.apexbt.com/search.php?catalog=B1198,1
689,B1199,Tandospirone,87760-53-0,G08,L1021-08,383.49,DMSO,C21H29N5O2,C1CC2CC1C3C2C(=O)N(C3=O)CCCCN4CCN(CC4)C5=NC=CC=N5,≥38.3 mg/mL in DMSO; insoluble in H2O; ≥12.8 mg/mL in EtOH,,Neuroscience,5-HT Receptor,,https://www.apexbt.com/search.php?catalog=B1199,0
690,B1204,Ondansetron hydrochloride dihydrate,103639-04-9,G09,L1021-08,365.85,DMSO,C18H24ClN3O3,CC1=NC=CN1CC2CCC3=C(C2=O)C4=CC=CC=C4N3C.O.O.Cl,≥12.7 mg/mL in EtOH with ultrasonic; ≥7.57 mg/mL in H2O with ultrasonic; ≥9.15 mg/mL in DMSO,hydrochloride,Neuroscience,5-HT Receptor,5-HT3 receptor antagonist,https://www.apexbt.com/search.php?catalog=B1204,1
691,B1206,Pizotifen,15574-96-6,G10,L1021-08,295.44,DMSO,C19H21NS,CN1CCC(=C2C3=C(CCC4=CC=CC=C42)SC=C3)CC1,insoluble in H2O; ≥14.77 mg/mL in DMSO; ≥21.63 mg/mL in EtOH with ultrasonic,,Neuroscience,5-HT Receptor,Highly selective 5-HT receptor blocking agent,https://www.apexbt.com/search.php?catalog=B1206,1
692,B1210,Aniracetam,72432-10-1,G11,L1021-08,219.24,DMSO,C12H13NO3,COC1=CC=C(C=C1)C(=O)N2CCCC2=O,insoluble in H2O; ≥10.96 mg/mL in DMSO; ≥11.06 mg/mL in EtOH,Free Base,Membrane Transporter/Ion Channel,AMPAR,Nootropic drug for senile dementia,https://www.apexbt.com/search.php?catalog=B1210,1
693,B1215,Gatifloxacin hydrochloride,121577-32-0,H01,L1021-08,411.86,H2O,C19H23ClFN3O4,CC1CN(CCN1)C2=C(C=C3C(=C2OC)N(C=C(C3=O)C(=O)O)C4CC4)F.Cl,Insoluble in DMSO; insoluble in EtOH; ≥14.8 mg/mL in H2O with ultrasonic,,DNA Damage/DNA Repair,Topoisomerase,potent fluoroquinolone antibiotics,https://www.apexbt.com/search.php?catalog=B1215,1
694,B1217,Meropenem trihydrate,119478-56-7,H02,L1021-08,437.51,DMSO,C17H31N3O8S,CC1C2C(C(=O)N2C(=C1SC3CC(NC3)C(=O)N(C)C)C(=O)O)C(C)O.O.O.O,≥20.7 mg/mL in H2O with gentle warming; insoluble in EtOH; ≥49.2 mg/mL in DMSO,trihydrate,Microbiology & Virology,Antibiotic,Broad-spectum β-lactam antibiotic,https://www.apexbt.com/search.php?catalog=B1217,1
695,B1223,Vancomycin hydrochloride,1404-93-9,H03,L1021-08,1485.72,DMSO,C66H76Cl3N9O24,Cl.CNC(CC(C)C)C(=O)NC1C(O)C2=CC=C(OC3=CC4=CC(=C3OC5OC(CO)C(O)C(O)C5OC6CC(C)(N)C(O)C(C)O6)OC7=CC=C(C=C7Cl)C(O)C8NC(=O)C(NC(=O)C4NC(=O)C(CC(N)=O)NC1=O)C9=CC(=C(O)C=C9)C%10=C(C=C(O)C=C%10O)C(NC8=O)C(O)=O)C(=C2)Cl,≥55.8 mg/mL in DMSO with gentle warming; insoluble in EtOH; ≥22.15 mg/mL in H2O,Hydrochloride,Microbiology & Virology,Antibiotic,Narrow-spectrum glycopeptide antibacterial agent,https://www.apexbt.com/search.php?catalog=B1223,1
696,B1224,Anidulafungin,166663-25-8,H04,L1021-08,1140.24,DMSO,C58H73N7O17,CCCCCOC1=CC=C(C=C1)C2=CC=C(C=C2)C3=CC=C(C=C3)C(=O)NC4CC(C(NC(=O)C5C(C(CN5C(=O)C(NC(=O)C(NC(=O)C6CC(CN6C(=O)C(NC4=O)C(C)O)O)C(C(C7=CC=C(C=C7)O)O)O)C(C)O)C)O)O)O,insoluble in EtOH; insoluble in H2O; ≥20.8 mg/mL in DMSO,,Microbiology & Virology,Antibiotic,Antifungal drug,https://www.apexbt.com/search.php?catalog=B1224,0
697,B1226,Fluconazole hydrate,155347-36-7,H05,L1021-08,324.29,DMSO,C13H14F2N6O2,FC1=CC(F)=C(C(CN2C=NC=N2)(O)CN3C=NC=N3)C=C1.O,≥16.35 mg/mL in DMSO; ≥28.8 mg/mL in EtOH; ≥3.2 mg/mL in H2O with ultrasonic,hydrate,Microbiology & Virology,Antibiotic,Triazole antifungal drug,https://www.apexbt.com/search.php?catalog=B1226,1
698,B1239,Parecoxib Sodium,198470-85-8,H06,L1021-08,392.4,DMSO,C19H17N2NaO4S,CCC(=O)[N-]S(=O)(=O)C1=CC=C(C=C1)C2=C(ON=C2C3=CC=CC=C3)C.[Na+],≥10.7 mg/mL in EtOH; ≥118.6 mg/mL in DMSO; ≥43.9 mg/mL in H2O,,Neuroscience,COX,COX-2 inhibitor,https://www.apexbt.com/search.php?catalog=B1239,1
699,B1240,(+)-Ketoconazole,142128-59-4,H07,L1021-08,531.43,DMSO,C26H28Cl2N4O4,CC(=O)N1CCN(CC1)C2=CC=C(C=C2)OCC3COC(O3)(CN4C=CN=C4)C5=C(C=C(C=C5)Cl)Cl,≥25.5 mg/mL in DMSO with gentle warming; insoluble in H2O; insoluble in EtOH,Free Base,Metabolism,P450,Potent inhibitor of cytochrome P450c17,https://www.apexbt.com/search.php?catalog=B1240,1
700,B1242,Haloperidol hydrochloride,1511-16-6,H08,L1021-08,412.33,DMSO,C21H24Cl2FNO2,C1CN(CCC1(C2=CC=C(C=C2)Cl)O)CCCC(=O)C3=CC=C(C=C3)F.Cl,insoluble in H2O; ≥10.31 mg/mL in DMSO; ≥2.96 mg/mL in EtOH with gentle warming and ultrasonic,Hydrochloride,Neuroscience,Dopamine Receptor,Antipsychotic drug,https://www.apexbt.com/search.php?catalog=B1242,1
701,B1246,Etomidate hydrochloride,53188-20-8,H09,L1021-08,280.75,DMSO,C14H17ClN2O2,CCOC(=O)C1=CN=CN1C(C)C2=CC=CC=C2.Cl,≥12.35 mg/mL in DMSO; ≥36.65 mg/mL in EtOH; ≥39.45 mg/mL in H2O with ultrasonic,Hydrochloride,Membrane Transporter/Ion Channel,GABA Receptor,GABAA receptors agonist,https://www.apexbt.com/search.php?catalog=B1246,1
702,B1248,Beclomethasone dipropionate,5534-09-8,H10,L1021-08,521.04,DMSO,C28H37ClO7,CCC(=O)OCC(=O)C1(C(CC2C1(CC(C3(C2CCC4=CC(=O)C=CC43C)Cl)O)C)C)OC(=O)CC,insoluble in H2O; ≥12.72 mg/mL in EtOH with ultrasonic; ≥16.95 mg/mL in DMSO,Free Base,GPCR/G protein,Glucocorticoid Receptor,Corticosteroid used for asthma and rhinitis,https://www.apexbt.com/search.php?catalog=B1248,1
703,B1251,Valproic acid,99-66-1,H11,L1021-08,144.21,DMSO,C8H16O2,CCCC(CCC)C(=O)O,≥12.35 mg/mL in DMSO; ≥29 mg/mL in EtOH; ≥36 mg/mL in H2O,Free Base,DNA Damage/DNA Repair,HDAC,HDAC1 inhibitor,https://www.apexbt.com/search.php?catalog=B1251,1
704,B1266,Glycopyrrolate,596-51-0,A01,L1021-09,398.33,DMSO,C19H28BrNO3,C[N+]1(CCC(C1)OC(=O)C(C2CCCC2)(C3=CC=CC=C3)O)C.[Br-],≥19.92 mg/mL in DMSO; ≥57.5 mg/mL in EtOH; ≥85 mg/mL in H2O,Free Base,Neuroscience,AChR,Muscarinic competitive antagonist,https://www.apexbt.com/search.php?catalog=B1266,1
705,B1270,Reserpine hydrochloride,16994-56-2,A02,L1021-09,645.14,DMSO,C33H41ClN2O9,COC1C(CC2CN3CCC4=C(C3CC2C1C(=O)OC)NC5=C4C=CC(=C5)OC)OC(=O)C6=CC(=C(C(=C6)OC)OC)OC.Cl,≥25 mg/mL in DMSO; insoluble in H2O; ≥2.74 mg/mL in EtOH with gentle warming and ultrasonic,Hydrochloride,Membrane Transporter/Ion Channel,Monoamine transporter,Blocker of VMAT,https://www.apexbt.com/search.php?catalog=B1270,1
706,B1277,Adapalene sodium salt,911110-93-5,A03,L1021-09,434.5,DMSO,C28H27NaO3,COC1=C(C=C(C=C1)C2=CC3=C(C=C2)C=C(C=C3)C(=O)O)C45CC6CC(C4)CC(C6)C5.[Na],insoluble in H2O; insoluble in EtOH; ≥4.35 mg/mL in DMSO with gentle warming,sodium salt,Others,Others,Retinoic acid receptor agonist,https://www.apexbt.com/search.php?catalog=B1277,0
707,B1278,Benazepril,86541-75-5,A04,L1021-09,424.49,DMSO,C24H28N2O5,CCOC(=O)C(CCC1=CC=CC=C1)NC2CCC3=CC=CC=C3N(C2=O)CC(=O)O,insoluble in EtOH; ≥38.3 mg/mL in H2O; ≥47.6 mg/mL in DMSO,,Others,Others,ACE inhibitor,https://www.apexbt.com/search.php?catalog=B1278,1
708,B1280,Prilocaine hydrochloride,1786-81-8,A05,L1021-09,256.77,DMSO,C13H21ClN2O,CCCNC(C)C(=O)NC1=CC=CC=C1C.Cl,≥10.4 mg/mL in DMSO; ≥50.8 mg/mL in H2O; ≥52.7 mg/mL in EtOH,Hydrochloride,Others,Others,Local anesthetic of the amino amide type,https://www.apexbt.com/search.php?catalog=B1280,1
709,B1283,Prasugrel hydrochloride,389574-19-0,A06,L1021-09,409.9,DMSO,C20H21ClFNO3S,CC(=O)OC1=CC2=C(S1)CCN(C2)C(C3=CC=CC=C3F)C(=O)C4CC4.Cl,≥18.9 mg/mL in DMSO with gentle warming; insoluble in H2O; ≥10.42 mg/mL in EtOH with ultrasonic,Hydrochloride,GPCR/G protein,P2Y Receptor,P2 Receptor inhibitor,https://www.apexbt.com/search.php?catalog=B1283,1
710,B1286,AZD7545,252017-04-2,A07,L1021-09,478.87,DMSO,C19H18ClF3N2O5S,CC(C(=O)NC1=C(C=C(C=C1)S(=O)(=O)C2=CC=C(C=C2)C(=O)N(C)C)Cl)(C(F)(F)F)O,≥21.85 mg/mL in DMSO; insoluble in H2O; ≥15.63 mg/mL in EtOH with ultrasonic,,Others,PDHK,,https://www.apexbt.com/search.php?catalog=B1286,1
711,B1289,Minoxidil,38304-91-5,A08,L1021-09,209.25,DMSO,C9H15N5O,C1CCN(CC1)C2=NC(=N)N(C(=C2)N)O,insoluble in H2O; ≥14.35 mg/mL in EtOH with ultrasonic; ≥2.32 mg/mL in DMSO with gentle warming,,Membrane Transporter/Ion Channel,Potassium Channel,Kir6 channel (KATP) activator.,https://www.apexbt.com/search.php?catalog=B1289,1
712,B1290,Lansoprazole sodium,226904-00-3,A09,L1021-09,391.34,DMSO,C16H13F3N3NaO2S,CC1=C(C=CN=C1CS(=O)C2=NC3=CC=CC=C3[N-]2)OCC(F)(F)F.[Na+],insoluble in H2O; ≥15.05 mg/mL in EtOH; ≥58.9 mg/mL in DMSO,sodium,Membrane Transporter/Ion Channel,Proton Pump,PPI/cytochrome P450 inhibitor,https://www.apexbt.com/search.php?catalog=B1290,1
713,B1296,Glibenclamide,10238-21-8,A10,L1021-09,494,DMSO,C23H28ClN3O5S,COC1=C(C=C(C=C1)Cl)C(=O)NCCC2=CC=C(C=C2)S(=O)(=O)NC(=O)NC3CCCCC3,≥49.4 mg/mL in DMSO; insoluble in H2O; insoluble in EtOH,,Metabolism,Saccharometabolism,Insulin production modulator,https://www.apexbt.com/search.php?catalog=B1296,1
714,B1302,Amsacrine,51264-14-3,A11,L1021-09,393.46,DMSO,C21H19N3O3S,COC1=C(C=CC(=C1)NS(=O)(=O)C)NC2=C3C=CC=CC3=NC4=CC=CC=C42,Soluble in DMSO,,DNA Damage/DNA Repair,Topoisomerase,Topoisomerase 2 inhibitor,https://www.apexbt.com/search.php?catalog=B1302,1
715,B1303,Amsacrine hydrochloride,54301-15-4,B01,L1021-09,429.92,DMSO,C21H20ClN3O3S,COC1=C(C=CC(=C1)NS(=O)(=O)C)NC2=C3C=CC=CC3=NC4=CC=CC=C42.Cl,≥55.56 mg/mL in DMSO; insoluble in H2O; ≥2.83 mg/mL in EtOH with gentle warming and ultrasonic,,DNA Damage/DNA Repair,Topoisomerase,,https://www.apexbt.com/search.php?catalog=B1303,1
716,B1327,Epinephrine HCl,55-31-2,B02,L1021-09,219.67,DMSO,C9H13NO3·HCl,CNCC(C1=CC(=C(C=C1)O)O)O.Cl,≥44.7 mg/mL in H2O; ≥5.1 mg/mL in EtOH with ultrasonic; ≥9.2 mg/mL in DMSO,,GPCR/G protein,Adrenergic Receptor,Adrenergic receptor agonist,https://www.apexbt.com/search.php?catalog=B1327,1
717,B1328,Terbutaline Sulfate,23031-32-5,B03,L1021-09,548.65,DMSO,C24H38N2O6·H2O4S,CC(C)(C)NCC(C1=CC(=CC(=C1)O)O)O.CC(C)(C)NCC(C1=CC(=CC(=C1)O)O)O.OS(=O)(=O)O,≥26.9 mg/mL in H2O; insoluble in EtOH; ≥11.18 mg/mL in H2O,Sulfate,GPCR/G protein,Adrenergic Receptor,Selective β2-adrenergic receptor agonist,https://www.apexbt.com/search.php?catalog=B1328,1
718,B1329,Tolazoline HCl,59-97-2,B04,L1021-09,196.68,DMSO,C10H12N2·HCl,C1CN=C(N1)CC2=CC=CC=C2.Cl,≥25.73 mg/mL in EtOH; ≥51.9 mg/mL in H2O; ≥8.65 mg/mL in DMSO,,GPCR/G protein,Adrenergic Receptor,non-selective competitive α-adrenergic receptor antagonist,https://www.apexbt.com/search.php?catalog=B1329,1
719,B1330,Acebutolol HCl,34381-68-5,B05,L1021-09,372.89,DMSO,C18H28N2O4·HCl,CCCC(=O)NC1=CC(=C(C=C1)OCC(CNC(C)C)O)C(=O)C.Cl,≥11.76 mg/mL in EtOH with ultrasonic; ≥18.64 mg/mL in DMSO; ≥57.8 mg/mL in H2O,Hydrochloride,GPCR/G protein,Adrenergic Receptor,β-adrenergic receptors antagonist,https://www.apexbt.com/search.php?catalog=B1330,1
720,B1331,Adrenalone HCl,62-13-5,B06,L1021-09,217.65,DMSO,C9H11NO3·HCl,CNCC(=O)C1=CC(=C(C=C1)O)O.Cl,≥10.88 mg/mL in DMSO; ≥2.16 mg/mL in EtOH with gentle warming and ultrasonic; ≥50.2 mg/mL in H2O,Hydrochloride,GPCR/G protein,Adrenergic Receptor,Adrenergic receptor agonist,https://www.apexbt.com/search.php?catalog=B1331,1
721,B1332,Carvedilol,72956-09-3,B07,L1021-09,406.47,DMSO,C24H26N2O4,COC1=CC=CC=C1OCCNCC(COC2=CC=CC3=C2C4=CC=CC=C4N3)O,≥40.6 mg/mL in DMSO; insoluble in H2O; ≥2.415 mg/mL in EtOH with gentle warming and ultrasonic,Free Base,GPCR/G protein,Adrenergic Receptor,Potent β-adrenoceptor and α1-adrenoceptor antagonist,https://www.apexbt.com/search.php?catalog=B1332,1
722,B1333,Clonidine HCl,4205-91-8,B08,L1021-09,266.5,DMSO,C9H9Cl2N3·HCl,C1CN=C(N1)NC2=C(C=CC=C2Cl)Cl.Cl,≥13.33 mg/mL in DMSO; ≥15.53 mg/mL in EtOH with ultrasonic; ≥19.27 mg/mL in H2O with ultrasonic,Hydrochloride,GPCR/G protein,Adrenergic Receptor,α2-adrenergic receptor agonist,https://www.apexbt.com/search.php?catalog=B1333,1
723,B1334,Dexmedetomidine,113775-47-6,B09,L1021-09,200.28,DMSO,C13H16N2,CC1=C(C(=CC=C1)C(C)C2=CN=CN2)C,insoluble in H2O; ≥55.7 mg/mL in EtOH; ≥9.95 mg/mL in DMSO,Free Base,GPCR/G protein,Adrenergic Receptor,α2-adrenergic receptor agonist,https://www.apexbt.com/search.php?catalog=B1334,1
724,B1335,Guanabenz Acetate,23256-50-0,B10,L1021-09,291.13,DMSO,C8H8Cl2N4·C2H4O2,CC(=O)O.C1=CC(=C(C(=C1)Cl)C=NN=C(N)N)Cl,insoluble in EtOH; insoluble in H2O; ≥14.56 mg/mL in DMSO,Acetate,GPCR/G protein,Adrenergic Receptor,α2-adrenergic receptor agonist,https://www.apexbt.com/search.php?catalog=B1335,1
725,B1336,Isoprenaline HCl,51-30-9,B11,L1021-09,247.72,DMSO,C11H17NO3·HCl,CC(C)NCC(C1=CC(=C(C=C1)O)O)O.Cl,≥12.39 mg/mL in DMSO; ≥16.6 mg/mL in EtOH with gentle warming and ultrasonic; ≥50.2 mg/mL in H2O with gentle warming,Hydrochloride,GPCR/G protein,Adrenergic Receptor,β-adrenergic receptor agonist,https://www.apexbt.com/search.php?catalog=B1336,1
726,B1338,Maprotiline HCl,10347-81-6,C02,L1021-09,313.86,DMSO,C20H23N·HCl,Cl[H].[H]C12C([H])([H])C([H])([H])C(C3=C([H])C([H])=C([H])C([H])=C23)(C([H])([H])C([H])([H])C([H])([H])N([H])C([H])([H])[H])C4=C([H])C([H])=C([H])C([H])=C14,≥13.95 mg/mL in DMSO; ≥2.11 mg/mL in H2O with gentle warming and ultrasonic; ≥5.84 mg/mL in EtOH with ultrasonic,,GPCR/G protein,Adrenergic Receptor,Selective noradrenalin re-uptake inhibitor,https://www.apexbt.com/search.php?catalog=B1338,1
727,B1339,Metoprolol Tartrate,56392-17-7,C03,L1021-09,684.81,DMSO,2C15H25NO3·C4H6O6,CC(C)NCC(COC1=CC=C(C=C1)CCOC)O.CC(C)NCC(COC1=CC=C(C=C1)CCOC)O.C(C(C(=O)O)O)(C(=O)O)O,≥32.25 mg/mL in DMSO; ≥10.47 mg/mL in EtOH with ultrasonic; ≥108.6 mg/mL in H2O,Tartrate,GPCR/G protein,Adrenergic Receptor,β1-adrenergic blocking agent,https://www.apexbt.com/search.php?catalog=B1339,1
728,B1340,Naphazoline HCl,550-99-2,C04,L1021-09,246.74,DMSO,C14H14N2·HCl,C1CN=C(N1)CC2=CC=CC3=CC=CC=C32.Cl,≥11.13 mg/mL in EtOH with ultrasonic; ≥12.34 mg/mL in DMSO; ≥52.5 mg/mL in H2O,Hydrochloride,GPCR/G protein,Adrenergic Receptor,Adrenergic receptor agonist,https://www.apexbt.com/search.php?catalog=B1340,1
729,B1341,Nebivolol,152520-56-4,C05,L1021-09,441.9,DMSO,C22H26ClF2NO4,C1CC2=C(C=CC(=C2)F)OC1C(CNCC(C3CCC4=C(O3)C=CC(=C4)F)O)O.Cl,≥22.1 mg/mL in DMSO; insoluble in H2O; insoluble in EtOH,Free Base,GPCR/G protein,Adrenergic Receptor,Highly selective β1-adrenoceptor antagonist,https://www.apexbt.com/search.php?catalog=B1341,1
730,B1343,Phenoxybenzamine HCl,63-92-3,C06,L1021-09,340.3,DMSO,C18H22ClNO·HCl,CC(COC1=CC=CC=C1)N(CCCl)CC2=CC=CC=C2.Cl,insoluble in H2O; ≥17.02 mg/mL in DMSO; ≥21.2 mg/mL in EtOH with ultrasonic,Hydrochloride,GPCR/G protein,Adrenergic Receptor,Adrenergic receptor antagonist,https://www.apexbt.com/search.php?catalog=B1343,1
731,B1344,Phenylephrine HCl,61-76-7,C07,L1021-09,203.67,DMSO,C9H13NO2·HCl,CNCC(C1=CC(=CC=C1)O)O.Cl,≥10.18 mg/mL in DMSO; ≥17.08 mg/mL in EtOH with ultrasonic; ≥54.2 mg/mL in H2O,Hydrochloride,GPCR/G protein,Adrenergic Receptor,Selective α1-adrenergic receptor agonist,https://www.apexbt.com/search.php?catalog=B1344,1
732,B1346,Propranolol HCl,318-98-9,C08,L1021-09,295.8,DMSO,C16H21NO2·HCl,OC(COC1=CC=CC2=CC=CC=C21)CNC(C)C.Cl,≥100 mg/mL in H2O; ≥12.4 mg/mL in DMSO; ≥9.76 mg/mL in EtOH,Hydrochloride,GPCR/G protein,Adrenergic Receptor,Competitive non-selective beta-adrenergic receptors inhibitor,https://www.apexbt.com/search.php?catalog=B1346,1
733,B1347,Ritodrine HCl,23239-51-2,C09,L1021-09,323.81,DMSO,C17H21NO3·HCl,CC(C(C1=CC=C(C=C1)O)O)NCCC2=CC=C(C=C2)O.Cl,≥16.19 mg/mL in DMSO; ≥23.1 mg/mL in H2O; ≥60.8 mg/mL in EtOH,Hydrochloride,GPCR/G protein,Adrenergic Receptor,β-2 adrenergic receptor agonist,https://www.apexbt.com/search.php?catalog=B1347,1
734,B1348,Salbutamol Sulfate,51022-70-9,C10,L1021-09,337.39,DMSO,C13H21NO3·H2SO4,CC(C)(C)NCC(C1=CC(=C(C=C1)O)CO)O.OS(=O)(=O)O,insoluble in EtOH; ≥16.87 mg/mL in H2O; ≥9.64 mg/mL in H2O,Sulfate,GPCR/G protein,Adrenergic Receptor,β-2 adrenergic receptor agonist,https://www.apexbt.com/search.php?catalog=B1348,1
735,B1349,Tetrahydrozoline HCl,522-48-5,C11,L1021-09,236.74,DMSO,C13H16N2·HCl,C1CC(C2=CC=CC=C2C1)C3=NCCN3.Cl,≥11.33 mg/mL in EtOH; ≥14.7 mg/mL in H2O; ≥5.92 mg/mL in DMSO,Free Base,GPCR/G protein,Adrenergic Receptor,Adrenergic receptor agonist,https://www.apexbt.com/search.php?catalog=B1349,1
736,B1350,Timolol Maleate,26921-17-5,D01,L1021-09,432.49,DMSO,C17H28N4O7S,CC(C)(C)NCC(COC1=NSN=C1N2CCOCC2)O.C(=CC(=O)O)C(=O)O,≥21.62 mg/mL in DMSO; ≥10.53 mg/mL in EtOH; ≥11.83 mg/mL in H2O,Maleate,GPCR/G protein,Adrenergic Receptor,"Non-selective, beta-adrenergic receptor antagonist",https://www.apexbt.com/search.php?catalog=B1350,1
737,B1351,Xylazine HCl,23076-35-9,D02,L1021-09,256.79,DMSO,C12H16N2S·HCl,CC1=C(C(=CC=C1)C)NC2=NCCCS2.Cl,≥12.84 mg/mL in DMSO; ≥24.1 mg/mL in EtOH; ≥24.15 mg/mL in H2O,Hydrochloride,GPCR/G protein,Adrenergic Receptor,α2 Adrenoceptor agonist,https://www.apexbt.com/search.php?catalog=B1351,1
738,B1352,Betaxolol,63659-18-7,D03,L1021-09,307.43,DMSO,C18H29NO3,CC(NCC(O)COC1=CC=C(CCOCC2CC2)C=C1)C,≥30.7 mg/mL in DMSO; insoluble in H2O; ≥17.7 mg/mL in EtOH,,GPCR/G protein,Adrenergic Receptor,βadrenergic receptor blocker,https://www.apexbt.com/search.php?catalog=B1352,1
739,B1353,Betaxolol HCl,63659-19-8,D04,L1021-09,343.89,DMSO,C18H29NO3·HCl,CC(C)NCC(COC1=CC=C(C=C1)CCOCC2CC2)O.Cl,≥17.19 mg/mL in DMSO; ≥24.9 mg/mL in EtOH; ≥28.05 mg/mL in H2O,Hydrochloride,GPCR/G protein,Adrenergic Receptor,β1 adrenergic receptor blocker,https://www.apexbt.com/search.php?catalog=B1353,1
740,B1354,Bisoprolol fumarate,104344-23-2,D05,L1021-09,441.52,DMSO,C22H35NO8,CC(C)NCC(COC1=CC=C(C=C1)COCCOC(C)C)O.C(=CC(=O)O)C(=O)O,≥22.08 mg/mL in DMSO; ≥19.83 mg/mL in EtOH; ≥31.15 mg/mL in H2O,Free Base,GPCR/G protein,Adrenergic Receptor,Selective α-adrenergic blocker,https://www.apexbt.com/search.php?catalog=B1354,1
741,B1355,Cisatracurium Besylate,96946-42-8,D06,L1021-09,1243.48,DMSO,C53H72N2O12·2C6H5O3S,C[N+]1(CCC2=CC(=C(C=C2C1CC3=CC(=C(C=C3)OC)OC)OC)OC)CCC(=O)OCCCCCOC(=O)CC[N+]4(CCC5=CC(=C(C=C5C4CC6=CC(=C(C=C6)OC)OC)OC)OC)C.C1=CC=C(C=C1)S(=O)(=O)[O-].C1=CC=C(C=C1)S(=O)(=O)[O-],≥62.17 mg/mL in DMSO; ≥24.7 mg/mL in H2O; ≥33 mg/mL in EtOH,Besylate,GPCR/G protein,Adrenergic Receptor,Neuromuscular-blocking drug,https://www.apexbt.com/search.php?catalog=B1355,1
742,B1356,Detomidine HCl,90038-01-0,D07,L1021-09,222.71,DMSO,C12H15ClN2,CC1=C(C(=CC=C1)CC2=CN=CN2)C.Cl,≥11.14 mg/mL in DMSO; ≥25.7 mg/mL in EtOH; ≥27.25 mg/mL in H2O,Hydrochloride,GPCR/G protein,Adrenergic Receptor,Adrenergic receptor agonist,https://www.apexbt.com/search.php?catalog=B1356,1
743,B1357,Dexmedetomidine HCl,145108-58-3,D08,L1021-09,236.74,DMSO,C13H16N2·HCl,CC1=C(C(=CC=C1)C(C)C2=CN=CN2)C.Cl,≥126.2 mg/mL in H2O; ≥11.84 mg/mL in DMSO; ≥27.87 mg/mL in EtOH,Hydrochloride,GPCR/G protein,Adrenergic Receptor,Highly selective and potent alpha-2 adrenoceptor agonist,https://www.apexbt.com/search.php?catalog=B1357,1
744,B1358,Epinephrine Bitartrate,51-42-3,D09,L1021-09,333.29,DMSO,C9H13NO3·C4H6O6,CNCC(C1=CC(=C(C=C1)O)O)O.C(C(C(=O)O)O)(C(=O)O)O,insoluble in EtOH; ≥16.66 mg/mL in DMSO; ≥22.9 mg/mL in H2O,Bitartrate,GPCR/G protein,Adrenergic Receptor,Adrenergic receptor agonist,https://www.apexbt.com/search.php?catalog=B1358,1
745,B1360,Ivabradine HCl,148849-67-6,D10,L1021-09,505.05,DMSO,C27H37ClN2O5,CN(CCCN1CCC2=CC(=C(C=C2CC1=O)OC)OC)CC3CC4=CC(=C(C=C34)OC)OC.Cl,≥25.25 mg/mL in DMSO; ≥15.87 mg/mL in H2O; ≥8.14 mg/mL in EtOH,Hydrochloride,GPCR/G protein,Adrenergic Receptor,Adrenergic receptor inhibitor,https://www.apexbt.com/search.php?catalog=B1360,1
746,B1361,Medetomidine HCl,86347-15-1,D11,L1021-09,236.74,DMSO,C13H16N2·HCl,CC1=C(C(=CC=C1)C(C)C2=CN=CN2)C.Cl,≥11.84 mg/mL in DMSO; ≥51 mg/mL in H2O; ≥65.7 mg/mL in EtOH,Hydrochloride,GPCR/G protein,Adrenergic Receptor,Selective α2-adrenoceptor agonist,https://www.apexbt.com/search.php?catalog=B1361,1
747,B1362,Naftopidil,57149-07-2,E01,L1021-09,392.49,DMSO,C24H28N2O3,COC1=CC=CC=C1N2CCN(CC2)CC(COC3=CC=CC4=CC=CC=C43)O,insoluble in H2O; ≥19.62 mg/mL in DMSO; ≥2.48 mg/mL in EtOH with gentle warming,Free Base,GPCR/G protein,Adrenergic Receptor,α1-adrenergic receptor antagonist,https://www.apexbt.com/search.php?catalog=B1362,1
748,B1363,Phentolamine Mesylate,65-28-1,E02,L1021-09,377.46,DMSO,C17H19N3O·CH4O3S,CC1=CC=C(C=C1)N(CC2=NCCN2)C3=CC(=CC=C3)O.CS(=O)(=O)O,≥18.87 mg/mL in DMSO; ≥55.6 mg/mL in H2O; ≥59.8 mg/mL in EtOH,Mesylate,GPCR/G protein,Adrenergic Receptor,Alpha 1/2-blocking agent,https://www.apexbt.com/search.php?catalog=B1363,1
749,B1364,Scopine,498-45-3,E03,L1021-09,155.19,DMSO,C8H13NO2,CN1C2CC(CC1C3C2O3)O,≥4.99 mg/mL in H2O; ≥46.8 mg/mL in EtOH; ≥7.6 mg/mL in DMSO,Free Base,GPCR/G protein,Adrenergic Receptor,α1-adrenergic receptor agonist,https://www.apexbt.com/search.php?catalog=B1364,0
750,B1365,Terazosin HCl,70024-40-7,E04,L1021-09,459.92,DMSO,C19H25N5O4·HCl·2H2O,COC1=C(C=C2C(=C1)C(=NC(=N2)N3CCN(CC3)C(=O)C4CCCO4)N)OC.O.O.Cl,≥23.0 mg/mL in DMSO; ≥4.48 mg/mL in H2O; ≥54.6 mg/mL in EtOH,Hydrochloride,GPCR/G protein,Adrenergic Receptor,Selective α1-adrenoceptor antagonist,https://www.apexbt.com/search.php?catalog=B1365,1
751,B1367,Sotalol,3930-20-9,E05,L1021-09,272.36,DMSO,C12H20N2O3S,CC(C)NCC(C1=CC=C(C=C1)NS(=O)(=O)C)O,insoluble in EtOH; ≥15.44 mg/mL in DMSO; ≥50.7 mg/mL in H2O,Hydrochloride,GPCR/G protein,Adrenergic Receptor,Adrenergic receptor antagonist,https://www.apexbt.com/search.php?catalog=B1367,0
752,B1368,Tizanidine HCl,64461-82-1,E06,L1021-09,290.17,DMSO,C9H9Cl2N5S,C1CN=C(N1)NC2=C(C=CC3=NSN=C32)Cl.Cl,≥14.51 mg/mL in DMSO; ≥3.45 mg/mL in EtOH with gentle warming; ≥48.3 mg/mL in H2O,Hydrochloride,GPCR/G protein,Adrenergic Receptor,α2-adrenergic receptor agonist,https://www.apexbt.com/search.php?catalog=B1368,1
753,B1369,Indacaterol Maleate,753498-25-8,E07,L1021-09,508.56,DMSO,C24H28N2O3·C4H4O4,CCC1=C(C=C2CC(CC2=C1)NCC(C3=C4C=CC(=O)NC4=C(C=C3)O)O)CC.C(=CC(=O)O)C(=O)O,insoluble in H2O; ≥10.02 mg/mL in ETOH with gentle warming; ≥51.6 mg/mL in DMSO,,GPCR/G protein,Adrenergic Receptor,Ultra-long-acting β-adrenoceptor agonist,https://www.apexbt.com/search.php?catalog=B1369,1
754,B1371,Miltefosine,58066-85-6,E08,L1021-09,407.57,H2O,C21H46NO4P,CCCCCCCCCCCCCCCCOP(=O)([O-])OCC[N+](C)(C)C,≥10.2 mg/mL in H2O; ≥2.115 mg/mL in DMSO with gentle warming and ultrasonic; ≥49.7 mg/mL in EtOH,Free Base,PI3K/Akt/mTOR Signaling,Akt,PI3K/Akt inhibitor,https://www.apexbt.com/search.php?catalog=B1371,1
755,B1373,Phenformin HCl,834-28-6,E09,L1021-09,241.72,DMSO,C10H16ClN5,C1=CC=C(C=C1)CCN=C(N)N=C(N)N.Cl,≥12.1 mg/mL in DMSO; ≥17.53 mg/mL in EtOH; ≥24.5 mg/mL in H2O with ultrasonic,Hydrochloride,Others,Others,biguanidine drug with anti-diabetic activity,https://www.apexbt.com/search.php?catalog=B1373,1
756,B1375,Dehydroepiandrosterone (DHEA),53-43-0,E10,L1021-09,288.42,DMSO,C19H28O2,CC12CCC3C(C1CCC2=O)CC=C4C3(CCC(C4)O)C,insoluble in H2O; ≥13.7 mg/mL in DMSO; ≥58.6 mg/mL in ETOH,Free Base,Membrane Transporter/Ion Channel,Calcium Channel,Endogenous steroid hormone,https://www.apexbt.com/search.php?catalog=B1375,1
757,B1376,Flutamide,13311-84-7,E11,L1021-09,276.21,DMSO,C11H11F3N2O3,CC(C)C(=O)NC1=CC(=C(C=C1)[N+](=O)[O-])C(F)(F)F,insoluble in H2O; ≥12.5 mg/mL in DMSO; ≥50.4 mg/mL in EtOH,Free Base,Endocrinology and Hormones,Androgen Receptor,Androgen receptor antagonists,https://www.apexbt.com/search.php?catalog=B1376,1
758,B1377,Megestrol Acetate,595-33-5,F01,L1021-09,384.51,DMSO,C24H32O4,CC1=CC2C(CCC3(C2CCC3(C(=O)C)OC(=O)C)C)C4(C1=CC(=O)CC4)C,insoluble in H2O; ≥2.54 mg/mL in EtOH with gentle warming; ≥3.84 mg/mL in DMSO with gentle warming,,Endocrinology and Hormones,Estrogen/progestogen Receptor,Anti-estrogen agent,https://www.apexbt.com/search.php?catalog=B1377,1
759,B1378,Spironolactone,52-01-7,F02,L1021-09,416.57,DMSO,C24H32O4S,CC(=O)SC1CC2=CC(=O)CCC2(C3C1C4CCC5(C4(CC3)C)CCC(=O)O5)C,insoluble in H2O; ≥16.23 mg/mL in EtOH; ≥18 mg/mL in DMSO,Free Base,Endocrinology and Hormones,Androgen Receptor,Competitive mineralocorticoid (aldosterone) receptor antagonist,https://www.apexbt.com/search.php?catalog=B1378,1
760,B1380,Aminoglutethimide,125-84-8,F03,L1021-09,232.28,DMSO,C13H16N2O2,CCC1(CCC(=O)NC1=O)C2=CC=C(C=C2)N,insoluble in H2O; ≥13.8 mg/mL in DMSO; ≥7.16 mg/mL in EtOH,Free Base,Endocrinology and Hormones,Aromatase,Aromatase inhibitor,https://www.apexbt.com/search.php?catalog=B1380,1
761,B1381,Formestane,566-48-3,F04,L1021-09,302.41,DMSO,C19H26O3,CC12CCC(=O)C(=C1CCC3C2CCC4(C3CCC4=O)C)O,insoluble in H2O; ≥3.54 mg/mL in EtOH with gentle warming and ultrasonic; ≥30.6 mg/mL in DMSO with ultrasonic,,Endocrinology and Hormones,Aromatase,Type I steroidal aromatase inhibitor,https://www.apexbt.com/search.php?catalog=B1381,1
762,B1382,Anastrozole,120511-73-1,F05,L1021-09,293.37,DMSO,C17H19N5,CC(C)(C#N)C1=CC(=CC(=C1)CN2C=NC=N2)C(C)(C)C#N,insoluble in H2O; ≥14.15 mg/mL in DMSO; ≥8.62 mg/mL in EtOH,Free Base,Endocrinology and Hormones,Aromatase,Aromatase inhibitor,https://www.apexbt.com/search.php?catalog=B1382,1
763,B1384,Ciclopirox ethanolamine,41621-49-2,F06,L1021-09,268.35,DMSO,C12H17NO2·C2H7NO,CC1=CC(=O)N(C(=C1)C2CCCCC2)O.C(CO)N,≥10.74 mg/mL in EtOH; ≥11.6 mg/mL in H2O; ≥16.4 mg/mL in DMSO,Ethanolamine,Membrane Transporter/Ion Channel,ATPase,"iron chelator, broad-spectrum antifungal agent",https://www.apexbt.com/search.php?catalog=B1384,1
764,B1386,Milrinone,78415-72-2,F07,L1021-09,211.22,DMSO,C12H9N3O,CC1=C(C=C(C(=O)N1)C#N)C2=CC=NC=C2,insoluble in H2O; insoluble in EtOH; ≥8.2 mg/mL in DMSO,Free Base,Metabolism,PDE,PDE-3 inhibitor,https://www.apexbt.com/search.php?catalog=B1386,1
765,B1388,Esomeprazole Sodium,161796-78-7,F08,L1021-09,367.4,DMSO,C17H18N3NaO3S,CC1=CN=C(C(=C1OC)C)CS(=O)C2=NC3=C([N-]2)C=C(C=C3)OC.[Na+],≥140.8 mg/mL in DMSO; ≥22.15 mg/mL in H2O; ≥6.06 mg/mL in EtOH with ultrasonic,,Membrane Transporter/Ion Channel,Proton Pump,Proton pump inhibitor,https://www.apexbt.com/search.php?catalog=B1388,1
766,B1389,Amiodarone HCl,19774-82-4,F09,L1021-09,681.77,DMSO,C25H30ClI2NO3,CCCCC1=C(C2=CC=CC=C2O1)C(=O)C3=CC(=C(C(=C3)I)OCCN(CC)CC)I.Cl,insoluble in H2O; ≥13.8 mg/mL in DMSO with gentle warming; ≥3.36 mg/mL in EtOH with ultrasonic,Hydrochloride,Membrane Transporter/Ion Channel,Potassium Channel,Anti-arrhythmic drug,https://www.apexbt.com/search.php?catalog=B1389,1
767,B1390,Carbamazepine,298-46-4,F10,L1021-09,236.27,DMSO,C15H12N2O,C1=CC=C2C(=C1)C=CC3=CC=CC=C3N2C(=O)N,insoluble in H2O; ≥10.85 mg/mL in DMSO; ≥3.33 mg/mL in EtOH with ultrasonic,Free Base,Membrane Transporter/Ion Channel,Sodium Channel,Inhibitor of neuronal voltage-gated Na+ channels,https://www.apexbt.com/search.php?catalog=B1390,1
768,B1391,Divalproex Sodium,76584-70-8,F11,L1021-09,310.41,DMSO,C8H16O2·C8H15O2·Na,CCCC(CCC)C(=O)O.CCCC(CCC)C(=O)[O-].[Na+],≥14.2 mg/mL in DMSO; ≥23.9 mg/mL in H2O; ≥29.55 mg/mL in EtOH,Sodium,Ubiquitination/Proteasome,Autophagy,Epilepsy/migraines/bipolar disorder medicine,https://www.apexbt.com/search.php?catalog=B1391,1
769,B1392,Loperamide HCl,34552-83-5,G01,L1021-09,513.5,DMSO,C29H33ClN2O2.HCl,CN(C)C(=O)C(CCN1CCC(CC1)(C2=CC=C(C=C2)Cl)O)(C3=CC=CC=C3)C4=CC=CC=C4.Cl,50mg/mL (97.37 mM; Need ultrasonic) in DMSO;1mg/mL (1.95 mM; Need ultrasonic) in H2O,,Neuroscience,"Opioid Receptor,Autophagy","μ opioid receptors agonist, voltage-sensitive sodium channels blocker",https://www.apexbt.com/search.php?catalog=B1392,1
770,B1393,Nitrendipine,39562-70-4,G02,L1021-09,360.3699,DMSO,C18H20N2O6,CCOC(=O)C1=C(NC(=C(C1C2=CC(=CC=C2)[N+](=O)[O-])C(=O)OC)C)C,insoluble in H2O; ≥13.7 mg/mL in DMSO; ≥2.3 mg/mL in EtOH with ultrasonic,Free Base,Membrane Transporter/Ion Channel,Calcium Channel,Calcium channel blocker,https://www.apexbt.com/search.php?catalog=B1393,1
771,B1394,Tamoxifen Citrate,54965-24-1,G03,L1021-09,563.64,DMSO,C32H37NO8,CCC(=C(C1=CC=CC=C1)C2=CC=C(C=C2)OCCN(C)C)C3=CC=CC=C3.C(C(=O)O)C(CC(=O)O)(C(=O)O)O,≥28.2 mg/mL in Etoh with gentle warming; insoluble in H2O; ≥97 mg/mL in DMSO,Citrate,Endocrinology and Hormones,Estrogen/progestogen Receptor,Antiestrogen drug,https://www.apexbt.com/search.php?catalog=B1394,1
772,B1395,Sulfacetamide Sodium,127-56-0,G04,L1021-09,236.22,DMSO,C8H10N2O3S·Na,CC(=O)[N-]S(=O)(=O)C1=CC=C(C=C1)N.[Na+],≥10.65 mg/mL in H2O; ≥12.45 mg/mL in EtOH with ultrasonic; ≥28.4 mg/mL in DMSO with ultrasonic,Sodium,Ubiquitination/Proteasome,Autophagy,Sulfonamide antibiotic,https://www.apexbt.com/search.php?catalog=B1395,1
773,B1397,Trifluoperazine 2HCl,440-17-5,G05,L1021-09,480.42,DMSO,C21H24F3N3S·2HCl,CN1CCN(CC1)CCCN2C3=CC=CC=C3SC4=C2C=C(C=C4)C(F)(F)F.Cl.Cl,≥24.02 mg/mL in DMSO; ≥48 mg/mL in H2O; ≥7.26 mg/mL in EtOH with ultrasonic,Dihydrochloride,Ubiquitination/Proteasome,Autophagy,Dopamine D2 receptor inhibitor,https://www.apexbt.com/search.php?catalog=B1397,1
774,B1398,Azithromycin,83905-01-5,G06,L1021-09,748.98,DMSO,C38H72N2O12,CCC1C(C(C(N(CC(CC(C(C(C(C(C(=O)O1)C)OC2CC(C(C(O2)C)O)(C)OC)C)OC3C(C(CC(O3)C)N(C)C)O)(C)O)C)C)C)O)(C)O,≥30.05 mg/mL in DMSO; insoluble in H2O; ≥102.8 mg/mL in EtOH,Free Base,Microbiology & Virology,Antibiotic,Antibiotic by inhibiting protein synthesis,https://www.apexbt.com/search.php?catalog=B1398,1
775,B1399,Temozolomide,85622-93-1,G07,L1021-09,194.15,DMSO,C6H6N6O2,CN1C(=O)N2C=NC(=C2N=N1)C(=O)N,insoluble in EtOH; insoluble in H2O; ≥29.61 mg/mL in DMSO,Free Base,DNA Damage/DNA Repair,DNA Alkylating,"DNA methylating, chemotherapeutic agent",https://www.apexbt.com/search.php?catalog=B1399,1
776,B1401,Cabozantinib malate (XL184),1140909-48-3,G08,L1021-09,635.59,DMSO,C32H30FN3O10,COC1=CC2=C(C=CN=C2C=C1OC)OC3=CC=C(C=C3)NC(=O)C4(CC4)C(=O)NC5=CC=C(C=C5)F.C(C(C(=O)O)O)C(=O)O,≥31.8 mg/mL in DMSO; insoluble in H2O; ≥2.5 mg/mL in EtOH with gentle warming and ultrasonic,,Tyrosine Kinase,c-MET,MET andVEGF receptor2 inhibitor,https://www.apexbt.com/search.php?catalog=B1401,1
777,B1407,Dabrafenib (GSK2118436),1195765-45-7,G09,L1021-09,519.56,DMSO,C23H20F3N5O2S2,CC(C)(C)C1=NC(=C(S1)C2=NC(=NC=C2)N)C3=C(C(=CC=C3)NS(=O)(=O)C4=C(C=CC=C4F)F)F,≥26 mg/mL in DMSO; insoluble in H2O; ≥2.59 mg/mL in EtOH with gentle warming and ultrasonic,Free Base,MAPK Signaling,Raf,Inhibitor of BRAF(V600) mutants,https://www.apexbt.com/search.php?catalog=B1407,1
778,B1409,Benidipine HCl,91599-74-5,G10,L1021-09,542.02,DMSO,C28H31N3O6·HCl,CC1=C(C(C(=C(N1)C)C(=O)OC2CCCN(C2)CC3=CC=CC=C3)C4=CC(=CC=C4)[N+](=O)[O-])C(=O)OC.Cl,≥21.8 mg/mL in DMSO with gentle warming; insoluble in H2O; ≥8.27 mg/mL in EtOH with ultrasonic,Hydrochloride,Membrane Transporter/Ion Channel,Calcium Channel,Calcium channel blocker,https://www.apexbt.com/search.php?catalog=B1409,1
779,B1410,Amlodipine,88150-42-9,G11,L1021-09,408.88,DMSO,C20H25ClN2O5,CCOC(=O)C1=C(NC(=C(C1C2=CC=CC=C2Cl)C(=O)OC)C)COCCN,insoluble in H2O; ≥17.7 mg/mL in DMSO; ≥49.8 mg/mL in EtOH,Free Base,Membrane Transporter/Ion Channel,Calcium Channel,Calcium channel blocker,https://www.apexbt.com/search.php?catalog=B1410,1
780,B1411,Amlodipine Besylate,111470-99-6,H01,L1021-09,567.05,DMSO,C20H25ClN2O5·C6H6O3S,CCOC(=O)C1=C(NC(=C(C1C2=CC=CC=C2Cl)C(=O)OC)C)COCCN.C1=CC=C(C=C1)S(=O)(=O)O,≥26.05 mg/mL in DMSO; insoluble in H2O; ≥11.26 mg/mL in EtOH with ultrasonic,Besylate,Membrane Transporter/Ion Channel,Calcium Channel,Block of L-type calcium channel,https://www.apexbt.com/search.php?catalog=B1411,1
781,B1412,Flunarizine 2HCl,30484-77-6,H02,L1021-09,477.42,DMSO,C26H26F2N2·2HCl,C1CN(CCN1CC=CC2=CC=CC=C2)C(C3=CC=C(C=C3)F)C4=CC=C(C=C4)F.Cl.Cl,insoluble in H2O; ≥2.21 mg/mL in EtOH with ultrasonic; ≥20.65 mg/mL in DMSO,Dihydrochloride,Membrane Transporter/Ion Channel,Calcium Channel,Calcium entry blocker,https://www.apexbt.com/search.php?catalog=B1412,1
782,B1413,Tetracaine HCl,136-47-0,H03,L1021-09,300.82,DMSO,C15H24N2O2·HCl,CCCCNC1=CC=C(C=C1)C(=O)OCCN(C)C.Cl,≥10.85 mg/mL in DMSO; ≥30.2 mg/mL in H2O; ≥9.5 mg/mL in EtOH,Hydrochloride,Membrane Transporter/Ion Channel,Calcium Channel,Anaesthetic and allosteric inhibitor,https://www.apexbt.com/search.php?catalog=B1413,1
783,B1414,Azelnidipine,123524-52-7,H04,L1021-09,582.65,DMSO,C33H34N4O6,CC1=C(C(C(=C(N1)N)C(=O)OC2CN(C2)C(C3=CC=CC=C3)C4=CC=CC=C4)C5=CC(=CC=C5)[N+](=O)[O-])C(=O)OC(C)C,≥27.15 mg/mL in DMSO; insoluble in H2O; ≥24.2 mg/mL in EtOH,,Membrane Transporter/Ion Channel,Calcium Channel,L-type calcium channel blocker;antihypertensive,https://www.apexbt.com/search.php?catalog=B1414,1
784,B1415,Clevidipine Butyrate,167221-71-8,H05,L1021-09,456.32,DMSO,C21H23Cl2NO6,CCCC(=O)OCOC(=O)C1=C(NC(=C(C1C2=C(C(=CC=C2)Cl)Cl)C(=O)OC)C)C,≥21.4 mg/mL in DMSO; insoluble in H2O; ≥7.45 mg/mL in EtOH with ultrasonic,Free Base,Membrane Transporter/Ion Channel,Calcium Channel,Dihydropyridine calcium channel blocker,https://www.apexbt.com/search.php?catalog=B1415,1
785,B1416,Felodipine,72509-76-3,H06,L1021-09,384.25,DMSO,C18H19Cl2NO4,CCOC(=O)C1=C(NC(=C(C1C2=C(C(=CC=C2)Cl)Cl)C(=O)OC)C)C,insoluble in H2O; ≥17.65 mg/mL in DMSO; ≥34.55 mg/mL in EtOH,Free Base,Membrane Transporter/Ion Channel,Calcium Channel,Selective L-type Ca2+ channel blocker,https://www.apexbt.com/search.php?catalog=B1416,1
786,B1417,Lacidipine,103890-78-4,H07,L1021-09,455.54,DMSO,C26H33NO6,CCOC(=O)C1=C(NC(=C(C1C2=CC=CC=C2C=CC(=O)OC(C)(C)C)C(=O)OCC)C)C,≥21.25 mg/mL in DMSO; insoluble in H2O; ≥12.96 mg/mL in EtOH with ultrasonic,Free Base,Membrane Transporter/Ion Channel,Calcium Channel,L-type calcium channel blocker,https://www.apexbt.com/search.php?catalog=B1417,1
787,B1418,Manidipine,89226-50-6,H08,L1021-09,610.7,DMSO,C35H38N4O6,CC1=C(C(C(=C(N1)C)C(=O)OCCN2CCN(CC2)C(C3=CC=CC=C3)C4=CC=CC=C4)C5=CC(=CC=C5)[N+](=O)[O-])C(=O)OC,≥61.1 mg/mL in DMSO; insoluble in H2O; ≥3.75 mg/mL in EtOH with ultrasonic,,Membrane Transporter/Ion Channel,Calcium Channel,Calcium channel blocker,https://www.apexbt.com/search.php?catalog=B1418,1
788,B1419,Manidipine 2HCl,89226-75-5,H09,L1021-09,683.62,DMSO,C35H40Cl2N4O6,CC1=C(C(C(=C(N1)C)C(=O)OCCN2CCN(CC2)C(C3=CC=CC=C3)C4=CC=CC=C4)C5=CC(=CC=C5)[N+](=O)[O-])C(=O)OC.Cl.Cl,insoluble in H2O; ≥69 mg/mL in DMSO with gentle warming; ≥69.2 mg/mL in EtOH with gentle warming,,Membrane Transporter/Ion Channel,Calcium Channel,Calcium channel blocker,https://www.apexbt.com/search.php?catalog=B1419,1
789,B1420,Bupivacaine HCl,18010-40-7,H10,L1021-09,324.89,DMSO,C18H28N2O·HCl,CCCCN1CCCCC1C(=O)NC2=C(C=CC=C2C)C.Cl,≥10.25 mg/mL in DMSO; ≥16.23 mg/mL in H2O with ultrasonic; ≥69.2 mg/mL in EtOH,Hydrochloride,Membrane Transporter/Ion Channel,Sodium Channel,Anaesthetic drug,https://www.apexbt.com/search.php?catalog=B1420,1
790,B1422,Tasisulam,519055-62-0,H11,L1021-09,415.11,DMSO,C11H6BrCl2NO3S2,C1=CC(=C(C=C1Cl)Cl)C(=O)NS(=O)(=O)C2=CC=C(S2)Br,insoluble in H2O; ≥20.3 mg/mL in DMSO; ≥85.6 mg/mL in EtOH,Free Base,Apoptosis,Caspase,antitumor agent,https://www.apexbt.com/search.php?catalog=B1422,1
791,B1423,Cinacalcet HCl,364782-34-3,A01,L1021-10,393.87,DMSO,C22H23ClF3N,CC(C1=CC=CC2=CC=CC=C21)NCCCC3=CC(=CC=C3)C(F)(F)F.Cl,insoluble in H2O; ≥17.85 mg/mL in DMSO; ≥56 mg/mL in EtOH,Hydrochloride,GPCR/G protein,Calcimimetic Agent,Calcium-sensing receptor (CaR) agonist,https://www.apexbt.com/search.php?catalog=B1423,1
792,B1429,Rimonabant,168273-06-1,A02,L1021-10,463.79,DMSO,C22H21Cl3N4O,CC1=C(N(N=C1C(=O)NN2CCCCC2)C3=C(C=C(C=C3)Cl)Cl)C4=CC=C(C=C4)Cl,≥23.19 mg/mL in DMSO; insoluble in H2O; ≥57.1 mg/mL in EtOH,Free Base,GPCR/G protein,Cannabinoid Receptor,CB1 receptor antagonist,https://www.apexbt.com/search.php?catalog=B1429,1
793,B1440,Acemetacin,53164-05-9,A03,L1021-10,415.82,DMSO,C21H18ClNO6,CC1=C(C2=C(N1C(=O)C3=CC=C(C=C3)Cl)C=CC(=C2)OC)CC(=O)OCC(=O)O,insoluble in H2O; ≥20.79 mg/mL in DMSO; ≥3.39 mg/mL in EtOH with gentle warming and ultrasonic,Free Base,Neuroscience,COX,COX inhibitor,https://www.apexbt.com/search.php?catalog=B1440,1
794,B1441,Lornoxicam,70374-39-9,A04,L1021-10,371.82,DMSO,C13H10ClN3O4S2,CN1C(=C(C2=C(S1(=O)=O)C=C(S2)Cl)O)C(=O)NC3=CC=CC=N3,insoluble in H2O; insoluble in EtOH; ≥18.59 mg/mL in DMSO with gentle warming,,Neuroscience,COX,COX-1/COX-2 inhibitor,https://www.apexbt.com/search.php?catalog=B1441,1
795,B1443,Bufexamac,2438-72-4,A05,L1021-10,223.27,DMSO,C12H17NO3,CCCCOC1=CC=C(C=C1)CC(=O)NO,insoluble in EtOH; ≥11.16 mg/mL in DMSO; ≥2.89 mg/mL in H2O with gentle warming and ultrasonic,Free Base,Neuroscience,COX,COX inhibitor,https://www.apexbt.com/search.php?catalog=B1443,1
796,B1444,Etodolac,41340-25-4,A06,L1021-10,287.35,DMSO,C17H21NO3,CCC1=CC=CC2=C1NC3=C2CCOC3(CC)CC(=O)O,insoluble in H2O; ≥14.37 mg/mL in DMSO; ≥77.7 mg/mL in EtOH,Free Base,Neuroscience,COX,COX-2 inhibitor,https://www.apexbt.com/search.php?catalog=B1444,1
797,B1445,Flunixin Meglumin,42461-84-7,A07,L1021-10,491.46,DMSO,C14H11F3N2O2·C7H17NO5,CC1=C(C=CC=C1NC2=C(C=CC=N2)C(=O)O)C(F)(F)F.CNCC(C(C(C(CO)O)O)O)O,≥24.55 mg/mL in DMSO; ≥17.75 mg/mL in EtOH; ≥23.2 mg/mL in H2O,Meglumin,Neuroscience,COX,potent cyclooxygenase inhibitor,https://www.apexbt.com/search.php?catalog=B1445,1
798,B1446,Ketoprofen,22071-15-4,A08,L1021-10,254.28,DMSO,C16H14O3,CC(C1=CC=CC(=C1)C(=O)C2=CC=CC=C2)C(=O)O,insoluble in H2O; ≥12.71 mg/mL in DMSO; ≥27.8 mg/mL in EtOH,Free Base,Neuroscience,COX,Dual COX1/2 inhibitor,https://www.apexbt.com/search.php?catalog=B1446,1
799,B1447,Ketorolac tromethamine salt ,74103-07-4,A09,L1021-10,376.4,DMSO,C19H24N2O6,C1CN2C(=CC=C2C(=O)C3=CC=CC=C3)C1C(=O)O.C(C(CO)(CO)N)O,≥13.1 mg/mL in DMSO; ≥9.9 mg/mL in EtOH with ultrasonic; ≥92.8 mg/mL in H2O,,Neuroscience,COX,Non-selective COX inhibitor,https://www.apexbt.com/search.php?catalog=B1447,1
800,B1448,Licofelone,156897-06-2,A10,L1021-10,379.88,DMSO,C23H22ClNO2,CC1(CC2=C(C(=C(N2C1)CC(=O)O)C3=CC=C(C=C3)Cl)C4=CC=CC=C4)C,insoluble in H2O; insoluble in EtOH; ≥6.33 mg/mL in DMSO with gentle warming,,Neuroscience,COX,"COX-1, COX-2 and 5-LOX inhibitor",https://www.apexbt.com/search.php?catalog=B1448,1
801,B1449,Mefenamic Acid,61-68-7,A11,L1021-10,241.29,DMSO,C15H15NO2,CC1=C(C(=CC=C1)NC2=CC=CC=C2C(=O)O)C,insoluble in H2O; ≥12.06 mg/mL in DMSO; ≥5.97 mg/mL in EtOH with ultrasonic,Free Base,Neuroscience,COX,Anti-inflammatory agent,https://www.apexbt.com/search.php?catalog=B1449,1
802,B1450,Nabumetone,42924-53-8,B01,L1021-10,228.29,DMSO,C15H16O2,CC(=O)CCC1=CC2=C(C=C1)C=C(C=C2)OC,insoluble in H2O; ≥10.8 mg/mL in EtOH with ultrasonic; ≥11.41 mg/mL in DMSO,Free Base,Neuroscience,COX,COX inhibitor,https://www.apexbt.com/search.php?catalog=B1450,1
803,B1452,Nimesulide,51803-78-2,B02,L1021-10,308.31,DMSO,C13H12N2O5S,CS(=O)(=O)NC1=C(C=C(C=C1)[N+](=O)[O-])OC2=CC=CC=C2,insoluble in H2O; ≥15.42 mg/mL in DMSO; ≥2.96 mg/mL in EtOH with ultrasonic,Free Base,Neuroscience,COX,Non-steroidal anti-inflammatory drug,https://www.apexbt.com/search.php?catalog=B1452,1
804,B1453,Phenacetin,62-44-2,B03,L1021-10,179.22,DMSO,C10H13NO2,CCOC1=CC=C(C=C1)NC(=O)C,insoluble in H2O; ≥24.32 mg/mL in EtOH with ultrasonic; ≥8.96 mg/mL in DMSO,Free Base,Neuroscience,COX,Non-opioid analgesic,https://www.apexbt.com/search.php?catalog=B1453,1
805,B1454,Rofecoxib,162011-90-7,B04,L1021-10,314.36,DMSO,C17H14O4S,CS(=O)(=O)C1=CC=C(C=C1)C2=C(C(=O)OC2)C3=CC=CC=C3,insoluble in H2O; insoluble in EtOH; ≥15.72 mg/mL in DMSO,Free Base,Neuroscience,COX,COX-2 inhibitor,https://www.apexbt.com/search.php?catalog=B1454,1
806,B1455,Tolfenamic Acid,13710-19-5,B05,L1021-10,261.7,DMSO,C14H12ClNO2,CC1=C(C=CC=C1Cl)NC2=CC=CC=C2C(=O)O,insoluble in H2O; ≥13.09 mg/mL in DMSO; ≥6.68 mg/mL in EtOH with ultrasonic,Free Base,Neuroscience,COX,Non-steroidal anti-inflammatory drug,https://www.apexbt.com/search.php?catalog=B1455,1
807,B1457,Diclofenac Sodium,15307-79-6,B06,L1021-10,318.13,DMSO,C14H10Cl2NNaO2,C1=CC=C(C(=C1)CC(=O)[O-])NC2=C(C=CC=C2Cl)Cl.[Na+],≥15.91 mg/mL in DMSO; ≥26.1 mg/mL in H2O with ultrasonic; ≥48.6 mg/mL in EtOH,Sodium Salt,Neuroscience,COX,COX inhibitor,https://www.apexbt.com/search.php?catalog=B1457,1
808,B1458,Lumiracoxib,220991-20-8,B07,L1021-10,293.72,DMSO,C15H13ClFNO2,CC1=CC(=C(C=C1)NC2=C(C=CC=C2Cl)F)CC(=O)O,≥29.4 mg/mL in DMSO; insoluble in H2O; ≥27.15 mg/mL in EtOH with ultrasonic,,Neuroscience,COX,,https://www.apexbt.com/search.php?catalog=B1458,1
809,B1459,Valdecoxib,181695-72-7,B08,L1021-10,314.36,DMSO,C16H14N2O3S,CC1=C(C(=NO1)C2=CC=CC=C2)C3=CC=C(C=C3)S(=O)(=O)N,insoluble in H2O; ≥15.72 mg/mL in DMSO; ≥5.42 mg/mL in EtOH with ultrasonic,Free Base,Neuroscience,COX,COX-2 inhibitor,https://www.apexbt.com/search.php?catalog=B1459,1
810,B1460,Zaltoprofen,74711-43-6,B09,L1021-10,298.36,DMSO,C17H14O3S,CC(C1=CC2=C(C=C1)SC3=CC=CC=C3C(=O)C2)C(=O)O,insoluble in H2O; ≥14.92 mg/mL in DMSO; ≥48.6 mg/mL in EtOH,Free Base,Neuroscience,COX,Cyclooxygenase (COX) inhibitor,https://www.apexbt.com/search.php?catalog=B1460,1
811,B1461,Triflusal,322-79-2,B10,L1021-10,248.16,DMSO,C10H7F3O4,CC(=O)OC1=C(C=CC(=C1)C(F)(F)F)C(=O)O,insoluble in H2O; ≥106 mg/mL in EtOH; ≥12.41 mg/mL in DMSO,Free Base,Neuroscience,COX,COX inhibitor,https://www.apexbt.com/search.php?catalog=B1461,1
812,B1464,KPT-330,1393477-72-9,B11,L1021-10,443.31,DMSO,C17H11F6N7O,C1=CN=C(C=N1)NNC(=O)C=CN2C=NC(=N2)C3=CC(=CC(=C3)C(F)(F)F)C(F)(F)F,insoluble in H2O; ≥11.52 mg/mL in EtOH; ≥15.15 mg/mL in DMSO,,Cell Cycle/Checkpoint,CRM1,"CRM1 inhibitor, orally bioavailable and selective",https://www.apexbt.com/search.php?catalog=B1464,1
813,B1465,Plerixafor 8HCl (AMD3100 8HCl),155148-31-5,C01,L1021-10,794.47,H2O,C28H62Cl8N8,C1CNCCNCCCN(CCNC1)CC2=CC=C(C=C2)CN3CCCNCCNCCCNCC3.Cl.Cl.Cl.Cl.Cl.Cl.Cl.Cl,≥155.4 mg/mL in H2O; insoluble in DMSO; insoluble in EtOH,,GPCR/G protein,CXCR,CXCR4 antagonist,https://www.apexbt.com/search.php?catalog=B1465,1
814,B1468,Adenine,73-24-5,C02,L1021-10,135.13,DMSO,C5H5N5,C1=NC2=C(N1)C(=NC=N2)N,insoluble in H2O; insoluble in EtOH; ≥6.75 mg/mL in DMSO with ultrasonic,,DNA Damage/DNA Repair,Nucleoside Antimetabolite/Analogue,High affinity adenine receptor agonist,https://www.apexbt.com/search.php?catalog=B1468,1
815,B1469,Adenine sulfate,321-30-2,C03,L1021-10,368.33,DMSO,2(C5H5N5)·H2SO4,C1=NC2=C(N1)C(=NC=N2)N.C1=NC2=C(N1)C(=NC=N2)N.OS(=O)(=O)O,insoluble in EtOH; ≥66.9 mg/mL in DMSO; ≥8.45 mg/mL in H2O with gentle warming,,DNA Damage/DNA Repair,DNA Synthesis,,https://www.apexbt.com/search.php?catalog=B1469,1
816,B1470,Procarbazine HCl,366-70-1,C04,L1021-10,257.76,DMSO,C12H19N3O·HCl,CC(C)NC(=O)C1=CC=C(C=C1)CNNC.Cl,≥12.82 mg/mL in H2O; ≥2.56 mg/mL in EtOH with ultrasonic; ≥27.3 mg/mL in DMSO,Hydrochloride,DNA Damage/DNA Repair,DNA Synthesis,Antineoplastic chemotherapy drug,https://www.apexbt.com/search.php?catalog=B1470,1
817,B1471,Adenine HCl,2922-28-3,C05,L1021-10,171.59,DMSO,C5H5N5·HCl,C1=NC2=C(N1)C(=NC=N2)N.Cl,insoluble in EtOH; ≥11.5 mg/mL in DMSO with gentle warming; ≥6.91 mg/mL in H2O with gentle warming,Hydrochloride,DNA Damage/DNA Repair,DNA Synthesis,Adenine receptor agonist,https://www.apexbt.com/search.php?catalog=B1471,1
818,B1472,Mizoribine,50924-49-7,C06,L1021-10,259.22,DMSO,C9H13N3O6,C1=NC(=C(N1C2C(C(C(O2)CO)O)O)O)C(=O)N,insoluble in EtOH; ≥88.2 mg/mL in DMSO; ≥27.6 mg/mL in H2O,,Others,IMPDH,DNA/RNA synthesis inhibitor,https://www.apexbt.com/search.php?catalog=B1472,1
819,B1473,Uridine,58-96-8,C07,L1021-10,244.2,DMSO,C9H12N2O6,C1=CN(C(=O)NC1=O)C2C(C(C(O2)CO)O)O,≥71.43 mg/mL in DMSO; ≥3.9 mg/mL in EtOH with gentle warming and ultrasonic; ≥58.6 mg/mL in H2O,Free Base,DNA Damage/DNA Repair,DNA Synthesis,DNA/RNA synthesis chemical,https://www.apexbt.com/search.php?catalog=B1473,1
820,B1474,FT-207 (NSC 148958),17902-23-7,C08,L1021-10,200.17,DMSO,C8H9FN2O3,C1CC(OC1)N2C=C(C(=O)NC2=O)F,≥100 mg/mL in DMSO; ≥3.23 mg/mL in H2O; ≥3.87 mg/mL in EtOH with ultrasonic,Free Base,DNA Damage/DNA Repair,Nucleoside Antimetabolite/Analogue,DNA/RNA synthesis inhibitor,https://www.apexbt.com/search.php?catalog=B1474,1
821,B1475,Flupirtine maleate,75507-68-5,C09,L1021-10,420.39,DMSO,C19H21FN4O6,CCOC(=O)NC1=C(N=C(C=C1)NCC2=CC=C(C=C2)F)N.C(=CC(=O)O)C(=O)O,insoluble in H2O; ≥17.55 mg/mL in DMSO; ≥2.49 mg/mL in EtOH with gentle warming and ultrasonic,,Membrane Transporter/Ion Channel,NMDA Receptor,NMDA receptor antagonist,https://www.apexbt.com/search.php?catalog=B1475,1
822,B1476,Raltitrexed,112887-68-0,C10,L1021-10,458.49,DMSO,C21H22N4O6S,CC1=NC(=O)C2=C(N1)C=CC(=C2)CN(C)C3=CC=C(S3)C(=O)NC(CCC(=O)O)C(=O)O,insoluble in H2O; ≥154 mg/mL in DMSO; ≥10.62 mg/mL in EtOH with ultrasonic,,DNA Damage/DNA Repair,DNA Synthesis,Thymidylate synthase inhibitor,https://www.apexbt.com/search.php?catalog=B1476,1
823,B1477,Lurasidone HCl,367514-88-3,C11,L1021-10,529.14,DMSO,C28H37ClN4O2S,C1CCC(C(C1)CN2CCN(CC2)C3=NSC4=CC=CC=C43)CN5C(=O)C6C7CCC(C7)C6C5=O.Cl,insoluble in H2O; insoluble in EtOH; ≥11.11 mg/mL in DMSO with gentle warming,,Neuroscience,5-HT Receptor,,https://www.apexbt.com/search.php?catalog=B1477,0
824,B1479,Amisulpride,71675-85-9,D01,L1021-10,369.48,DMSO,C17H27N3O4S,CCN1C(CCC1)CNC(C2=CC(S(=O)(CC)=O)=C(C=C2OC)N)=O,insoluble in H2O; ≥14.83 mg/mL in EtOH with ultrasonic; ≥18.47 mg/mL in DMSO,Free Base,Neuroscience,Dopamine Receptor,Dopamine D2/D3 receptor antagonist,https://www.apexbt.com/search.php?catalog=B1479,1
825,B1480,Chlorpromazine HCl,69-09-0,D02,L1021-10,355.33,DMSO,C17H19ClN2S·HCl,CN(C)CCCN1C2=CC=CC=C2SC3=C1C=C(C=C3)Cl.Cl,≥17.77 mg/mL in DMSO; ≥71.4 mg/mL in H2O; ≥74.8 mg/mL in EtOH,Hydrochloride,Neuroscience,Dopamine Receptor,dopamine receptor antagonist,https://www.apexbt.com/search.php?catalog=B1480,1
826,B1481,Domperidone,57808-66-9,D03,L1021-10,425.91,DMSO,C22H24ClN5O2,C1CN(CCC1N2C3=C(C=C(C=C3)Cl)NC2=O)CCCN4C5=CC=CC=C5NC4=O,≥21.3 mg/mL in DMSO; insoluble in EtOH; insoluble in H2O,Free Base,Neuroscience,Dopamine Receptor,Drug for gastroparesis,https://www.apexbt.com/search.php?catalog=B1481,1
827,B1482,Dopamine HCl,62-31-7,D04,L1021-10,189.64,DMSO,C8H11NO2·HCl,C1=CC(=C(C=C1CCN)O)O.Cl,≥24.9 mg/mL in H2O; ≥3.16 mg/mL in EtOH with ultrasonic; ≥9.48 mg/mL in DMSO,Hydrochloride,Neuroscience,Dopamine Receptor,Dopamine D1-5 receptors agonist,https://www.apexbt.com/search.php?catalog=B1482,1
828,B1483,Fenoldopam,67227-56-9,D05,L1021-10,305.76,DMSO,C16H16ClNO3,C1CNCC(C2=CC(=C(C(=C21)Cl)O)O)C3=CC=C(C=C3)O,insoluble in EtOH; ≥12.55 mg/mL in H2O with ultrasonic; ≥15.29 mg/mL in DMSO,Free Base,Neuroscience,Dopamine Receptor,D1-like dopamine receptor partial agonist,https://www.apexbt.com/search.php?catalog=B1483,1
829,B1484,Levosulpiride,23672-07-3,D06,L1021-10,341.43,DMSO,C15H23N3O4S,CCN1CCCC1CNC(=O)C2=C(C=CC(=C2)S(=O)(=O)N)OC,insoluble in H2O; ≥17.07 mg/mL in DMSO; ≥2.35 mg/mL in EtOH with ultrasonic,Free Base,Neuroscience,Dopamine Receptor,Antipsychotic drug,https://www.apexbt.com/search.php?catalog=B1484,1
830,B1485,Pergolide mesylate,66104-23-2,D07,L1021-10,410.59,DMSO,C19H26N2S·CH4O3S,CCCN1CC(CC2C1CC3=CNC4=CC=CC2=C34)CSC.CS(=O)(=O)O,insoluble in EtOH; insoluble in H2O; ≥6.84 mg/mL in DMSO,Mesylate,Neuroscience,Dopamine Receptor,Dopaminergic agonist,https://www.apexbt.com/search.php?catalog=B1485,1
831,B1486,Amantadine HCl,665-66-7,D08,L1021-10,187.7,DMSO,C10H17N·HCl,C1C2CC3CC1CC(C2)(C3)N.Cl,≥22.73 mg/mL in EtOH; ≥31.55 mg/mL in H2O; ≥9.39 mg/mL in DMSO,Hydrochloride,Neuroscience,Dopamine Receptor,Dopamine receptor agonist,https://www.apexbt.com/search.php?catalog=B1486,1
832,B1487,Pramipexole 2HCl Monohydrate,191217-81-9,D09,L1021-10,302.26,DMSO,C10H17N3S·2HCl·H2O,CCCNC1CCC2=C(C1)SC(=N2)N.O.Cl.Cl,≥15.11 mg/mL in DMSO; ≥2.37 mg/mL in EtOH with ultrasonic; ≥26.2 mg/mL in H2O,Dihydrochloride,Neuroscience,Dopamine Receptor,Novel non-ergoline dopamine receptor agonist,https://www.apexbt.com/search.php?catalog=B1487,1
833,B1488,Pramipexole,104632-26-0,D10,L1021-10,211.33,DMSO,C10H17N3S,CCCNC1CCC2=C(C1)SC(=N2)N,insoluble in H2O; ≥10.57 mg/mL in DMSO; ≥22.75 mg/mL in EtOH,Free Base,Neuroscience,Dopamine Receptor,Dopamine agonist,https://www.apexbt.com/search.php?catalog=B1488,1
834,B1489,Benserazide HCl,14919-77-8,D11,L1021-10,293.7,DMSO,C10H15N3O5·HCl,C1=CC(=C(C(=C1CNNC(=O)C(CO)N)O)O)O.Cl,insoluble in EtOH; ≥12.15 mg/mL in DMSO; ≥17.98 mg/mL in H2O,,Metabolism,Decarboxylase,Decarboxylase inhibitor,https://www.apexbt.com/search.php?catalog=B1489,1
835,B1490,Quetiapine Fumarate,111974-72-2,E01,L1021-10,883.09,DMSO,C46H54N6O8S2,C1CN(CCN1CCOCCO)C2=NC3=CC=CC=C3SC4=CC=CC=C42.C1CN(CCN1CCOCCO)C2=NC3=CC=CC=C3SC4=CC=CC=C42.C(=CC(=O)O)C(=O)O,insoluble in H2O; insoluble in EtOH; ≥11.03 mg/mL in DMSO,Fumarate,Neuroscience,Dopamine Receptor,Dopamine receptor antagonist,https://www.apexbt.com/search.php?catalog=B1490,1
836,B1496,Icotinib,610798-31-7,E02,L1021-10,391.42,DMSO,C22H21N3O4,[H]C1=C2OC([H])([H])C([H])([H])OC([H])([H])C([H])([H])OC([H])([H])C([H])([H])OC2=C([H])C3=NC([H])=NC(N([H])C4=C([H])C([H])=C([H])C(C#C[H])=C4[H])=C31,insoluble in H2O; ≥129.6 mg/mL in DMSO; ≥14.13 mg/mL in EtOH with ultrasonic,,JAK/STAT Signaling,EGFR,EGFR tyrosine kinase inhibitor,https://www.apexbt.com/search.php?catalog=B1496,1
837,B1501,Estradiol Cypionate,313-06-4,E03,L1021-10,396.56,DMSO,C26H36O3,CC12CCC3C(C1CCC2OC(=O)CCC4CCCC4)CCC5=C3C=CC(=C5)O,insoluble in H2O; ≥15 mg/mL in DMSO; ≥52 mg/mL in EtOH,Free Base,Endocrinology and Hormones,Estrogen/progestogen Receptor,Estrogen receptor inhibitor,https://www.apexbt.com/search.php?catalog=B1501,1
838,B1502,Ethisterone,434-03-7,E04,L1021-10,312.45,DMSO,C21H28O2,CC12CCC(=O)C=C1CCC3C2CCC4(C3CCC4(C#C)O)C,≥31.2 mg/mL in DMSO with gentle warming; insoluble in EtOH; insoluble in H2O,,Endocrinology and Hormones,Estrogen/progestogen Receptor,Progestogen hormone,https://www.apexbt.com/search.php?catalog=B1502,1
839,B1503,Altrenogest,850-52-2,E05,L1021-10,310.43,DMSO,C21H26O2,CC12C=CC3=C4CCC(=O)C=C4CCC3C1CCC2(CC=C)O,insoluble in H2O; ≥14.4 mg/mL in DMSO; ≥56 mg/mL in EtOH,Free Base,Endocrinology and Hormones,Estrogen/progestogen Receptor,Progestogen receptor agonist,https://www.apexbt.com/search.php?catalog=B1503,1
840,B1504,Clomiphene citrate,50-41-9,E06,L1021-10,598.08,DMSO,C26H28ClNO·C6H8O7,CCN(CC)CCOC1=CC=C(C=C1)C(=C(C2=CC=CC=C2)Cl)C3=CC=CC=C3.C(C(=O)O)C(CC(=O)O)(C(=O)O)O,≥23 mg/mL in DMSO; insoluble in H2O; ≥12.93 mg/mL in EtOH with ultrasonic,Citrate,Endocrinology and Hormones,Estrogen/progestogen Receptor,Selective estrogen receptor modulator,https://www.apexbt.com/search.php?catalog=B1504,1
841,B1505,Epiandrosterone,481-29-8,E07,L1021-10,290.44,DMSO,C19H30O2,CC12CCC(CC1CCC3C2CCC4(C3CCC4=O)C)O,insoluble in H2O; ≥12.35 mg/mL in EtOH; ≥28.27 mg/mL in DMSO,,Endocrinology and Hormones,Androgen Receptor,,https://www.apexbt.com/search.php?catalog=B1505,1
842,B1506,Estradiol valerate,979-32-8,E08,L1021-10,356.5,DMSO,C23H32O3,CCCCC(=O)OC1CCC2C1(CCC3C2CCC4=C3C=CC(=C4)O)C,insoluble in H2O; ≥15.45 mg/mL in DMSO; ≥41.7 mg/mL in EtOH,Free Base,Endocrinology and Hormones,Androgen Receptor,Estrogen receptor agonist,https://www.apexbt.com/search.php?catalog=B1506,1
843,B1507,Estriol,50-27-1,E09,L1021-10,288.39,DMSO,C18H24O3,CC12CCC3C(C1CC(C2O)O)CCC4=C3C=CC(=C4)O,insoluble in H2O; ≥10.33 mg/mL in EtOH with ultrasonic; ≥9.25 mg/mL in DMSO,Free Base,Endocrinology and Hormones,Estrogen/progestogen Receptor,Estrogen receptor antagonist,https://www.apexbt.com/search.php?catalog=B1507,1
844,B1508,Ethynodiol diacetate,297-76-7,E10,L1021-10,384.51,DMSO,C24H32O4,CC(=O)OC1CCC2C3CCC4(C(C3CCC2=C1)CCC4(C#C)OC(=O)C)C,insoluble in H2O; ≥19.2 mg/mL in DMSO; ≥60.8 mg/mL in EtOH,Free Base,Endocrinology and Hormones,Estrogen/progestogen Receptor,Progestogen receptor agonist,https://www.apexbt.com/search.php?catalog=B1508,1
845,B1509,Hexestrol,84-16-2,E11,L1021-10,270.37,DMSO,C18H22O2,CCC(C1=CC=C(C=C1)O)C(CC)C2=CC=C(C=C2)O,insoluble in H2O; ≥12.65 mg/mL in DMSO; ≥64 mg/mL in EtOH,,Endocrinology and Hormones,Estrogen/progestogen Receptor,Estrogen receptor agonist,https://www.apexbt.com/search.php?catalog=B1509,1
846,B1510,Medroxyprogesterone acetate,71-58-9,F01,L1021-10,386.52,DMSO,C24H34O4,CC1CC2C(CCC3(C2CCC3(C(=O)C)OC(=O)C)C)C4(C1=CC(=O)CC4)C,insoluble in H2O; ≥2.21 mg/mL in EtOH with ultrasonic; ≥9.48 mg/mL in DMSO with gentle warming,Free Base,Endocrinology and Hormones,Estrogen/progestogen Receptor,Steroidal progestin,https://www.apexbt.com/search.php?catalog=B1510,1
847,B1511,Mifepristone,84371-65-3,F02,L1021-10,429.59,DMSO,C29H35NO2,CC#CC1(CCC2C1(CC(C3=C4CCC(=O)C=C4CCC23)C5=CC=C(C=C5)N(C)C)C)O,≥21.48 mg/mL in DMSO; insoluble in H2O; ≥21.45 mg/mL in EtOH with gentle warming,Free Base,GPCR/G protein,Glucocorticoid Receptor,Progesterone receptor antagonist,https://www.apexbt.com/search.php?catalog=B1511,1
848,B1512,Pregnenolone,145-13-1,F03,L1021-10,316.48,DMSO,C21H32O2,CC(=O)C1CCC2C1(CCC3C2CC=C4C3(CCC(C4)O)C)C,insoluble in H2O; ≥15.82 mg/mL in DMSO with gentle warming; ≥2.42 mg/mL in EtOH with ultrasonic,Free Base,Neuroscience,AChR,steroid hormone,https://www.apexbt.com/search.php?catalog=B1512,1
849,B1513,Toremifene Citrate,89778-27-8,F04,L1021-10,598.08,DMSO,C32H36ClNO8,CN(C)CCOC1=CC=C(C=C1)C(=C(CCCl)C2=CC=CC=C2)C3=CC=CC=C3.C(C(=O)O)C(CC(=O)O)(C(=O)O)O,≥24.15 mg/mL in DMSO; insoluble in EtOH; insoluble in H2O,Citrate,Endocrinology and Hormones,Estrogen/progestogen Receptor,Oral selective estrogen receptor modulator (SERM),https://www.apexbt.com/search.php?catalog=B1513,1
850,B1514,Equol,531-95-3,F05,L1021-10,242.27,DMSO,C15H14O3,C1C(COC2=C1C=CC(=C2)O)C3=CC=C(C=C3)O,insoluble in H2O; ≥12.1 mg/mL in DMSO; ≥44.8 mg/mL in EtOH,,Endocrinology and Hormones,Estrogen/progestogen Receptor,,https://www.apexbt.com/search.php?catalog=B1514,1
851,B1515,Raloxifene HCl,82640-04-8,F06,L1021-10,510.04,DMSO,C28H28ClNO4S,C1CCN(CC1)CCOC2=CC=C(C=C2)C(=O)C3=C(SC4=C3C=CC(=C4)O)C5=CC=C(C=C5)O.Cl,≥22.35 mg/mL in DMSO; insoluble in H2O; insoluble in EtOH,Hydrochloride,Endocrinology and Hormones,Estrogen/progestogen Receptor,Estrogen receptor (ER),https://www.apexbt.com/search.php?catalog=B1515,1
852,B1516,Dienogest,65928-58-7,F07,L1021-10,311.42,DMSO,C20H25NO2,CC12CCC3=C4CCC(=O)C=C4CCC3C1CCC2(CC#N)O,insoluble in H2O; ≥14.8 mg/mL in DMSO; ≥2.35 mg/mL in EtOH with gentle warming and ultrasonic,Free Base,Endocrinology and Hormones,Estrogen/progestogen Receptor,Orally active synthetic progesterone,https://www.apexbt.com/search.php?catalog=B1516,1
853,B1517,Gestodene,60282-87-3,F08,L1021-10,310.43,DMSO,C21H26O2,CCC12CCC3C(C1C=CC2(C#C)O)CCC4=CC(=O)CCC34,insoluble in H2O; ≥12.65 mg/mL in DMSO; ≥13.75 mg/mL in EtOH with ultrasonic,Free Base,Endocrinology and Hormones,Estrogen/progestogen Receptor,Progestogen hormonal contraceptive,https://www.apexbt.com/search.php?catalog=B1517,1
854,B1520,Drospirenone,67392-87-4,F09,L1021-10,366.49,DMSO,C24H30O3,O=C1OC2(C([H])([H])C1([H])[H])C3([H])C(C3([H])[H])([H])C4([H])C2(C([H])([H])[H])C([H])([H])C([H])([H])C(C(C([H])([H])C5([H])[H])(C([H])([H])[H])C6=C([H])C5=O)([H])C4([H])C7([H])C6([H])C7([H])[H],insoluble in H2O; ≥10.8 mg/mL in EtOH with ultrasonic; ≥12.35 mg/mL in DMSO,Free Base,Endocrinology and Hormones,Estrogen/progestogen Receptor,Synthetic progestin,https://www.apexbt.com/search.php?catalog=B1520,1
855,B1521,Bosentan Hydrate,157212-55-0,F10,L1021-10,569.63,DMSO,C27H31N5O7S,CC(C)(C)C1=CC=C(C=C1)S(=O)(=O)NC2=C(C(=NC(=N2)C3=NC=CC=N3)OCCO)OC4=CC=CC=C4OC.O,≥28.5 mg/mL in DMSO; insoluble in H2O; ≥2.45 mg/mL in EtOH with gentle warming and ultrasonic,Hydrate,GPCR/G protein,Endothelin Receptor,endothelin receptor antagonist,https://www.apexbt.com/search.php?catalog=B1521,1
856,B1529,Gabapentin HCl,60142-95-2,F11,L1021-10,207.7,DMSO,C9H18ClNO2,C1CCC(CC1)(CC(=O)O)CN.Cl,≥55.1 mg/mL in EtOH; ≥9.35 mg/mL in H2O; ≥95.4 mg/mL in DMSO,Hydrochloride,Membrane Transporter/Ion Channel,Calcium Channel,GABA analog,https://www.apexbt.com/search.php?catalog=B1529,1
857,B1530,Niflumic acid,4394-00-7,G01,L1021-10,282.22,DMSO,C13H9F3N2O2,C1=CC(=CC(=C1)NC2=C(C=CC=N2)C(=O)O)C(F)(F)F,insoluble in H2O; ≥12.15 mg/mL in DMSO; ≥18.17 mg/mL in EtOH with ultrasonic,Free Base,Neuroscience,GABA Receptor,Ca2+-activated Cl- channel blocker,https://www.apexbt.com/search.php?catalog=B1530,1
858,B1531,(R)-baclofen,69308-37-8,G02,L1021-10,213.66,H2O,C10H12ClNO2,C1=CC(=CC=C1C(CC(=O)O)CN)Cl,insoluble in DMSO; insoluble in EtOH; ≥7.13 mg/mL in H2O with gentle warming,,Membrane Transporter/Ion Channel,GABA Receptor,GABA receptor agonist,https://www.apexbt.com/search.php?catalog=B1531,1
859,B1532,Nefiracetam,77191-36-7,G03,L1021-10,246.3,DMSO,C14H18N2O2,CC1=C(C(=CC=C1)C)NC(=O)CN2CCCC2=O,insoluble in H2O; ≥11.15 mg/mL in DMSO; ≥59.4 mg/mL in EtOH,Free Base,Neuroscience,GABA Receptor,GABA receptor activator,https://www.apexbt.com/search.php?catalog=B1532,1
860,B1539,Tideglusib,865854-05-3,G04,L1021-10,334.39,DMSO,C19H14N2O2S,C1=CC=C(C=C1)CN2C(=O)N(SC2=O)C3=CC=CC4=CC=CC=C43,insoluble in EtOH; insoluble in H2O; ≥16.7 mg/mL in DMSO with gentle warming,Free Base,PI3K/Akt/mTOR Signaling,GSK-3,non-ATP-competitive GSK-3β inhibitor,https://www.apexbt.com/search.php?catalog=B1539,1
861,B1543,Mubritinib (TAK 165),366017-09-6,G05,L1021-10,468.47,DMSO,C25H23F3N4O2,C1=CC(=CC=C1CCCCN2C=CN=N2)OCC3=COC(=N3)C=CC4=CC=C(C=C4)C(F)(F)F,insoluble in H2O; ≥76.9 mg/mL in DMSO with gentle warming; ≥3.09 mg/mL in EtOH with gentle warming and ultrasonic,,Tyrosine Kinase,HER2,Potent inhibitor of HER2/ErbB2,https://www.apexbt.com/search.php?catalog=B1543,1
862,B1545,Brompheniramine hydrogen maleate,980-71-2,G06,L1021-10,435.31,DMSO,C16H19BrN2·C4H4O4,CN(C)CCC(C1=CC=C(C=C1)Br)C2=CC=CC=N2.C(=CC(=O)O)C(=O)O,≥11.58 mg/mL in EtOH with ultrasonic; ≥12.24 mg/mL in H2O with ultrasonic; ≥21.76 mg/mL in DMSO,Maleate,Neuroscience,Histamine Receptor,Histamine H1 receptors antagonist,https://www.apexbt.com/search.php?catalog=B1545,1
863,B1547,Cetirizine DiHCl,83881-52-1,G07,L1021-10,461.81,DMSO,C21H27Cl3N2O3,C1CN(CCN1CCOCC(=O)O)C(C2=CC=CC=C2)C3=CC=C(C=C3)Cl.Cl.Cl,insoluble in EtOH; ≥2.66 mg/mL in H2O with gentle warming and ultrasonic; ≥23.09 mg/mL in DMSO with gentle warming,2HCl,Neuroscience,Histamine Receptor,H1 receptor inverse agonist,https://www.apexbt.com/search.php?catalog=B1547,1
864,B1549,Hydroxyzine 2HCl,2192-20-3,G08,L1021-10,447.83,DMSO,C21H27ClN2O2·2HCl,C1CN(CCN1CCOCCO)C(C2=CC=CC=C2)C3=CC=C(C=C3)Cl.Cl.Cl,≥10.14 mg/mL in EtOH; ≥21.5 mg/mL in DMSO; ≥9.5 mg/mL in H2O with ultrasonic,Dihydrochloride,Neuroscience,Histamine Receptor,Histamine H1-receptor antagonist,https://www.apexbt.com/search.php?catalog=B1549,1
865,B1550,Levodropropizine,99291-25-5,G09,L1021-10,236.31,DMSO,C13H20N2O2,C1CN(CCN1CC(CO)O)C2=CC=CC=C2,≥35 mg/mL in DMSO; ≥17.25 mg/mL in EtOH; ≥18.5 mg/mL in H2O,,Neuronal Signaling,Histamine Receptor, histamine receptor inhibitor,https://www.apexbt.com/search.php?catalog=B1550,1
866,B1551,Mizolastine,108612-45-9,G10,L1021-10,432.49,DMSO,C24H25FN6O,CN(C1CCN(CC1)C2=NC3=CC=CC=C3N2CC4=CC=C(C=C4)F)C5=NC=CC(=O)N5,insoluble in H2O; ≥21.62 mg/mL in DMSO with ultrasonic; ≥9.8 mg/mL in EtOH with ultrasonic,,Neuroscience,Histamine Receptor,,https://www.apexbt.com/search.php?catalog=B1551,1
867,B1552,Nizatidine,76963-41-2,G11,L1021-10,331.46,DMSO,C12H21N5O2S2,CNC(=C[N+](=O)[O-])NCCSCC1=CSC(=N1)CN(C)C,≥16.57 mg/mL in DMSO; ≥2.23 mg/mL in H2O; ≥3.04 mg/mL in EtOH with ultrasonic,Free Base,Neuroscience,Histamine Receptor,Histamine H2 receptor antagonist,https://www.apexbt.com/search.php?catalog=B1552,1
868,B1553,Tripelennamine HCl,154-69-8,H01,L1021-10,291.82,H2O,C16H22ClN3,CN(C)CCN(CC1=CC=CC=C1)C2=CC=CC=N2.Cl,≥86.4 mg/mL in H2O; ≥2.33 mg/mL in DMSO with ultrasonic; ≥3.45 mg/mL in EtOH with ultrasonic,,Neuroscience,Histamine Receptor,H1-receptor antagonist,https://www.apexbt.com/search.php?catalog=B1553,1
869,B1554,Benztropine mesylate,132-17-2,H02,L1021-10,403.53,DMSO,C21H25NO·CH4SO3,CN1C2CCC1CC(C2)OC(C3=CC=CC=C3)C4=CC=CC=C4.CS(=O)(=O)O,≥20.18 mg/mL in DMSO; ≥29.65 mg/mL in H2O; ≥52.8 mg/mL in EtOH,Mesylate,Neuroscience,Histamine Receptor,Dopamine transporter (DAT) inhibitor,https://www.apexbt.com/search.php?catalog=B1554,1
870,B1555,Betahistine 2HCl,5579-84-0,H03,L1021-10,209.12,DMSO,C8H12N2·2HCl,CNCCC1=CC=CC=N1.Cl.Cl,≥10.46 mg/mL in DMSO; ≥2.1 mg/mL in H2O with ultrasonic; ≥48.7 mg/mL in EtOH,Dihydrochloride,Neuroscience,Histamine Receptor,Histamine H3 receptor inhibitor,https://www.apexbt.com/search.php?catalog=B1555,1
871,B1556,Chlorpheniramine Maleate,113-92-8,H04,L1021-10,390.86,DMSO,C16H19ClN2·C4H4O4,CN(C)CCC(C1=CC=C(C=C1)Cl)C2=CC=CC=N2.C(=CC(=O)O)C(=O)O,≥10.68 mg/mL in H2O; ≥19.54 mg/mL in DMSO; ≥3.95 mg/mL in EtOH with ultrasonic,Maleate,Neuroscience,Histamine Receptor,Histamine H1 receptor antagonist,https://www.apexbt.com/search.php?catalog=B1556,1
872,B1557,Cimetidine,51481-61-9,H05,L1021-10,252.34,DMSO,C10H16N6S,CC1=C(N=CN1)CSCCNC(=NC)NC#N,≥12.62 mg/mL in DMSO; ≥2.54 mg/mL in H2O with gentle warming and ultrasonic; ≥9.37 mg/mL in EtOH,Free Base,Neuroscience,Histamine Receptor,H2 receptor antagonist,https://www.apexbt.com/search.php?catalog=B1557,1
873,B1558,Clemastine Fumarate,14976-57-9,H06,L1021-10,459.96,DMSO,C21H26ClNO·C4H4O4,CC(C1=CC=CC=C1)(C2=CC=C(C=C2)Cl)OCCC3CCCN3C.C(=CC(=O)O)C(=O)O,insoluble in EtOH; insoluble in H2O; ≥11.58 mg/mL in DMSO,Free Base,Neuroscience,Histamine Receptor,Selective histamine H1 receptor antagonist,https://www.apexbt.com/search.php?catalog=B1558,0
874,B1560,Famotidine,76824-35-6,H07,L1021-10,337.45,DMSO,C8H15N7O2S3,C1=C(N=C(S1)N=C(N)N)CSCCC(=NS(=O)(=O)N)N,insoluble in H2O; insoluble in EtOH; ≥16.87 mg/mL in DMSO,Free Base,Neuroscience,Histamine Receptor,Histamine H2-receptor antagonist,https://www.apexbt.com/search.php?catalog=B1560,1
875,B1561,Histamine 2HCl,56-92-8,H08,L1021-10,184.07,DMSO,C5H9N3·2HCl,C1=C(NC=N1)CCN.Cl.Cl,insoluble in EtOH; ≥117.4 mg/mL in H2O; ≥9.20 mg/mL in DMSO,Dihydrochloride,Neuroscience,Histamine Receptor,Histamine receptor agonist,https://www.apexbt.com/search.php?catalog=B1561,1
876,B1562,Ketotifen Fumarate,34580-14-8,H09,L1021-10,425.5,DMSO,C23H23NO5S,CN1CCC(=C2C3=C(C(=O)CC4=CC=CC=C42)SC=C3)CC1.C(=CC(=O)O)C(=O)O,insoluble in EtOH; ≥21.28 mg/mL in DMSO; ≥3.35 mg/mL in H2O with ultrasonic,Fumarate,Neuroscience,Histamine Receptor,Histamine H1 receptor antagonist,https://www.apexbt.com/search.php?catalog=B1562,1
877,B1563,Pemirolast potassium,100299-08-9,H10,L1021-10,266.3,H2O,C10H7N6O·K,CC1=CC=CN2C1=NC=C(C2=O)C3=NN=N[N-]3.[K+],insoluble in EtOH; ≥85.4 mg/mL in H2O; ≥5.37 mg/mL in DMSO with ultrasonic,,Neuroscience,Histamine Receptor,Histamine H1 receptor antagonist,https://www.apexbt.com/search.php?catalog=B1563,1
878,B1564,Ranitidine,66357-59-3,H11,L1021-10,350.86,DMSO,C13H22N4O3S·HCl,CN(C)CC1=CC=C(CSCCN/C(NC)=C/[N+]([O-])=O)O1.Cl,≥17.54 mg/mL in DMSO; ≥3.46 mg/mL in EtOH with ultrasonic; ≥99 mg/mL in H2O,Hydrochloride,Neuroscience,Histamine Receptor,Histamine H2-receptor antagonist,https://www.apexbt.com/search.php?catalog=B1564,1
879,B1565,Roxatidine Acetate HCl,93793-83-0,A01,L1021-11,384.9,DMSO,C19H28N2O4·HCl,CC(=O)OCC(=O)NCCCOC1=CC=CC(=C1)CN2CCCCC2.Cl,≥113.4 mg/mL in H2O; ≥19.25 mg/mL in DMSO; ≥20.87 mg/mL in EtOH with ultrasonic,Hydrochloride,Neuroscience,Histamine Receptor,Specific and competitive histamin H2-receptor antagonist,https://www.apexbt.com/search.php?catalog=B1565,1
880,B1566,Rupatadine Fumarate,182349-12-8,A02,L1021-11,532.03,DMSO,C26H26ClN3·C4H4O4,CC1=CC(=CN=C1)CN2CCC(=C3C4=C(CCC5=C3N=CC=C5)C=C(C=C4)Cl)CC2.C(=CC(=O)O)C(=O)O,insoluble in H2O; ≥11.75 mg/mL in DMSO; ≥12.55 mg/mL in EtOH with gentle warming,,Neuroscience,Histamine Receptor,Inhibitor of PAF and histamine (H1) receptor,https://www.apexbt.com/search.php?catalog=B1566,1
881,B1568,Azelastine HCl,79307-93-0,A03,L1021-11,418.36,DMSO,C22H24ClN3O·HCl,CN1CCCC(CC1)N2C(=O)C3=CC=CC=C3C(=N2)CC4=CC=C(C=C4)Cl.Cl,≥20.92 mg/mL in DMSO; ≥5 mg/mL in EtOH with ultrasonic; ≥5.42 mg/mL in H2O with ultrasonic,Hydrochloride,Neuroscience,Histamine Receptor,"Potent, second-generation, selective, histamine receptor antagonist",https://www.apexbt.com/search.php?catalog=B1568,1
882,B1569,Bepotastine Besilate,190786-44-8,A04,L1021-11,547.06,DMSO,C27H31ClN2O6S,C1CN(CCC1OC(C2=CC=C(C=C2)Cl)C3=CC=CC=N3)CCCC(=O)O.C1=CC=C(C=C1)S(=O)(=O)O,≥15.9 mg/mL in H2O with ultrasonic; ≥27.35 mg/mL in DMSO; ≥6.09 mg/mL in EtOH with ultrasonic,Free Base,Neuroscience,Histamine Receptor,"Non-sedating, selective antagonist of histamine 1 (H1) receptor",https://www.apexbt.com/search.php?catalog=B1569,1
883,B1571,Desloratadine,100643-71-8,A05,L1021-11,310.82,DMSO,C19H19ClN2,C1CC2=C(C=CC(=C2)Cl)C(=C3CCNCC3)C4=C1C=CC=N4,insoluble in H2O; ≥15.54 mg/mL in DMSO; ≥53.3 mg/mL in EtOH,Free Base,Neuroscience,Histamine Receptor,High affinity histamine H1 receptor antagonist,https://www.apexbt.com/search.php?catalog=B1571,1
884,B1572,Latrepirdine,97657-92-6,A06,L1021-11,392.37,DMSO,C21H25N3·2HCl,CC1=CC2=C(C=C1)N(C3=C2CN(CC3)C)CCC4=CN=C(C=C4)C.Cl.Cl,insoluble in H2O; ≥19.62 mg/mL in DMSO; ≥54.7 mg/mL in EtOH,,Neuroscience,GluR,Brain cell death inhibitor,https://www.apexbt.com/search.php?catalog=B1572,1
885,B1573,Fexofenadine HCl,153439-40-8,A07,L1021-11,538.12,DMSO,C32H39NO4·HCl,CC(C)(C1=CC=C(C=C1)C(CCCN2CCC(CC2)C(C3=CC=CC=C3)(C4=CC=CC=C4)O)O)C(=O)O.Cl,insoluble in H2O; ≥26.91 mg/mL in DMSO; ≥51.2 mg/mL in EtOH,Hydrochloride,Neuroscience,Histamine Receptor,Histamine H1 receptor inhibitor,https://www.apexbt.com/search.php?catalog=B1573,1
886,B1575,Lafutidine,118288-08-7,A08,L1021-11,431.55,DMSO,C22H29N3O4S,C1CCN(CC1)CC2=CC(=NC=C2)OCC=CCNC(=O)CS(=O)CC3=CC=CO3,insoluble in H2O; ≥21.58 mg/mL in DMSO; ≥3.44 mg/mL in EtOH,Free Base,Neuroscience,Histamine Receptor,Histamine H2-receptor antagonist,https://www.apexbt.com/search.php?catalog=B1575,1
887,B1576,Olopatadine HCl,140462-76-6,A09,L1021-11,373.87,DMSO,C21H23NO3·HCl,CN(C)CCC=C1C2=CC=CC=C2COC3=C1C=C(C=C3)CC(=O)O.Cl,≥18.69 mg/mL in DMSO; ≥2.87 mg/mL in H2O with ultrasonic; ≥3.03 mg/mL in EtOH with ultrasonic,Hydrochloride,Neuroscience,Histamine Receptor,Histamine blocker,https://www.apexbt.com/search.php?catalog=B1576,1
888,B1589,Pacritinib (SB1518),937272-79-2,A10,L1021-11,472.58,DMSO,C28H32N4O3,[H]C1([H])N(C([H])([H])C([H])([H])OC(C([H])=C2[H])=C(C([H])([H])OC([H])([H])/C([H])=C([H])\C([H])([H])OC([H])([H])C3=C([H])C4=C([H])C([H])=C3[H])C([H])=C2N([H])C5=NC([H])=C([H])C4=N5)C([H])([H])C([H])([H])C1([H])[H],insoluble in EtOH; insoluble in H2O; ≥11.05 mg/mL in DMSO with gentle warming,,JAK/STAT Signaling,"FLT3, JAK",JAK2/FLT3 inhibitor,https://www.apexbt.com/search.php?catalog=B1589,1
889,B1592,Hexamethonium Bromide,55-97-0,A11,L1021-11,362.19,DMSO,C12H30N2·2Br,C[N+](C)(C)CCCCCC[N+](C)(C)C.[Br-].[Br-],≥36.2 mg/mL in EtOH with gentle warming; ≥36.3 mg/mL in DMSO with gentle warming; ≥36.6 mg/mL in H2O,,Neuroscience,AChR,Selective antagonist of neuronal-type nicotinic AChR,https://www.apexbt.com/search.php?catalog=B1592,1
890,B1593,Irsogladine,57381-26-7,B01,L1021-11,256.09,DMSO,C9H7Cl2N5,C1=CC(=C(C=C1Cl)C2=NC(=NC(=N2)N)N)Cl,insoluble in H2O; insoluble in EtOH; ≥12.80 mg/mL in DMSO,,Metabolism,PDE,PDE4 inhibitor,https://www.apexbt.com/search.php?catalog=B1593,1
891,B1594,Neostigmine Bromide,114-80-7,B02,L1021-11,303.2,DMSO,C12H19N2O2·Br,CN(C)C(=O)OC1=CC=CC(=C1)[N+](C)(C)C.[Br-],≥15.16 mg/mL in H2O; ≥29.2 mg/mL in EtOH; ≥45.3 mg/mL in DMSO,,Neuroscience,AChR,Cholinesterase inhibitor,https://www.apexbt.com/search.php?catalog=B1594,1
892,B1595,Succinylcholine Chloride Dihydrate,6101-15-1,B03,L1021-11,397.34,H2O,C14H30N2O4·2Cl·2H2O,C[N+](C)(C)CCOC(=O)CCC(=O)OCC[N+](C)(C)C.O.O.[Cl-].[Cl-],≥10.48 mg/mL in EtOH with ultrasonic; ≥19.87 mg/mL in H2O; ≥6.1 mg/mL in DMSO with ultrasonic,Chloride,Neuroscience,AChR,Nicotinic AChR agonist,https://www.apexbt.com/search.php?catalog=B1595,1
893,B1596,Acetylcholine Chloride,60-31-1,B04,L1021-11,181.66,DMSO,C7H16NO2·Cl,CC(=O)OCC[N+](C)(C)C.[Cl-],≥49.3 mg/mL in DMSO; ≥9.08 mg/mL in H2O; ≥95.6 mg/mL in EtOH,Chloride,Neuroscience,AChR,Major transmitter at many nervous sites,https://www.apexbt.com/search.php?catalog=B1596,1
894,B1598,Biperiden HCl,1235-82-1,B05,L1021-11,347.92,DMSO,C21H30ClNO,C1CCN(CC1)CCC(C2CC3CC2C=C3)(C4=CC=CC=C4)O.Cl,insoluble in H2O; ≥8.27 mg/mL in EtOH with ultrasonic; ≥8.7 mg/mL in DMSO,,Neuroscience,Muscarinic Receptor,,https://www.apexbt.com/search.php?catalog=B1598,1
895,B1599,Bethanechol chloride,590-63-6,B06,L1021-11,196.68,DMSO,C7H17N2O2·Cl,CC(C[N+](C)(C)C)OC(=O)N.[Cl-],≥20.47 mg/mL in DMSO with ultrasonic; ≥31.53 mg/mL in EtOH; ≥9.83 mg/mL in H2O,,Neuroscience,AChR,Muscarinic receptor agonist,https://www.apexbt.com/search.php?catalog=B1599,1
896,B1600,Darifenacin HBr,133099-07-7,B07,L1021-11,507.48,DMSO,C28H31BrN2O2,C1CN(CC1C(C2=CC=CC=C2)(C3=CC=CC=C3)C(=O)N)CCC4=CC5=C(C=C4)OCC5.Br,insoluble in EtOH; insoluble in H2O; ≥20.2 mg/mL in DMSO,HBr,Neuroscience,Muscarinic Receptor,Selective M3 muscarinic receptor antagonist,https://www.apexbt.com/search.php?catalog=B1600,1
897,B1601,Decamethonium Bromide,541-22-0,B08,L1021-11,418.29,DMSO,C16H38N2·2Br,C[N+](C)(C)CCCCCCCCCC[N+](C)(C)C.[Br-].[Br-],≥116 mg/mL in H2O; ≥20.91 mg/mL in DMSO; ≥36.47 mg/mL in EtOH,Bromide,Neuroscience,AChR,Nicotinic AChR partial agonist,https://www.apexbt.com/search.php?catalog=B1601,1
898,B1602,Donepezil HCl,120011-70-3,B09,L1021-11,415.95,H2O,C24H30ClNO3,COC1=C(C=C2C(=C1)CC(C2=O)CC3CCN(CC3)CC4=CC=CC=C4)OC.Cl,insoluble in EtOH; insoluble in DMSO; ≥10.4 mg/mL in H2O,Hydrochloride,Chromatin/Epigenetics,Histone Acetyltransferases,AChE inhibitor,https://www.apexbt.com/search.php?catalog=B1602,1
899,B1603,Homatropine Bromide,51-56-9,B10,L1021-11,356.25,DMSO,C16H21NO3·HBr,CN1C2CCC1CC(C2)OC(=O)C(C3=CC=CC=C3)O.Br,insoluble in EtOH; ≥17.81 mg/mL in DMSO; ≥47.4 mg/mL in H2O,Bromide,Neuroscience,AChR,Muscarinic AChR antagonist,https://www.apexbt.com/search.php?catalog=B1603,1
900,B1604,Homatropine Methylbromide,80-49-9,B11,L1021-11,370.28,DMSO,C17H24NO3·Br,C[N+]1(C2CCC1CC(C2)OC(=O)C(C3=CC=CC=C3)O)C.[Br-],≥108.2 mg/mL in H2O; ≥17.95 mg/mL in DMSO; ≥23.9 mg/mL in EtOH with ultrasonic,,Neuroscience,AChR,Muscarinic AChR antagonist,https://www.apexbt.com/search.php?catalog=B1604,1
901,B1605,Hyoscyamine,101-31-5,C01,L1021-11,289.37,DMSO,C17H23NO3,CN1C2CCC1CC(C2)OC(=O)C(CO)C3=CC=CC=C3,≥14.47 mg/mL in DMSO; ≥2.58 mg/mL in H2O with gentle warming and ultrasonic; ≥60.2 mg/mL in EtOH,Free Base,Neuroscience,AChR,AChR inhibitor,https://www.apexbt.com/search.php?catalog=B1605,1
902,B1606,Orphenadrine Citrate,4682-36-4,C02,L1021-11,461.5,DMSO,C18H23NO·C6H8O7,CC1=CC=CC=C1C(C2=CC=CC=C2)OCCN(C)C.C(C(=O)O)C(CC(=O)O)(C(=O)O)O,≥23.07 mg/mL in DMSO; ≥2.74 mg/mL in EtOH with gentle warming and ultrasonic; ≥5.74 mg/mL in H2O with ultrasonic,Citrate,Neuroscience,AChR,Antiparkinsonian and analgesic drug,https://www.apexbt.com/search.php?catalog=B1606,1
903,B1607,Otilonium Bromide,26095-59-0,C03,L1021-11,563.57,DMSO,C29H43BrN2O4,CCCCCCCCOC1=CC=CC=C1C(=O)NC2=CC=C(C=C2)C(=O)OCC[N+](C)(CC)CC.[Br-],≥28.18 mg/mL in DMSO; ≥55.8 mg/mL in H2O; ≥91 mg/mL in EtOH,Free Base,Neuroscience,AChR,AChR inhibitor,https://www.apexbt.com/search.php?catalog=B1607,1
904,B1608,Tropicamide,1508-75-4,C04,L1021-11,284.35,DMSO,C17H20N2O2,CCN(CC1=CC=NC=C1)C(=O)C(CO)C2=CC=CC=C2,insoluble in H2O; ≥14.22 mg/mL in DMSO; ≥47.4 mg/mL in EtOH,Free Base,Neuroscience,AChR,Antimuscarinic drug,https://www.apexbt.com/search.php?catalog=B1608,1
905,B1609,Aclidinium Bromide,320345-99-1,C05,L1021-11,564.55,DMSO,C26H30BrNO4S2,C1C[N+]2(CCC1C(C2)OC(=O)C(C3=CC=CS3)(C4=CC=CS4)O)CCCOC5=CC=CC=C5.[Br-],≥28.23 mg/mL in DMSO; insoluble in H2O; insoluble in EtOH,Free Base,Neuroscience,Muscarinic Receptor,LAMAs antagonist,https://www.apexbt.com/search.php?catalog=B1609,1
906,B1610,Gallamine Triethiodide,65-29-2,C06,L1021-11,891.53,DMSO,C30H60I3N3O3,CC[N+](CC)(CC)CCOC1=C(C(=CC=C1)OCC[N+](CC)(CC)CC)OCC[N+](CC)(CC)CC.[I-].[I-].[I-],≥44.58 mg/mL in DMSO; insoluble in EtOH; ≥54.6 mg/mL in H2O,,Neuroscience,AChR,Cholinergic receptor blocker,https://www.apexbt.com/search.php?catalog=B1610,1
907,B1611,Methscopolamine,155-41-9,C07,L1021-11,398.29,DMSO,C18H24BrNO4,C[N+]1(C2CC(CC1C3C2O3)OC(=O)C(CO)C4=CC=CC=C4)C,insoluble in EtOH; ≥19.91 mg/mL in DMSO; ≥59.2 mg/mL in H2O,Bromide,Neuroscience,AChR,Muscarinic acetylcholine receptor blocker,https://www.apexbt.com/search.php?catalog=B1611,0
908,B1612,Pancuronium dibromide,15500-66-0,C08,L1021-11,732.67,DMSO,C35H60N2O4·2Br,CC(=O)OC1CC2CCC3C(C2(CC1[N+]4(CCCCC4)C)C)CCC5(C3CC(C5OC(=O)C)[N+]6(CCCCC6)C)C.[Br-].[Br-],≥36.63 mg/mL in DMSO; ≥49.4 mg/mL in H2O; ≥58.1 mg/mL in EtOH,Bromide,Neuroscience,AChR,AChR antagonist,https://www.apexbt.com/search.php?catalog=B1612,1
909,B1613,Pyridostigmine Bromide,101-26-8,C09,L1021-11,261.12,DMSO,C9H13BrN2O2,C[N+]1=CC=CC(=C1)OC(=O)N(C)C.[Br-],≥13.06 mg/mL in DMSO; ≥40 mg/mL in EtOH; ≥55.4 mg/mL in H2O,Bromide,Neuroscience,AChE,Reversible cholinesterase inhibitor,https://www.apexbt.com/search.php?catalog=B1613,1
910,B1614,Solifenacin succinate,242478-38-2,C10,L1021-11,480.55,DMSO,C27H32N2O6,C1CN2CCC1C(C2)OC(=O)N3CCC4=CC=CC=C4C3C5=CC=CC=C5.C(CC(=O)O)C(=O)O,≥24.05 mg/mL in DMSO; ≥23.6 mg/mL in EtOH with ultrasonic; ≥53.6 mg/mL in H2O,Succinate,Neuroscience,Muscarinic Receptor,Muscarinic receptor antagonist,https://www.apexbt.com/search.php?catalog=B1614,1
911,B1616,Trospium chloride,10405-02-4,C11,L1021-11,427.96,DMSO,C25H30NO3·Cl,C1CC[N+]2(C1)C3CCC2CC(C3)OC(=O)C(C4=CC=CC=C4)(C5=CC=CC=C5)O.[Cl-],≥21.4 mg/mL in DMSO; ≥27.65 mg/mL in EtOH with ultrasonic; ≥29.25 mg/mL in H2O,Chloride,Neuroscience,AChR,Antimuscarinic agent,https://www.apexbt.com/search.php?catalog=B1616,1
912,B1619,Tiotropium Bromide hydrate,139404-48-1,D01,L1021-11,490.43,DMSO,C19H22NO4S2·Br·xH2O,C[N+]1(C2CC(CC1C3C2O3)OC(=O)C(C4=CC=CS4)(C5=CC=CS5)O)C.O.[Br-],≥18.87 mg/mL in H2O with ultrasonic; ≥3.74 mg/mL in EtOH with ultrasonic; ≥64.7 mg/mL in DMSO,,Neuroscience,AChR,Muscarinic antagonist,https://www.apexbt.com/search.php?catalog=B1619,0
913,B1620,Tolterodine tartrate,124937-52-6,D02,L1021-11,475.57,DMSO,C26H37NO7,CC1=CC(=C(C=C1)O)C(CCN(C(C)C)C(C)C)C2=CC=CC=C2.C(C(C(=O)O)O)(C(=O)O)O,≥23.78 mg/mL in DMSO; insoluble in H2O; insoluble in EtOH,Tartrate,Neuroscience,Muscarinic Receptor,Competitive muscarinic receptor antagonist,https://www.apexbt.com/search.php?catalog=B1620,1
914,B1623,Ifenprodil Tartrate,23210-58-4,D03,L1021-11,475.53,DMSO,C21H27NO2·1/2C4H6O6,CC(C(C1=CC=C(C=C1)O)O)N2CCC(CC2)CC3=CC=CC=C3.C(C(C(=O)O)O)(C(=O)O)O,≥23.78 mg/mL in DMSO; insoluble in H2O; ≥42.5 mg/mL in EtOH,,Neuroscience,GluR,NMDA receptor antagonist,https://www.apexbt.com/search.php?catalog=B1623,1
915,B1628,MPEP,96206-92-7,D04,L1021-11,193.24,DMSO,C14H11N,CC1=CC=CC(=N1)C#CC2=CC=CC=C2,insoluble in H2O; ≥9.95 mg/mL in DMSO; ≥95 mg/mL in EtOH,,GPCR/G protein,mGluR,,https://www.apexbt.com/search.php?catalog=B1628,1
916,B1634,Fosbretabulin (Combretastatin A4 Phosphate (CA4P)) Disodium,168555-66-6,D05,L1021-11,440.29,H2O,C18H19Na2O8P,COC1=C(C=C(C=C1)C=CC2=CC(=C(C(=C2)OC)OC)OC)OP(=O)([O-])[O-].[Na+].[Na+],insoluble in H2O; insoluble in EtOH; ≥11.7 mg/mL in DMSO,Phosphate,Cell Cycle/Checkpoint,Microtubule/Tubulin,"microtubule destabilizing drug, water-soluble",https://www.apexbt.com/search.php?catalog=B1634,1
917,B1639,"Ridaforolimus (Deforolimus, MK-8669)",572924-54-0,D06,L1021-11,990.21,DMSO,C53H84NO14P,O=P(C)(C)O[C@H]1[C@H](OC)C[C@H](C[C@@H](C)[C@@H](OC([C@@H]2CCCCN2C(C([C@]3([C@@H](CC[C@@H](C[C@H](OC)/C(C)=C/C=C/C=C/[C@@H](C)C[C@@H](C)C([C@H](OC)[C@@H]4O)=O)O3)C)O)=O)=O)=O)CC([C@H](C)/C=C4\C)=O)CC1,≥49.5 mg/mL in DMSO; insoluble in EtOH; insoluble in H2O,,PI3K/Akt/mTOR Signaling,mTOR,,https://www.apexbt.com/search.php?catalog=B1639,0
918,B1643,Sodium 4-Aminosalicylate,6018-19-5,D07,L1021-11,211.15,DMSO,C7H7NO3·2H2O·Na,C1=CC(=C(C=C1N)O)C(=O)[O-].O.O.[Na+],≥10.65 mg/mL in DMSO; ≥130 mg/mL in H2O; ≥7.85 mg/mL in EtOH with ultrasonic,Sodium,Immunology/Inflammation,NF-κB,NF-κB inhibitor,https://www.apexbt.com/search.php?catalog=B1643,1
919,B1648,Naltrexone HCl,16676-29-2,D08,L1021-11,377.86,DMSO,C20H24ClNO4,O=C1[C@H]2[C@]3([C@@](O)(CC1)[C@H]4CC5=CC=C(C(O2)=C53)O)CCN4CC6CC6.Cl,14mg/mL(37.05 mM) in DMSO;14mg/mL(37.05 mM) in H2O;Insoluble in Ethanol,,Endocrinology and Hormones,Opioid Receptor,Opioid receptors antagonist,https://www.apexbt.com/search.php?catalog=B1648,1
920,B1649,Racecadotril,81110-73-8,D09,L1021-11,385.48,DMSO,C21H23NO4S,CC(=O)SCC(CC1=CC=CC=C1)C(=O)NCC(=O)OCC2=CC=CC=C2,insoluble in H2O; ≥103 mg/mL in DMSO; ≥18.45 mg/mL in EtOH,Free Base,Others,Endopeptidase,Potent enkephalinase inhibitor,https://www.apexbt.com/search.php?catalog=B1649,1
921,B1650,Trimebutine,39133-31-8,D10,L1021-11,387.47,DMSO,C22H29NO5,CCC(COC(=O)C1=CC(=C(C(=C1)OC)OC)OC)(C2=CC=CC=C2)N(C)C,insoluble in H2O; ≥16.2 mg/mL in DMSO; ≥26.65 mg/mL in EtOH,Free Base,Endocrinology and Hormones,Opioid Receptor,Antimuscarinic,https://www.apexbt.com/search.php?catalog=B1650,1
922,B1651,1-Hexadecanol,36653-82-4,D11,L1021-11,242.44,DMSO,C16H34O,CCCCCCCCCCCCCCCCO,insoluble in H2O; ≥10.75 mg/mL in DMSO; ≥12.5 mg/mL in EtOH with ultrasonic,Free Base,Others,Others,Fatty alcohol,https://www.apexbt.com/search.php?catalog=B1651,1
923,B1655,Alverine Citrate,5560-59-8,E01,L1021-11,473.56,DMSO,C20H27N·C6H8O7,CCN(CCCC1=CC=CC=C1)CCCC2=CC=CC=C2.C(C(=O)O)C(CC(=O)O)(C(=O)O)O,≥23.68 mg/mL in DMSO; ≥2.71 mg/mL in H2O with ultrasonic; ≥2.76 mg/mL in EtOH with ultrasonic,Citrate,GPCR/G protein,OX Receptor,Drug used for functional gastrointestinal disorders,https://www.apexbt.com/search.php?catalog=B1655,1
924,B1656,Amfenac Sodium Monohydrate,61618-27-7,E02,L1021-11,295.27,DMSO,C15H12NO3·H2O·Na,C1=CC=C(C=C1)C(=O)C2=C(C(=CC=C2)CC(=O)[O-])N.O.[Na+],≥10.16 mg/mL in EtOH with ultrasonic; ≥12.65 mg/mL in DMSO; ≥26.15 mg/mL in H2O,Free Base,Neuroscience,COX,COX inhibitor,https://www.apexbt.com/search.php?catalog=B1656,1
925,B1658,Amikacin disulfate,39831-55-5,E03,L1021-11,781.76,H2O,C22H43N5O13·2H2O4S,C1C(C(C(C(C1NC(=O)C(CCN)O)OC2C(C(C(C(O2)CO)O)N)O)O)OC3C(C(C(C(O3)CN)O)O)O)N.OS(=O)(=O)O.OS(=O)(=O)O,insoluble in DMSO; insoluble in EtOH; ≥17.37 mg/mL in H2O,,Microbiology & Virology,Anti-infection,Semisynthetic aminoglycoside antibiotic,https://www.apexbt.com/search.php?catalog=B1658,1
926,B1659,Aminothiazole,96-50-4,E04,L1021-11,100.14,DMSO,C3H4N2S,C1=CSC(=N1)N,≥2.21 mg/mL in H2O with ultrasonic; ≥4.55 mg/mL in DMSO; ≥59.1 mg/mL in EtOH,Free Base,Microbiology & Virology,Anti-infection,Thyroid inhibitor,https://www.apexbt.com/search.php?catalog=B1659,1
927,B1660,Amoxapine,14028-44-5,E05,L1021-11,313.78,DMSO,C17H16ClN3O,C1CN(CCN1)C2=NC3=CC=CC=C3OC4=C2C=C(C=C4)Cl,insoluble in H2O; ≥14.2 mg/mL in DMSO with gentle warming; ≥3.26 mg/mL in EtOH with gentle warming and ultrasonic,,Neuroscience,GlyT,GLYT2a transport activity inhibitor,https://www.apexbt.com/search.php?catalog=B1660,1
928,B1661,Amoxicillin,26787-78-0,E06,L1021-11,365.4,DMSO,C16H19N3O5S,CC1(C(N2C(S1)C(C2=O)NC(=O)C(C3=CC=C(C=C3)O)N)C(=O)O)C,insoluble in H2O; insoluble in EtOH; ≥14.3 mg/mL in DMSO,Free Base,Microbiology & Virology,Anti-infection,"Moderate-spectrum, bacteriolytic, β-lactam antibiotic",https://www.apexbt.com/search.php?catalog=B1661,1
929,B1662,Ampicillin Trihydrate,7177-48-2,E07,L1021-11,403.45,DMSO,C16H19N3O4S·3H2O,CC1(C(N2C(S1)C(C2=O)NC(=O)C(C3=CC=CC=C3)N)C(=O)O)C.O.O.O,insoluble in EtOH; ≥16.7 mg/mL in DMSO; ≥2.39 mg/mL in H2O with ultrasonic,Free Base,Microbiology & Virology,Anti-infection,β-lactam antibiotic,https://www.apexbt.com/search.php?catalog=B1662,1
930,B1663,Amprolium HCl,137-88-2,E08,L1021-11,315.24,H2O,C14H19N4·HCl·Cl,CCCC1=NC=C(C(=N1)N)C[N+]2=CC=CC=C2C.Cl.[Cl-],insoluble in DMSO; ≥14.25 mg/mL in H2O; ≥2.52 mg/mL in EtOH with ultrasonic,Hydrochloride,Metabolism,Vitamin,Thiamin antagonist/coccidiostat,https://www.apexbt.com/search.php?catalog=B1663,1
931,B1664,Antazoline HCl,2508-72-7,E09,L1021-11,301.81,DMSO,C17H19N3·HCl,C1CN=C(N1)CN(CC2=CC=CC=C2)C3=CC=CC=C3.Cl,≥10.6 mg/mL in H2O; ≥13.4 mg/mL in DMSO; ≥2.69 mg/mL in EtOH with ultrasonic,Hydrochloride,Neuroscience,Histamine Receptor,Histamine receptor inhibitor,https://www.apexbt.com/search.php?catalog=B1664,1
932,B1665,Apramycin Sulfate,65710-07-8,E10,L1021-11,637.66,H2O,C21H41N5O11·xH2O4S,CNC1C(C2C(CC(C(O2)OC3C(CC(C(C3O)O)N)N)N)OC1OC4C(C(C(C(O4)CO)N)O)O)O.OS(=O)(=O)O,insoluble in EtOH; insoluble in DMSO; ≥64.2 mg/mL in H2O,,Microbiology & Virology,Anti-infection,Aminoglycoside antibiotic,https://www.apexbt.com/search.php?catalog=B1665,1
933,B1666,Atracurium Besylate,64228-81-5,E11,L1021-11,1243.48,DMSO,C53H72N2O12·2(C6H5O3S),C[N+]1(CCC2=CC(=C(C=C2C1CC3=CC(=C(C=C3)OC)OC)OC)OC)CCC(=O)OCCCCCOC(=O)CC[N+]4(CCC5=CC(=C(C=C5C4CC6=CC(=C(C=C6)OC)OC)OC)OC)C.C1=CC=C(C=C1)S(=O)(=O)[O-].C1=CC=C(C=C1)S(=O)(=O)[O-],≥62.17 mg/mL in DMSO; ≥113.8 mg/mL in EtOH; ≥49.7 mg/mL in H2O,,Neuroscience,AChR,Neuromuscular blocking agent,https://www.apexbt.com/search.php?catalog=B1666,1
934,B1667,Azaguanine-8,134-58-7,F01,L1021-11,152.11,DMSO,C4H4N6O,C12=NNNC1=NC(=NC2=O)N,insoluble in H2O; insoluble in EtOH; ≥3.93 mg/mL in DMSO,Free Base,Others,Others,Purine analogs,https://www.apexbt.com/search.php?catalog=B1667,1
935,B1668,Azaperone,1649-18-9,F02,L1021-11,327.4,DMSO,C19H22FN3O,C1CN(CCN1CCCC(=O)C2=CC=C(C=C2)F)C3=CC=CC=N3,insoluble in H2O; ≥10.88 mg/mL in EtOH with ultrasonic; ≥12.75 mg/mL in DMSO,Free Base,Neuroscience,Dopamine Receptor,Dopamine antagonist,https://www.apexbt.com/search.php?catalog=B1668,1
936,B1669,Azithromycin Dihydrate,117772-70-0,F03,L1021-11,785.02,DMSO,C38H72N2O12·2H2O,CCC1C(C(C(N(CC(CC(C(C(C(C(C(=O)O1)C)OC2CC(C(C(O2)C)O)(C)OC)C)OC3C(C(CC(O3)C)N(C)C)O)(C)O)C)C)C)O)(C)O.O.O,≥25.85 mg/mL in DMSO; insoluble in H2O; ≥48.6 mg/mL in EtOH,Free Base,Microbiology & Virology,Anti-infection,Macrolide antibiotic,https://www.apexbt.com/search.php?catalog=B1669,1
937,B1670,Bacitracin,1405-87-4,F04,L1021-11,1408.67,DMSO,C65H101N17O16S,CCC(C)C1C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NCCCCC(C(=O)NC(C(=O)N1)CCCN)NC(=O)C(C(C)C)NC(=O)C(CCC(=O)O)NC(=O)C(CC(C)C)NC(=O)C2CSC(=N2)C(C(C)CC)N)CC(=O)N)CC(=O)O)CC3=CN=CN3)CC4=CC=CC=C4,≥2.58 mg/mL in EtOH with ultrasonic; ≥228.9 mg/mL in H2O; ≥26.45 mg/mL in DMSO,,Microbiology & Virology,Anti-infection,Peptide antibiotic,https://www.apexbt.com/search.php?catalog=B1670,1
938,B1671,Bacitracin Zinc,1405-89-6,F05,L1021-11,1486.06,DMSO,C66H101N17O16SZn,CCC(C)C1C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NCCCCC(C(=O)NC(C(=O)N1)CCCN)NC(=O)C(C(C)CC)NC(=O)C(CCC(=O)O)NC(=O)C(CC(C)C)NC(=O)C2CSC(=N2)C(C(C)CC)N)CC(=O)N)CC(=O)O)CC3C=NC=N3)CC4=CC=CC=C4.[Zn],≥49.53 mg/mL in DMSO with gentle warming; insoluble in EtOH; insoluble in H2O,,Microbiology & Virology,Antibiotic,,https://www.apexbt.com/search.php?catalog=B1671,1
939,B1672,Bemegride,64-65-3,F06,L1021-11,155.19,DMSO,C8H13NO2,CCC1(CC(=O)NC(=O)C1)C,≥10.66 mg/mL in EtOH with ultrasonic; ≥2.48 mg/mL in H2O with ultrasonic; ≥7.76 mg/mL in DMSO,Free Base,Neuroscience,GABA Receptor,GABA receptor antagonist,https://www.apexbt.com/search.php?catalog=B1672,1
940,B1673,Benzbromarone,3562-84-3,F07,L1021-11,424.08,DMSO,C17H12Br2O3,CCC1=C(C2=CC=CC=C2O1)C(=O)C3=CC(=C(C(=C3)Br)O)Br,insoluble in H2O; ≥19.55 mg/mL in DMSO; ≥6.13 mg/mL in EtOH,Free Base,Metabolism,P450,TMEM16A/B calcium-activated chloride channel (CaCC) blocker,https://www.apexbt.com/search.php?catalog=B1673,1
941,B1674,Benzethonium Chloride,121-54-0,F08,L1021-11,448.08,DMSO,C27H42NO2·Cl,CC(C)(C)CC(C)(C)C1=CC=C(C=C1)OCCOCC[N+](C)(C)CC2=CC=CC=C2.[Cl-],≥22.4 mg/mL in DMSO; ≥30.15 mg/mL in H2O; ≥55.3 mg/mL in EtOH,Chloride,Neuroscience,AChR,Potent inhibitor of nAChRs,https://www.apexbt.com/search.php?catalog=B1674,1
942,B1675,Benzocaine,94-09-7,F09,L1021-11,165.19,DMSO,C9H11NO2,CCOC(=O)C1=CC=C(C=C1)N,insoluble in H2O; ≥5.05 mg/mL in DMSO; ≥56.8 mg/mL in EtOH,Free Base,Membrane Transporter/Ion Channel,Sodium Channel,Sodium channel inhibitor,https://www.apexbt.com/search.php?catalog=B1675,1
943,B1676,Benzoic Acid,65-85-0,F10,L1021-11,122.12,DMSO,C7H6O2,C1=CC=C(C=C1)C(=O)O,insoluble in H2O; ≥4.45 mg/mL in DMSO; ≥55 mg/mL in EtOH,Free Base,Others,Others,Organic aromatic monocarboxylic acid,https://www.apexbt.com/search.php?catalog=B1676,1
944,B1677,Benzydamine HCl,132-69-4,F11,L1021-11,345.87,DMSO,C19H23N3O·HCl,CN(C)CCCOC1=NN(C2=CC=CC=C21)CC3=CC=CC=C3.Cl,≥17.05 mg/mL in DMSO; ≥28.2 mg/mL in EtOH; ≥54.6 mg/mL in H2O,Hydrochloride,Immunology/Inflammation,PGE synthase,Topical nonsteroidal anti-inflammatory drug (NSAID),https://www.apexbt.com/search.php?catalog=B1677,1
945,B1678,Penicillin G Sodium,69-57-8,G01,L1021-11,356.37,DMSO,C16H18N2O4S·Na,CC1(C(N2C(S1)C(C2=O)NC(=O)CC3=CC=CC=C3)C(=O)[O-])C.[Na+],insoluble in EtOH; ≥13.7 mg/mL in DMSO; ≥58.7 mg/mL in H2O,Sodium,Microbiology & Virology,Anti-infection,penicillin antibiotic,https://www.apexbt.com/search.php?catalog=B1678,1
946,B1679,Betamipron,3440-28-6,G02,L1021-11,193.2,DMSO,C10H11NO3,C1=CC=C(C=C1)C(=O)NCCC(=O)O,insoluble in H2O; ≥30.2 mg/mL in EtOH; ≥5.65 mg/mL in DMSO,Free Base,Microbiology & Virology,Anti-infection,Parenteral carbapenem antibiotic,https://www.apexbt.com/search.php?catalog=B1679,1
947,B1680,Bezafibrate,41859-67-0,G03,L1021-11,361.82,DMSO,C19H20ClNO4,CC(C)(C(=O)O)OC1=CC=C(C=C1)CCNC(=O)C2=CC=C(C=C2)Cl,insoluble in H2O; ≥15 mg/mL in EtOH with ultrasonic; ≥17.25 mg/mL in DMSO,Free Base,Metabolism,PPAR,Lipid-lowering agent,https://www.apexbt.com/search.php?catalog=B1680,1
948,B1682,Bosentan,147536-97-8,G04,L1021-11,551.63,DMSO,C27H29N5O6S,CC(C)(C)C1=CC=C(C=C1)S(=O)(=O)NC2=C(C(=NC(=N2)C3=NC=CC=N3)OCCO)OC4=CC=CC=C4OC,≥26.45 mg/mL in DMSO; insoluble in H2O; ≥14.87 mg/mL in EtOH with ultrasonic,Free Base,GPCR/G protein,Endothelin Receptor,Endothelin receptor antagonist,https://www.apexbt.com/search.php?catalog=B1682,1
949,B1683,Brimonidine Tartrate,70359-46-5,G05,L1021-11,442.22,DMSO,C15H16BrN5O6,C1CN=C(N1)NC2=C(C3=NC=CN=C3C=C2)Br.C(C(C(=O)O)O)(C(=O)O)O,≥22.11 mg/mL in DMSO; insoluble in EtOH; ≥10.14 mg/mL in H2O with ultrasonic,Tartrate,GPCR/G protein,Adrenergic Receptor,Highly selective α-adrenergic receptor agonist,https://www.apexbt.com/search.php?catalog=B1683,1
950,B1684,Bromfenac Sodium,91714-93-1,G06,L1021-11,356.15,DMSO,C15H11BrNO3·Na,C1=CC(=C(C(=C1)CC(=O)[O-])N)C(=O)C2=CC=C(C=C2)Br.[Na+],insoluble in EtOH; ≥14.7 mg/mL in DMSO; ≥26.85 mg/mL in H2O,Sodium,Neuroscience,COX,COX inhibitor,https://www.apexbt.com/search.php?catalog=B1684,1
951,B1685,Broxyquinoline,521-74-4,G07,L1021-11,302.95,DMSO,C9H5Br2NO,C1=CC2=C(C(=C(C=C2Br)Br)O)N=C1,insoluble in H2O; insoluble in EtOH; ≥9.75 mg/mL in DMSO,Free Base,Microbiology & Virology,Anti-infection,Antiprotozoal agent,https://www.apexbt.com/search.php?catalog=B1685,1
952,B1687,Buspirone HCl,33386-08-2,G08,L1021-11,421.96,DMSO,C21H31N5O2·HCl,C1CCC2(C1)CC(=O)N(C(=O)C2)CCCCN3CCN(CC3)C4=NC=CC=N4.Cl,≥19.55 mg/mL in DMSO; ≥27.65 mg/mL in H2O; ≥8.37 mg/mL in EtOH with ultrasonic,Hydrochloride,Neuroscience,5-HT Receptor,Classic 5-HT1A partial agonist,https://www.apexbt.com/search.php?catalog=B1687,1
953,B1689,Capreomycin Sulfate,1405-37-4,G09,L1021-11,652.71,H2O,C25H44N14O7,O=C([C@H](C)NC([C@@H](N)CNC1=O)=O)N[C@@H](CNC(C[C@H](CCCN)N)=O)C(N/C(C(N[C@H]1[C@H]2N=C(N)NCC2)=O)=C/NC(N)=O)=O,insoluble in EtOH; insoluble in DMSO; ≥251.8 mg/mL in H2O,,Microbiology & Virology,Anti-infection,Cyclic peptide antibiotic,https://www.apexbt.com/search.php?catalog=B1689,0
954,B1690,Carprofen,53716-49-7,G10,L1021-11,273.71,DMSO,C15 H12ClNO2,CC(C1=CC2=C(C=C1)C3=C(N2)C=CC(=C3)Cl)C(=O)O,insoluble in H2O; ≥11.05 mg/mL in DMSO; ≥19.17 mg/mL in EtOH,Free Base,Neuroscience,COX,COX inhibitor,https://www.apexbt.com/search.php?catalog=B1690,1
955,B1691,Ceftriaxone Sodium Trihydrate,104376-79-6,G11,L1021-11,663.61,DMSO,C18H16N8O7S3·7/2H2O·2Na,OC(C1=C(CSC(N2C)=NC(C(N2)=O)=O)CS[C@](N1C3=O)([H])[C@@H]3NC(/C(C4=CSC(N)=N4)=N\OC)=O)=O.[Na+].[Na+],≥26.3 mg/mL in DMSO with gentle warming; insoluble in EtOH; ≥48.4 mg/mL in H2O,Sodium,Microbiology & Virology,Anti-infection,Third-generation cephalosporin antibiotic,https://www.apexbt.com/search.php?catalog=B1691,0
956,B1692,Cephalexin,15686-71-2,H01,L1021-11,347.39,H2O,C16H17N3O4S,CC1=C(N2C(C(C2=O)NC(=O)C(C3=CC=CC=C3)N)SC1)C(=O)O,insoluble in DMSO; insoluble in EtOH; ≥8.7 mg/mL in H2O,Free Base,Microbiology & Virology,Antibiotic,Antibiotic,https://www.apexbt.com/search.php?catalog=B1692,1
957,B1693,Cetrimonium Bromide (CTAB),57-09-0,H02,L1021-11,364.45,DMSO,C19H42N·Br,CCCCCCCCCCCCCCCC[N+](C)(C)C.[Br-],≥112.6 mg/mL in EtOH; ≥5.33 mg/mL in DMSO; ≥54.3 mg/mL in H2O,Free Base,Microbiology & Virology,Anti-infection,Component of the broad-spectrum antiseptic cetrimide,https://www.apexbt.com/search.php?catalog=B1693,1
958,B1694,Cetylpyridinium Chloride,123-03-5,H03,L1021-11,339.99,DMSO,C21H38N·Cl,CCCCCCCCCCCCCCCC[N+]1=CC=CC=C1.[Cl-],≥117.8 mg/mL in H2O; ≥123.8 mg/mL in EtOH; ≥16.1 mg/mL in DMSO,Chloride,Microbiology & Virology,Anti-infection,Cationic quaternary ammonium compound used as oropharyngeal antiseptic.,https://www.apexbt.com/search.php?catalog=B1694,1
959,B1695,Chlorhexidine HCl,3697-42-5,H04,L1021-11,578.37,DMSO,C22H30Cl2N10·2HCl,C1=CC(=CC=C1NC(=NC(=NCCCCCCN=C(N)N=C(N)NC2=CC=C(C=C2)Cl)N)N)Cl.Cl.Cl,≥24 mg/mL in DMSO with gentle warming; insoluble in H2O; insoluble in EtOH,,Microbiology & Virology,Anti-infection,Antiseptic,https://www.apexbt.com/search.php?catalog=B1695,1
960,B1696,Chlorocresol,59-50-7,H05,L1021-11,142.58,DMSO,C7H7ClO,CC1=C(C=CC(=C1)O)Cl,insoluble in H2O; ≥5.3 mg/mL in DMSO; ≥50.4 mg/mL in EtOH,Free Base,Membrane Transporter/Ion Channel,Calcium Channel,Activator of ryanodine receptor,https://www.apexbt.com/search.php?catalog=B1696,1
961,B1697,Chlorpropamide,94-20-2,H06,L1021-11,276.74,DMSO,C10H13ClN2O3S,CCCNC(=O)NS(=O)(=O)C1=CC=C(C=C1)Cl,insoluble in H2O; ≥14 mg/mL in DMSO; ≥27.5 mg/mL in EtOH,Free Base,Others,Others,Oral antihyperglycemic agent,https://www.apexbt.com/search.php?catalog=B1697,1
962,B1698,Chlorquinaldol,72-80-0,H07,L1021-11,228.07,DMSO,C10H7Cl2NO,CC1=NC2=C(C=C1)C(=CC(=C2O)Cl)Cl,insoluble in H2O; ≥10.55 mg/mL in DMSO; ≥5.57 mg/mL in EtOH with ultrasonic,Free Base,Microbiology & Virology,Anti-infection,Antifungal and antibacterial,https://www.apexbt.com/search.php?catalog=B1698,1
963,B1699,Chlortetracycline HCl,64-72-2,H08,L1021-11,515.34,DMSO,C22H23ClN2O8·HCl,CC1(C2CC3C(C(=O)C(=C(C3(C(=O)C2=C(C4=C(C=CC(=C41)Cl)O)O)O)O)C(=O)N)N(C)C)O.Cl,insoluble in EtOH; ≥12.88 mg/mL in H2O with gentle warming and ultrasonic; ≥25.8 mg/mL in DMSO with gentle warming,,Microbiology & Virology,Anti-infection,Tetracycline antibiotic,https://www.apexbt.com/search.php?catalog=B1699,1
964,B1701,Chlorzoxazone,95-25-0,H09,L1021-11,169.57,DMSO,C7H4ClNO2,C1=CC2=C(C=C1Cl)NC(=O)O2,insoluble in H2O; ≥24.8 mg/mL in EtOH; ≥7.9 mg/mL in DMSO,Free Base,Metabolism,P450,Muscle-relaxing drug,https://www.apexbt.com/search.php?catalog=B1701,1
965,B1703,Choline Chloride,67-48-1,H10,L1021-11,139.62,DMSO,C5H14NO·Cl,C[N+](C)(C)CCO.[Cl-],≥112 mg/mL in H2O; ≥6.3 mg/mL in DMSO; ≥65.7 mg/mL in EtOH,Chloride,Neuroscience,AChR,Quaternary ammonium salt,https://www.apexbt.com/search.php?catalog=B1703,1
966,B1704,Chromocarb,4940-39-0,H11,L1021-11,190.15,DMSO,C10H6O4,C1=CC=C2C(=C1)C(=O)C=C(O2)C(=O)O,insoluble in H2O; insoluble in EtOH; ≥7.55 mg/mL in DMSO,Free Base,Others,Others,Vasoprotectant,https://www.apexbt.com/search.php?catalog=B1704,1
967,B1705,Cinchophen,132-60-5,A01,L1021-12,249.26,DMSO,C16H11NO2,C1=CC=C(C=C1)C2=NC3=CC=CC=C3C(=C2)C(=O)O,insoluble in H2O; ≥2.5 mg/mL in EtOH with ultrasonic; ≥6.65 mg/mL in DMSO,Free Base,Others,Others,Analgesic drug,https://www.apexbt.com/search.php?catalog=B1705,1
968,B1706,Climbazole,38083-17-9,A02,L1021-12,292.76,DMSO,C15H17ClN2O2,CC(C)(C)C(=O)C(N1C=CN=C1)OC2=CC=C(C=C2)Cl,insoluble in H2O; ≥13.25 mg/mL in DMSO; ≥59.9 mg/mL in EtOH,Free Base,Microbiology & Virology,Anti-infection,Broad-spectrum imidazole antifungal agent,https://www.apexbt.com/search.php?catalog=B1706,1
969,B1707,Clindamycin,18323-44-9,A03,L1021-12,424.98,DMSO,C18H33ClN2O5S,CCCC1CC(N(C1)C)C(=O)NC(C2C(C(C(C(O2)SC)O)O)O)C(C)Cl,insoluble in EtOH; ≥15.3 mg/mL in DMSO; ≥50.6 mg/mL in H2O,Free Base,Others,Others,Antibiotic,https://www.apexbt.com/search.php?catalog=B1707,1
970,B1708,Clindamycin Phosphate,24729-96-2,A04,L1021-12,504.96,H2O,C18H34ClN2O8PS,CCCC1CC(N(C1)C)C(=O)NC(C2C(C(C(C(O2)SC)OP(=O)(O)O)O)O)C(C)Cl,≥21.7 mg/mL in H2O; insoluble in EtOH; insoluble in DMSO,Phosphate,Microbiology & Virology,Anti-infection,Lincosamide antibiotic,https://www.apexbt.com/search.php?catalog=B1708,1
971,B1709,Clodronate Disodium,22560-50-5,A05,L1021-12,288.86,H2O,CH2Cl2Na2O6P2,O=P(O)([O-])C(Cl)(Cl)P(O)([O-])=O.[Na+].[Na+],≥28.9 mg/mL in H2O; insoluble in DMSO; insoluble in EtOH,,Others,Others,,https://www.apexbt.com/search.php?catalog=B1709,1
972,B1710,Clofazimine,2030-63-9,A06,L1021-12,473.4,DMSO,C27H22Cl2N4,CC(C)N=C1C=C2C(=NC3=CC=CC=C3N2C4=CC=C(C=C4)Cl)C=C1NC5=CC=C(C=C5)Cl,insoluble in H2O; insoluble in EtOH; ≥7 mg/mL in DMSO with gentle warming,Free Base,Metabolism,Phospholipase,Tuberculosis drug,https://www.apexbt.com/search.php?catalog=B1710,1
973,B1711,Clofibric Acid,882-09-7,A07,L1021-12,214.65,DMSO,C10H11ClO3,CC(C)(C(=O)O)OC1=CC=C(C=C1)Cl,insoluble in H2O; ≥123.2 mg/mL in EtOH; ≥9.35 mg/mL in DMSO,Free Base,Metabolism,PPAR,PPAR agonist,https://www.apexbt.com/search.php?catalog=B1711,1
974,B1713,Clorprenaline HCL,6933-90-0,A08,L1021-12,250.16,DMSO,C11H16ClNO·HCl,CC(C)NCC(C1=CC=CC=C1Cl)O.Cl,≥46.8 mg/mL in H2O; ≥47.8 mg/mL in EtOH; ≥8.35 mg/mL in DMSO,Hydrochloride,GPCR/G protein,Adrenergic Receptor,Adrenergic receptor agonist,https://www.apexbt.com/search.php?catalog=B1713,1
975,B1714,Closantel,57808-65-8,A09,L1021-12,663.07,DMSO,C22H14Cl2I2N2O2,CC1=CC(=C(C=C1NC(=O)C2=CC(=CC(=C2O)I)I)Cl)C(C#N)C3=CC=C(C=C3)Cl,≥29.9 mg/mL in DMSO; insoluble in EtOH; insoluble in H2O,Free Base,Microbiology & Virology,Anti-infection,Gram positive antibacterial activity inhibitor,https://www.apexbt.com/search.php?catalog=B1714,1
976,B1715,Closantel Sodium,61438-64-0,A10,L1021-12,685.06,DMSO,C22 H13 Cl2I2N2O2·Na,CC1=CC(=C(C=C1NC(=O)C2=CC(=CC(=C2[O-])I)I)Cl)C(C#N)C3=CC=C(C=C3)Cl.[Na+],≥33.95 mg/mL in DMSO; insoluble in H2O; ≥124.6 mg/mL in EtOH,Free Base,Microbiology & Virology,Anti-infection,Gram positive antibacterial activity inhibitor,https://www.apexbt.com/search.php?catalog=B1715,1
977,B1716,Colistin Sulfate,1264-72-8,A11,L1021-12,1253.51,H2O,H2O4S.xUnspecified,[O-]S(=O)(=O)[O-],≥42.47 mg/mL in H2O with gentle warming; insoluble in DMSO; insoluble in EtOH,,Microbiology & Virology,Anti-infection,Cationic polypeptide antibiotic,https://www.apexbt.com/search.php?catalog=B1716,0
978,B1717,Creatinine,60-27-5,B01,L1021-12,113.12,H2O,C4H7N3O,CN1CC(=O)N=C1N,insoluble in EtOH; ≥11.3 mg/mL in H2O; ≥2.5 mg/mL in DMSO with gentle warming and ultrasonic,,Others,Others,,https://www.apexbt.com/search.php?catalog=B1717,1
979,B1718,Cyclandelate,456-59-7,B02,L1021-12,276.37,DMSO,C17H24O3,CC1CC(CC(C1)(C)C)OC(=O)C(C2=CC=CC=C2)O,≥12.35 mg/mL in DMSO; ≥2.61 mg/mL in H2O with gentle warming and ultrasonic; ≥52.2 mg/mL in EtOH,Free Base,Others,Others,Inhibitor of rat hepatic acycloenzyme A,https://www.apexbt.com/search.php?catalog=B1718,1
980,B1719,Cysteamine HCl,156-57-0,B03,L1021-12,113.61,DMSO,C2H7NS·HCl,C(CS)N.Cl,≥24.35 mg/mL in EtOH; ≥52.1 mg/mL in H2O; ≥7.05 mg/mL in DMSO,Hydrochloride,Others,Others,Drug used to treat cystinosis,https://www.apexbt.com/search.php?catalog=B1719,1
981,B1721,D-Cycloserine,68-41-7,B04,L1021-12,102.09,H2O,C3H6N2O2,C1C(C(=O)NO1)N,insoluble in DMSO; insoluble in EtOH; ≥51 mg/mL in H2O,,Microbiology & Virology,Anti-infection,NMDA receptor (NMDAR) partial agonist,https://www.apexbt.com/search.php?catalog=B1721,1
982,B1723,Deferiprone,30652-11-0,B05,L1021-12,139.15,H2O,C7H9NO2,CC1=C(C(=O)C=CN1C)O,insoluble in DMSO; insoluble in EtOH; ≥10.96 mg/mL in H2O,,Others,Others,Chelating agent,https://www.apexbt.com/search.php?catalog=B1723,1
983,B1724,Deoxycorticosterone acetate,56-47-3,B06,L1021-12,372.5,DMSO,C23H32O4,CC(=O)OCC(=O)C1CCC2C1(CCC3C2CCC4=CC(=O)CCC34C)C,insoluble in H2O; insoluble in EtOH; ≥16.4 mg/mL in DMSO,Free Base,GPCR/G protein,Adrenergic Receptor,Steroid hormone,https://www.apexbt.com/search.php?catalog=B1724,1
984,B1725,Dexlansoprazole,138530-94-6,B07,L1021-12,369.36,DMSO,C16H14F3N3O2S,CC1=C(C=CN=C1CS(=O)C2=NC3=CC=CC=C3N2)OCC(F)(F)F,insoluble in H2O; ≥12.6 mg/mL in DMSO; ≥46.4 mg/mL in EtOH,Free Base,Membrane Transporter/Ion Channel,Proton Pump,Proton pump inhibitor,https://www.apexbt.com/search.php?catalog=B1725,1
985,B1726,Diacerein,13739-02-1,B08,L1021-12,368.29,DMSO,C19H12O8,CC(=O)OC1=CC=CC2=C1C(=O)C3=C(C=C(C=C3C2=O)C(=O)O)OC(=O)C,insoluble in EtOH; insoluble in H2O; ≥46.07 mg/mL in DMSO,,Others,IL Receptor,IL receptor inhibitor,https://www.apexbt.com/search.php?catalog=B1726,1
986,B1727,Dibenzothiophene,132-65-0,B09,L1021-12,184.26,DMSO,C12H8S,C1=CC=C2C(=C1)C3=CC=CC=C3S2,insoluble in EtOH; insoluble in H2O; ≥8.75 mg/mL in DMSO ,Free Base,Others,Others,Intermediate of organic synthesis,https://www.apexbt.com/search.php?catalog=B1727,1
987,B1728,Difluprednate,23674-86-4,B10,L1021-12,508.55,DMSO,C27H34F2O7,CCCC(=O)OC1(CCC2C1(CC(C3(C2CC(C4=CC(=O)C=CC43C)F)F)O)C)C(=O)COC(=O)C,insoluble in H2O; insoluble in EtOH; ≥138.6 mg/mL in DMSO,,Others,Others,Corticosteroid,https://www.apexbt.com/search.php?catalog=B1728,1
988,B1729,Diminazene Aceturate,908-54-3,B11,L1021-12,515.52,DMSO,C14H15N7·2C4H7NO3,CC(=O)NCC(=O)O.CC(=O)NCC(=O)O.C1=CC(=CC=C1C(=N)N)NN=NC2=CC=C(C=C2)C(=N)N,≥24.35 mg/mL in DMSO; insoluble in EtOH; ≥53.7 mg/mL in H2O,,Others,Others,,https://www.apexbt.com/search.php?catalog=B1729,1
989,B1730,Dinitolmide,148-01-6,C01,L1021-12,225.16,DMSO,C8H7N3O5,CC1=C(C=C(C=C1C(=O)N)[N+](=O)[O-])[N+](=O)[O-],≥45 mg/mL in DMSO; insoluble in EtOH; insoluble in H2O,,Microbiology,Anti-infection,broad-spectrum anticoccidial drug,https://www.apexbt.com/search.php?catalog=B1730,1
990,B1731,Dirithromycin,62013-04-1,C02,L1021-12,835.07,EtOH,C42H78N2O14,CCC1C(C2C(C(C(CC(C(C(C(C(C(=O)O1)C)OC3CC(C(C(O3)C)O)(C)OC)C)OC4C(C(CC(O4)C)N(C)C)O)(C)O)C)NC(O2)COCCOC)C)(C)O,≥40.5 mg/mL in EtOH; insoluble in H2O; ≥42.3 mg/mL in DMSO,Free Base,Microbiology & Virology,Anti-infection,Macrolide glycopeptide antibiotic,https://www.apexbt.com/search.php?catalog=B1731,1
991,B1733,Domiphen Bromide,538-71-6,C03,L1021-12,414.46,DMSO,C22H40NO·Br,CCCCCCCCCCCC[N+](C)(C)CCOC1=CC=CC=C1.[Br-],≥11.55 mg/mL in DMSO; ≥14.33 mg/mL in H2O with ultrasonic; ≥48.9 mg/mL in EtOH,Free Base,Others,Others,Quaternary ammonium antiseptic,https://www.apexbt.com/search.php?catalog=B1733,1
992,B1734,Doxofylline,69975-86-6,C04,L1021-12,266.25,DMSO,C11H14N4O4,CN1C2=C(C(=O)N(C1=O)C)N(C=N2)CC3OCCO3,insoluble in EtOH; ≥11.4 mg/mL in DMSO; ≥8.32 mg/mL in H2O with ultrasonic,Free Base,Metabolism,PDE,PDE inhibitor,https://www.apexbt.com/search.php?catalog=B1734,1
993,B1735,Doxylamine Succinate,562-10-7,C05,L1021-12,388.46,DMSO,C17H22N2O·C4H6O4,CC(C1=CC=CC=C1)(C2=CC=CC=N2)OCCN(C)C.C(CC(=O)O)C(=O)O,≥117 mg/mL in H2O; ≥14.2 mg/mL in DMSO; ≥46.6 mg/mL in EtOH,Succinate,Neuroscience,Histamine Receptor,Histamine receptor inhibitor,https://www.apexbt.com/search.php?catalog=B1735,1
994,B1736,Droperidol,548-73-2,C06,L1021-12,379.43,DMSO,C22H22FN3O2,C1CN(CC=C1N2C3=CC=CC=C3NC2=O)CCCC(=O)C4=CC=C(C=C4)F,insoluble in EtOH; insoluble in H2O; ≥18.97 mg/mL in DMSO,Free Base,Neuroscience,Dopamine Receptor,Dopamine-2 receptor antagonist,https://www.apexbt.com/search.php?catalog=B1736,1
995,B1737,Dropropizine,17692-31-8,C07,L1021-12,236.31,DMSO,C13H20N2O2,C1CN(CCN1CC(CO)O)C2=CC=CC=C2,≥10.3 mg/mL in DMSO; ≥11.7 mg/mL in H2O with ultrasonic; ≥24.9 mg/mL in EtOH,Free Base,Others,Others,Racemic non-opiate antitussive agent,https://www.apexbt.com/search.php?catalog=B1737,1
996,B1740,Ebastine,90729-43-4,C08,L1021-12,469.66,DMSO,C32H39NO2,CC(C)(C)C1=CC=C(C=C1)C(=O)CCCN2CCC(CC2)OC(C3=CC=CC=C3)C4=CC=CC=C4,insoluble in H2O; ≥16.6 mg/mL in EtOH; ≥8.8 mg/mL in DMSO with ultrasonic,Free Base,Neuroscience,Histamine Receptor,Histamine receptor antagonist,https://www.apexbt.com/search.php?catalog=B1740,1
997,B1741,Efaproxiral Sodium,170787-99-2,C09,L1021-12,363.38,DMSO,C20H23NO4·Na,CC1=CC(=CC(=C1)NC(=O)CC2=CC=C(C=C2)OC(C)(C)C(=O)[O-])C.[Na+],≥12.83 mg/mL in H2O with ultrasonic; ≥18.4 mg/mL in DMSO; ≥18.45 mg/mL in EtOH,,Others,Others,Synthetic allosteric modifier of hemoglobin,https://www.apexbt.com/search.php?catalog=B1741,1
998,B1742,Enrofloxacin,93106-60-6,C10,L1021-12,359.39,DMSO,C19H22FN3O3,CCN1CCN(CC1)C2=C(C=C3C(=C2)N(C=C(C3=O)C(=O)O)C4CC4)F,insoluble in H2O; ≥15 mg/mL in DMSO with gentle warming; ≥2.49 mg/mL in EtOH with gentle warming and ultrasonic,,Microbiology & Virology,Anti-infection,Fluoroquinolone antibiotic,https://www.apexbt.com/search.php?catalog=B1742,1